{"551c5105a50ea1d7d52d13424441d1788f67bc91": [["Middle East Respiratory Syndrome (MERS)Middle East respiratory syndrome (MERS) is a type of coronavirus first discovered in Saudi Arabia in 2012 [1, 2] .", [["Middle East Respiratory Syndrome", "DISEASE", 0, 32], ["Middle East respiratory syndrome", "DISEASE", 39, 71], ["MERS", "DISEASE", 73, 77], ["coronavirus", "DISEASE", 92, 103], ["Middle East Respiratory", "ORGANISM", 0, 23], ["coronavirus", "ORGANISM", 92, 103], ["Middle East Respiratory Syndrome (MERS)Middle East respiratory syndrome (MERS)", "SPECIES", 0, 78], ["Middle East Respiratory Syndrome", "PROBLEM", 0, 32], ["Middle East respiratory syndrome", "PROBLEM", 39, 71], ["coronavirus", "PROBLEM", 92, 103], ["Respiratory Syndrome", "OBSERVATION", 12, 32], ["Middle", "ANATOMY_MODIFIER", 39, 45], ["respiratory syndrome", "OBSERVATION", 51, 71]]], ["The virus causes a range of respiratory and gastrointestinal symptoms including fever, cough, shortness of breath, and diarrhea.", [["respiratory", "ANATOMY", 28, 39], ["gastrointestinal", "ANATOMY", 44, 60], ["respiratory and gastrointestinal symptoms", "DISEASE", 28, 69], ["fever", "DISEASE", 80, 85], ["cough", "DISEASE", 87, 92], ["shortness of breath", "DISEASE", 94, 113], ["diarrhea", "DISEASE", 119, 127], ["gastrointestinal", "ORGAN", 44, 60], ["The virus", "PROBLEM", 0, 9], ["respiratory and gastrointestinal symptoms", "PROBLEM", 28, 69], ["fever", "PROBLEM", 80, 85], ["cough", "PROBLEM", 87, 92], ["shortness of breath", "PROBLEM", 94, 113], ["diarrhea", "PROBLEM", 119, 127], ["virus", "OBSERVATION", 4, 9], ["range", "OBSERVATION_MODIFIER", 19, 24], ["gastrointestinal", "ANATOMY", 44, 60], ["diarrhea", "OBSERVATION", 119, 127]]], ["Infections may progress to pneumonia and organ failure leading to approximately 35% reported mortality rate [3] .Middle East Respiratory Syndrome (MERS)MERS in the region was previously attributed to local bats.", [["organ", "ANATOMY", 41, 46], ["Infections", "DISEASE", 0, 10], ["pneumonia", "DISEASE", 27, 36], ["organ failure", "DISEASE", 41, 54], ["Middle East Respiratory Syndrome", "DISEASE", 113, 145], ["organ", "ORGAN", 41, 46], ["Infections", "PROBLEM", 0, 10], ["pneumonia", "PROBLEM", 27, 36], ["organ failure", "PROBLEM", 41, 54], ["mortality rate", "TEST", 93, 107], ["Middle East Respiratory Syndrome", "PROBLEM", 113, 145], ["pneumonia", "OBSERVATION", 27, 36], ["organ", "ANATOMY", 41, 46], ["failure", "OBSERVATION", 47, 54], ["Respiratory Syndrome", "OBSERVATION", 125, 145], ["local bats", "OBSERVATION", 200, 210]]], ["Recent studies indicated that animal to human transmission is a cause, but with camels, instead of bats, as the most likely source [4] .", [["human", "ORGANISM", 40, 45], ["human", "SPECIES", 40, 45], ["human", "SPECIES", 40, 45], ["Recent studies", "TEST", 0, 14]]], ["Per an August 2017 Ministry of Health Report 4, the MERS coronavirus has infected a total of 1609 people with 685 fatalities in Saudi Arabia [5] .", [["coronavirus", "DISEASE", 57, 68], ["fatalities", "DISEASE", 114, 124], ["MERS coronavirus", "ORGANISM", 52, 68], ["people", "ORGANISM", 98, 104], ["people", "SPECIES", 98, 104], ["MERS coronavirus", "SPECIES", 52, 68], ["the MERS coronavirus", "PROBLEM", 48, 68]]], ["Chowell et al. conclude that a significant number of MERS cases are linked to healthcare settings, ranging from 43.5% for the outbreak in Jeddah, Saudi Arabia, in 2014, to 100% for the outbreaks in Al-Hasa, Saudi Arabia, in 2013 [6] .Transmission of Virus in HospitalsMERS, a droplet-transmitted virus, is primarily transmitted by contact with surfaces or patients already infected with the virus.", [["Virus", "ORGANISM", 250, 255], ["patients", "ORGANISM", 356, 364], ["patients", "SPECIES", 356, 364], ["Virus", "PROBLEM", 250, 255], ["a droplet-transmitted virus", "PROBLEM", 274, 301], ["the virus", "PROBLEM", 387, 396], ["significant", "OBSERVATION_MODIFIER", 31, 42], ["Virus", "OBSERVATION", 250, 255]]], ["Patients with MERS can present with mild and atypical symptoms, making it hard to identify the virus from the initial medical visit.", [["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["MERS", "PROBLEM", 14, 18], ["mild and atypical symptoms", "PROBLEM", 36, 62], ["the virus", "PROBLEM", 91, 100], ["mild", "OBSERVATION_MODIFIER", 36, 40], ["atypical", "OBSERVATION_MODIFIER", 45, 53]]], ["Healthcare workers, in order to protect themselves and other patients, should practice standard precautions, including hand-washing hygiene before and after patient contact, use of personal protective equipment, adequate sterilization of patient care equipment before subsequent use, and respiratory etiquette (giving masks to patients with coughs and encouraging patients to appropriately cover their mouths) [7] .Transmission of Virus in HospitalsThe World Health Organization proclaimed hand hygiene to be the major component of standard precaution and one of the most effective methods to prevent transmission of pathogens.", [["hand", "ANATOMY", 119, 123], ["hand", "ANATOMY", 490, 494], ["coughs", "DISEASE", 341, 347], ["patients", "ORGANISM", 61, 69], ["patient", "ORGANISM", 157, 164], ["patient", "ORGANISM", 238, 245], ["patients", "ORGANISM", 327, 335], ["patients", "ORGANISM", 364, 372], ["Virus", "ORGANISM", 431, 436], ["hand", "ORGANISM_SUBDIVISION", 490, 494], ["patients", "SPECIES", 61, 69], ["patient", "SPECIES", 157, 164], ["patient", "SPECIES", 238, 245], ["patients", "SPECIES", 327, 335], ["patients", "SPECIES", 364, 372], ["practice standard precautions", "TREATMENT", 78, 107], ["personal protective equipment", "TREATMENT", 181, 210], ["adequate sterilization of patient care equipment", "TREATMENT", 212, 260], ["respiratory etiquette (giving masks", "TREATMENT", 288, 323], ["coughs", "PROBLEM", 341, 347], ["Virus", "PROBLEM", 431, 436], ["standard precaution", "TREATMENT", 532, 551], ["pathogens", "PROBLEM", 617, 626], ["Virus", "OBSERVATION", 431, 436], ["pathogens", "OBSERVATION", 617, 626]]], ["Specifically, hand hygiene practice refers to washing hands with plain soap and water, using water alone, or rubbing hands with an alcohol-based solution [8] .", [["hand", "ANATOMY", 14, 18], ["alcohol", "CHEMICAL", 131, 138], ["alcohol", "CHEMICAL", 131, 138], ["hand", "ORGANISM_SUBDIVISION", 14, 18], ["alcohol", "SIMPLE_CHEMICAL", 131, 138]]], ["The MERS outbreak in Saudi Arabia raised questions about the potential exposure to the virus, as well as the hygiene protocols followed by healthcare workers.", [["the virus", "PROBLEM", 83, 92], ["the hygiene protocols", "TREATMENT", 105, 126]]], ["Numerous researchers concur that effective hand hygiene practices could significantly limit the transmission of MERS and other emerging viruses in endemic regions [2, 7, 9] .", [["hand", "ANATOMY", 43, 47], ["MERS", "DISEASE", 112, 116], ["hand", "ORGANISM_SUBDIVISION", 43, 47]]], ["In Western medical practice, patients enter a waiting room and check in at the reception.", [["patients", "ORGANISM", 29, 37], ["patients", "SPECIES", 29, 37]]], ["Healthcare providers usually use either hand sanitizer or wash hands when entering the room with a new patient.", [["hand", "ANATOMY", 40, 44], ["hand", "ORGANISM_SUBDIVISION", 40, 44], ["patient", "ORGANISM", 103, 110], ["patient", "SPECIES", 103, 110]]], ["In Saudi Arabia, a doctor is assigned a stationary examination room where he/she waits at a desk and successive patients enter the room.", [["patients", "ORGANISM", 112, 120], ["patients", "SPECIES", 112, 120]]], ["The physician may not move and lacks the physical prompt to implement hand hygiene practices between patients.", [["hand", "ANATOMY", 70, 74], ["hand", "ORGANISM_SUBDIVISION", 70, 74], ["patients", "ORGANISM", 101, 109], ["patients", "SPECIES", 101, 109]]], ["Additionally, a few studies have examined a combination of questionnaires and observations [14, 15] .", [["a few studies", "TEST", 14, 27]]], ["The current research investigates the differences noted between healthcare workers' self-reports of hand hygiene practices and researcher observations of actual hand hygiene behavior.Materials and MethodsQuantitative data was collected using a dichotomous scale, with questionnaire data utilizing a five-level Likert scale [16] to measure each participant's hand hygiene reports and behavior.SettingThe study took place in three types of hospitals, i.e., public, security forces, and private, in Eastern Saudi Arabia, with approval of the study design and instruments granted by the University of Arizona Institutional Review Board (UA-IRB) as well as approvals obtained from each hospital, including the general directory of health affairs in Eastern Saudi Arabia.", [["hand", "ANATOMY", 100, 104], ["hand", "ANATOMY", 161, 165], ["hand", "ANATOMY", 358, 362], ["hand", "ORGANISM_SUBDIVISION", 100, 104], ["hand", "ORGANISM_SUBDIVISION", 161, 165], ["hand", "ORGANISM_SUBDIVISION", 358, 362], ["participant", "SPECIES", 344, 355], ["hand hygiene practices", "TREATMENT", 100, 122], ["MethodsQuantitative data", "TEST", 197, 221], ["a dichotomous scale", "TREATMENT", 242, 261], ["questionnaire data", "TEST", 268, 286], ["a five-level Likert scale", "TREATMENT", 297, 322], ["The study", "TEST", 399, 408], ["the study", "TEST", 535, 544]]], ["Each hospital had specific characteristics as follows.Public HospitalThis hospital is one of the main public hospitals in the region, with a capacity of 500 beds.", [["main", "OBSERVATION_MODIFIER", 97, 101], ["region", "ANATOMY_MODIFIER", 126, 132]]], ["The facility has several other outpatient clinics, such as dermatologic, internal medicine, and orthopedics, and committees established to address infection control and organ transplants.Security Forces HospitalThis hospital serves security force personnel and their families.", [["organ", "ANATOMY", 169, 174], ["infection", "DISEASE", 147, 156], ["organ", "ORGAN", 169, 174], ["infection control", "TREATMENT", 147, 164], ["organ transplants", "TREATMENT", 169, 186], ["infection", "OBSERVATION", 147, 156]]], ["It has 132 beds and some outpatient clinics and other departments created to manage infection and environmental controls.Private ClinicThis clinic serves people who have insurance or pay for services out-of-pocket.", [["infection", "DISEASE", 84, 93], ["people", "ORGANISM", 154, 160], ["people", "SPECIES", 154, 160], ["infection", "PROBLEM", 84, 93], ["infection", "OBSERVATION", 84, 93]]], ["Also, at the time of this study, it operated a 24-h emergency room in addition to its treatment room.Participant RecruitmentNurses and medical doctors were recruited from the outpatient and emergency room departments of each of the three hospital types.", [["Participant", "SPECIES", 101, 112], ["this study", "TEST", 21, 31]]], ["During a weeklong visit at each setting, the premise of the study was explained to all healthcare workers, and participant permission was obtained to observe hand hygiene practices and to administer the self-report questionnaires.", [["hand", "ANATOMY", 158, 162], ["hand", "ORGANISM_SUBDIVISION", 158, 162], ["the study", "TEST", 56, 65]]], ["At the Security Forces hospital, infection control personnel assisted in providing access to healthcare workers on duty.", [["infection", "DISEASE", 33, 42], ["infection control personnel", "TREATMENT", 33, 60]]], ["Ultimately, 87 participants (46 medical doctors, 21 from the public hospital, 9 from the private clinic, and 16 from the Security Forces; and 41 nurses, 14 from the public hospital, 9 from the private clinic, and 18 from the security forces hospital) were recruited.", [["participants", "SPECIES", 15, 27]]], ["Of the 87 participants who completed the questionnaire, 83 participants were observed during exams with at least three patients and hand hygiene practices were recorded using the checklist.", [["hand", "ANATOMY", 132, 136], ["participants", "ORGANISM", 10, 22], ["participants", "ORGANISM", 59, 71], ["patients", "ORGANISM", 119, 127], ["hand", "ORGANISM_SUBDIVISION", 132, 136], ["participants", "SPECIES", 10, 22], ["participants", "SPECIES", 59, 71], ["patients", "SPECIES", 119, 127], ["exams", "TEST", 93, 98]]], ["No data were collected regarding patient behaviors, characteristics, reason for hospital visit, or diagnosis.", [["patient", "ORGANISM", 33, 40], ["patient", "SPECIES", 33, 40]]], ["Hand hygiene practices of healthcare workers (i.e., physicians and nurses) were evaluated before, during, and after interactions with patients, devices, and/or surrounding surfaces in each of the three Saudi Arabian hospitals.Data CollectionTwo instruments were utilized for this study, an Observation Checklist and Self-report Questionnaire.Observation ChecklistDirect observations of healthcare workers' hand hygiene practices were conducted during work hours using a questionnaire, which contained 16 items, and was developed by the primary researcher's application of the following three sources: CDC standards [17] , WHO's Five Moments for Hand Hygiene in Health Care [18] , and Boyce and Pittet's (2002) guidelines [19] .", [["hand", "ANATOMY", 406, 410], ["patients", "ORGANISM", 134, 142], ["hand", "ORGANISM_SUBDIVISION", 406, 410], ["patients", "SPECIES", 134, 142], ["devices", "TREATMENT", 144, 151], ["Data Collection", "TEST", 226, 241], ["this study", "TEST", 275, 285]]], ["Items were grouped into three patient-related time-dependent categories: (a) contact with a patient prior to entrance into an examination room (Before), (b) contact during the exam (During), and (c) contact with a patient upon exit from an examination room (After).Self-Report QuestionnaireFor the self-assessments, the questionnaire was reworded with the same 16 items from the observation sheet, making the statements active with a five-point Likert scale (i.e., 'Never', 'Rarely', 'Every once in a while', 'Sometimes', and 'Always') to allow healthcare workers to report their perceptions about their own hand hygiene practices after each scheduled observation in this study.Person CorrelationPearson correlation was used to examine data by the questionnaire regarding healthcare workers' beliefs about hand hygiene practices obtained and their actual observed behavior of hand hygiene practices.", [["hand", "ANATOMY", 608, 612], ["hand", "ANATOMY", 806, 810], ["hand", "ANATOMY", 876, 880], ["patient", "ORGANISM", 30, 37], ["patient", "ORGANISM", 92, 99], ["patient", "ORGANISM", 214, 221], ["hand", "ORGANISM_SUBDIVISION", 608, 612], ["hand", "ORGANISM_SUBDIVISION", 806, 810], ["hand", "ORGANISM_SUBDIVISION", 876, 880], ["patient", "SPECIES", 30, 37], ["patient", "SPECIES", 92, 99], ["patient", "SPECIES", 214, 221], ["the exam", "TEST", 172, 180], ["an examination", "TEST", 237, 251], ["the self-assessments", "TEST", 294, 314], ["this study", "TEST", 667, 677], ["hand hygiene practices", "TREATMENT", 806, 828]]], ["Data lacking both self-assessment and observations were excluded when testing the primary hypothesis, as a result, only data from the healthcare workers who were actually observed by the researcher and who had questionnaires completed were analyzed.t-testTwo independent sample t-tests were used to examine differences between hand hygiene practices among healthcare workers, two hospital types, and gender.", [["hand", "ANATOMY", 327, 331], ["hand", "ORGANISM_SUBDIVISION", 327, 331], ["Two independent sample t-tests", "TEST", 255, 285]]], ["A multivariate analysis of covariance (MANCOVA) was used to further assess the relationship.", [["A multivariate analysis", "TEST", 0, 23], ["covariance (MANCOVA)", "TREATMENT", 27, 47]]], ["The practice of hand hygiene measured under three conditions (before, during, and after) was the dependent variable.", [["hand", "ANATOMY", 16, 20], ["hand", "ORGANISM_SUBDIVISION", 16, 20], ["hand hygiene", "TREATMENT", 16, 28]]], ["Statistical analysis controlled for department (emergency rooms or outpatient department), hospital type (public, private, or security forces), and gender (male and female) of the care provider.ResultsSixty-four (53/83) percent of the observed participants completed the questionnaire, four completed the questionnaire without being observed.", [["participants", "ORGANISM", 244, 256], ["participants", "SPECIES", 244, 256], ["Statistical analysis", "TEST", 0, 20]]], ["The participants selected for the study are summarized in Table 1 .Descriptive StatisticsAn overview of the data in descriptive statistics for selective variables is presented.", [["participants", "SPECIES", 4, 16], ["the study", "TEST", 30, 39]]], ["Table 2 (observations) and Table 3 (self-reports) include minimum scores, maximum scores, means, and standard deviations of all variables, based on the observation and questionnaire data.", [["the observation", "TEST", 148, 163], ["questionnaire data", "TEST", 168, 186]]], ["The figures also indicate the percentage of observed hand hygiene compliance for physicians (27%) and nurses (29%) among the three time frames.", [["hand", "ANATOMY", 53, 57], ["hand", "ORGANISM_SUBDIVISION", 53, 57]]], ["In general, hand hygiene compliance scores before contacting patients among all variables were lower than compliance scores during and after contact with patients.", [["hand", "ANATOMY", 12, 16], ["hand", "ORGANISM_SUBDIVISION", 12, 16], ["patients", "ORGANISM", 61, 69], ["patients", "ORGANISM", 154, 162], ["patients", "SPECIES", 61, 69], ["patients", "SPECIES", 154, 162]]], ["Moreover, compliance scores during and after contact with patients were comparable to each other, except for the mean compliance score observed in the private clinic.", [["patients", "ORGANISM", 58, 66], ["patients", "SPECIES", 58, 66]]], ["In addition, the mean scores derived from the self-report questionnaire data were compared across conditions of patient contact.", [["patient", "ORGANISM", 112, 119], ["patient", "SPECIES", 112, 119], ["the mean scores", "TEST", 13, 28]]], ["Based on the questionnaire data, all healthcare workers generally believed that they were compliant with hand hygiene procedures.", [["hand", "ANATOMY", 105, 109], ["hand", "ORGANISM_SUBDIVISION", 105, 109], ["hand hygiene procedures", "TREATMENT", 105, 128]]], ["Figures 1 and 2 show that physicians appear to be more self-aware about their hand hygiene practices than nurses.Person CorrelationThe results of the Pearson correlation indicated that the healthcare workers' beliefs of hygiene practices and the healthcare workers' actual behaviors did not correlate, ranging from r = \u22120.01 to r = \u22120.20.DiscussionThe results of this study are robust and relevant to clinical practice in general and specifically in Saudi Arabia.", [["hand", "ANATOMY", 78, 82], ["hand", "ORGANISM_SUBDIVISION", 78, 82], ["hygiene practices", "TREATMENT", 220, 237], ["this study", "TEST", 363, 373]]], ["First, the study design employed two observation methods (i.e., direct observation and self-report questionnaires).", [["the study", "TEST", 7, 16]]], ["Second, conduct of this study increased the awareness of hand hygiene issues in healthcare settings in Saudi Arabia.", [["hand", "ANATOMY", 57, 61], ["hand", "ORGANISM_SUBDIVISION", 57, 61], ["this study", "TEST", 19, 29]]], ["Third, this study evaluated compliance with hospital hand hygiene policy in multiple types of Saudi Arabian hospitals in Eastern Saudi Arabia and considered the role played by healthcare settings and practice differences, since doctors tend to stay in a single office and patients rotate through each doctor's office.DiscussionThe study had three main findings.", [["hand", "ANATOMY", 53, 57], ["hand", "ORGANISM_SUBDIVISION", 53, 57], ["patients", "ORGANISM", 272, 280], ["patients", "SPECIES", 272, 280], ["this study", "TEST", 7, 17], ["The study", "TEST", 327, 336]]], ["First, hand hygiene compliance was considered low among healthcare workers in Saudi Arabia for physicians (27%) and nurses (29%), with no statistical difference observed between the two.", [["hand", "ANATOMY", 7, 11], ["hand", "ORGANISM_SUBDIVISION", 7, 11], ["statistical difference", "PROBLEM", 138, 160]]], ["This finding is consistent with the literature.", [["consistent with", "UNCERTAINTY", 16, 31]]], ["According to Caglar et.al [14] , an extensive literature review about hand hygiene practices among healthcare workers indicated that only 12.9% to 56% were compliant.", [["hand", "ANATOMY", 70, 74], ["hand", "ORGANISM_SUBDIVISION", 70, 74]]], ["For the self-report questionnaires, nurses reported higher hand hygiene compliance than physicians.", [["hand", "ANATOMY", 59, 63], ["hand", "ORGANISM_SUBDIVISION", 59, 63]]], ["Similarly, Harris et al. [20] found that non-physicians reported a higher compliance with hand hygiene when compared to physicians.", [["hand", "ANATOMY", 90, 94], ["hand", "ORGANISM_SUBDIVISION", 90, 94]]], ["This element of the data implied that the healthcare workers believed themselves to be more compliant with hand hygiene procedures than they actually were.", [["hand", "ANATOMY", 107, 111], ["hand", "ORGANISM_SUBDIVISION", 107, 111], ["hand hygiene procedures", "TREATMENT", 107, 130]]], ["A possible explanation for this discrepancy could be ignorance of hand hygiene protocols or failure to be aware of their own hand hygiene behavior.DiscussionWhen comparing the results from data collected in the public hospital to the data from the security forces hospital, no statistical differences existed.", [["hand", "ANATOMY", 66, 70], ["hand", "ANATOMY", 125, 129], ["hand", "ORGANISM_SUBDIVISION", 66, 70], ["hand", "ORGANISM_SUBDIVISION", 125, 129], ["this discrepancy", "PROBLEM", 27, 43], ["hand hygiene protocols", "TREATMENT", 66, 88], ["failure", "PROBLEM", 92, 99], ["possible explanation for", "UNCERTAINTY", 2, 26]]], ["This is of note because the public hospital had a dedicated MERS hand hygiene intervention campaign, while the security forces hospital only had an annual seminar regarding hand hygiene procedures.", [["hand", "ANATOMY", 65, 69], ["hand", "ANATOMY", 173, 177], ["hand", "ORGANISM_SUBDIVISION", 173, 177], ["hand hygiene procedures", "TREATMENT", 173, 196]]], ["This suggests that the campaign to increase hand hygiene in the public hospital needs to be rethought with a different implementation strategy.", [["hand", "ANATOMY", 44, 48], ["hand", "ORGANISM_SUBDIVISION", 44, 48], ["a different implementation strategy", "TREATMENT", 107, 142]]], ["Antoniak's findings supported this idea that changes in hand hygiene behavior were not sustained beyond the period of educational intervention, demonstrating that education is not significantly effective [21] .", [["hand", "ANATOMY", 56, 60], ["hand", "ORGANISM_SUBDIVISION", 56, 60], ["changes in hand hygiene behavior", "PROBLEM", 45, 77], ["educational intervention", "TREATMENT", 118, 142]]], ["Results from the private clinic showed the lowest compliance rates, possibly due to absence of hygiene practice materials and resources, like alcohol-based hand sanitizers in the examination rooms.DiscussionIn this study, a single person was assigned to observe the hand hygiene practices of each healthcare worker.", [["hand", "ANATOMY", 156, 160], ["hand", "ANATOMY", 266, 270], ["alcohol", "CHEMICAL", 142, 149], ["alcohol", "CHEMICAL", 142, 149], ["alcohol", "SIMPLE_CHEMICAL", 142, 149], ["hand", "ORGANISM_SUBDIVISION", 156, 160], ["hand", "ORGANISM_SUBDIVISION", 266, 270], ["person", "SPECIES", 231, 237], ["hygiene practice materials", "TREATMENT", 95, 121], ["this study", "TEST", 210, 220]]], ["While the design used in this study minimized inconsistencies among observations, it was difficult for just one observer to fully measure the proper protocol of hand hygiene (i.e., duration and technique).", [["hand", "ANATOMY", 161, 165], ["hand", "ORGANISM_SUBDIVISION", 161, 165], ["this study", "TEST", 25, 35]]], ["Future researchers could use either video recordings or two or more observers to collect a more accurate representation of the behaviors of each participant.", [["video recordings", "TEST", 36, 52]]], ["The premise of the study was explained fully to the study participants prior to observation sessions.", [["participants", "SPECIES", 58, 70], ["the study", "TEST", 15, 24], ["the study", "TEST", 48, 57], ["observation sessions", "TEST", 80, 100]]], ["This prior knowledge could have added bias to the study results by increasing rates of compliance.", [["the study", "TEST", 46, 55]]], ["However, the results indicated very low hand hygiene compliance rates.", [["hand", "ANATOMY", 40, 44], ["hand", "ORGANISM_SUBDIVISION", 40, 44]]], ["This could signify that either the participants actually performed their usual practices with patient exams or that though they tried to comply due to the observer in the room they were unsuccessful because they had not had proper training.", [["patient", "ORGANISM", 94, 101], ["participants", "SPECIES", 35, 47], ["patient", "SPECIES", 94, 101], ["patient exams", "TEST", 94, 107]]], ["Neither of these explanations would be conclusive unless future studies of the participants' hand hygiene knowledge are conducted.DiscussionScientific research has proven that hand hygiene is an important tool and the most effective way to prevent the spread of infectious diseases [11] .", [["hand", "ANATOMY", 93, 97], ["hand", "ANATOMY", 176, 180], ["infectious diseases", "DISEASE", 262, 281], ["hand", "ORGANISM_SUBDIVISION", 93, 97], ["hand", "ORGANISM_SUBDIVISION", 176, 180], ["participants", "SPECIES", 79, 91], ["infectious diseases", "PROBLEM", 262, 281]]], ["Unfortunately, prior to this study, hand hygiene practices in Saudi hospitals had not been investigated and no published articles were found.", [["hand", "ANATOMY", 36, 40], ["hand", "ORGANISM_SUBDIVISION", 36, 40], ["this study", "TEST", 24, 34]]], ["Throughout the study, the primary researcher observed many unexpected behaviors that infection control personnel at all hospitals should note and address.", [["infection", "DISEASE", 85, 94], ["the study", "TEST", 11, 20], ["infection", "OBSERVATION", 85, 94]]], ["For example, in one observation, a healthcare worker washed her hands, then used a tissue to close the water handle, and then used the same tissue to clean nearby surfaces.", [["tissue", "ANATOMY", 83, 89], ["tissue", "ANATOMY", 140, 146], ["tissue", "TISSUE", 83, 89], ["tissue", "TISSUE", 140, 146]]], ["On other observations, a few healthcare workers were observed not implementing proper alcohol application protocol, by using a tissue to dry excess alcohol on their hands.", [["tissue", "ANATOMY", 127, 133], ["alcohol", "CHEMICAL", 86, 93], ["alcohol", "CHEMICAL", 148, 155], ["alcohol", "CHEMICAL", 86, 93], ["alcohol", "CHEMICAL", 148, 155], ["alcohol", "SIMPLE_CHEMICAL", 86, 93], ["tissue", "TISSUE", 127, 133], ["alcohol", "SIMPLE_CHEMICAL", 148, 155], ["hands", "ORGANISM_SUBDIVISION", 165, 170]]], ["In other cases, some healthcare workers used alcohol wipes to clean their hands, not after hand-washing, as deemed in the proper protocol, clearly contributing to the lack of hand hygiene compliance.", [["hand", "ANATOMY", 91, 95], ["hand", "ANATOMY", 175, 179], ["alcohol", "CHEMICAL", 45, 52], ["alcohol", "CHEMICAL", 45, 52], ["hand", "ORGANISM_SUBDIVISION", 175, 179], ["hand-washing", "TREATMENT", 91, 103], ["hands", "ANATOMY", 74, 79]]], ["These behaviors should be further documented and referenced in order to improve the education of healthcare workers in the practice of proper hand hygiene.ConclusionsIn summary, no statistically significant correlations were found between healthcare workers' reports of hand hygiene practices and the observed behaviors of hand hygiene practices.", [["hand", "ANATOMY", 142, 146], ["hand", "ANATOMY", 270, 274], ["hand", "ANATOMY", 323, 327], ["hand", "ORGANISM_SUBDIVISION", 142, 146], ["hand", "ORGANISM_SUBDIVISION", 270, 274], ["hand", "ORGANISM_SUBDIVISION", 323, 327], ["hand hygiene practices", "TREATMENT", 270, 292]]], ["Additionally, there were no statistically significant differences among the two types of healthcare workers (i.e., nurses and physicians) when observed.", [["no", "UNCERTAINTY", 25, 27], ["statistically", "OBSERVATION_MODIFIER", 28, 41], ["significant", "OBSERVATION_MODIFIER", 42, 53]]], ["However, there were statistically significant differences when comparing the self-reported questionnaire data to observations of physicians' and nurses' hand hygiene practices.", [["hand", "ANATOMY", 153, 157], ["hand", "ORGANISM_SUBDIVISION", 153, 157], ["statistically", "OBSERVATION_MODIFIER", 20, 33], ["significant", "OBSERVATION_MODIFIER", 34, 45]]], ["These results demonstrate that healthcare workers likely understand the importance of hand hygiene, but in practice fail to implement appropriate hand hygiene in routine activities.ConclusionsFuture research should utilize surrogate viral tracers to appropriately track virus transmission and portability in healthcare environments in Saudi Arabia.", [["hand", "ANATOMY", 86, 90], ["hand", "ANATOMY", 146, 150], ["hand", "ORGANISM_SUBDIVISION", 86, 90], ["hand", "ORGANISM_SUBDIVISION", 146, 150], ["surrogate viral tracers", "TREATMENT", 223, 246]]], ["This is crucial for public health researchers to fully understand exposure probabilities and infection risks as well as the role of hand hygiene in the reduction of infection in order to create more focused and effective interventions.", [["hand", "ANATOMY", 132, 136], ["infection", "DISEASE", 93, 102], ["infection", "DISEASE", 165, 174], ["hand", "ORGANISM_SUBDIVISION", 132, 136], ["infection risks", "PROBLEM", 93, 108], ["hand hygiene", "TREATMENT", 132, 144], ["infection", "PROBLEM", 165, 174], ["effective interventions", "TREATMENT", 211, 234], ["infection", "OBSERVATION", 165, 174]]], ["Additionally, the significant differences between physicians' and nurses' self-reports regarding hand hygiene compliance suggest further targeted inquiry and experimental research is needed to fully explore these large discrepancies.", [["hand", "ANATOMY", 97, 101], ["hand", "ORGANISM_SUBDIVISION", 97, 101], ["hand hygiene compliance", "TREATMENT", 97, 120], ["these large discrepancies", "PROBLEM", 207, 232], ["significant", "OBSERVATION_MODIFIER", 18, 29], ["differences", "OBSERVATION_MODIFIER", 30, 41]]]], "PMC7223000": [["BackgroundRecently, the overweight and obesity in children\u2019s prevalence are steadily increasing worldwide.", [["overweight", "DISEASE", 24, 34], ["obesity", "DISEASE", 39, 46], ["children", "ORGANISM", 50, 58], ["children", "SPECIES", 50, 58], ["obesity", "PROBLEM", 39, 46], ["obesity", "OBSERVATION", 39, 46], ["steadily", "OBSERVATION_MODIFIER", 76, 84], ["increasing", "OBSERVATION_MODIFIER", 85, 95]]], ["The World Health Organization has outlined obesity as \u201ca world epidemic disease\u201d [1].", [["obesity", "DISEASE", 43, 50], ["outlined obesity", "PROBLEM", 34, 50], ["obesity", "OBSERVATION", 43, 50]]], ["Childhood obesity is related to multiple serious health problems and an enhanced risk of premature onset of diseases, including diabetes and heart disease [2].", [["heart", "ANATOMY", 141, 146], ["obesity", "DISEASE", 10, 17], ["diabetes", "DISEASE", 128, 136], ["heart disease", "DISEASE", 141, 154], ["heart", "ORGAN", 141, 146], ["Childhood obesity", "PROBLEM", 0, 17], ["multiple serious health problems", "PROBLEM", 32, 64], ["premature onset of diseases", "PROBLEM", 89, 116], ["diabetes", "PROBLEM", 128, 136], ["heart disease", "PROBLEM", 141, 154], ["obesity", "OBSERVATION", 10, 17], ["multiple", "OBSERVATION_MODIFIER", 32, 40], ["serious", "OBSERVATION_MODIFIER", 41, 48], ["premature", "OBSERVATION_MODIFIER", 89, 98], ["diseases", "OBSERVATION", 108, 116], ["heart", "ANATOMY", 141, 146], ["disease", "OBSERVATION", 147, 154]]], ["Skeletal maturity is used to measure the development depending on bone size, shape, and degree of its mineralization to determine its closeness to full maturation [3].", [["Skeletal", "ANATOMY", 0, 8], ["bone", "ANATOMY", 66, 70], ["Skeletal", "ORGAN", 0, 8], ["bone", "TISSUE", 66, 70], ["Skeletal maturity", "PROBLEM", 0, 17], ["its mineralization", "PROBLEM", 98, 116], ["maturity", "OBSERVATION", 9, 17], ["bone", "ANATOMY", 66, 70], ["size", "OBSERVATION_MODIFIER", 71, 75], ["shape", "OBSERVATION_MODIFIER", 77, 82], ["degree", "OBSERVATION_MODIFIER", 88, 94], ["mineralization", "OBSERVATION", 102, 116]]], ["In general, females have advanced bone age compared to boys.", [["bone", "ANATOMY", 34, 38], ["bone", "TISSUE", 34, 38], ["boys", "SPECIES", 55, 59]]], ["The distinction is present at birth and persists along the growth period; however, it is more noticeable after the beginning of puberty [4].BackgroundThe hand and wrist radiographs are appropriate for assessment of the bone age because it is simple, and it possesses several bones.", [["hand", "ANATOMY", 154, 158], ["wrist", "ANATOMY", 163, 168], ["bone", "ANATOMY", 219, 223], ["bones", "ANATOMY", 275, 280], ["hand", "ORGANISM_SUBDIVISION", 154, 158], ["wrist", "ORGANISM_SUBDIVISION", 163, 168], ["bone", "TISSUE", 219, 223], ["bones", "TISSUE", 275, 280], ["The hand and wrist radiographs", "TEST", 150, 180], ["assessment", "TEST", 201, 211], ["growth", "OBSERVATION_MODIFIER", 59, 65], ["hand", "ANATOMY", 154, 158], ["wrist", "ANATOMY", 163, 168], ["bone", "ANATOMY", 219, 223], ["simple", "OBSERVATION_MODIFIER", 242, 248], ["several", "OBSERVATION_MODIFIER", 267, 274], ["bones", "ANATOMY", 275, 280]]], ["The radiographs are performed in chronologic steps up to 19 years in boys and 18 years in girls.", [["boys", "SPECIES", 69, 73], ["girls", "SPECIES", 90, 95], ["The radiographs", "TEST", 0, 15]]], ["The simplicity and speed with which a skeletal age can be assigned have created this atlas the foremost ordinarily used customary used of reference for skeletal maturation worldwide [3].", [["skeletal", "ANATOMY", 38, 46], ["skeletal", "ANATOMY", 152, 160], ["skeletal", "ORGAN", 38, 46], ["skeletal", "ORGAN", 152, 160]]], ["Bone age (BA) is compared with the chronological age (CA).", [["Bone", "ANATOMY", 0, 4], ["Bone", "TISSUE", 0, 4]]], ["A distinction between these two values indicates abnormalities in skeletal development.", [["skeletal", "ANATOMY", 66, 74], ["skeletal", "ORGAN", 66, 74], ["these two values", "TEST", 22, 38], ["abnormalities in skeletal development", "PROBLEM", 49, 86], ["abnormalities", "OBSERVATION", 49, 62], ["skeletal", "ANATOMY", 66, 74]]], ["It is usually utilized in the diagnosis and management of endocrine disorders, and it may serve as a sign of the therapeutic result of treatment [4].BackgroundPrevious studies showed contradictory results concerning the relation of skeletal maturation to obesity [5].", [["endocrine", "ANATOMY", 58, 67], ["skeletal", "ANATOMY", 232, 240], ["endocrine disorders", "DISEASE", 58, 77], ["obesity", "DISEASE", 255, 262], ["endocrine", "ANATOMICAL_SYSTEM", 58, 67], ["skeletal", "ORGAN", 232, 240], ["endocrine disorders", "PROBLEM", 58, 77], ["BackgroundPrevious studies", "TEST", 149, 175], ["skeletal maturation", "PROBLEM", 232, 251], ["obesity", "PROBLEM", 255, 262], ["skeletal", "ANATOMY", 232, 240]]], ["The sole body measurement that directly calculates the relative composition of the body and presents a measure of fitness level, regardless of the height or weight, is body fat percentage (BF%).", [["body", "ANATOMY", 9, 13], ["body", "ANATOMY", 83, 87], ["body fat", "ANATOMY", 168, 176], ["body", "ORGANISM_SUBDIVISION", 9, 13], ["body", "ORGANISM_SUBDIVISION", 83, 87], ["body fat", "TISSUE", 168, 176], ["The sole body measurement", "TEST", 0, 25], ["sole body", "ANATOMY_MODIFIER", 4, 13], ["relative", "OBSERVATION_MODIFIER", 55, 63], ["composition", "OBSERVATION_MODIFIER", 64, 75], ["body", "ANATOMY", 83, 87]]], ["Wide application of body mass index (BMI) affords a measure that permits a comparison with the overweight subjects of various heights and weights [6].", [["body", "ANATOMY", 20, 24], ["overweight", "DISEASE", 95, 105], ["body", "ORGANISM_SUBDIVISION", 20, 24], ["body mass index", "PROBLEM", 20, 35], ["body", "OBSERVATION_MODIFIER", 20, 24], ["mass", "OBSERVATION", 25, 29]]], ["The level of body fat can affect the neuroendocrine events that are responsible for the onset of premature puberty, despite low levels of the growth hormone.", [["body fat", "ANATOMY", 13, 21], ["neuroendocrine", "ANATOMY", 37, 51], ["premature puberty", "DISEASE", 97, 114], ["body fat", "TISSUE", 13, 21], ["neuroendocrine", "ANATOMICAL_SYSTEM", 37, 51], ["the neuroendocrine events", "PROBLEM", 33, 58], ["premature puberty", "PROBLEM", 97, 114], ["low levels of the growth hormone", "PROBLEM", 124, 156], ["body fat", "ANATOMY", 13, 21]]], ["More specific, leptin is the key hormone concerned in this method [7].", [["leptin", "GENE_OR_GENE_PRODUCT", 15, 21], ["leptin", "PROTEIN", 15, 21]]], ["Knowledge of skeletal development is important as the patient\u2019s response to the treatment will be more effective if skeletal development has not yet reached its end.", [["skeletal", "ANATOMY", 13, 21], ["skeletal", "ANATOMY", 116, 124], ["skeletal", "ORGAN", 13, 21], ["patient", "ORGANISM", 54, 61], ["skeletal", "ORGAN", 116, 124], ["patient", "SPECIES", 54, 61], ["the treatment", "TREATMENT", 76, 89], ["skeletal", "ANATOMY", 13, 21]]], ["Moreover, dentofacial and orthopedic treatment performed after the growth phase is not effective in improving skeletal discrepancies.", [["skeletal", "ANATOMY", 110, 118], ["skeletal", "ORGAN", 110, 118], ["dentofacial and orthopedic treatment", "TREATMENT", 10, 46], ["the growth phase", "TEST", 63, 79], ["dentofacial", "ANATOMY", 10, 21], ["skeletal", "ANATOMY", 110, 118], ["discrepancies", "OBSERVATION", 119, 132]]], ["So it is important to assess skeletal maturity in growing patients to determine the best timing for orthopedic and orthodontic treatment around the growth spurt [8].Statistical analysis ::: MethodsThe data were analysed using the S-plus Statistics Software (SPSS version 21).", [["skeletal", "ANATOMY", 29, 37], ["skeletal", "TISSUE", 29, 37], ["patients", "ORGANISM", 58, 66], ["patients", "SPECIES", 58, 66], ["skeletal maturity", "PROBLEM", 29, 46], ["orthopedic and orthodontic treatment", "TREATMENT", 100, 136], ["Methods", "TREATMENT", 190, 197], ["The data", "TEST", 197, 205], ["SPSS version", "TEST", 258, 270], ["skeletal", "ANATOMY", 29, 37]]], ["Statistical analysis was performed by comparing each independent variable between case and control group using the independent t test, as applicable for quantitative variables and Pearson\u2019s chi-square test for qualitative variables.", [["Statistical analysis", "TEST", 0, 20], ["the independent t test", "TEST", 111, 133], ["chi-square test", "TEST", 190, 205], ["qualitative variables", "PROBLEM", 210, 231]]], ["Two-tailed P values of less than 0.05 were considered to be significant.", [["Two-tailed P values", "TEST", 0, 19], ["significant", "OBSERVATION_MODIFIER", 60, 71]]], ["Mann-Whitney test was used to express the relation between laboratory results between case and control.", [["Whitney test", "TEST", 5, 17]]], ["Multivariable regression analysis was used to examine the relation between skeletal maturation; bone age and other variables, as adjusted for the possible confounding effect of variables expected to influence the outcome of interest.ResultsThe study population included 30 obese children and adolescents, 14 males (46.7%) and 16 females (53.3%) with male to female ratio (1: 1.1).", [["skeletal", "ANATOMY", 75, 83], ["bone", "ANATOMY", 96, 100], ["skeletal", "TISSUE", 75, 83], ["bone", "TISSUE", 96, 100], ["children", "ORGANISM", 279, 287], ["adolescents", "ORGANISM", 292, 303], ["children", "SPECIES", 279, 287], ["adolescents", "SPECIES", 292, 303], ["Multivariable regression analysis", "TEST", 0, 33], ["The study population", "TEST", 240, 260], ["skeletal", "ANATOMY", 75, 83], ["bone", "ANATOMY", 96, 100]]], ["Patients were compared with 30 age and sex-matched healthy subjects enrolled as controls.", [["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8]]], ["The mean age of the obese group was 10.07 \u00b1 1.5 years while that of controls was 9.8 \u00b1 1.5 years.ResultsIn this study, we found no significant difference in the Tanner stage in females; this may be due to a small sample size; however, in males, there is a significant difference between obese and control groups (Table 1).", [["obese", "DISEASE", 20, 25], ["this study", "TEST", 107, 117], ["the Tanner stage in females", "PROBLEM", 157, 184], ["a small sample size", "PROBLEM", 205, 224], ["a significant difference between obese and control groups", "PROBLEM", 254, 311], ["obese", "OBSERVATION", 20, 25], ["no", "UNCERTAINTY", 128, 130], ["significant", "OBSERVATION_MODIFIER", 131, 142], ["difference", "OBSERVATION_MODIFIER", 143, 153], ["may be due to", "UNCERTAINTY", 191, 204], ["small", "OBSERVATION_MODIFIER", 207, 212], ["sample", "OBSERVATION_MODIFIER", 213, 219], ["size", "OBSERVATION_MODIFIER", 220, 224], ["significant", "OBSERVATION_MODIFIER", 256, 267], ["difference", "OBSERVATION_MODIFIER", 268, 278], ["obese", "OBSERVATION", 287, 292]]]], "fe7156c3ca7f7efcd4d78da73d3a54a8f0f5b209": [["IntroductionDue to the recent development of science and technology in the world, the smartphone industry has made exponential growth in the mobile phone application market [1] .", [["growth", "OBSERVATION_MODIFIER", 127, 133]]], ["These devices are well known as one of the most important Internet-of-Things (IoT) devices as well, according to their diverse capabilities including data storage and processing [2] .", [["These devices", "TREATMENT", 0, 13], ["Things (IoT) devices", "TREATMENT", 70, 90]]], ["Today's smartphone is also considered as \"a next-generation, multi-functional cell phone that facilitates data processing as well as enhanced wireless connectivity\", i.e., a combination of \"a powerful cell phone\" and a \"wireless-enabled PDA\" [3] .", [["cell", "ANATOMY", 78, 82], ["cell", "ANATOMY", 201, 205], ["cell", "CELL", 78, 82], ["cell", "CELL", 201, 205]]], ["In our earlier paper [4] , we have shown that users' interest on \"Mobile Phones\" is more and more than other platforms like \"Desktop Computer\", \"Laptop Computer\" or \"Tablet Computer\" for the last five years from 2014 to 2019 according to Google Trends data [5] , shown in Fig. 1 .IntroductionIn the real world, people use smartphones not only for voice communication between individuals but also for various activities with different mobile apps like e-mailing, instant messaging, online shopping, Internet browsing, entertainment, social media like Facebook, Linkedin, Twitter, or various IoT services like smart cities, health or transport services, etc. [2, 6] .", [["people", "ORGANISM", 311, 317], ["people", "SPECIES", 311, 317], ["smartphones", "TREATMENT", 322, 333]]], ["Smartphone applications differ from desktop applications due to their execution environment [7] .", [["Smartphone applications", "TREATMENT", 0, 23], ["desktop applications", "TREATMENT", 36, 56]]], ["Thus, mobile applications should adapt to the changing environment according to the contexts and behave accordingly, which is known as context-awareness [8] .IntroductionArtificial intelligence (AI) techniques have grown rapidly in recent years in the context of computing with smart mobile phones that typically allows the devices to function in an intelligent manner.", [["mobile applications", "TREATMENT", 6, 25], ["smart mobile phones", "TREATMENT", 278, 297], ["rapidly", "OBSERVATION_MODIFIER", 221, 228]]], ["AI can be applied to various types of mobile data such as structured, semi-structured, and unstructured [9] .", [["AI", "TREATMENT", 0, 2], ["mobile data", "TEST", 38, 49]]], ["Popular AI techniques include machine learning (ML) and deep learning (DL) methods, natural language processing (NLP), as well as knowledge representation and expert systems (ES), can be used according to their data characteristics, in order to make the target mobile applications intelligent.", [["Popular AI techniques", "TREATMENT", 0, 21], ["deep learning (DL) methods", "TREATMENT", 56, 82], ["deep", "ANATOMY_MODIFIER", 56, 60]]], ["AIbased models and their usage in practice can be seen in many intelligent mobile applications, such as personalized recommendation, virtual assistant, mobile business, healthcare services, and even the corona-virus COVID-19 pandemic management in recent days.", [["the corona-virus COVID", "TREATMENT", 199, 221], ["pandemic management", "TREATMENT", 225, 244]]], ["A brief discussion of these apps and their relation with AI techniques within the area of mobile data science has been conducted in Section 6.", [["these apps", "TREATMENT", 22, 32], ["AI techniques", "TREATMENT", 57, 70]]], ["This made a paradigm shift to context-aware intelligent computing, powered by the increasing availability of contextual smartphone data and the rapid progress of data analytics techniques.", [["contextual smartphone data", "TEST", 109, 135]]], ["Thus AI-based modeling for intelligent decision making, is the key to achieve our goal in this paper.IntroductionBased on the importance of AI in mobile apps, mentioned above, in this paper, we study on mobile data science and intelligent apps that covers how the artificial intelligence methods can be used to design and develop data-driven intelligent mobile applications for the betterment of human life in different application scenarios.", [["human", "ORGANISM", 396, 401], ["human", "SPECIES", 396, 401], ["human", "SPECIES", 396, 401], ["human life", "TREATMENT", 396, 406]]], ["Thus, the purpose of this paper is to provide a base reference for those academia and industry people who want to study and develop various AI-powered intelligent mobile apps considering these characteristics rather than traditional apps, in which we are interested.IntroductionThe main contributions of this paper are listed as follows:Introduction& To provide a brief overview and concept of the mobile data science paradigm for the purpose of building datadriven intelligent apps.", [["people", "ORGANISM", 95, 101], ["people", "SPECIES", 95, 101], ["various AI", "PROBLEM", 132, 142], ["main", "OBSERVATION_MODIFIER", 282, 286]]], ["For this, we first briefly review the relevant methods and systems, to motivate our study in this area. & To present AI-based modeling for intelligent mobile apps where various machine learning and deep learning algorithms, the concept of natural language processing, as well as knowledge representation and rule-based expert systems, are used. & To discuss the usefulness of various AI-powered intelligent apps in several application domains, and the role of AI-based modeling in practice for the betterment of human life. & To highlight and summarize the potential research directions relevant to our study and analysis in the area of mobile data science and intelligent apps.IntroductionThe rest of the paper is organized as follows.", [["human", "ORGANISM", 512, 517], ["human", "SPECIES", 512, 517], ["human", "SPECIES", 512, 517], ["our study", "TEST", 80, 89], ["various machine learning", "TREATMENT", 169, 193], ["deep learning algorithms", "TREATMENT", 198, 222], ["human life", "TREATMENT", 512, 522], ["our study", "TEST", 599, 608], ["analysis", "TEST", 613, 621]]], ["Section 2 motivates and defines the scope of our study.", [["our study", "TEST", 45, 54]]], ["In Section 3, we provide a background of our study including traditional data science and context-aware mobile computing, and review the works related to data-driven mobile systems and services.", [["our study", "TEST", 41, 50]]], ["In Section 5, we present our AI-based Fig. 1 Users' interest trends over time where x-axis represents the timestamp information and y-axis represents the popularity score in a range of 0 (min) to 100 (max) modeling within the scope of our study.", [["our study", "TEST", 235, 244]]], ["In Section 8, we highlight some key points regarding our studies, and finally, Section 9 concludes this paper.The motivation and scope of the studyIn this section, our goal is to motivate the study of exploring mobile data analytics and artificial intelligence methods that work well together in data-driven intelligent modeling and mobile applications in the interconnected world, especially in the environment of today's smartphones and Internet-of-Things (IoT), where these devices are well known as one of the most important IoT devices.", [["our studies", "TEST", 53, 64], ["the study", "TEST", 138, 147], ["the study", "TEST", 188, 197], ["mobile applications", "TREATMENT", 333, 352], ["these devices", "TREATMENT", 471, 484]]], ["Hence, we also present the scope of our study.The motivation and scope of the studyWe are currently living in the era of Data Science (DS), Machine Learning (ML), Artificial Intelligence (AI), Internetof-Things (IoT), and Cybersecurity, which are commonly known as the most popular latest technologies in the fourth industrial revolution (4IR) [10, 11] .", [["our study", "TEST", 36, 45]]], ["The computing devices like smartphones and corresponding applications are now used beyond the desktop, in diverse environments, and this trend toward ubiquitous and context-aware smart computing is accelerating.", [["The computing devices", "TREATMENT", 0, 21]]], ["One key challenge that remains in this emerging research domain is the ability to effectively process mobile data and enhance the behavior of any application by informing it of the surrounding contextual information such as temporal context, spatial context, social context, environmental or device-related context, etc. Typically, by context, we refer to any information that characterizes a situation related to the interaction between humans, applications, and the surrounding environment [4, 12] .The motivation and scope of the studyFor AI-based modeling, several machine learning and deep learning algorithms, the concept of natural language processing, as well as knowledge representation and rule-based expert systems, can be used according to their data characteristics, in order to make the target mobile applications intelligent.", [["humans", "ORGANISM", 438, 444], ["humans", "SPECIES", 438, 444], ["humans", "SPECIES", 438, 444], ["the study", "TEST", 529, 538], ["AI", "TEST", 542, 544], ["several machine learning", "TREATMENT", 561, 585], ["deep learning algorithms", "TREATMENT", 590, 614]]], ["Deep learning is a part of machine learning that allows us to solve complex problems even when using a diverse data set.", [["complex problems", "PROBLEM", 68, 84]]], ["Another important part of AI is knowledge representation and a rule-based expert system that is also considered in our analysis.", [["our analysis", "TEST", 115, 127]]], ["Expert system (ES) typically emulates the decision-making ability of a human expert in an intelligent system that is designed to solve complex problems by reasoning through knowledge, represented mainly as IF-THEN rules rather than conventional procedural code.The motivation and scope of the studyThus, the overall performance of the AI-based mobile applications depends on the nature of the contextual data, and artificial intelligence tasks that can play a significant role to build an effective model, in which we are interested in this paper.", [["human", "ORGANISM", 71, 76], ["IF", "PROTEIN", 206, 208], ["human", "SPECIES", 71, 76], ["human", "SPECIES", 71, 76], ["the study", "TEST", 289, 298], ["the AI", "TREATMENT", 331, 337], ["artificial intelligence tasks", "TREATMENT", 414, 443]]], ["Overall, the reasons for AI-tasks in mobile applications and systems can be summarized as below -& to empower the evolution of the mobile industry by making smartphone apps as intelligent pieces of software that can predict future outcomes and make decisions according to users' needs. & to learn from data including user-centric, and devicecentric contexts, by analyzing the data patterns. & to deliver an enhanced personalized experience while adapting quickly to changing innovations and environments. & to better utilization of available resources with higher effectiveness and efficiency. & to understand the real-world problems and to provide intelligent and automated services accordingly as well as complex problems in this mobile domain. & to enable the smartphones more secured through predictive analytics by taking into account possible threats in real-time.The motivation and scope of the studyTo achieve our goal, in this study, we mainly explore mobile data science and intelligent apps that aims at providing an overview of how AI-based modeling by taking into account various techniques' that can be used to design and develop intelligent mobile apps for the betterment of human life in various application domains, briefly discussed in Section 5, and Section 6.Background and related workIn this section, we give an overview of the related technologies of mobile data science that include the traditional data science, as well as the computing device and Internet, and context-aware mobile computing in the scope of our study.Data scienceWe are living in the age of data [16] .", [["human", "ORGANISM", 1190, 1195], ["human", "SPECIES", 1190, 1195], ["human", "SPECIES", 1190, 1195], ["AI", "PROBLEM", 25, 27], ["user-centric", "TREATMENT", 317, 329], ["complex problems", "PROBLEM", 707, 723], ["the smartphones", "TREATMENT", 759, 774], ["the study", "TEST", 898, 907], ["this study", "TEST", 931, 941], ["human life", "TREATMENT", 1190, 1200], ["our study", "TEST", 1534, 1543]]], ["As a high-level statement, it is the study of data to provide datadriven solutions for the given problems, as known as \"the science of data\".Computing devices and internetThe advancement of mobile computing and the Internet have played a central role in the development of the current digital age.", [["the study", "TEST", 33, 42], ["datadriven solutions", "TREATMENT", 62, 82], ["Computing devices", "TREATMENT", 141, 158], ["advancement", "OBSERVATION_MODIFIER", 175, 186], ["mobile", "OBSERVATION_MODIFIER", 190, 196], ["central", "OBSERVATION_MODIFIER", 238, 245]]], ["The use of the Internet with mobile devices makes it the most popular computing device, for the people in the real world.Computing devices and internetMobile devices have become one of the primary ways, in which people around the globe communicate with each other for various purposes.", [["people", "ORGANISM", 96, 102], ["people", "ORGANISM", 212, 218], ["people", "SPECIES", 96, 102], ["people", "SPECIES", 212, 218], ["mobile devices", "TREATMENT", 29, 43], ["Computing devices", "TREATMENT", 121, 138], ["internetMobile devices", "TREATMENT", 143, 165], ["globe", "ANATOMY", 230, 235]]], ["While mobile phones may come in various forms in the real world, in this paper, they refer to smartphones or mobile devices with the capability of computing and Internet access.", [["mobile devices", "TREATMENT", 109, 123]]], ["These devices have incorporated a variety of significant and interesting features to facilitate better information access through smart computing and the proper utilization of the devices for the benefit of the users.", [["These devices", "TREATMENT", 0, 13], ["the devices", "TREATMENT", 176, 187], ["variety", "OBSERVATION_MODIFIER", 34, 41], ["significant", "OBSERVATION_MODIFIER", 45, 56]]], ["As such, in addition to being used as a communication device, these smart mobile phones are capable of doing a variety of things relevant to users' daily life such as instant messaging, Internet or web browsing, e-mail, social network systems, online shopping, or various IoT services like smart cities, health or transport services [2, 6] .", [["a communication device", "TREATMENT", 38, 60]]], ["The future smartphones will be more powerful than current devices, communicate more quickly, store more data, and integrate new interaction technologies.Context-aware Mobile computingThe notion of context has been used in numerous areas, including mobile and pervasive computing, human-centered computing, and ambient intelligence [17] .", [["human", "ORGANISM", 280, 285], ["human", "SPECIES", 280, 285], ["human", "SPECIES", 280, 285], ["current devices", "TREATMENT", 50, 65]]], ["In the area of mobile and pervasive computing, several early works on contextaware computing, or context-awareness referred context as the location of people and objects [18] .", [["people", "ORGANISM", 151, 157], ["people", "SPECIES", 151, 157], ["mobile", "OBSERVATION", 15, 21]]], ["Dey et al. [12] define context, which is perhaps now the most widely accepted.", [["most widely", "OBSERVATION_MODIFIER", 57, 68]]], ["According to Dey et al. [12] \"Context is any information that can be used to characterize the situation of an entity.", [["entity", "OBSERVATION", 110, 116]]], ["An entity is person, place, or object that is considered relevant to the interaction between a user and an application, including the user and the application themselves\".", [["person", "SPECIES", 13, 19]]], ["The use of contextual information in mobile applications is thus able to reduce the amount of human effort and attention that is needed for an application to provide the services according to user's needs or preferences, in a pervasive computing environment [28] .", [["human", "ORGANISM", 94, 99], ["human", "SPECIES", 94, 99], ["human", "SPECIES", 94, 99], ["mobile applications", "TREATMENT", 37, 56]]], ["Different types of contexts might have a different impact on the applications that are discussed briefly in our earlier paper, Sarker et al. [4, 29] .Mobile systems and servicesResearch that relies on mobile data collected from diverse sources is mostly application-specific, which differs from application-to-application.", [["mobile data", "TEST", 201, 212]]], ["App usages log contains various contextual information such as date, time-of-the-day, battery level, profile type such as general, silent, meeting, outdoor, offline, charging state such as charging, complete, or not connected, location such as home, workplace, on the way, etc. and other apps relatedmetadata with various kinds of mobile apps [34] [35] [36] [37] [38] .", [["[34] [35] [36] [37] [38]", "SIMPLE_CHEMICAL", 343, 367], ["mobile apps", "TEST", 331, 342]]], ["Game log contains the information about playing various types such games of individual mobile phone users, and related contextual information such as date, time-of-the-day, weekdays, weekends etc. [43] .Mobile systems and servicesThe ubiquity of smart mobile phones and their computing capabilities for vairous real life purposes provide an opportunity of using these devices as a life-logging device, i.g., personal e-memories [44] .", [["vairous real life purposes", "TREATMENT", 303, 329], ["these devices", "TREATMENT", 362, 375], ["a life-logging device", "TREATMENT", 379, 400]]], ["In a more technical sense, life-logs sense and store individual's contextual information from their surrounding environment through a variety of sensors available in their smart mobile phones, which are the core components of lifelogs such as user phone calls, SMS headers (no content), App use (e.g., Skype, Whatsapp, Youtube etc.), physical activities form Google play API, and related contextual information such as WiFi and Bluetooth devices in user's proximity, geographical location, temporal information [44] .", [["Bluetooth devices", "TREATMENT", 428, 445]]], ["Several applications such as smart context-aware mobile communication, intelligent mobile notification management, context-aware mobile recommendation etc. are popular in the area of mobile analytics and applications.", [["popular", "OBSERVATION_MODIFIER", 160, 167], ["area", "OBSERVATION_MODIFIER", 175, 179], ["mobile analytics", "OBSERVATION", 183, 199]]], ["Smart context-aware mobile communication (e.g., intelligent phone call interruption management) is one of the most compelling and widely studied applications [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] .", [["[45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55]", "CHEMICAL", 158, 212], ["[45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55]", "SIMPLE_CHEMICAL", 158, 212]]], ["For mobile notification management, several research [39, [56] [57] [58] [59] has been done.", [["[56] [57] [58] [59]", "SIMPLE_CHEMICAL", 58, 77]]], ["Similarly, a number of research [34, [60] [61] [62] [63] [64] [65] has been done on recommendation system.Mobile systems and servicesVarious techniques are used in various applications, such as interruption management, activity recognition, recommendation system, mobile commerce, etc. in the area of mobile analytics.", [["[60] [61] [62] [63] [64", "SIMPLE_CHEMICAL", 37, 60], ["Various techniques", "TREATMENT", 133, 151], ["interruption management", "TREATMENT", 194, 217]]], ["For instance, Seo et al. [66] design a context-aware configuration manager for smartphones PYP.", [["PYP", "SIMPLE_CHEMICAL", 91, 94], ["PYP", "PROTEIN", 91, 94]]], ["An intelligent interruption management system is proposed in [48] , use decision tree for making decisions.", [["An intelligent interruption management system", "TREATMENT", 0, 45]]], ["Bozanta et al. [67] , Lee et al. [68] use classification technique to build a personalized hybrid recommender system.", [["classification technique", "TREATMENT", 42, 66]]], ["Turner et al. [59, 69] , Fogarty et al. [70] use classification technique in their interruptibility predictionand management system.", [["classification technique", "TREATMENT", 49, 73]]], ["To adopt mobile learning, Tan et al. [72] investigates using a multilayer perceptron model.", [["a multilayer perceptron model", "TREATMENT", 61, 90]]], ["Moreover, regression techniques such as Linear regression [9] , support vector regression [73] , and ensemble learning techniques, such as Random Forest learning [74] are popular in the area of supervised learning.Mobile systems and servicesBeside the above mentioned approaches, several researchers [34, 35, 39] use association rules that are used to build various context-aware mobile service according to users needs.", [["Linear regression", "PROBLEM", 40, 57]]], ["A number of research [40, [98] [99] [100] [101] [102] have been done based on clustering approach for different purposes in their study.", [["[98] [99] [100] [101] [102]", "SIMPLE_CHEMICAL", 26, 53], ["their study", "TEST", 124, 135]]], ["Moreover, a significant amount of research [72, [94] [95] [96] [97] have been done on deep learning for various purposes in the area of mobile analytics.", [["significant", "OBSERVATION_MODIFIER", 12, 23], ["amount", "OBSERVATION_MODIFIER", 24, 30]]], ["Moreover, context engineering including principal component analysis, or context correlation analysis [77, 78] is another important issue to work in this area.", [["principal component analysis", "TEST", 40, 68], ["context correlation analysis", "TEST", 73, 101]]], ["In Table 1 , we have summarized this research based on the most popular approaches and data-driven tasks within the scope of our analysis.Mobile systems and servicesAlthough various types of mobile phone data and techniques discussed above are used in the area of mobile analytics and systems for different purposes, a comprehensive AI-based modeling for building intelligent apps is being interested, according to the needs of the current in the community.", [["our analysis", "TEST", 125, 137]]], ["Thus, in this paper, we focus on mobile data science and corresponding intelligent apps, where the most popular AI techniques including machine learning and deep learning methods, the concept of natural language processing, as well as knowledge representation and expert systems, can be used to build intelligent mobile apps in various application domains.Mobile data science paradigmIn this section, we provide a brief overview of mobile data science and its related components within the scope of our study.Understanding Mobile dataMobile data science and data-driven intelligent apps are largely driven by the availability of data.", [["our study", "TEST", 499, 508]]], ["Mobile datasets typically represent a collection of information records that consist of several attributes or contextual features and related facts.", [["Mobile datasets", "PROBLEM", 0, 15], ["contextual features", "PROBLEM", 110, 129]]], ["Moreover, IoT data, smart cities data, business data, health data, mobile security data, or various sensors data associated with the mobile devices and target application can also be used as data sources.", [["IoT data", "TEST", 10, 18], ["smart cities data", "TEST", 20, 37], ["business data", "TEST", 39, 52], ["health data", "TEST", 54, 65], ["mobile security data", "TEST", 67, 87], ["various sensors data", "TEST", 92, 112], ["the mobile devices", "TREATMENT", 129, 147], ["target application", "TREATMENT", 152, 170]]], ["Intelligent apps are based on the extracted insight from such kinds of relevant datasets depending on apps characteristics.", [["relevant datasets", "PROBLEM", 71, 88]]], ["Rather, the apps can study user behavior and deliver personalized and actionable results using the power of predictive analytics. & Adaptive in Nature: The apps should be adaptive in nature.", [["predictive analytics", "TEST", 108, 128]]], ["It makes the apps much smarter use by taking into account users contexts as well as the device's contexts to proactively deliver highly relevant information and suggestions. & Cross-Platform Operation: The app also should have the ability to understand and process the desired output in a way that the users feel the same experience while working on cross platforms.Intelligent apps characteristicsIn this study, we take into account the above-discussed characteristics of mobile apps that could be able to intelligently assist the users in their diverse daily life activities.", [["the device's contexts", "TREATMENT", 84, 105], ["this study", "TEST", 401, 411]]], ["Based on [97] these characteristics, in the next, we briefly discuss the concept of mobile data science and AI that can help to achieve the goal.Mobile data science and AIData science is transforming the world's industries.", [["AI", "TREATMENT", 108, 110]]], ["Although, a number of recent research [4, 29, 34, 38, 48] has been done based on machine learning techniques to model and build mobile applications, most of existing mobile applications are static or used customwritten rules like signatures, or manually defined heuristics for their different applications [47, 66] .", [["learning techniques", "TREATMENT", 89, 108], ["build mobile applications", "TREATMENT", 122, 147], ["existing mobile applications", "TREATMENT", 157, 185]]], ["The main drawback of these custom-written rules-based approaches is that the knowledge or rules used by the applications are not automatically discovered; users need to define and maintain the rules manually.", [["main", "OBSERVATION_MODIFIER", 4, 8]]], ["On the contrary, data science can make a massive shift in technology and its operations, where AI techniques including machine learning and deep learning methods, natural language processing, as well as knowledge representation and expert systems, can be used to learn and making intelligent decisions.", [["a massive shift", "PROBLEM", 39, 54], ["its operations", "TREATMENT", 73, 87], ["AI techniques", "TREATMENT", 95, 108]]], ["Overall, data science is a comprehensive process that involves data collection, pre-processing, data analysis, visualization, and decision making [16] , whereas AI makes use of computer algorithms that can show human intelligence.", [["human", "ORGANISM", 211, 216], ["human", "SPECIES", 211, 216], ["human", "SPECIES", 211, 216], ["data analysis", "TEST", 96, 109], ["visualization", "TEST", 111, 124], ["computer algorithms", "TEST", 177, 196]]], ["The combination of these technologies has given birth to the term \"mobile data science\", which refers to collect a large amount of mobile data from different sources and analyze it using machine learning techniques through the discovery of useful insights or the data-driven patterns, which is primarily defined in our earlier paper [104] .", [["learning techniques", "TREATMENT", 195, 214], ["the data", "TEST", 259, 267], ["large", "OBSERVATION_MODIFIER", 115, 120]]], ["It is, however, worth remembering that mobile data science is not just about a collection of AI techniques.", [["AI techniques", "TREATMENT", 93, 106]]], ["Thus in a broader sense, we can say that \"Mobile data science is research or working area existing at the intersection of context-aware mobile computing, data science, and artificial intelligence, which is mainly datafocused associated with target mobile apps, applies AI techniques for modeling, and eventually making intelligent decisions in applications.", [["AI techniques", "TREATMENT", 269, 282]]], ["Thus it aims to seek for optimizing solutions to build automated and intelligent mobile applications to intelligently assist the users in their various daily activities.\".", [["optimizing solutions", "TREATMENT", 25, 45], ["intelligent mobile applications", "TREATMENT", 69, 100]]], ["Several key modules, such as data collection, data processing, context and usage analysis, and building models, are involved in mobile data science, which are discussed briefly in our earlier paper [104] .", [["Several key modules", "PROBLEM", 0, 19], ["data collection", "TEST", 29, 44], ["usage analysis", "TEST", 75, 89], ["key", "OBSERVATION_MODIFIER", 8, 11], ["modules", "OBSERVATION", 12, 19]]], ["In this paper, we mainly explore on AI-based modeling and its role in mobile apps in various application domains ranging from personalized services to healthcare services, which includes machine learning (ML) and deep learning (DL) methods, the concept of natural language processing (NLP), as well as knowledge representation, and rule-based expert systems (ES).Mobile data science and AIOverall, the outputs of mobile data science are typically mobile data products, which can be a data-driven AI-based model, potential mobile service and recommendation, or the corresponding intelligent mobile apps.", [["deep learning (DL) methods", "TREATMENT", 213, 239]]], ["In Section 6, we have discussed about AI-powered intelligent mobile apps in several application domains within the area of mobile data science.Mobile security and privacyAlthough we focus on intelligent apps from the perspective of artificial intelligence within the scope of our study discussed above, mobile security and privacy could be another part related to mobile data science in terms of data-driven security solutions.", [["artificial intelligence", "PROBLEM", 232, 255], ["our study", "TEST", 276, 285]]], ["In the real world, most of the people including business people use smartphones not only to communicate but also to plan and organize their various kinds of daily works and also in their private life with family and friends.", [["people", "ORGANISM", 31, 37], ["people", "ORGANISM", 57, 63], ["people", "SPECIES", 31, 37], ["people", "SPECIES", 57, 63]]], ["In most cases, both the business or personal information are stored on smartphones and people use such information when needed [105, 106] .", [["people", "ORGANISM", 87, 93], ["people", "SPECIES", 87, 93]]], ["Besides, there are several threats to mobile devices, including mobile malware, botnet, denial-of-service (DoS), eavesdropping, phishing, data breaches, etc. [106] [107] [108] .", [["mobile devices", "TREATMENT", 38, 52], ["mobile devices", "OBSERVATION", 38, 52]]], ["In terms of security analytics, in our earlier paper, Sarker et al. [10] , we have discussed various types of security data and the effectiveness of the data-driven cybersecurity modeling based on artificial intelligence, particularly using machine learning techniques.", [["the data", "TEST", 149, 157]]], ["Thus data-driven intelligent solutions through finding security insight could be effective to detect and mitigate such kind of mobile security threats.Mobile security and privacyAs discussed earlier, mobile data science is data-focused, applies various artificial intelligence methods that eventually seek for intelligent decision making in mobile applications or services.", [["driven intelligent solutions", "TREATMENT", 10, 38], ["various artificial intelligence methods", "TREATMENT", 245, 284]]], ["In our analysis, we divide the artificial intelligence methods into several categories, such as basic machine learning and deep learning algorithms, natural language processing, knowledge representation and expert systems, within the scope of our study.", [["basic machine learning", "TREATMENT", 96, 118], ["deep learning algorithms", "TREATMENT", 123, 147], ["our study", "TEST", 243, 252]]], ["These AI-based methods potentially can be used to make intelligent decisions in apps, which are discussed briefly in the following.Machine learning modeling with Mobile dataMachine Learning (ML) including deep neural network learning is an important part of Artificial Intelligence (AI) which can empower mobile devices to learn, explore, and envisage outcomes automatically without user interference.", [["neural network", "ANATOMY", 210, 224], ["neural network", "MULTI-TISSUE_STRUCTURE", 210, 224], ["Mobile dataMachine Learning (ML)", "TREATMENT", 162, 194], ["Artificial Intelligence (AI)", "TREATMENT", 258, 286]]], ["Typically, a machine learning model for building intelligent apps is a collection of target apprelated data from relevant diverse sources, such as phone logs, sensors, or external sources, etc. and the chosen algorithms that work on that data in order to deduce the output.Machine learning modeling with Mobile dataTo build a model utilizing collected data, supervised learning is performed when specific target classes are defined to reach from a certain set of inputs [13] .", [["Mobile dataTo", "DNA", 304, 317]]], ["For instance, to classify or predict the future outcome, several popular algorithms such as Navies Bayes [109] , Decision Trees [93, 110, 111] , Knearest neighbors [112] , Support vector machines [73] , Adaptive boosting [113] , Logistic regression [114] etc. can be used.", [["Support vector machines", "TREATMENT", 172, 195], ["Adaptive boosting", "TREATMENT", 203, 220]]], ["Several feature engineering tasks, such as feature selection, extraction, etc., or context pre-modeling [78] can make the resultant predictive model more effective.", [["Several feature engineering tasks", "PROBLEM", 0, 33], ["extraction", "TREATMENT", 62, 72], ["engineering tasks", "OBSERVATION", 16, 33]]], ["Several clustering algorithms such as K-means [115] , K-medoids [116] , Single linkage [117] , Complete linkage [118] , BOTS [75] can be used for such modeling by taking into account certain similarity measures depending on the data characteristics.", [["Several clustering algorithms", "PROBLEM", 0, 29], ["K-means", "TEST", 38, 45], ["K-medoids", "TEST", 54, 63]]], ["Moreover, association rule learning techniques such as AIS [119] , Apriori [120] , FP-Tree [121] , RARM [122] , Eclat [123] , ABC-RuleMiner [29] can be used for building rule-based machine learning model for the mobile phone users.", [["AIS", "TEST", 55, 58], ["Apriori", "TEST", 67, 74], ["FP", "TEST", 83, 85], ["RARM", "TEST", 99, 103], ["Eclat", "TEST", 112, 117], ["ABC", "TEST", 126, 129]]], ["In addition to these basic machine learning techniques, several deep neural learning methods such as recurrent neural network, long-short term memory, convolutional neural network, multilayer perceptron, etc. that are originated from an Artificial Neural Network (ANN) can be used in the learning process [9, 13] .", [["neural", "ANATOMY", 69, 75], ["neural network", "ANATOMY", 111, 125], ["neural network", "MULTI-TISSUE_STRUCTURE", 111, 125], ["neural network", "MULTI-TISSUE_STRUCTURE", 165, 179], ["learning techniques", "TREATMENT", 35, 54], ["several deep neural learning methods", "PROBLEM", 56, 92], ["recurrent neural network", "PROBLEM", 101, 125], ["long-short term memory", "PROBLEM", 127, 149], ["convolutional neural network", "PROBLEM", 151, 179], ["multilayer perceptron", "TREATMENT", 181, 202], ["deep", "ANATOMY_MODIFIER", 64, 68], ["neural", "ANATOMY", 69, 75], ["neural network", "OBSERVATION", 111, 125]]], ["In these deep learning models, several hidden layers can be included to complete the overall process.Machine learning modeling with Mobile dataTo understand and analyze the actual phenomena with mobile data, the above-discussed machine learning and deep learning techniques are useful to build AI-based modeling, depending on the target application and corresponding data characteristics.", [["machine learning", "TREATMENT", 228, 244], ["deep learning techniques", "TREATMENT", 249, 273], ["deep", "ANATOMY_MODIFIER", 9, 13]]], ["Overall, the machine learning models can change the future of mobile applications and industry because of its learning capability from data.", [["mobile applications", "TREATMENT", 62, 81]]], ["Therefore, machine learning methods including deep neural networks, on a global scale, is able to make mobile platforms more userfriendly, improve users' experiences, and aid in building intelligent applications.Natural language processing for Mobile contentNatural Language Processing (NLP) is an important branch of artificial intelligence that typically deals with the interaction between computers and humans using the natural language.", [["neural networks", "ANATOMY", 51, 66], ["neural networks", "MULTI-TISSUE_STRUCTURE", 51, 66], ["humans", "ORGANISM", 406, 412], ["humans", "SPECIES", 406, 412], ["humans", "SPECIES", 406, 412], ["deep neural networks", "TREATMENT", 46, 66], ["a global scale", "TREATMENT", 71, 85], ["deep", "ANATOMY_MODIFIER", 46, 50], ["neural", "ANATOMY", 51, 57]]], ["As each language has a unique set of grammar and syntax, and convention, NLP techniques can make it possible for computers to read text, hear speech, interpret it, measure sentiment or to mine opinions, and eventually determine which parts are important in an intelligent system [124] .", [["syntax", "TREATMENT", 49, 55]]], ["For instance, to extract sentiments associated with positive, neutral, or negative polarities for specific subjects from a text document, an NLP-based methodology can be used.", [["specific subjects", "PROBLEM", 98, 115], ["a text document", "TEST", 121, 136], ["an NLP", "TEST", 138, 144]]], ["Thus, NLP can play a significant role to build intelligent apps when unstructured mobile content is available, and to be an important part within the scope of our study.Natural language processing for Mobile contentIn recent days, a large amount of content read on mobile devices is text-based, such as emails, web pages, comments, blogs, or documents [15] .", [["NLP", "PROTEIN", 6, 9], ["our study", "TEST", 159, 168], ["mobile devices", "TREATMENT", 265, 279], ["large", "OBSERVATION_MODIFIER", 233, 238], ["amount", "OBSERVATION_MODIFIER", 239, 245]]], ["NLP techniques particularly, text mining extracts patterns and structured information from textual content that could make the apps smarter and intelligent, in which we are interested.", [["NLP techniques", "TREATMENT", 0, 14]]], ["For instance, browsing through large amounts of textual content on a small-screen mobile device may be tedious or time-consuming.", [["textual content", "PROBLEM", 48, 63], ["a small-screen mobile device", "TREATMENT", 67, 95], ["large", "OBSERVATION_MODIFIER", 31, 36], ["amounts", "OBSERVATION_MODIFIER", 37, 44], ["textual content", "OBSERVATION", 48, 63]]], ["Thus, document summarization based on NLP might be the potential solution to provide a summary with high quality and minimal time.Natural language processing for Mobile contentInformation extraction from mobile content could be another example of NLP based modeling.", [["NLP", "TEST", 38, 41]]], ["In addition to information extraction, NLP techniques can also be used when needed to develop the new mobile content.", [["information extraction", "TREATMENT", 15, 37], ["NLP techniques", "TREATMENT", 39, 53]]], ["Thus, NLP techniques can play a significant role to build AIbased modeling depending on the target application and corresponding data type and characteristics.Domain knowledge representation and Mobile expert system modelingDue to the diversity of mobile users, contexts, increasing information, and variations in mobile computing platforms, mobile applications today are facing the challenges to provide the expected services.", [["NLP techniques", "TREATMENT", 6, 20], ["Domain knowledge representation", "PROBLEM", 159, 190], ["mobile applications", "TREATMENT", 342, 361]]], ["It is typically a study of how the beliefs, intentions, and judgments of an intelligent agent can be expressed suitably for automated reasoning to solve problems.", [["a study", "TEST", 16, 23], ["an intelligent agent", "TREATMENT", 73, 93]]], ["Thus, the main purpose of knowledge representation is modeling the intelligent behavior of an agent.", [["an agent", "TREATMENT", 91, 99], ["main", "OBSERVATION_MODIFIER", 10, 14]]], ["It allows a machine to learn from that knowledge and behave intelligently like a human being.", [["human", "ORGANISM", 81, 86], ["human", "SPECIES", 81, 86], ["human", "SPECIES", 81, 86]]], ["To represent knowledge in Artificial Intelligence (AI), \"Ontology\" in general has become popular as a paradigm by providing a methodology for easier development of interoperable and reusable knowledge bases (KB).", [["KB", "CANCER", 208, 210]]], ["According to [125] , formally, an ontology is represented as \"{O = C, R, I, H, A}, where {C = C 1 , C 2 , \u2026, C n } represents a set of concepts, and {R = R 1 , R 2 , \u2026, R m } represents a set of relations defined over the concepts.", [["O", "CHEMICAL", 63, 64], ["C", "CHEMICAL", 67, 68], ["I", "CHEMICAL", 73, 74], ["H", "CHEMICAL", 76, 77], ["A}", "CHEMICAL", 79, 81], ["C", "CHEMICAL", 90, 91], ["C", "CHEMICAL", 94, 95], ["C", "CHEMICAL", 100, 101], ["C", "CHEMICAL", 109, 110], ["{O = C, R, I, H, A}", "SIMPLE_CHEMICAL", 62, 81], ["{C = C 1 , C 2 , \u2026, C n }", "SIMPLE_CHEMICAL", 89, 114], ["C", "TEST", 94, 95], ["C", "TEST", 100, 101], ["\u2026", "TEST", 106, 107], ["C", "TEST", 109, 110], ["concepts", "TEST", 135, 143], ["{R", "TEST", 149, 151], ["\u2026", "TEST", 166, 167]]], ["I represents a set of instances of concepts, and H represents a Directed AcyclicGraph (DAG) defined by the subsumption relation between concepts, and A represents a set of axioms bringing additional constraints on the ontology\".", [["DAG", "SIMPLE_CHEMICAL", 87, 90]]], ["Let's consider an inference rules in ontologies for deductive reasoning.", [["deductive reasoning", "TEST", 52, 71]]], ["Thus, particular domain ontologies can help for building an effective semantic mobile application.", [["an effective semantic mobile application", "TREATMENT", 57, 97]]], ["Moreover, ontologies capturing complex dependencies between concepts for a particular problem domain provide a flexible and expressive tool for modeling high-level concepts and relations among the given attributes, which allows both the system and the user to operate the same taxonomy and play an important role to build an expert system [125] .Mobile expert system modelingA mobile expert system is an example of a knowledge-based system, which is broadly divided into two subsystems, such as the inference engine and the knowledge base, shown in Fig. 2 .", [["a particular problem domain", "PROBLEM", 73, 100], ["a flexible and expressive tool", "PROBLEM", 109, 139], ["modeling high-level concepts", "TREATMENT", 144, 172], ["Fig", "OBSERVATION_MODIFIER", 549, 552]]], ["The knowledge base typically represents facts and rules, while the inference engine applies the rules to the known facts to deduce new facts.", [["base", "ANATOMY_MODIFIER", 14, 18]]], ["The knowledge-base module is the core of this expert system as it consists of knowledge of the target mobile application domain as well as operational knowledge of apps' decision rules.", [["base", "ANATOMY_MODIFIER", 14, 18]]], ["The user interface accepts the original facts and invokes the inference engine to activate the decision rules in the knowledge base.", [["base", "ANATOMY_MODIFIER", 127, 131]]], ["Such an IF-THEN rule-based expert system model can have the decision-making ability of a human expert in an intelligent system that is designed to solve complex problems as well through knowledge reasoning.", [["human", "ORGANISM", 89, 94], ["human", "SPECIES", 89, 94], ["human", "SPECIES", 89, 94]]], ["To develop the knowledge base module, an ontology-based knowledge representation platform discussed earlier can play a major role to generate the conceptual rules.", [["the knowledge base module", "PROBLEM", 11, 36]]], ["To provide a continuous supply of knowledge to a rule-based expert system, data mining, and machine learning techniques can be used.", [["machine learning techniques", "TREATMENT", 92, 119]]], ["Thus, intelligent mobile apps are those applications that use AI-based modeling discussed above, in order to make intelligent decisions and to provide useful suggestions and recommendations.", [["those applications", "TREATMENT", 34, 52], ["AI", "TREATMENT", 62, 64]]], ["Based on this, the target mobile applications for various daily life services are outlined in the following subsections ranging from personalized to community services.Personalized Mobile user experienceIn the real world, people want their experience to be absolutely personalized these days.", [["people", "ORGANISM", 222, 228], ["people", "SPECIES", 222, 228], ["various daily life services", "TREATMENT", 50, 77]]], ["For instance, an intelligent phone call interruption management system can be a real-life application based on the discovered rules, which handles the incoming phone calls automatically according to the behavior of an individual user [29] .", [["interruption management system", "TREATMENT", 40, 70], ["a real-life application", "TREATMENT", 78, 101]]], ["Similarly, a knowledge-based mobile expert system considering a set of context-aware IF-THEN rules, can also help to provide personalized services for individual users.Mobile recommendationRecommender systems are typically developed to overcome the problem of information overload by aiding users in the search for relevant information and helping them identify which items (e.g., media, product, or service) are worth viewing in detail.", [["information overload", "PROBLEM", 260, 280]]], ["The advanced mobile apps Fig. 2 A structure of a mobile expert system modeling powered by predictive intelligent capabilities using ML-based models make recommend engines smart enough to analyze the user content preferences and cater to the appropriate content that the user is looking for.", [["advanced", "OBSERVATION_MODIFIER", 4, 12], ["mobile", "OBSERVATION_MODIFIER", 13, 19]]], ["For instance, a mobile system generating shopping recommendations helps the user to find the most satisfying product by reducing search effort and information overload.", [["information overload", "PROBLEM", 147, 167]]], ["Moreover, an NLP-based methodology can be a way to retrieve the best recommendation service based on public comments.Mobile virtual assistanceAn intelligent virtual assistant is also known as an intelligent personal assistant that is typically a software agent to perform tasks or services for an individual based on queries like commands or questions.", [["an NLP", "TEST", 10, 16]]], ["AI-based models including NLP and ML can be used to build such applications.", [["AI", "TEST", 0, 2], ["NLP and ML", "TREATMENT", 26, 36]]], ["Moreover, people are now typically spending more time on different messaging apps that are the platforms of communication and bots will be how their users access all sorts of services.", [["people", "ORGANISM", 10, 16], ["people", "SPECIES", 10, 16]]], ["Smart cities use IoT devices as well to collect and analyze data, and become the most extensive application domain these days.", [["IoT devices", "TREATMENT", 17, 28], ["analyze data", "TEST", 52, 64]]], ["In general, the smart city development is considered as a new way of thinking among cities, businesses, citizens, academia, industry people or others, who are the key stakeholders.", [["people", "SPECIES", 133, 139]]], ["As today's smartphones are considered as one of the most important IoT devices [2] , integrating mobile apps with IoT developments can dramatically improve the quality of human life.", [["human", "ORGANISM", 171, 176], ["human", "SPECIES", 171, 176], ["human", "SPECIES", 171, 176], ["integrating mobile apps", "TREATMENT", 85, 108], ["IoT developments", "TREATMENT", 114, 130]]], ["AI-based modeling in apps can provide relevant intelligent services in this domain, as well as can bring technology, government, and different layers of society together for the betterment of human life.", [["human", "ORGANISM", 192, 197], ["human", "SPECIES", 192, 197], ["human", "SPECIES", 192, 197]]], ["For instance, machine learning-based modeling utilizing sensor data collected from parking places, or traffic signals, can be used for a better city planning for the governments.", [["sensor data", "TEST", 56, 67]]], ["The new availability and advancement of AI and machine learning are causing a revolutionary shift in business and is considered as the new digital frontier for enterprises.", [["AI and machine learning", "TREATMENT", 40, 63], ["new", "OBSERVATION_MODIFIER", 4, 7]]], ["Since, almost every organization deal with customer service, the businesses people think about intelligent interactions within mobile applications these days according to consumer demands.", [["people", "ORGANISM", 76, 82], ["people", "SPECIES", 76, 82]]], ["Businesses can leverage the data that are collected from various sources such as point-of-sale machines, online traffic, mobile devices, etc. to analyze and strategically improve the user experience.", [["mobile devices", "TREATMENT", 121, 135]]], ["AI techniques can find trends from data and adjust the apps themselves to create more meaningful and context-rich opportunities to engage users.", [["AI techniques", "TREATMENT", 0, 13]]], ["Moreover, an NLP-based methodology of sentiment evaluation such as positive, neutral, or negetive sentiment (also known as opinion mining) on business data, e.g., review comments, can retrieve the best and perfect suggestions and product recommendations in terms of quality and quantity for the customers.", [["an NLP", "TEST", 10, 16], ["sentiment evaluation", "TEST", 38, 58]]], ["Overall, AI mobile applications in the business domain help in expanding businesses, introducing new products or services, identifying customer interests, and maintaining a prominent position in the global market.Mobile healthcare and medicineIntelligent mobile healthcare applications are bringing better opportunities for both the patients, medical practitioners, or related organizations through simplifying their physical interactions.", [["patients", "ORGANISM", 333, 341], ["patients", "SPECIES", 333, 341], ["AI mobile applications", "TREATMENT", 9, 31], ["prominent", "OBSERVATION_MODIFIER", 173, 182], ["position", "OBSERVATION_MODIFIER", 183, 191]]], ["These apps can provide opportunities to several health-related services such as medical diagnosis, medicine recommendation including e-prescription, suggesting primary precautions, remote health monitoring, or effectively patient management in the hospital.", [["patient", "ORGANISM", 222, 229], ["patient", "SPECIES", 222, 229], ["e-prescription", "TREATMENT", 133, 147], ["primary precautions", "TREATMENT", 160, 179], ["remote health monitoring", "TEST", 181, 205]]], ["With the help of AI methods including ML-based models, intelligent health services can be provided.", [["AI methods", "TREATMENT", 17, 27]]], ["Thus it may reduce the expense and time of the patients and clinics, as they offer customized medicines and drugs as well as give preventive measures through continuous information accumulation.", [["patients", "ORGANISM", 47, 55], ["patients", "SPECIES", 47, 55], ["customized medicines", "TREATMENT", 83, 103], ["drugs", "TREATMENT", 108, 113], ["preventive measures", "TREATMENT", 130, 149]]], ["Moreover, AI-powered mobile applications could also be applicable to find the best nearest doctor, to book a consultation, to keep reminders of medication, getting a basic knowledge of each medication, and more.", [["AI-powered mobile applications", "TREATMENT", 10, 40], ["medication", "TREATMENT", 144, 154], ["each medication", "TREATMENT", 185, 200]]], ["Mobile healthcare app is also able to help doctors with remaining updates with real-time status of consultations, assigning duties to staff, ensuring the availability of equipment, maintaining a proper temperature for medicines, and more.", [["medicines", "TREATMENT", 218, 227]]], ["In addition, the healthcare virtual assistant services like chatbots can be used to provide basic healthcare service as well, as these online programs can assist patients in many ways, such as scheduling appointments, answering common questions, aiding in the payment process, and even providing basic virtual diagnostics.", [["patients", "ORGANISM", 162, 170], ["patients", "SPECIES", 162, 170], ["basic virtual diagnostics", "TEST", 296, 321]]], ["Overall, AI-modeling based mobile healthcare services may create a new endeavor for all citizens in a country including the rural people of low-income countries.The novel coronavirus COVID-19Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus [131] .", [["infectious disease", "DISEASE", 228, 246], ["coronavirus COVID-19Coronavirus", "ORGANISM", 171, 202], ["COVID-19", "ORGANISM", 212, 220], ["coronavirus", "ORGANISM", 276, 287], ["people", "SPECIES", 130, 136], ["coronavirus", "SPECIES", 171, 182], ["coronavirus", "SPECIES", 276, 287], ["coronavirus COVID-19Coronavirus disease (COVID-19", "SPECIES", 171, 220], ["The novel coronavirus COVID", "TEST", 161, 188], ["19Coronavirus disease", "PROBLEM", 189, 210], ["COVID", "TEST", 212, 217], ["an infectious disease", "PROBLEM", 225, 246], ["a newly discovered coronavirus", "PROBLEM", 257, 287], ["coronavirus", "OBSERVATION_MODIFIER", 171, 182], ["infectious", "OBSERVATION", 228, 238]]], ["COVID-19 apps typically are known as the mobile software applications that use digital contact tracing in response to the COVID-19 pandemic, i.e. the process of identifying persons (\"contacts\") who may have been in contact with an infected person.", [["persons", "ORGANISM", 173, 180], ["persons", "SPECIES", 173, 180], ["person", "SPECIES", 240, 246], ["digital contact tracing", "TEST", 79, 102], ["infected", "OBSERVATION", 231, 239]]], ["According to the World Health Organization (WHO) [131], most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment.", [["respiratory", "ANATOMY", 134, 145], ["respiratory illness", "DISEASE", 134, 153], ["people", "ORGANISM", 61, 67], ["COVID-19 virus", "ORGANISM", 86, 100], ["people", "SPECIES", 61, 67], ["COVID-19 virus", "SPECIES", 86, 100], ["the COVID", "TEST", 82, 91], ["mild to moderate respiratory illness", "PROBLEM", 117, 153], ["special treatment", "TREATMENT", 184, 201], ["mild", "OBSERVATION_MODIFIER", 117, 121], ["moderate", "OBSERVATION_MODIFIER", 125, 133], ["respiratory", "ANATOMY", 134, 145], ["illness", "OBSERVATION", 146, 153]]], ["Thus, in order to keep this infectious disease in control, \"contact tracing\" is an important factor.", [["infectious disease", "DISEASE", 28, 46], ["this infectious disease in control", "PROBLEM", 23, 57], ["infectious", "OBSERVATION", 28, 38]]], ["Smartphone apps are playing a big role in the response to the COVID-19 pandemic.", [["Smartphone apps", "TREATMENT", 0, 15], ["the COVID", "TEST", 58, 67]]], ["These apps are being used to track infected people, social distancing, detecting COVID-19 symptoms, self-quarantine guidelines, the latest communication to the citizens, and ease the burden on healthcare staff.", [["people", "ORGANISM", 44, 50], ["people", "SPECIES", 44, 50], ["symptoms", "PROBLEM", 90, 98]]], ["Thus, mobile apps are considered as an effective control strategy against the spread of COVID-19 or similar future pandemics, considering the patient and social sensing data.", [["patient", "ORGANISM", 142, 149], ["patient", "SPECIES", 142, 149], ["mobile apps", "TREATMENT", 6, 17], ["an effective control strategy", "TREATMENT", 36, 65], ["COVID", "TEST", 88, 93]]], ["An intelligent framework and mobile application design will not only strengthen the fight against ongoing COVID-19 challenges based on the collected data by mobile phones, but also against similar disasters in a post-COVID world.The novel coronavirus COVID-19In addition to these application areas, AI-based models in mobile applications can also be applicable to several other domains, such as financial, manufacturing, smart robotics, security and privacy, and many more.", [["coronavirus", "ORGANISM", 239, 250], ["coronavirus", "SPECIES", 239, 250], ["mobile application design", "TREATMENT", 29, 54], ["ongoing COVID", "TREATMENT", 98, 111], ["The novel coronavirus COVID", "TREATMENT", 229, 256], ["these application areas", "TREATMENT", 274, 297], ["AI-based models in mobile applications", "TREATMENT", 299, 337]]], ["Thus, the impact of AI-models in mobile app development and user experience is significant in these days and can be considered as nextgeneration mobile learning.Research issues and future directionsWith the rapid development of smartphones, Internet-of-Things (IoT), and AI technologies, the most fundamental challenge is to explore the relevant data collected from diverse sources and to extract useful insights for future actions.", [["AI-models", "TREATMENT", 20, 29], ["AI technologies", "TREATMENT", 271, 286], ["significant", "OBSERVATION_MODIFIER", 79, 90]]], ["Thus, in this section, we highlight and analyze the main challenges and research issues in the scope of our study.", [["our study", "TEST", 104, 113], ["main", "OBSERVATION_MODIFIER", 52, 56]]], ["In the following, the issues that we identified and corresponding future directions are discussed briefly.Research issues and future directions& According to our study in this paper, source datasets are the primary component to work in the area of mobile data science.", [["our study", "TEST", 158, 167]]], ["For instance, to manage mobile interruptions, the relevant contextual information and an individual's behavioral data is needed to be analyzed [4] .", [["an individual's behavioral data", "TEST", 86, 117]]], ["Similarly, for smart healthcare services, patient data and corresponding contextual information might be useful.", [["patient", "ORGANISM", 42, 49], ["patient", "SPECIES", 42, 49]]], ["Thus, to facilitate the extraction of reliable insight from the data using AI techniques and to use the knowledge in context-aware applications, integrating and effective management of mobile data is important.", [["the extraction", "TREATMENT", 20, 34], ["AI techniques", "TREATMENT", 75, 88]]], ["The reason is that AI methods particularly machine learning techniques highly impact on data [9] .", [["AI methods", "TREATMENT", 19, 29]]], ["Therefore, establishing a large number of recent datasets from diverse sources and to integrate and manage such information for effective data analysis is needed, which could be one of the major challenges to work in the area of mobile data science and data-driven intelligent applications. & The next challenge is an effective modeling of mobile users and their activities from the relevant data.", [["recent datasets", "PROBLEM", 42, 57], ["effective data analysis", "TEST", 128, 151], ["large", "OBSERVATION_MODIFIER", 26, 31]]], ["The main goal of mobile user modeling is the customization and adaptation of systems to the user's specific needs.", [["main", "OBSERVATION_MODIFIER", 4, 8]]], ["The system needs to output the 'right' outcome at the 'right' time or contexts in the 'right' way [4] .", [["right", "ANATOMY_MODIFIER", 87, 92]]], ["Therefore, effectively modeling mobile users considering these aspects, could be another research issue in the area of mobile data science and intelligent applications. & The context-sensitive features in mobile data and their patterns are of high interest to be discovered and analyzed to make context-aware intelligent decisions for a particular application in a pervasive computing environment.", [["intelligent applications", "TREATMENT", 143, 167]]], ["The traditional analytical techniques including data science and machine learning may not be applicable to make real-time decisions for analyzing smartphone data, because of a large number of data processing that may reduce the performance of mobile phones.", [["analyzing smartphone data", "TEST", 136, 161], ["large", "OBSERVATION_MODIFIER", 176, 181]]], ["For instance, the association rule mining technique [120] may discover a large number of redundant rules that become useless and make the decision-making process complex and ineffective [29] .", [["large", "OBSERVATION_MODIFIER", 73, 78]]], ["Such traditional techniques may not be applicable for analyzing smartphone data.", [["analyzing smartphone data", "TEST", 54, 79]]], ["Thus, a deeper understanding is necessary on the strengths and weaknesses of state-of-the-art big data processing and analytics systems to realize large-scale context-awareness and to build a smart context-aware model.", [["analytics systems", "TEST", 118, 135]]], ["Therefore effectively building a data-driven context-aware model for intelligent decision-making on smartphones, could be another research issue in the area of mobile data science and intelligent applications. & Real-life mobile phone datasets may contain many features or high-dimensions of contexts, which may cause several issues such as increases model complexity, may arise over-fitting problem, and consequently decreases the outcome of the resultant AI-based model [77] .", [["smartphones", "TREATMENT", 100, 111], ["high-dimensions", "OBSERVATION_MODIFIER", 273, 288], ["may cause", "UNCERTAINTY", 308, 317]]], ["The reason is that the performance of AI methods particularly machine learning algorithms heavily depends on the choice of features or data representation.", [["AI methods", "TREATMENT", 38, 48]]], ["Having irrelevant features or contextual information in the data makes the model learn based on irrelevant features that consequently decrease the accuracy of the models [132] .", [["irrelevant features", "PROBLEM", 7, 26], ["irrelevant features", "PROBLEM", 96, 115]]], ["In the area of AI, particularly data science and machine learning, feature optimization problem is considered as an important pre-processing step that helps to build an effective and simplified model and consequently improves the performance of the learning algorithms by removing the redundant and irrelevant features [111] .", [["AI", "PROBLEM", 15, 17], ["AI", "OBSERVATION", 15, 17]]], ["Therefore, feature optimization could be a significant research issue in the area of mobile data science and intelligent applications. & The next challenge is the extraction of the relevant and accurate information from the unstructured or semistructured data on mobile phones.", [["intelligent applications", "TREATMENT", 109, 133], ["the extraction", "TREATMENT", 159, 173], ["significant", "OBSERVATION_MODIFIER", 43, 54]]], ["A large amount of content such as emails, web pages, or documents is read on these devices frequently that is text-based [15] .", [["these devices", "TREATMENT", 77, 90], ["large", "OBSERVATION_MODIFIER", 2, 7], ["amount", "OBSERVATION_MODIFIER", 8, 14], ["content", "OBSERVATION", 18, 25]]], ["Thus the problem of information overload arises due to the small screen of the devices rather than the desktop computer.", [["information overload", "PROBLEM", 20, 40], ["the devices", "TREATMENT", 75, 86]]], ["Therefore effectively mining the contents or texts considering these aspects, could be another research issue in the area of mobile data science and intelligent applications.", [["intelligent applications", "TREATMENT", 149, 173]]], ["Several NLP tasks such as automatic summarization, information extraction, or new content development, etc. could be useful to minimize the issue. & Mobile expert system uses expert knowledge represented mainly as IF-THEN rules, to offer recommendations or making decisions in relevant application areas.", [["Several NLP tasks", "TEST", 0, 17], ["information extraction", "TREATMENT", 51, 73]]], ["However, the development of large-scale rule-based systems may face numerous challenges.", [["large", "OBSERVATION_MODIFIER", 28, 33], ["-scale", "OBSERVATION_MODIFIER", 33, 39], ["numerous", "OBSERVATION_MODIFIER", 68, 76], ["challenges", "OBSERVATION", 77, 87]]], ["For instance, the reasoning process can be very complex, and designing of such systems becomes hard to manage [133] .", [["such systems", "PROBLEM", 74, 86]]], ["There is still a lack of lightweight rule-based inference engines that will allow for reasoning on mobile devices [133] .", [["mobile devices", "TREATMENT", 99, 113]]], ["Thus a set of concise and effective rules will be beneficial in terms of outcome and simplicity for such a rule-based expert system for mobile devices.", [["mobile devices", "TREATMENT", 136, 150]]], ["Moreover, ontologies [125] capturing complex dependencies between concepts for a particular problem domain provides a flexible and expressive tool for modeling high-level concepts and relations among the given attributes, which allows both the system and the user to operate the same taxonomy and play an important role to build an expert system.", [["complex dependencies", "PROBLEM", 37, 57], ["a particular problem domain", "PROBLEM", 79, 106], ["a flexible and expressive tool", "PROBLEM", 116, 146], ["modeling high-level concepts", "TREATMENT", 151, 179]]], ["Thus, an effective design of ontology, or knowledge representation model for the respective problem domain could be another research issue.Research issues and future directions& The mobility of computing devices, e.g., smartphones, applications, and users leads to highly dynamic computing environments.", [["the respective problem domain", "PROBLEM", 77, 106], ["computing devices", "TREATMENT", 194, 211], ["smartphones", "TREATMENT", 219, 230], ["applications", "TREATMENT", 232, 244], ["mobility", "OBSERVATION_MODIFIER", 182, 190]]], ["Unlike desktop applications, which rely on a carefully configured, and largely static set of resources, pervasive computing applications are subjected to changes in available resources such as network connectivity, user contexts, etc. Moreover, they are frequently required to cooperate spontaneously and opportunistically with previous unknown software services to accomplish tasks on behalf of users.", [["pervasive computing applications", "TREATMENT", 104, 136]]], ["Context-awareness represents the ability of mobile devices to sense their physical environment and adapt their behavior accordingly, incorporating this property in the applications could be a potential solution to overcome this issue.DiscussionAlthough several research efforts have been directed towards intelligent mobile apps, discussed throughout the paper, this paper presents a comprehensive view of mobile data science and intelligent apps in terms of concepts and AI-based modeling.", [["mobile devices", "TREATMENT", 44, 58], ["a potential solution", "TREATMENT", 190, 210]]], ["For this, we have conducted a literature review to understand the contexts, mobile data, context-aware computing, data science, intelligent apps characteristics, and different types of mobile systems and services, as well as the used techniques, related to mobile applications.", [["mobile applications", "TREATMENT", 257, 276]]], ["Traditionally mobile app development mostly focused on knowledge that is not automatically discovered [47, 66] .", [["mobile", "OBSERVATION", 14, 20]]], ["Considering the volume of collected data and the features, one can decide whether the standalone or cloud-based application is more suitable to provide the target service.", [["the standalone", "TREATMENT", 82, 96], ["cloud-based application", "TREATMENT", 100, 123]]], ["Thus, the output of AI-based modeling can be used in many application areas such as mobile analytics, context-aware computing, pervasive computing, health analytics, smart cities, as well as the Internet of things (IoT).", [["the output", "TEST", 6, 16], ["AI", "TEST", 20, 22]]], ["Moreover, intelligent data-driven solutions could also be effective in AI-based mobile security and privacy, where AI works with huge volumes of security event data to extract the useful insights using machine learning techniques [10] .DiscussionAlthough the intelligent apps discussed in this paper can play a significant role in the betterment of human life in different directions, several dependencies may pose additional challenges, such as the availability of network and the data transfer speeds or the battery life of mobile devices.", [["human", "ORGANISM", 349, 354], ["network", "MULTI-TISSUE_STRUCTURE", 466, 473], ["human", "SPECIES", 349, 354], ["human", "SPECIES", 349, 354], ["driven solutions", "TREATMENT", 27, 43], ["mobile devices", "TREATMENT", 526, 540]]], ["Moreover, privacy and security issues may become another challenge while considering the data collection and processing over the cloud or within the device.", [["the data collection", "TEST", 85, 104], ["the device", "TREATMENT", 145, 155]]], ["Taking the advantages of these issues considering the application type and target goal, we believe this analysis and guidelines will be helpful for both the researchers and application developers to work in the area of mobile data science and intelligent apps.ConclusionIn this paper, we have studied on mobile data science and reviewed the motivation of using AI in mobile apps to make it intelligent.", [["this analysis", "TEST", 99, 112], ["AI in mobile apps", "TREATMENT", 361, 378]]], ["We aimed to provide an overview of how artificial intelligence can be used to design and develop data-driven intelligent mobile applications for the betterment of human life.", [["human", "ORGANISM", 163, 168], ["human", "SPECIES", 163, 168], ["human", "SPECIES", 163, 168], ["human life", "TREATMENT", 163, 173]]], ["Such AI-based modeling can be used to build intelligent mobile applications ranging from personalized recommendations to healthcare services including COVID-19 pandemic management, that are discussed briefly in this paper.", [["COVID-19 pandemic management", "TREATMENT", 151, 179]]], ["A successful intelligent mobile system must possess the relevant AI-based modeling depending on the data characteristics.", [["A successful intelligent mobile system", "TREATMENT", 0, 38], ["mobile system", "OBSERVATION", 25, 38]]], ["We have concluded with a discussion about various research issues and future directions relevant to our analysis in the area of mobile data science and intelligent apps, that can help the researchers to do future research in the identified directions.", [["our analysis", "TEST", 100, 112]]]], "4d7925e35692720096f5f7ba467e83da594e8207": [["31The COVID-19, also known as the coronavirus pandemic, is an ongoing pandemic of coronavirus Concern on 30th of January, and a pandemic on March 11 [14, 15] .", [["COVID-19", "CHEMICAL", 6, 14], ["coronavirus pandemic", "DISEASE", 34, 54], ["coronavirus", "DISEASE", 82, 93], ["coronavirus", "ORGANISM", 82, 93], ["The COVID", "TEST", 2, 11], ["the coronavirus pandemic", "PROBLEM", 30, 54], ["coronavirus", "PROBLEM", 82, 93], ["coronavirus", "OBSERVATION", 34, 45], ["coronavirus", "OBSERVATION", 82, 93]]], ["As of May 17, 2020, more than 463 36 million cases of COVID-19 have been reported in more than 188 countries and territories, resulting in 37 more than 311000 deaths.", [["deaths", "DISEASE", 159, 165], ["COVID", "TEST", 54, 59]]], ["More than 1.69 million people have recovered [16] .", [["people", "ORGANISM", 23, 29], ["people", "SPECIES", 23, 29]]], ["38 The virus is primarily spread between people during close contact, most often via small droplets 39 produced by coughing, sneezing, and talking [17, 18, 19] .", [["coughing", "DISEASE", 115, 123], ["people", "ORGANISM", 41, 47], ["people", "SPECIES", 41, 47], ["The virus", "PROBLEM", 3, 12], ["coughing", "PROBLEM", 115, 123], ["sneezing", "PROBLEM", 125, 133], ["virus", "OBSERVATION", 7, 12], ["primarily", "OBSERVATION_MODIFIER", 16, 25], ["spread", "OBSERVATION_MODIFIER", 26, 32]]], ["The droplets usually fall to the ground or 40 onto surfaces rather than traveling through air over long distances [17] .", [["droplets", "ANATOMY", 4, 12], ["The droplets", "PROBLEM", 0, 12], ["droplets", "OBSERVATION", 4, 12]]], ["Less commonly, people may 41 become infected by touching a contaminated surface and then touching their face [17, 18] .", [["surface", "ANATOMY", 72, 79], ["people", "ORGANISM", 15, 21], ["people", "SPECIES", 15, 21], ["infected", "OBSERVATION", 36, 44]]], ["92 In this paper, we formulated a mathematical model for the COVID-19 disease, which incorporates 93 some key epidemiological and biological features of the disease such as variation infection form, con-94 trol strategies taking account on some specificities of the Cameroon population.", [["infection", "DISEASE", 183, 192], ["the COVID-19 disease", "PROBLEM", 57, 77], ["the disease", "PROBLEM", 153, 164], ["variation infection", "PROBLEM", 173, 192], ["con-94 trol strategies", "TREATMENT", 199, 221], ["disease", "OBSERVATION", 157, 164]]], ["100 That's why it is important to consider the class of susceptible people who consider and apply these 101 measures of partial confinement and total confinement.", [["people", "ORGANISM", 68, 74], ["people", "SPECIES", 68, 74]]], ["Another particularity of the model concerns 102 variation of infection form which is very important on epidemiological view.", [["infection", "DISEASE", 61, 70], ["infection", "PROBLEM", 61, 70], ["infection", "OBSERVATION", 61, 70]]], ["The model suggested was 103 deeply analyzed and numerical simulations have been performed to supported theoretical studies and 104 to illustrate the effectiveness of each control strategy integrated.", [["numerical simulations", "TEST", 48, 69], ["theoretical studies", "TEST", 103, 122]]], ["The sensitivity analysis of the model 105 is carried out to identify the most influential parameters on the model output variables related to 106 infected classes, which is the most robust estimations that are required.107The rest of the paper is organized as follows.", [["The sensitivity analysis", "TEST", 0, 24], ["the model output", "TEST", 104, 120], ["infected", "OBSERVATION", 146, 154], ["most robust", "OBSERVATION_MODIFIER", 177, 188]]], ["After the formulation of the model in Section 2, we 108 present its quantitative and qualitative analysis in Section 3.", [["qualitative analysis", "TEST", 85, 105]]], ["Numerical simulations are provided in 109 Section 4.", [["Numerical simulations", "TEST", 0, 21]]], ["The last section is devoted to concluding remarks on how our work fits in the literature.107The population of coronavirus is denoted by V .107where \u03c0 is the proportion of infectious contact identified by public health workers.127In Cameroon, individuals partially confined are supposed able only to go work and market (for 128 catering) but should avoid being where there are many people (more than 50) like mosques, churches, 129 beer-houses, snack bars, etc [1, 40, 41] .", [["coronavirus", "ORGANISM", 110, 121], ["\u03c0", "GENE_OR_GENE_PRODUCT", 148, 149], ["people", "ORGANISM", 381, 387], ["people", "SPECIES", 381, 387], ["coronavirus", "PROBLEM", 110, 121], ["coronavirus", "OBSERVATION", 110, 121], ["infectious", "OBSERVATION", 171, 181]]], ["The people partially confined are exposed to the disease 130 through the force of infection \u03bb p = \u03b5\u03bb s where \u03b5 is the modification parameter which takes into ac-131 count the fact that people partially confined are less exposed than the susceptible individuals.", [["infection", "DISEASE", 82, 91], ["people", "ORGANISM", 4, 10], ["people", "ORGANISM", 185, 191], ["people", "SPECIES", 4, 10], ["people", "SPECIES", 185, 191], ["the disease", "PROBLEM", 45, 56], ["infection", "PROBLEM", 82, 91], ["ac", "TEST", 158, 160], ["infection", "OBSERVATION", 82, 91]]], ["When the situation becomes dramatic, the partial confinement could tends to the total 134 confinement at the rate of t 2 and return to partial confinement t 1 .135Susceptible individuals who have been known exposed with infected individuals or individuals in 136 latency phases should be quarantined to observe their disease status and anticipate their treatment 137 if it is necessary.", [["infected individuals or individuals in 136 latency phases", "PROBLEM", 220, 277], ["their disease status", "PROBLEM", 311, 331], ["their treatment", "TREATMENT", 347, 362], ["dramatic", "OBSERVATION_MODIFIER", 27, 35]]], ["This strategy control strategy reduces the expansion of the disease and its lethality.138Thus, the force of infection, in this case, is given by Eq.", [["infection", "DISEASE", 108, 117], ["This strategy control strategy", "TREATMENT", 0, 30], ["the disease", "PROBLEM", 56, 67], ["its lethality", "PROBLEM", 72, 85], ["infection", "PROBLEM", 108, 117], ["expansion", "OBSERVATION_MODIFIER", 43, 52], ["disease", "OBSERVATION", 60, 67], ["lethality", "OBSERVATION_MODIFIER", 76, 85], ["infection", "OBSERVATION", 108, 117]]], ["3.138where the modification parameter 0 \u2264 \u03ba \u2264 1 accounts for the assumed reduction in transmissibility of 140 latent individuals relative to infectious individuals.", [["the modification parameter", "TEST", 11, 37], ["infectious individuals", "PROBLEM", 141, 163], ["reduction", "OBSERVATION_MODIFIER", 73, 82], ["infectious", "OBSERVATION", 141, 151]]], ["But if they have a positive test, they will be treated.", [["a positive test", "PROBLEM", 17, 32]]], ["They can heal at 142 the rate of \u03b1 q or die at the rate of d 1 .4After the latency phase, most people with the COVID-19 will experience an asymptomatic form 144 of infection at the rate of \u03c9 a and others will experience moderate respiratory illness at the rate of 145 \u03c9 b .", [["respiratory", "ANATOMY", 229, 240], ["infection", "DISEASE", 164, 173], ["respiratory illness", "DISEASE", 229, 248], ["people", "ORGANISM", 95, 101], ["people", "SPECIES", 95, 101], ["the COVID", "TEST", 107, 116], ["infection", "PROBLEM", 164, 173], ["moderate respiratory illness", "PROBLEM", 220, 248], ["the rate", "TEST", 252, 260], ["infection", "OBSERVATION", 164, 173], ["moderate", "OBSERVATION_MODIFIER", 220, 228], ["respiratory illness", "OBSERVATION", 229, 248]]], ["In the two cases, they will recover without requiring special treatment \u03b1 a and \u03b1 b respectively.146The older people and those with underlying medical problems like cardiovascular disease, diabetes, 147 chronic respiratory disease and cancer are more likely to develop a serious illness at the rate of \u03c9 s .148Those who experience moderate respiratory illness may, at rate \u03c3 , develop serious illness in case quarantined (I q and Q) could die due to the disease at the rate d 1 (which is supposed be less than d 2 ).158The human population is submitted to the natural mortality of \u00b5 h .159The structure of the model is shown in Fig.1 .", [["cardiovascular", "ANATOMY", 165, 179], ["respiratory", "ANATOMY", 211, 222], ["cancer", "ANATOMY", 235, 241], ["respiratory", "ANATOMY", 340, 351], ["cardiovascular disease", "DISEASE", 165, 187], ["diabetes", "DISEASE", 189, 197], ["chronic respiratory disease", "DISEASE", 203, 230], ["cancer", "DISEASE", 235, 241], ["illness", "DISEASE", 279, 286], ["respiratory illness", "DISEASE", 340, 359], ["illness", "DISEASE", 393, 400], ["\u03b1 b", "GENE_OR_GENE_PRODUCT", 80, 83], ["people", "ORGANISM", 110, 116], ["cardiovascular", "ANATOMICAL_SYSTEM", 165, 179], ["cancer", "CANCER", 235, 241], ["human", "ORGANISM", 523, 528], ["\u03b1", "PROTEIN", 72, 73], ["people", "SPECIES", 110, 116], ["human", "SPECIES", 523, 528], ["human", "SPECIES", 523, 528], ["special treatment", "TREATMENT", 54, 71], ["underlying medical problems", "PROBLEM", 132, 159], ["cardiovascular disease", "PROBLEM", 165, 187], ["diabetes", "PROBLEM", 189, 197], ["chronic respiratory disease", "PROBLEM", 203, 230], ["cancer", "PROBLEM", 235, 241], ["a serious illness", "PROBLEM", 269, 286], ["moderate respiratory illness", "PROBLEM", 331, 359], ["serious illness", "PROBLEM", 385, 400], ["the disease", "PROBLEM", 450, 461], ["cardiovascular disease", "OBSERVATION", 165, 187], ["chronic", "OBSERVATION_MODIFIER", 203, 210], ["respiratory disease", "OBSERVATION", 211, 230], ["cancer", "OBSERVATION", 235, 241], ["moderate", "OBSERVATION_MODIFIER", 331, 339], ["respiratory illness", "OBSERVATION", 340, 359], ["disease", "OBSERVATION", 454, 461]]], ["The dashed arrow indicates contamination of the 160 environment by infected humans.", [["humans", "ORGANISM", 76, 82], ["humans", "SPECIES", 76, 82], ["humans", "SPECIES", 76, 82], ["infected", "OBSERVATION", 67, 75]]], ["The dynamics of the disease can be described by the following system of non-linear differential 162 5 equations:159We set159The parameter values of system (4) used for numerical simulations are given in Tab We investigate the asymptotic behavior of orbits starting in the nonnegative cone R 11 + .", [["the disease", "PROBLEM", 16, 27], ["non-linear differential", "TEST", 72, 95], ["numerical simulations", "TREATMENT", 168, 189], ["the asymptotic behavior of orbits", "PROBLEM", 222, 255], ["disease", "OBSERVATION", 20, 27], ["orbits", "ANATOMY", 249, 255]]], ["Obviously, 170 model (4) which is a C \u221e differential system, admits a unique maximal solution for any associated 171 Cauchy problem.172Theorem 3.1. :172) the maximal so-174 lution of the Cauchy problem associated to model (4).172By continuity of function S, C t , C p , Q, L, I a , I b , I q , I s , R and V one can see that \u2206 / 0.", [["a C \u221e differential system", "PROBLEM", 34, 59], ["a unique maximal solution", "TREATMENT", 68, 93], ["Cauchy problem", "PROBLEM", 117, 131], ["Theorem", "TEST", 135, 142], ["the Cauchy problem", "PROBLEM", 183, 201], ["I s", "TEST", 294, 297], ["170 model", "OBSERVATION_MODIFIER", 11, 20]]], ["LetT = sup \u2206.176Now, we are going to show thatT = T .", [["thatT = T", "GENE_OR_GENE_PRODUCT", 42, 51]]], ["SupposeT < T , then one has that S, C t , C p , Q, L, I a , I b , I q , I s ,177R and V are non negative on [0;T [.", [["177R", "PROTEIN", 77, 81], ["I s", "TEST", 72, 75], ["V", "TEST", 86, 87]]], ["AtT , at least one of the following conditions is satisfied S(T ) = 0,177Suppose S(T ) = 0, then from the first equation of model (4), one has177Integrating Eq.", [["AtT", "GENE_OR_GENE_PRODUCT", 0, 3], ["AtT", "PROTEIN", 0, 3]]], ["Then,T = T and consequently the maximal 187 We first split the model (4) into two parts, the human population, and the virus population.", [["T = T", "GENE_OR_GENE_PRODUCT", 5, 10], ["human", "ORGANISM", 93, 98], ["human", "SPECIES", 93, 98], ["human", "SPECIES", 93, 98], ["the human population", "TREATMENT", 89, 109], ["the virus population", "TREATMENT", 115, 135]]], ["Then, 188 using a model (4), the dynamics of the total human population satisfyBoundedness of solutionsIntegrating the above differential inequality yieldsBoundedness of solutionswhere r = max (r a , r b , r s ).", [["human", "ORGANISM", 55, 60], ["human", "SPECIES", 55, 60], ["human", "SPECIES", 55, 60], ["the total human population", "TREATMENT", 45, 71]]], ["(7) givesBoundedness of solutionsIt then follows thatBoundedness of solutionsThus, the region:Boundedness of solutionsis positively invariant and attracting for model (4).", [["Boundedness of solutions", "TREATMENT", 9, 33]]], ["Then, it is sufficient to consider the dynamics ofBoundedness of solutionswhere S 0 , C 0 p and C 0 t are given byBoundedness of solutionsNote that the total human population at the DFE, E , satisfiesBoundedness of solutionsThe basic reproduction number, which is very important for the qualitative analysis of the model, is determined here below by using the method of the next generation matrix used in [44] .", [["human", "ORGANISM", 158, 163], ["matrix", "CELLULAR_COMPONENT", 390, 396], ["human", "SPECIES", 158, 163], ["human", "SPECIES", 158, 163]]], ["Following notations in [44], matrices F and V for the new infection terms and the remaining transfer terms are, respectively, given byBoundedness of solutionsThe basic reproduction number denoted by R 0 is defined as the average number of secondary casesBoundedness of solutionswhere X S represents the class of non infected individuals (S, C p , C t ) and the vector X I represents the class of infected individuals (Q, L, I a ,Boundedness of solutionswith \u03d5 := 1 + \u03b5 and \u03b6 := 1 \u2212 \u03c0.218A direct computation shows that the eigenvalues of A 1 (X) are real and negative.", [["infection", "DISEASE", 58, 67], ["X S", "GENE_OR_GENE_PRODUCT", 284, 287], ["vector X I", "GENE_OR_GENE_PRODUCT", 361, 371], ["1 + \u03b5", "SIMPLE_CHEMICAL", 463, 468], ["X S", "DNA", 284, 287], ["vector X I", "DNA", 361, 371], ["the new infection terms", "PROBLEM", 50, 73], ["secondary cases", "PROBLEM", 239, 254], ["non infected individuals", "PROBLEM", 312, 336], ["infected individuals", "PROBLEM", 396, 416], ["\u03b6", "TEST", 473, 474], ["A direct computation", "TEST", 487, 507], ["new", "OBSERVATION_MODIFIER", 54, 57], ["infection", "OBSERVATION", 58, 67], ["infected", "OBSERVATION", 396, 404], ["negative", "OBSERVATION", 559, 567]]], ["Thus the system Let us consider the bounded set D:218Let us recall the following theorem [59]227(3) For any x \u2208 D, the matrix A 2 (X) is Metzler irreducible.228(4) There exists a matrix\u0100 2 , which is an upper bound of the set230(5) The stability modulus of\u0100 2 ,230Then the DFE is GAS in D. (See [59] for a proof).", [["DFE", "DNA", 273, 276], ["GAS", "DNA", 280, 283], ["Metzler irreducible", "PROBLEM", 137, 156], ["The stability modulus", "TEST", 232, 253], ["irreducible", "OBSERVATION", 145, 156], ["upper", "ANATOMY_MODIFIER", 203, 208], ["stability", "OBSERVATION_MODIFIER", 236, 245], ["modulus", "OBSERVATION_MODIFIER", 246, 253], ["GAS", "OBSERVATION", 280, 283]]], ["An upper bound of the set of matrices A 2 , which is the matrix\u0100 2 is given b\u0233230To check condition (5) Using lemma 3.2, matrix\u0100 2 can be express in the form of the matrix M with:230Clearly, A is a stable Metzler matrix.230and R 2 = \u03c9 b r s \u03c3 k 7 k 9 + \u03c9 s r s k 9 + \u03c9 b r b k 7 + \u03c9 a r a k 6 244 Theorem (3.3) means that for R 0 < R c \u2264 1, the DFE E is the unique equilibrium in D which is GAS.245If R c < R 0 \u2264 1, the backward bifurcation phenomenon may occurs in \u2126, i.e. the DFE E , may coexists 246 with two endemic equilibrium, one asymptotically stable and one unstable.247The epidemiological significance of the phenomenon of backward bifurcation is that the require-248 ment of R c < R 0 < 1 is, although necessary, no longer sufficient for disease eradication when the initial 249 condition is taken in \u2126.", [["Metzler matrix", "ANATOMY", 205, 219], ["Metzler matrix", "CELLULAR_COMPONENT", 205, 219], ["DFE E", "SIMPLE_CHEMICAL", 345, 350], ["D", "SIMPLE_CHEMICAL", 380, 381], ["R c", "GENE_OR_GENE_PRODUCT", 686, 689], ["matrix\u0100", "TREATMENT", 121, 128], ["k", "TEST", 243, 244], ["k", "TEST", 247, 248], ["k", "TEST", 261, 262], ["k", "TEST", 275, 276], ["a k", "TEST", 287, 290], ["Theorem", "TEST", 297, 304], ["means", "TEST", 311, 316], ["R", "TEST", 326, 327], ["the DFE E", "TEST", 341, 350], ["GAS", "TEST", 391, 394], ["the backward bifurcation phenomenon", "PROBLEM", 416, 451], ["two endemic equilibrium", "PROBLEM", 508, 531], ["disease eradication", "PROBLEM", 749, 768], ["upper bound", "OBSERVATION_MODIFIER", 3, 14], ["stable", "OBSERVATION", 198, 204], ["bifurcation", "OBSERVATION_MODIFIER", 429, 440], ["stable", "OBSERVATION_MODIFIER", 552, 558], ["unstable", "OBSERVATION_MODIFIER", 567, 575]]], ["In such a scenario, disease elimination would depend on various initial sizes of247\u03b2 v K (\u03c7 1 + \u03b5 \u03c7 2 ), A 2 = 2\u03b6 (2\u03c7 6 \u03c7 7 + 2\u03c7 6 \u03c7 9 + 2\u03c7 7 \u03c7 9 + \u03c7 2 6 + \u03c7 2 7 + \u03c7 2 9 ) \u00d7247so that247x 11 x 11 + K \u03bb p = \u03b5\u03bb s and \u03bb q = \u03c0\u03b2 h \u03bax 5 + x 6 + x 7 + x 9 N Further, by using the vector notation x = (x 1 , x 2 , x 3 , x 4 , x 5 , x 6 , x 7 , x 8 , x 9 , x 10 , x 11 ) T , model (4) can be written247The Jacobian of system (20) at the DFE E is247The basic reproduction number of the transformed (linearized) model system (20) is the same as 266 that of the original model given by Eq.", [["disease elimination", "PROBLEM", 20, 39], ["K", "TEST", 87, 88], ["\u03c7", "TEST", 90, 91], ["A", "TEST", 105, 106], ["\u03b6", "TEST", 112, 113], ["\u03c7", "TEST", 120, 121], ["\u03c7", "TEST", 131, 132], ["K", "TEST", 198, 199], ["p", "TEST", 202, 203], ["\u03b5\u03bb", "TEST", 206, 208], ["s", "TEST", 209, 210], ["\u03bb", "TEST", 215, 216], ["q", "TEST", 217, 218], ["\u03c0\u03b2", "TEST", 221, 223], ["h", "TEST", 224, 225], ["\u03bax", "TEST", 226, 228], ["N Further", "TEST", 249, 258], ["the vector notation x", "TEST", 269, 290], ["T , model", "TEST", 362, 371], ["The Jacobian of system", "TEST", 393, 415], ["disease", "OBSERVATION", 20, 27], ["sizes", "OBSERVATION_MODIFIER", 72, 77], ["\u03bax", "ANATOMY_MODIFIER", 226, 228], ["5 + x 6 + x 7 + x 9 N", "ANATOMY_MODIFIER", 229, 250], ["x 3 , x 4 , x 5 , x 6 , x 7 , x 8 , x 9", "ANATOMY_MODIFIER", 306, 345]]], ["Therefore, choosing \u03b2 h as a bifurcation parameter by solving 267 for \u03c0 when R 0 = 1, one obtains247It follows that the Jacobian J(E ) of system (20)247where 0 is an equilibrium point of the system (that is, f (0, \u03a6) \u2261 0 for all \u03a6) and assume In order to apply the above theorem, the following computations are necessary (it should be noted 295 that we are used \u03b2 * h as the bifurcation parameter, in place of \u03a6 in Theorem 3.5).296Eigenvectors of J \u03b2 * h : For the case when R 0 = 1, it can be shown that the Jacobian of system (20) has a right eigenvector U = (u 1 , u 2 , u 3 , u 4 , u 5 , u 6 , u 7 , u 8 , u 9 , u 10 , u 11 ) T verifying J \u03b2 * h U = 0 given by: u 1 = \u2212\u03c7 1 u 5 , u 2 = \u2212\u03c7 2 u 5 , u 3 = \u03c7 3 u 5 , u 4 = \u03c7 4 u 5 , u 5 = u 5 > 0, u 6 = \u03c7 6 u 5 , u 7 = \u03c7 7 u 5 , u 8 = \u03c7 8 u 5 , u 8 = \u03c7 8 u 5 u 9 = \u03c7 9 u 5 , u 10 = \u03c7 10 u 5 , and u 11 = \u03c7 11 u 5 where296\u03c7 10 = 1 \u00b5 h (\u03b1 q \u03c7 4 + \u03b1 a \u03c7 6 + \u03b1 b \u03c7 7 + \u03b1 i \u03c7 8 + \u03b1 s \u03c7 9 ),Similarly, the components of the left eigenvectorsV = (v 1 , v 2 , v 3 , v 4 , v 5 , v 6 , v 7 , v 8 , v 9 , v 10 , v 11 ) of J \u03b2 * h ver- ifying V J \u03b2 * h = 0 are given by v 1 = 0, v 2 = 0, v 3 = 0, v 4 = 0, v 5 = v 5 > 0, v 6 = \u03d1 6 v 5 , v 7 = \u03d1 7 v 5 , v 8 = 0, v 9 = \u03d1 9 v 5 , v 10 = 0 and v 11 = \u03d1 11 v 5 where \u03d1 6 = 1 k 6 A + Br a \u00b5 v , \u03d1 7 = 1 k 7 A + \u03c3 k 9 A + Br s \u00b5 v + Br b \u00b5 v , \u03d1 9 = 1 k 9 A + Br s \u00b5 v and \u03d1 11 = B \u00b5 v with A = (1 \u2212 \u03c0)\u03b2 h (S 0 + \u03b5C 0 p ) N 0 and B = (1 \u2212 \u03c0)\u03b2 v (S 0 + \u03b5C 0 p ) KComputation of a:The bifurcation coefficient a at the DFE is given byComputation of a:\u03b2 v K (\u03c7 1 + \u03b5 \u03c7 2 ), A 2 = 2\u03b6 (2\u03c7 6 \u03c7 7 + 2\u03c7 6 \u03c7 9 + 2\u03c7 7 \u03c7 9 + \u03c7 2 6 + \u03c7 2 7 + \u03c7 2 9 ) \u00d7Computation of a:Computation of b : The second bifurcation coefficient b is given by , \u03b1 a , p 2 \u03b2 h , \u03b1 a \u03b2 h , \u03b1 a \u03b2 h , \u03b1 a \u03b2 h , \u03b1 a \u03b2 h , \u03b1 a , \u00b5 v Table 3 : List of parameters statistically more influencing to state variables Q, I a , I b , I q and I s .322The parameters \u03b2 h (exposure rate to infected people) and \u03b1 a (recovery rate of asymptomatic infected 323 people) are those significantly correlated to state variables Q, I a , I b , I q , I s which are related to infected 324 14 people.", [["1 \u2212 \u03c0", "SIMPLE_CHEMICAL", 1378, 1383], ["B = (1 \u2212 \u03c0", "SIMPLE_CHEMICAL", 1412, 1422], ["people", "ORGANISM", 1929, 1935], ["people", "ORGANISM", 1989, 1995], ["people", "ORGANISM", 2113, 2119], ["\u03a6", "PROTEIN", 229, 230], ["J \u03b2", "PROTEIN", 642, 645], ["\u03c7 9", "PROTEIN", 929, 932], ["J \u03b2", "PROTEIN", 1061, 1064], [":\u03b2 v K", "CELL_LINE", 1529, 1535], ["\u03b1", "PROTEIN", 1707, 1708], ["\u03b1", "PROTEIN", 1723, 1724], ["\u03b1", "PROTEIN", 1733, 1734], ["\u03b1", "PROTEIN", 1743, 1744], ["\u03b1", "PROTEIN", 1753, 1754], ["\u03b1", "PROTEIN", 1763, 1764], ["people", "SPECIES", 1929, 1935], ["people", "SPECIES", 1989, 1995], ["people", "SPECIES", 2113, 2119], ["a right eigenvector U", "TEST", 537, 558], ["u", "TEST", 568, 569], ["u", "TEST", 574, 575], ["u", "TEST", 580, 581], ["u", "TEST", 586, 587], ["u", "TEST", 592, 593], ["u", "TEST", 598, 599], ["u", "TEST", 604, 605], ["u", "TEST", 610, 611], ["u", "TEST", 616, 617], ["u", "TEST", 623, 624], ["T", "TEST", 630, 631], ["J", "TEST", 642, 643], ["U", "TEST", 650, 651], ["u", "TEST", 666, 667], ["\u2212\u03c7", "TEST", 672, 674], ["u", "TEST", 677, 678], ["u", "TEST", 683, 684], ["\u2212\u03c7", "TEST", 689, 691], ["u", "TEST", 694, 695], ["u", "TEST", 700, 701], ["u", "TEST", 710, 711], ["u", "TEST", 716, 717], ["\u03c7", "TEST", 722, 723], ["u", "TEST", 726, 727], ["u", "TEST", 732, 733], ["u", "TEST", 738, 739], ["u", "TEST", 747, 748], ["\u03c7", "TEST", 753, 754], ["u", "TEST", 757, 758], ["u", "TEST", 763, 764], ["\u03c7", "TEST", 769, 770], ["u", "TEST", 773, 774], ["u", "TEST", 779, 780], ["\u03c7", "TEST", 785, 786], ["u", "TEST", 789, 790], ["u", "TEST", 795, 796], ["u", "TEST", 805, 806], ["u", "TEST", 809, 810], ["u", "TEST", 819, 820], ["u", "TEST", 825, 826], ["u", "TEST", 837, 838], ["u", "TEST", 847, 848], ["u", "TEST", 859, 860], ["\u03c7", "TEST", 889, 890], ["\u03c7", "TEST", 899, 900], ["\u03b1", "TEST", 905, 906], ["\u03c7", "TEST", 909, 910], ["\u03c7", "TEST", 919, 920], ["Similarly", "TEST", 935, 944], ["eigenvectorsV", "TEST", 973, 986], ["v", "TEST", 1002, 1003], ["v", "TEST", 1008, 1009], ["v", "TEST", 1014, 1015], ["v", "TEST", 1020, 1021], ["v", "TEST", 1026, 1027], ["v", "TEST", 1032, 1033], ["v", "TEST", 1038, 1039], ["v", "TEST", 1044, 1045], ["v", "TEST", 1051, 1052], ["J", "TEST", 1061, 1062], ["ver", "TEST", 1069, 1072], ["ifying", "TEST", 1074, 1080], ["J", "TEST", 1083, 1084], ["h", "TEST", 1089, 1090], ["are", "TEST", 1095, 1098], ["v", "TEST", 1108, 1109], ["v", "TEST", 1117, 1118], ["v", "TEST", 1126, 1127], ["v", "TEST", 1135, 1136], ["v", "TEST", 1144, 1145], ["v", "TEST", 1150, 1151], ["v", "TEST", 1159, 1160], ["v", "TEST", 1175, 1176], ["v", "TEST", 1191, 1192], ["v", "TEST", 1200, 1201], ["v", "TEST", 1210, 1211], ["v", "TEST", 1216, 1217], ["v", "TEST", 1229, 1230], ["v", "TEST", 1241, 1242], ["\u03d1", "TEST", 1251, 1252], ["k", "TEST", 1259, 1260], ["A", "TEST", 1263, 1264], ["Br", "TEST", 1267, 1269], ["a", "TEST", 1270, 1271], ["v", "TEST", 1274, 1275], ["\u03d1", "TEST", 1278, 1279], ["k", "TEST", 1286, 1287], ["A", "TEST", 1290, 1291], ["k", "TEST", 1296, 1297], ["A", "TEST", 1300, 1301], ["Br s", "TEST", 1304, 1308], ["\u00b5", "TEST", 1309, 1310], ["v", "TEST", 1311, 1312], ["Br", "TEST", 1315, 1317], ["b", "TEST", 1318, 1319], ["\u00b5", "TEST", 1320, 1321], ["v", "TEST", 1322, 1323], ["\u03d1", "TEST", 1326, 1327], ["k", "TEST", 1334, 1335], ["A", "TEST", 1338, 1339], ["Br s", "TEST", 1342, 1346], ["v", "TEST", 1349, 1350], ["\u03d1", "TEST", 1355, 1356], ["B", "TEST", 1362, 1363], ["\u00b5", "TEST", 1364, 1365], ["v", "TEST", 1366, 1367], ["A", "TEST", 1373, 1374], ["\u03c0", "TEST", 1382, 1383], ["h", "TEST", 1386, 1387], ["S", "TEST", 1389, 1390], ["C", "TEST", 1396, 1397], ["B", "TEST", 1412, 1413], ["\u03c0", "TEST", 1421, 1422], ["\u03b2", "TEST", 1423, 1424], ["v", "TEST", 1425, 1426], ["S", "TEST", 1428, 1429], ["C", "TEST", 1435, 1436], ["KComputation", "TEST", 1443, 1455], ["the DFE", "TEST", 1494, 1501], ["byComputation", "TEST", 1511, 1524], ["K", "TEST", 1534, 1535], ["\u03c7", "TEST", 1537, 1538], ["\u03c7", "TEST", 1545, 1546], ["A", "TEST", 1552, 1553], ["\u03b6", "TEST", 1559, 1560], ["\u03c7", "TEST", 1563, 1564], ["\u03c7", "TEST", 1567, 1568], ["\u03c7", "TEST", 1574, 1575], ["\u03c7", "TEST", 1585, 1586], ["\u03c7", "TEST", 1595, 1596], ["The second bifurcation coefficient", "TEST", 1656, 1690], ["a", "TEST", 1765, 1766], ["List of parameters", "TEST", 1783, 1801], ["I s", "TEST", 1875, 1878], ["The parameters", "TEST", 1883, 1897], ["exposure rate", "TEST", 1903, 1916], ["right", "ANATOMY_MODIFIER", 539, 544], ["left", "ANATOMY_MODIFIER", 968, 972], ["bifurcation", "ANATOMY", 1465, 1476], ["bifurcation", "OBSERVATION_MODIFIER", 1667, 1678]]], ["This suggests that an effective control strategy should aim to reduce significantly human 325 contact and to quickly identify asymptomatic infected people in order to isolate and treat them.326The relevance of the basic reproduction ratio of R 0 is due to the Lemma 3.1.", [["human", "ORGANISM", 84, 89], ["people", "ORGANISM", 148, 154], ["human", "SPECIES", 84, 89], ["people", "SPECIES", 148, 154], ["human", "SPECIES", 84, 89], ["an effective control strategy", "TREATMENT", 19, 48], ["asymptomatic infected people", "PROBLEM", 126, 154], ["the basic reproduction ratio", "TEST", 210, 238]]], ["5 we give the list of parameters of model (4) more correlated to R 0 , R max 0 and R c .", [["R c", "GENE_OR_GENE_PRODUCT", 83, 86]]], ["Table 5 : List of parameters more correlated to R 0 , R max 0 and R c .334It is clear that the parameter \u03b2 h is the one-parameter strongly correlated to R 0 , R max 0 and R c .334The result concerning the computation of the sensitivity index of R 0 , R max 0 and R c with respect 343 to each parameter is given in the Tab 6.", [["R c", "GENE_OR_GENE_PRODUCT", 263, 266], ["the sensitivity index", "TEST", 220, 241], ["clear", "OBSERVATION", 80, 85]]], ["The parameters whose sensitivity index has negative sign and R c .", [["R c", "GENE_OR_GENE_PRODUCT", 61, 64], ["R c", "PROTEIN", 61, 64], ["The parameters", "TEST", 0, 14], ["sensitivity index", "TEST", 21, 38]]], ["This means that it is firstly 350 urgent for Cameroonian authorities to improve strategies to identify exposed people in order to isolate them.", [["people", "ORGANISM", 111, 117], ["people", "SPECIES", 111, 117], ["Cameroonian authorities", "TREATMENT", 45, 68]]], ["Secondly, maximise the strategies to reduce human and environmental transmission.. conditions when \u039b = 10, K = 10 6 (so that R 0 = 0.6910 < 1).", [["human", "ORGANISM", 44, 49], ["human", "SPECIES", 44, 49], ["human", "SPECIES", 44, 49], ["\u039b", "TEST", 99, 100], ["K", "TEST", 107, 108]]], ["All other parameter values are as in Tab.", [["All other parameter values", "TEST", 0, 26]]], ["1.357As it is expected the solutions of (4) converge toward disease equilibrium. to isolate 80% of exposed people the disease disappears about 100 days.", [["people", "ORGANISM", 107, 113], ["people", "SPECIES", 107, 113], ["disease equilibrium", "PROBLEM", 60, 79], ["the disease", "PROBLEM", 114, 125], ["disease", "OBSERVATION", 118, 125]]], ["It is then vital to isolate 371 those who have been exposed to the disease or those coming from affected countries.", [["the disease", "PROBLEM", 63, 74], ["disease", "OBSERVATION", 67, 74]]], ["That's 372 why many countries used contact tracing to identify exposed people to isolate them.", [["people", "ORGANISM", 71, 77], ["people", "SPECIES", 71, 77], ["contact tracing", "TEST", 35, 50]]], ["Dr Laura Confinement: Partial confinement in Cameroon consist to avoid social gathering, imposing travel 378 restrictions and to maintain social distancing [1] .", [["Partial", "OBSERVATION_MODIFIER", 22, 29]]], ["The WHO recommend early execution of this 379 strategies when the disease is detected [9] .", [["the disease", "PROBLEM", 62, 73], ["disease", "OBSERVATION", 66, 73]]], ["2) less than those that are not confined to be infected.", [["infected", "PROBLEM", 47, 55], ["less", "OBSERVATION_MODIFIER", 3, 7], ["not confined to be", "UNCERTAINTY", 28, 46], ["infected", "OBSERVATION", 47, 55]]], ["382 We simulated model (4) for p 2 = 0.94 (R 0 = 3.03), p 2 = 0.54 (R 0 = 3.08) and p 2 = 0.04 (R 0 = 4.01) 383 when \u039b = 100, K = 10 3 and all other parameters values are as in Tab Mask and hygiene rules: Some studies to Hong Kong with hamsters showed that the transmission 405 of COVID-19 was reduced by more than 60% when the masks are massively used [10] .", [["COVID-19", "CHEMICAL", 281, 289], ["hamsters", "ORGANISM", 236, 244], ["COVID-19", "DNA", 281, 289], ["hamsters", "SPECIES", 236, 244], ["p", "TEST", 31, 32], ["p", "TEST", 56, 57], ["p", "TEST", 84, 85], ["K", "TEST", 126, 127], ["all other parameters values", "TEST", 139, 166], ["Tab Mask", "TREATMENT", 177, 185], ["COVID", "TEST", 281, 286]]], ["What413We presented a mathematical model for the dynamics of COVID-19 whose first 508 cases were We suggest a model that takes into account biological and epidemiological facts known of the dis-422 ease and the control actions used in Cameroon.", [["COVID", "TEST", 61, 66]]], ["A qualitative analysis of the model has been presented.423Our findings on the long term dynamics of the system can be summarized as follows: (1) we computed 424 the disease-free equilibrium and derived the basic reproduction number R 0 that determines the out-425 come of COVID-19;423(2) we proved that there exists a threshold parameter R c such that the disease-free 426 equilibrium is globally asymptotically stable whenever R 0 < R c < 1, while when R c < R 0 < 1 the model 427 can exhibit the phenomenon of backward bifurcation; (3) the sensitivity analysis of the system has 428 been performed.", [["A qualitative analysis", "TEST", 0, 22], ["the disease-free equilibrium", "PROBLEM", 161, 189], ["COVID", "TEST", 272, 277], ["the disease", "PROBLEM", 352, 363], ["the sensitivity analysis of the system", "TEST", 538, 576]]], ["We found that state variables related to infected people are most sensitive to expo-429 sure rates to infected people and the recovery rate of asymptomatic infected people.", [["people", "ORGANISM", 50, 56], ["people", "ORGANISM", 111, 117], ["people", "ORGANISM", 165, 171], ["people", "SPECIES", 50, 56], ["people", "SPECIES", 111, 117], ["people", "SPECIES", 165, 171], ["infected people", "PROBLEM", 41, 56], ["asymptomatic infected people", "PROBLEM", 143, 171], ["infected", "OBSERVATION", 41, 49], ["asymptomatic", "OBSERVATION_MODIFIER", 143, 155], ["infected", "OBSERVATION", 156, 164]]], ["This suggests that 430 effective control strategies should reduce significantly human contact and to quickly identify asymp-431 tomatic infected people in order to isolate and treat them; (4) numerical simulation has been presented 432 to illustrate the theoretical results on the general dynamic of the model.", [["human", "ORGANISM", 80, 85], ["people", "ORGANISM", 145, 151], ["human", "SPECIES", 80, 85], ["people", "SPECIES", 145, 151], ["human", "SPECIES", 80, 85], ["asymp", "TEST", 118, 123]]], ["A numerical evaluation of 433 control strategies has been performed.", [["A numerical evaluation", "TEST", 0, 22]]], ["We found that isolation has a real impact on COVID-19 trans-434 mission.", [["COVID", "TEST", 45, 50], ["isolation", "OBSERVATION", 14, 23]]], ["When efforts are made through tracing to isolate 80% of exposed people the disease disap-435 pears about 100 days.", [["people", "ORGANISM", 64, 70], ["people", "SPECIES", 64, 70], ["tracing", "TEST", 30, 37], ["the disease disap", "PROBLEM", 71, 88]]], ["Although partial confinement does not eradicate the disease it is observed that, 436 during partial confinement, when at least 10% of the partially confined population is totally confined,437COVID-19 spread stops after 150 days.", [["the disease", "PROBLEM", 48, 59], ["disease", "OBSERVATION", 52, 59]]], ["The strategy of testing has also a real impact on the disease.438In that model, we found that when more than 95% of moderate and symptomatic infected people are 439 identified and isolated, the disease is also really controlled after 90 days.", [["people", "ORGANISM", 150, 156], ["people", "SPECIES", 150, 156], ["testing", "TEST", 16, 23], ["the disease", "PROBLEM", 50, 61], ["moderate and symptomatic infected people", "PROBLEM", 116, 156], ["the disease", "PROBLEM", 190, 201], ["disease", "OBSERVATION", 54, 61], ["moderate", "OBSERVATION_MODIFIER", 116, 124], ["symptomatic", "OBSERVATION_MODIFIER", 129, 140], ["infected", "OBSERVATION", 141, 149], ["disease", "OBSERVATION", 194, 201]]], ["The wearing of mask and", [["mask", "TREATMENT", 15, 19]]]], "c93e251c48b43dfc3e162039968b8ce59810c410": [["Type III interferons, also known as interferon lambdas (IFN\u03bbs), are the most recent addition to the IFN family following their discovery in 2003.", [["Type III interferons", "GENE_OR_GENE_PRODUCT", 0, 20], ["interferon lambdas", "GENE_OR_GENE_PRODUCT", 36, 54], ["IFN\u03bb", "GENE_OR_GENE_PRODUCT", 56, 60], ["Type III interferons", "PROTEIN", 0, 20], ["interferon lambdas", "PROTEIN", 36, 54], ["IFN", "PROTEIN", 56, 59], ["IFN family", "PROTEIN", 100, 110], ["Type III interferons", "PROBLEM", 0, 20], ["interferon lambdas", "TREATMENT", 36, 54], ["interferons", "OBSERVATION", 9, 20]]], ["Initially, IFN\u03bb was demonstrated to induce expression of interferon-stimulated genes and exert antiviral properties in a similar manner to type I IFNs.", [["IFN\u03bb", "GENE_OR_GENE_PRODUCT", 11, 15], ["type I IFNs", "GENE_OR_GENE_PRODUCT", 139, 150], ["IFN\u03bb", "PROTEIN", 11, 15], ["interferon-stimulated genes", "DNA", 57, 84], ["type I IFNs", "PROTEIN", 139, 150], ["interferon", "TREATMENT", 57, 67], ["antiviral properties", "TREATMENT", 95, 115]]], ["However, while IFN\u03bb has been described to have largely overlapping expression and function with type I IFNs, it has become increasingly clear that type III IFNs also have distinct functions from type I IFNs.", [["IFN\u03bb", "GENE_OR_GENE_PRODUCT", 15, 19], ["type I IFNs", "GENE_OR_GENE_PRODUCT", 96, 107], ["type III IFNs", "GENE_OR_GENE_PRODUCT", 147, 160], ["type I IFNs", "GENE_OR_GENE_PRODUCT", 195, 206], ["IFN\u03bb", "PROTEIN", 15, 19], ["type I IFNs", "PROTEIN", 96, 107], ["type III IFNs", "PROTEIN", 147, 160], ["type I IFNs", "PROTEIN", 195, 206], ["type I IFNs", "PROBLEM", 96, 107], ["type I IFNs", "PROBLEM", 195, 206], ["clear", "OBSERVATION", 136, 141]]], ["In contrast to type I IFNs, whose receptor is ubiquitously expressed, type III IFNs signal and function largely at barrier epithelial surfaces, such as the respiratory and gastrointestinal tracts, as well as the blood-brain barrier.", [["barrier epithelial surfaces", "ANATOMY", 115, 142], ["respiratory", "ANATOMY", 156, 167], ["gastrointestinal tracts", "ANATOMY", 172, 195], ["blood-brain barrier", "ANATOMY", 212, 231], ["type I IFNs", "GENE_OR_GENE_PRODUCT", 15, 26], ["type III IFNs", "GENE_OR_GENE_PRODUCT", 70, 83], ["barrier epithelial surfaces", "TISSUE", 115, 142], ["gastrointestinal tracts", "MULTI-TISSUE_STRUCTURE", 172, 195], ["blood", "MULTI-TISSUE_STRUCTURE", 212, 217], ["brain barrier", "MULTI-TISSUE_STRUCTURE", 218, 231], ["type I IFNs", "PROTEIN", 15, 26], ["type III IFNs", "PROTEIN", 70, 83], ["type III IFNs signal", "PROBLEM", 70, 90], ["the respiratory and gastrointestinal tracts", "PROBLEM", 152, 195], ["the blood-brain barrier", "TREATMENT", 208, 231], ["respiratory", "ANATOMY", 156, 167], ["gastrointestinal tracts", "ANATOMY", 172, 195], ["brain", "ANATOMY", 218, 223]]], ["In further support of unique functions for type III IFNs, single nucleotide polymorphisms in IFNL genes in humans are strongly associated with outcomes to viral infection.", [["nucleotide", "CHEMICAL", 65, 75], ["viral infection", "DISEASE", 155, 170], ["type III IFNs", "GENE_OR_GENE_PRODUCT", 43, 56], ["IFNL", "GENE_OR_GENE_PRODUCT", 93, 97], ["humans", "ORGANISM", 107, 113], ["type III IFNs", "PROTEIN", 43, 56], ["IFNL genes", "DNA", 93, 103], ["humans", "SPECIES", 107, 113], ["humans", "SPECIES", 107, 113], ["type III IFNs", "PROBLEM", 43, 56], ["single nucleotide polymorphisms in IFNL genes in humans", "PROBLEM", 58, 113], ["viral infection", "PROBLEM", 155, 170], ["infection", "OBSERVATION", 161, 170]]], ["These biological linkages have also been more directly supported by studies in mice highlighting roles of IFN\u03bb in promoting antiviral immune responses.", [["mice", "ORGANISM", 79, 83], ["IFN\u03bb", "GENE_OR_GENE_PRODUCT", 106, 110], ["IFN\u03bb", "PROTEIN", 106, 110], ["mice", "SPECIES", 79, 83], ["mice", "SPECIES", 79, 83], ["antiviral immune", "OBSERVATION", 124, 140]]], ["In this review, we discuss the current understanding of type III IFNs, and how their functions are similar to, and different from, type I IFN in various immune cell subtypes and viral infections.", [["immune cell", "ANATOMY", 153, 164], ["viral infections", "DISEASE", 178, 194], ["type III IFNs", "GENE_OR_GENE_PRODUCT", 56, 69], ["type I IFN", "GENE_OR_GENE_PRODUCT", 131, 141], ["immune cell", "CELL", 153, 164], ["type III IFNs", "PROTEIN", 56, 69], ["type I IFN", "PROTEIN", 131, 141], ["type I IFN", "PROBLEM", 131, 141], ["various immune cell subtypes", "PROBLEM", 145, 173], ["viral infections", "PROBLEM", 178, 194], ["immune cell subtypes", "OBSERVATION", 153, 173], ["viral infections", "OBSERVATION", 178, 194]]]], "926f7fc1c2401c742046495262b43f957017ec40": [["| INTRODUCTIONSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus that causes severe respiratory diseases and is closely related to SARS-CoV, was described for the first time in the city of Wuhan in the Hubei province of China in late December 2019 (https://www.who.int/ csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/).", [["respiratory", "ANATOMY", 113, 124], ["acute respiratory syndrome coronavirus", "DISEASE", 21, 59], ["coronavirus", "DISEASE", 82, 93], ["respiratory diseases", "DISEASE", 113, 133], ["SARS", "DISEASE", 160, 164], ["INTRODUCTIONSevere acute respiratory syndrome coronavirus 2", "ORGANISM", 2, 61], ["SARS-CoV-2", "ORGANISM", 63, 73], ["coronavirus", "ORGANISM", 82, 93], ["SARS-CoV", "ORGANISM", 160, 168], ["INTRODUCTIONSevere acute respiratory syndrome coronavirus", "SPECIES", 2, 59], ["SARS-CoV-2", "SPECIES", 63, 73], ["SARS-CoV", "SPECIES", 160, 168], ["acute respiratory syndrome coronavirus", "PROBLEM", 21, 59], ["SARS", "TEST", 63, 67], ["CoV", "TEST", 68, 71], ["a new coronavirus", "PROBLEM", 76, 93], ["severe respiratory diseases", "PROBLEM", 106, 133], ["SARS", "PROBLEM", 160, 164], ["acute", "OBSERVATION_MODIFIER", 21, 26], ["respiratory syndrome", "OBSERVATION", 27, 47], ["severe", "OBSERVATION_MODIFIER", 106, 112], ["respiratory diseases", "OBSERVATION", 113, 133]]], ["It belongs to the \u03b2-coronavirus genus of the Coronaviridae family, and has 96% genomic identity with a previously detected SARS-like bat coronavirus.", [["SARS-like bat coronavirus", "DISEASE", 123, 148], ["Coronaviridae", "GENE_OR_GENE_PRODUCT", 45, 58], ["SARS-like bat coronavirus", "ORGANISM", 123, 148], ["Coronaviridae family", "PROTEIN", 45, 65], ["bat coronavirus", "SPECIES", 133, 148], ["bat coronavirus", "SPECIES", 133, 148], ["a previously detected SARS-like bat coronavirus", "PROBLEM", 101, 148]]], ["1, 2 The virus subsequently spread and, on 30 January 2020, the World Health Organisation (WHO) declared it a public health emergency of international concern (https://www.who.int/ news-room/detail/30-01-2020-statement-on-the-second-meeting-of-theinternational-health-regulations-(2005)-emergency-committee-regardingthe-outbreak-of-novel-coronavirus-(2019-nCoV).", [["spread", "OBSERVATION_MODIFIER", 28, 34]]], ["On 26 February, the Director-General of the WHO announced that the number of new cases of the disease, now officially known as COVID-19, reported outside China since the day before had for the first time exceeded the number of new cases in China (https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-mission-briefing-oncovid-19---26-february-2020).", [["the disease", "PROBLEM", 90, 101], ["disease", "OBSERVATION", 94, 101]]], ["By 13 March 2020, a total of 137 445 cases and 5088 fatalities had been reported in 117 countries (https:// gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda75947 40fd40299423467b48e9ecf6), giving rise to major concerns throughout the world, but particularly in South Korea, Iran, and Italy.", [["fatalities", "DISEASE", 52, 62]]], ["We have now molecularly characterized and phylogenetically analyzed three complete genomes of SARS-CoV-2 isolated from Gianguglielmo Zehender and Alessia Lai contributed equally to this paper. three of the first 16 patients observed in Italy, none of whom reported a recent history of foreign travel.| PATIENTS AND METHODSAll of the data used in this study were previously anonymized as using Geneious software, v. 9.1.5 (http://www.geneious.com).", [["SARS", "DISEASE", 94, 98], ["SARS-CoV-2", "ORGANISM", 94, 104], ["patients", "ORGANISM", 215, 223], ["patients", "SPECIES", 215, 223], ["SARS-CoV-2", "SPECIES", 94, 104], ["SARS", "PROBLEM", 94, 98], ["CoV", "TEST", 99, 102], ["Gianguglielmo Zehender", "TREATMENT", 119, 141], ["Alessia Lai", "TREATMENT", 146, 157], ["this study", "TEST", 346, 356], ["foreign travel", "OBSERVATION", 285, 299]]], ["4 The genomes obtained from the three patients were aligned with a total of 157 SARS-CoV-2 genomes obtained worldwide and publicly available at GISAID on 3 March 2020 (https://www.gisaid.org/), and with an additional Italian strain that became available during the study.", [["patients", "ORGANISM", 38, 46], ["SARS-CoV-2 genomes", "DNA", 80, 98], ["patients", "SPECIES", 38, 46], ["SARS-CoV", "SPECIES", 80, 88], ["CoV", "TEST", 85, 88], ["the study", "TEST", 261, 270]]], ["Table S1 shows the accession IDs, and sampling dates and locations of the sequences included in the dataset.| PATIENTS AND METHODSA root-to-tip regression analysis was made using TempEst in order to investigate the temporal signal of the dataset.", [["root", "ANATOMY", 132, 136], ["the sequences", "TEST", 70, 83], ["METHODSA root", "TREATMENT", 123, 136], ["TempEst", "TREATMENT", 179, 186]]], ["Two coalescent priors (constant population size and exponential growth) and strict vs relaxed molecular clock models were tested by means of path sampling (PS) and stepping stone (SS) sampling.", [["Two coalescent priors", "TEST", 0, 21], ["constant population size", "PROBLEM", 23, 47], ["exponential growth)", "PROBLEM", 52, 71], ["strict vs relaxed molecular clock models", "PROBLEM", 76, 116], ["path sampling", "TEST", 141, 154], ["stepping stone", "PROBLEM", 164, 178], ["size", "OBSERVATION_MODIFIER", 43, 47], ["exponential", "OBSERVATION_MODIFIER", 52, 63], ["growth", "OBSERVATION_MODIFIER", 64, 70], ["stone", "OBSERVATION", 173, 178]]], ["8 The substitution rate prior was set as a normal distribution with mean 2.2 \u00d7 10 \u22126 substitutions/site/day, standard deviation = 1.1 \u00d7 10 \u22126 (http:// virological.org/t/phylodynamic-analysis-176-genomes-6-mar-2020/356).", [["The substitution rate", "TEST", 2, 23], ["mean", "TEST", 68, 72], ["standard deviation", "TEST", 109, 127], ["normal", "OBSERVATION", 43, 49]]], ["9 The time of the most recent common ancestor (tMRCA) was calculated using days as the unit of time.| PATIENTS AND METHODSAll of the genes were tested for selection pressure using Datamonkey (https://www.datamonkey.org/).| DISCUSSIONThe present phylogenetic analysis confirms that the common origin of the SARS-CoV-2 strains characterized so far was several weeks before the first cases of COVID-19 pneumonia were described in| DISCUSSIONChina.", [["SARS", "DISEASE", 306, 310], ["pneumonia", "DISEASE", 399, 408], ["SARS-CoV-2", "ORGANISM", 306, 316], ["SARS-CoV", "SPECIES", 306, 314], ["selection pressure", "TEST", 155, 173], ["The present phylogenetic analysis", "TEST", 233, 266], ["the SARS", "PROBLEM", 302, 310], ["2 strains", "PROBLEM", 315, 324], ["COVID", "TEST", 390, 395], ["pneumonia", "PROBLEM", 399, 408], ["common", "OBSERVATION_MODIFIER", 285, 291], ["SARS", "OBSERVATION", 306, 310], ["pneumonia", "OBSERVATION", 399, 408]]], ["9 It also shows that the whole genomes of the three SARS-CoV-2 strains isolated from patients in northern Italy and characterized by us are closely related to each other, as well as to the other two published Italian sequences, and the German, Finnish, Mexican, and Brazilian sequences, all of which formed a highly supported clade.| DISCUSSIONThe German sequence at the outgroup of the clade came from a COVID-19 outbreak reported between 20 and 24 January and occurring after business meetings with a Shanghai business woman who tested positive after returning to China.", [["SARS", "DISEASE", 52, 56], ["SARS-CoV-2 strains", "ORGANISM", 52, 70], ["patients", "ORGANISM", 85, 93], ["woman", "ORGANISM", 521, 526], ["patients", "SPECIES", 85, 93], ["woman", "SPECIES", 521, 526], ["SARS-CoV-2", "SPECIES", 52, 62], ["Brazilian sequences", "TEST", 266, 285], ["a COVID", "TEST", 403, 410]]], ["10 Our tMRCA estimate showed that the root of clade A was in the month of January 2020, a period compatible with this event.", [["root", "ANATOMY", 38, 42], ["tMRCA", "PROTEIN", 7, 12], ["Our tMRCA estimate", "TEST", 3, 21], ["this event", "PROBLEM", 113, 123], ["root", "OBSERVATION_MODIFIER", 38, 42], ["compatible with", "UNCERTAINTY", 97, 112]]], ["However, our data do not allow us to make any hypotheses concerning the possible routes followed by the virus to reach Italy because, given the limited number of sparsely sampled sequences in the tree, 11 it is impossible to infer the directionality of transmission, and this means that multiple independent importations to Europe cannot be excluded.| DISCUSSIONOur data suggest that SARS-CoV-2 virus entered northern Italy between the second half of January and early February 2020, which is weeks before the first Italian case of COVID-19 was identified and therefore long before the current containment measures were taken.| DISCUSSIONF I G U R E 1 Root-to-tip regression analysis of the 161 SARS-CoV-2 sequences aligned F I G U R E 2 Dated tree of 161 SARS-CoV-2 sequences showing statistically significant support for clades along the branches (posterior probability >0.7).", [["SARS", "DISEASE", 384, 388], ["SARS", "DISEASE", 695, 699], ["SARS-CoV-2 virus", "ORGANISM", 384, 400], ["161 SARS-CoV-2 sequences", "DNA", 691, 715], ["161 SARS-CoV-2 sequences", "DNA", 752, 776], ["CoV-2 virus", "SPECIES", 389, 400], ["SARS-CoV-2 virus", "SPECIES", 384, 400], ["the virus", "PROBLEM", 100, 109], ["SARS", "PROBLEM", 384, 388], ["CoV", "TEST", 389, 392], ["tip regression analysis", "TEST", 660, 683], ["SARS", "TEST", 695, 699], ["CoV", "TEST", 700, 703], ["SARS", "TEST", 756, 760], ["CoV-2 sequences", "TEST", 761, 776], ["posterior probability", "TEST", 850, 871], ["tree", "ANATOMY_MODIFIER", 196, 200], ["multiple", "OBSERVATION_MODIFIER", 287, 295], ["cannot be excluded", "UNCERTAINTY", 331, 349], ["significant", "OBSERVATION_MODIFIER", 799, 810], ["support", "OBSERVATION", 811, 818], ["branches", "ANATOMY_MODIFIER", 840, 848], ["posterior", "ANATOMY_MODIFIER", 850, 859]]], ["The patients characterized in this study are indicated by a symbol.", [["patients", "ORGANISM", 4, 12], ["patients", "SPECIES", 4, 12], ["this study", "TEST", 30, 40]]], ["The table shows the time of the most recent common ancestor (tMRCA) estimates and 95% high posterior density of the significant clade A nodes.", [["A nodes", "ANATOMY", 134, 141], ["A nodes", "MULTI-TISSUE_STRUCTURE", 134, 141], ["high", "OBSERVATION_MODIFIER", 86, 90], ["posterior", "OBSERVATION_MODIFIER", 91, 100], ["density", "OBSERVATION_MODIFIER", 101, 108], ["significant", "OBSERVATION_MODIFIER", 116, 127], ["clade", "OBSERVATION_MODIFIER", 128, 133], ["nodes", "OBSERVATION", 136, 141]]], ["SARS-CoV-2, severe acute respiratory syndrome coronavirus 2", [["SARS", "DISEASE", 0, 4], ["acute respiratory syndrome coronavirus", "DISEASE", 19, 57], ["SARS-CoV-2", "ORGANISM", 0, 10], ["SARS-CoV", "SPECIES", 0, 8], ["severe acute respiratory syndrome coronavirus", "SPECIES", 12, 57], ["SARS", "TEST", 0, 4], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 12, 57], ["severe", "OBSERVATION_MODIFIER", 12, 18], ["acute", "OBSERVATION_MODIFIER", 19, 24], ["respiratory syndrome coronavirus", "OBSERVATION", 25, 57]]]], "PMC7223186": [["IntroductionKiwifruit [Actinidia chinensis Planch. var. chinensis and Actinidia chinensis var. deliciosa (A. Chev.)] production, which is mostly concentrated in China, Italy and New Zealand, generates a significant agricultural value of over three billion euros annually, with a retail market value worth over ten billion euros (FAO data, 2017).", [["var.", "CHEMICAL", 51, 55], ["Actinidia chinensis", "ORGANISM", 23, 42], ["Planch", "ORGANISM", 43, 49], ["chinensis", "ORGANISM", 56, 65], ["Actinidia chinensis", "ORGANISM", 70, 89], ["A. Chev.", "ORGANISM", 106, 114], ["Actinidia chinensis", "SPECIES", 23, 42], ["chinensis", "SPECIES", 56, 65], ["Actinidia chinensis", "SPECIES", 70, 89], ["deliciosa", "SPECIES", 95, 104], ["Actinidia chinensis Planch", "SPECIES", 23, 49], ["var.", "SPECIES", 51, 55], ["chinensis", "SPECIES", 56, 65], ["Actinidia chinensis var", "SPECIES", 70, 93], ["chinensis", "TREATMENT", 56, 65], ["Actinidia chinensis var", "OBSERVATION", 70, 93], ["mostly", "OBSERVATION_MODIFIER", 138, 144], ["concentrated", "OBSERVATION_MODIFIER", 145, 157], ["significant", "OBSERVATION_MODIFIER", 203, 214]]], ["The emergence and spread in all the key production areas of Pseudomonas syringae pv. actinidae (Psa), responsible for bacterial canker of kiwifruit, has compromised the viability of this production on a global scale [1\u20136].", [["canker", "ANATOMY", 128, 134], ["Pseudomonas syringae pv", "ORGANISM", 60, 83], ["actinidae", "ORGANISM", 85, 94], ["Psa", "GENE_OR_GENE_PRODUCT", 96, 99], ["kiwifruit", "ORGANISM_SUBDIVISION", 138, 147], ["Pseudomonas syringae", "SPECIES", 60, 80], ["actinidae", "SPECIES", 85, 94], ["Pseudomonas syringae", "SPECIES", 60, 80], ["Pseudomonas syringae pv", "PROBLEM", 60, 83], ["bacterial canker of kiwifruit", "PROBLEM", 118, 147], ["spread", "OBSERVATION_MODIFIER", 18, 24], ["Pseudomonas syringae pv", "OBSERVATION", 60, 83]]], ["The pathogen is highly virulent, spreading quickly between plants of different cultivars and vines of different ages [5\u20138].", [["The pathogen", "PROBLEM", 0, 12], ["highly virulent", "PROBLEM", 16, 31], ["highly", "OBSERVATION_MODIFIER", 16, 22], ["virulent", "OBSERVATION_MODIFIER", 23, 31]]], ["For example, in Italy, between 2010 and 2012, more than 2000 ha of kiwifruit orchards have been either destroyed by the disease or cut down, causing severe economic losses for growers, satellite industries, and other stakeholders of the kiwifruit production chain [9].IntroductionBecause of its recent and rapid emergence, the biology and ecology of Psa biovar 3, responsible for the pandemic outbreak of kiwifruit bacterial canker, has not yet been fully elucidated [3, 5, 6].", [["kiwifruit bacterial canker", "DISEASE", 405, 431], ["Psa biovar 3", "ORGANISM", 350, 362], ["Psa biovar", "SPECIES", 350, 360], ["kiwifruit orchards", "PROBLEM", 67, 85], ["the disease", "PROBLEM", 116, 127], ["severe economic losses", "PROBLEM", 149, 171], ["Psa biovar", "TEST", 350, 360], ["kiwifruit bacterial canker", "PROBLEM", 405, 431], ["severe", "OBSERVATION_MODIFIER", 149, 155], ["economic losses", "OBSERVATION", 156, 171], ["bacterial canker", "OBSERVATION", 415, 431]]], ["The information available on well-studied, related P. syringae pathovars, such as P. syringae pv. syringae, may provide general indication on conspecific bacteria.", [["P. syringae pathovars", "ORGANISM", 51, 72], ["P. syringae pv", "ORGANISM", 82, 96], ["syringae", "ORGANISM", 98, 106], ["P. syringae", "SPECIES", 51, 62], ["P. syringae", "SPECIES", 82, 93], ["syringae", "SPECIES", 98, 106], ["P. syringae", "SPECIES", 51, 62], ["P. syringae", "SPECIES", 82, 93], ["syringae", "SPECIES", 98, 106], ["P. syringae pathovars", "PROBLEM", 51, 72], ["syringae", "PROBLEM", 98, 106], ["conspecific bacteria", "PROBLEM", 142, 162]]], ["However, because of the strict host specificity, molecular and biochemical peculiarities must exist in Psa, and many aspects of this pathovar biology and disease epidemiology still require in-depth investigation.", [["Psa", "GENE_OR_GENE_PRODUCT", 103, 106], ["molecular and biochemical peculiarities", "PROBLEM", 49, 88], ["Psa", "TEST", 103, 106]]], ["Primary entry points and mechanisms of spread of Psa represent important aspects still to elucidate.", [["Psa", "GENE_OR_GENE_PRODUCT", 49, 52], ["spread of Psa", "PROBLEM", 39, 52]]], ["This information is the key to assist in the development of effective means of disease control which should be tailored on the key steps of the disease cycle.IntroductionThis work aims to elucidate the so far unresolved points in the epidemiology of bacterial canker, with a particular focus on the sources of inoculum and on the sites of infection.", [["canker", "ANATOMY", 260, 266], ["bacterial canker", "DISEASE", 250, 266], ["infection", "DISEASE", 339, 348], ["disease control", "TREATMENT", 79, 94], ["bacterial canker", "PROBLEM", 250, 266], ["inoculum", "PROBLEM", 310, 318], ["infection", "PROBLEM", 339, 348], ["bacterial canker", "OBSERVATION", 250, 266], ["inoculum", "OBSERVATION", 310, 318], ["infection", "OBSERVATION", 339, 348]]], ["Some short communications have listed plant tissues where the bacteria have been detected [10\u201312]: lenticels, lesion margins, buds, woody tissue, suckers and fruit pedicels.", [["tissues", "ANATOMY", 44, 51], ["lenticels", "ANATOMY", 99, 108], ["lesion margins", "ANATOMY", 110, 124], ["buds", "ANATOMY", 126, 130], ["tissue", "ANATOMY", 138, 144], ["suckers", "ANATOMY", 146, 153], ["fruit pedicels", "ANATOMY", 158, 172], ["tissues", "TISSUE", 44, 51], ["lesion margins", "TISSUE", 110, 124], ["buds", "TISSUE", 126, 130], ["woody tissue", "TISSUE", 132, 144], ["suckers", "TISSUE", 146, 153], ["fruit pedicels", "TISSUE", 158, 172], ["the bacteria", "PROBLEM", 58, 70], ["lesion margins", "PROBLEM", 110, 124], ["woody tissue", "PROBLEM", 132, 144], ["short", "OBSERVATION_MODIFIER", 5, 10], ["lesion", "OBSERVATION_MODIFIER", 110, 116], ["margins", "OBSERVATION_MODIFIER", 117, 124], ["buds", "ANATOMY_MODIFIER", 126, 130], ["woody tissue", "OBSERVATION", 132, 144], ["fruit pedicels", "OBSERVATION", 158, 172]]], ["However, such studies provided no evidence for direct tissue contamination, since Psa can migrate through the apoplast leading to a systemic plant infection.", [["tissue", "ANATOMY", 54, 60], ["apoplast", "ANATOMY", 110, 118], ["plant infection", "DISEASE", 141, 156], ["tissue", "TISSUE", 54, 60], ["Psa", "GENE_OR_GENE_PRODUCT", 82, 85], ["apoplast", "CELLULAR_COMPONENT", 110, 118], ["Psa", "PROTEIN", 82, 85], ["such studies", "TEST", 9, 21], ["direct tissue contamination", "PROBLEM", 47, 74], ["Psa", "TEST", 82, 85], ["the apoplast", "PROBLEM", 106, 118], ["a systemic plant infection", "PROBLEM", 130, 156], ["no evidence for", "UNCERTAINTY", 31, 46], ["contamination", "OBSERVATION", 61, 74], ["infection", "OBSERVATION", 147, 156]]], ["Further studies identified natural openings and lesions as important entry sites for Psa, as well as the importance of lenticels and fresh cut in the infection process, as observed through a scanning electron microscope [13, 14].", [["lesions", "ANATOMY", 48, 55], ["infection", "DISEASE", 150, 159], ["lesions", "PATHOLOGICAL_FORMATION", 48, 55], ["Psa", "GENE_OR_GENE_PRODUCT", 85, 88], ["Psa", "PROTEIN", 85, 88], ["Further studies", "TEST", 0, 15], ["natural openings", "PROBLEM", 27, 43], ["lesions", "PROBLEM", 48, 55], ["Psa", "TEST", 85, 88], ["the infection process", "PROBLEM", 146, 167], ["a scanning electron microscope", "TEST", 189, 219], ["natural openings", "OBSERVATION", 27, 43], ["lesions", "OBSERVATION", 48, 55], ["infection", "OBSERVATION", 150, 159]]], ["Furthermore, it was observed, through bacterial injections into leaf veins as described by Serizawa and Ichikawa [15], that bacteria can migrate from young leaves to twigs facilitating a systemic infection throughout the vine [8, 12, 13, 16\u201318].", [["leaf veins", "ANATOMY", 64, 74], ["leaves", "ANATOMY", 156, 162], ["twigs", "ANATOMY", 166, 171], ["infection", "DISEASE", 196, 205], ["leaf veins", "MULTI-TISSUE_STRUCTURE", 64, 74], ["twigs", "ORGANISM_SUBDIVISION", 166, 171], ["bacterial injections into leaf veins", "TREATMENT", 38, 74], ["bacteria", "PROBLEM", 124, 132], ["a systemic infection", "PROBLEM", 185, 205], ["leaf veins", "ANATOMY", 64, 74], ["systemic", "OBSERVATION_MODIFIER", 187, 195], ["infection", "OBSERVATION", 196, 205]]], ["The bacterium was retrieved in xylem vessels and phloem tissues, indicating that the systemic spread can rapidly reach potentially any tissue of the infected plant [14].IntroductionHowever, the methods used to obtain these results have inherent limitations.", [["xylem vessels", "ANATOMY", 31, 44], ["phloem tissues", "ANATOMY", 49, 63], ["tissue", "ANATOMY", 135, 141], ["xylem vessels", "MULTI-TISSUE_STRUCTURE", 31, 44], ["phloem tissues", "TISSUE", 49, 63], ["tissue", "TISSUE", 135, 141], ["The bacterium", "PROBLEM", 0, 13], ["the systemic spread", "PROBLEM", 81, 100], ["bacterium", "OBSERVATION", 4, 13], ["xylem", "ANATOMY_MODIFIER", 31, 36], ["vessels", "ANATOMY", 37, 44], ["phloem tissues", "OBSERVATION", 49, 63], ["infected", "OBSERVATION", 149, 157]]], ["The manipulation of plant material required to prepare the samples for the scanning electron microscope is well known to generate artefacts in the quantity and distribution of bacteria in the plant samples [19].", [["samples", "ANATOMY", 59, 66], ["samples", "ANATOMY", 198, 205], ["the scanning electron microscope", "TEST", 71, 103], ["bacteria", "PROBLEM", 176, 184], ["the plant samples", "TEST", 188, 205], ["plant material", "OBSERVATION", 20, 34], ["bacteria", "OBSERVATION", 176, 184]]], ["A less biassed method of observation is the use of the confocal laser scanning microscope (CLSM), in which plant material is not manipulated by treatments such as staining and fixing, providing a more accurate observation of bacteria distribution directly in vivo [19].", [["the confocal laser scanning microscope", "TEST", 51, 89], ["bacteria distribution", "PROBLEM", 225, 246]]], ["Furthermore, with the use of autofluorescent protein labelling, bacterial movement can be tracked visually in live plant tissues, providing more accurate information on migration through the plant [10, 14, 19].IntroductionLarge variability within the Actinidia Lindl. genus exists due to the large natural geographic range in which these plants are found [20].", [["tissues", "ANATOMY", 121, 128], ["plant tissues", "TISSUE", 115, 128], ["autofluorescent protein labelling", "TREATMENT", 29, 62], ["bacterial movement", "PROBLEM", 64, 82], ["IntroductionLarge variability", "PROBLEM", 210, 239], ["bacterial movement", "OBSERVATION", 64, 82], ["variability", "OBSERVATION_MODIFIER", 228, 239], ["Actinidia Lindl", "OBSERVATION", 251, 266], ["large", "OBSERVATION_MODIFIER", 292, 297]]], ["The main cultivated varieties are A. chinensis var. chinensis and A. chinensis var. deliciosa, the former being characterized by yellow- or red-fleshed fruit, while the latter includes primarily green-fleshed cultivars [21].", [["fruit", "ANATOMY", 152, 157], ["A. chinensis", "ORGANISM", 34, 46], ["chinensis", "ORGANISM", 52, 61], ["A. chinensis", "ORGANISM", 66, 78], ["deliciosa", "ORGANISM", 84, 93], ["A. chinensis", "SPECIES", 34, 46], ["chinensis", "SPECIES", 52, 61], ["A. chinensis", "SPECIES", 66, 78], ["deliciosa", "SPECIES", 84, 93], ["A. chinensis", "SPECIES", 34, 46], ["chinensis", "SPECIES", 52, 61], ["A. chinensis var", "SPECIES", 66, 82], ["deliciosa", "SPECIES", 84, 93], ["yellow- or red-fleshed fruit", "PROBLEM", 129, 157], ["main", "OBSERVATION_MODIFIER", 4, 8], ["cultivated varieties", "OBSERVATION", 9, 29], ["chinensis var", "OBSERVATION", 37, 50], ["chinensis var", "OBSERVATION", 69, 82]]], ["However, between A. chinensis var. chinensis and A. chinensis var. deliciosa, there are differences not only in vegetative morphology, flower and fruit morphology, and chromosome number [20, 22\u201324] but also in different susceptibility to Psa.", [["flower", "ANATOMY", 135, 141], ["fruit", "ANATOMY", 146, 151], ["chromosome", "ANATOMY", 168, 178], ["A. chinensis", "ORGANISM", 17, 29], ["chinensis", "ORGANISM", 35, 44], ["A. chinensis", "ORGANISM", 49, 61], ["deliciosa", "ORGANISM", 67, 76], ["flower", "ORGANISM_SUBDIVISION", 135, 141], ["chromosome", "CELLULAR_COMPONENT", 168, 178], ["Psa", "GENE_OR_GENE_PRODUCT", 238, 241], ["A. chinensis", "SPECIES", 17, 29], ["chinensis", "SPECIES", 35, 44], ["A. chinensis", "SPECIES", 49, 61], ["deliciosa", "SPECIES", 67, 76], ["A. chinensis var", "SPECIES", 17, 33], ["chinensis", "SPECIES", 35, 44], ["A. chinensis var", "SPECIES", 49, 65], ["deliciosa", "SPECIES", 67, 76], ["fruit morphology", "TEST", 146, 162], ["Psa", "TEST", 238, 241], ["chinensis var", "OBSERVATION", 20, 33], ["chinensis var", "OBSERVATION", 52, 65], ["vegetative morphology", "OBSERVATION_MODIFIER", 112, 133], ["flower", "OBSERVATION_MODIFIER", 135, 141], ["fruit morphology", "OBSERVATION", 146, 162]]], ["In fact, it has been observed that yellow- and red-fleshed kiwifruit (A. chinensis var. chinensis) are generally more susceptible than green-fleshed (A. chinensis var. deliciosa) cultivars such as \u2018Hayward\u2019 displaying a more pronounced symptomatology, enhanced spread, and faster dieback [25].IntroductionPossible explanations for differences in response to the Psa infection include variation in morphology features such as a higher density of lenticels and stomata and a larger leaf surface area [26].", [["lenticels", "ANATOMY", 445, 454], ["stomata", "ANATOMY", 459, 466], ["leaf surface area", "ANATOMY", 480, 497], ["infection", "DISEASE", 366, 375], ["red-fleshed kiwifruit", "ORGANISM", 47, 68], ["A. chinensis", "ORGANISM", 70, 82], ["var", "ORGANISM", 83, 86], ["chinensis", "ORGANISM", 88, 97], ["A. chinensis", "ORGANISM", 150, 162], ["deliciosa", "ORGANISM", 168, 177], ["Psa", "GENE_OR_GENE_PRODUCT", 362, 365], ["A. chinensis", "SPECIES", 70, 82], ["chinensis", "SPECIES", 88, 97], ["A. chinensis", "SPECIES", 150, 162], ["deliciosa", "SPECIES", 168, 177], ["A. chinensis var", "SPECIES", 70, 86], ["chinensis", "SPECIES", 88, 97], ["A. chinensis var", "SPECIES", 150, 166], ["yellow", "PROBLEM", 35, 41], ["a more pronounced symptomatology", "PROBLEM", 218, 250], ["the Psa infection", "PROBLEM", 358, 375], ["variation in morphology features", "PROBLEM", 384, 416], ["a higher density of lenticels and stomata", "PROBLEM", 425, 466], ["a larger leaf surface area", "PROBLEM", 471, 497], ["yellow", "OBSERVATION_MODIFIER", 35, 41], ["higher density", "OBSERVATION_MODIFIER", 427, 441], ["stomata", "ANATOMY", 459, 466], ["larger", "OBSERVATION_MODIFIER", 473, 479], ["leaf", "OBSERVATION_MODIFIER", 480, 484], ["surface", "OBSERVATION_MODIFIER", 485, 492]]], ["However, as for other pathogenic bacteria showing an epiphytic phase, factors that contribute to the creation of favourable leaf microhabitat conditions should not be overlooked [27, 28].IntroductionUnderstanding the disease epidemiology has significant practical applications in the improvement of disease management.", [["leaf", "ANATOMY", 124, 128], ["other pathogenic bacteria", "PROBLEM", 16, 41], ["an epiphytic phase", "PROBLEM", 50, 68], ["favourable leaf microhabitat conditions", "PROBLEM", 113, 152], ["disease management", "TREATMENT", 299, 317], ["epiphytic phase", "OBSERVATION", 53, 68], ["significant", "OBSERVATION_MODIFIER", 242, 253], ["disease", "OBSERVATION", 299, 306]]], ["A clear elucidation of the importance of entry points that may vary throughout the season, can enable fine-tuned disease management strategies based on the plant-pathogen phenological synchrony for enhanced plant protection.", [["fine-tuned disease management strategies", "TREATMENT", 102, 142], ["enhanced plant protection", "TREATMENT", 198, 223], ["clear", "OBSERVATION", 2, 7], ["plant protection", "OBSERVATION", 207, 223]]], ["Furthermore, cultivar factors influencing host-pathogen interactions are central for the appropriate selection of resistance genotypes in breeding programmes [29].IntroductionThis paper aims to evaluate the key steps of the infection process and the influence of the environmental factors on Psa growth and infection.", [["infection", "DISEASE", 224, 233], ["infection", "DISEASE", 307, 316], ["Psa", "GENE_OR_GENE_PRODUCT", 292, 295], ["cultivar factors", "PROTEIN", 13, 29], ["cultivar factors", "PROBLEM", 13, 29], ["resistance genotypes", "PROBLEM", 114, 134], ["the infection process", "PROBLEM", 220, 241], ["Psa growth", "PROBLEM", 292, 302], ["infection", "PROBLEM", 307, 316], ["infection", "OBSERVATION", 224, 233], ["infection", "OBSERVATION", 307, 316]]], ["Furthermore, the relative importance of the possible entry points of Psa, the colonization pathway, the environmental survival of the pathogen and its spread from plant to plant are determined.IntroductionThe study was conducted both in controlled and field conditions in Italy and New Zealand.", [["Psa", "GENE_OR_GENE_PRODUCT", 69, 72], ["Psa", "TEST", 69, 72], ["the colonization pathway", "TREATMENT", 74, 98], ["the pathogen", "PROBLEM", 130, 142], ["The study", "TEST", 205, 214]]], ["In controlled conditions, the inoculation of host plants was performed with the use of GFP-labelled bacteria and to allow for a non-invasive, real-time observation under CLSM of the plant-pathogen interactions both at the cell and whole plant level.", [["cell", "ANATOMY", 222, 226], ["GFP", "GENE_OR_GENE_PRODUCT", 87, 90], ["cell", "CELL", 222, 226], ["GFP", "PROTEIN", 87, 90], ["GFP", "TEST", 87, 90], ["labelled bacteria", "PROBLEM", 91, 108], ["a non-invasive", "TEST", 126, 140]]], ["Furthermore, the investigation of the successful colonization of Psa through various entry points in the two different species allowed to draw new hypotheses for the different susceptibility between A. chinensis var. chinensis and A. chinensis var. deliciosa.Plant Material ::: Materials and MethodsThe experiments in controlled conditions were performed on 1- to 3-year-old potted plants of A. chinensis var. deliciosa cv.", [["Psa", "GENE_OR_GENE_PRODUCT", 65, 68], ["A. chinensis", "ORGANISM", 199, 211], ["chinensis", "ORGANISM", 217, 226], ["A. chinensis", "ORGANISM", 231, 243], ["deliciosa", "ORGANISM", 249, 258], ["A. chinensis", "ORGANISM", 392, 404], ["deliciosa cv", "ORGANISM", 410, 422], ["A. chinensis", "SPECIES", 199, 211], ["chinensis", "SPECIES", 217, 226], ["A. chinensis", "SPECIES", 231, 243], ["deliciosa", "SPECIES", 249, 258], ["A. chinensis", "SPECIES", 392, 404], ["deliciosa", "SPECIES", 410, 419], ["A. chinensis var", "SPECIES", 199, 215], ["chinensis", "SPECIES", 217, 226], ["A. chinensis var", "SPECIES", 231, 247], ["deliciosa", "SPECIES", 249, 258], ["A. chinensis var", "SPECIES", 392, 408], ["deliciosa cv", "SPECIES", 410, 422], ["the successful colonization of Psa", "PROBLEM", 34, 68], ["the two different species", "PROBLEM", 101, 126], ["deliciosa", "PROBLEM", 249, 258], ["successful", "OBSERVATION_MODIFIER", 38, 48], ["colonization", "OBSERVATION", 49, 61], ["chinensis var", "OBSERVATION", 202, 215], ["chinensis var", "OBSERVATION", 234, 247]]], ["\u2018Hayward\u2019, or A. chinensis var. chinensis cvs.", [["A. chinensis", "ORGANISM", 14, 26], ["var", "ORGANISM", 27, 30], ["chinensis", "ORGANISM", 32, 41], ["A. chinensis", "SPECIES", 14, 26], ["chinensis", "SPECIES", 32, 41], ["A. chinensis var", "SPECIES", 14, 30], ["chinensis var", "OBSERVATION", 17, 30]]], ["\u2018Zesy002\u2019 (Gold3), \u2018Jintao\u2019 and \u2018Hort16A\u2019, A. arguta (Siebold & Zucc.)", [["A. arguta", "ORGANISM", 43, 52], ["A. arguta", "SPECIES", 43, 52], ["A. arguta", "SPECIES", 43, 52], ["Zesy002", "TREATMENT", 1, 8]]], ["Ex Miq, A. polygama (Siebold & Zucc.)", [["A. polygama", "ORGANISM", 8, 19], ["A. polygama", "SPECIES", 8, 19], ["A. polygama", "SPECIES", 8, 19]]], ["Maxim. and A. eriantha Bentham grown in a mixture of peat and sand (1:1, v/v) with standard irrigation and fertilization, and maintained in a growth chamber with a 16:8 h (light/dark) photoperiod.", [["A. eriantha", "SPECIES", 11, 22], ["standard irrigation", "TREATMENT", 83, 102], ["fertilization", "TREATMENT", 107, 120], ["light/dark) photoperiod", "TREATMENT", 172, 195]]], ["Normal growth conditions were 24 \u00b0C and approximately 85% relative humidity (RH).", [["growth", "OBSERVATION_MODIFIER", 7, 13]]], ["Semi-field experiments were performed on 4- to 5-year-old potted plants of A. chinensis var. deliciosa cv.", [["A. chinensis", "ORGANISM", 75, 87], ["deliciosa cv", "ORGANISM", 93, 105], ["A. chinensis", "SPECIES", 75, 87], ["deliciosa", "SPECIES", 93, 102], ["A. chinensis var", "SPECIES", 75, 91], ["deliciosa cv", "SPECIES", 93, 105], ["Semi-field experiments", "TEST", 0, 22], ["chinensis var", "OBSERVATION", 78, 91]]], ["\u2018Hayward\u2019, or A. chinensis var. chinensis cv.", [["A. chinensis", "ORGANISM", 14, 26], ["var", "ORGANISM", 27, 30], ["chinensis cv", "ORGANISM", 32, 44], ["A. chinensis", "SPECIES", 14, 26], ["chinensis", "SPECIES", 32, 41], ["A. chinensis var", "SPECIES", 14, 30], ["chinensis cv", "SPECIES", 32, 44], ["chinensis var", "OBSERVATION", 17, 30]]], ["\u2018Hort16A\u2019.Plant Material ::: Materials and MethodsField experiments were carried out in commercial orchards of A. chinensis var. deliciosa cv.", [["orchards", "ORGANISM_SUBDIVISION", 99, 107], ["A. chinensis", "ORGANISM", 111, 123], ["deliciosa cv", "ORGANISM", 129, 141], ["A. chinensis", "SPECIES", 111, 123], ["deliciosa", "SPECIES", 129, 138], ["A. chinensis var", "SPECIES", 111, 127], ["deliciosa cv", "SPECIES", 129, 141]]], ["\u2018Hayward\u2019 or cv.", [["cv", "SPECIES", 13, 15]]], ["\u2018Tomuri\u2019 or \u2018Matua\u2019 and A. chinensis var. chinensis cv.", [["A. chinensis", "ORGANISM", 24, 36], ["chinensis cv", "ORGANISM", 42, 54], ["A. chinensis", "SPECIES", 24, 36], ["chinensis", "SPECIES", 42, 51], ["A. chinensis var", "SPECIES", 24, 40], ["chinensis cv", "SPECIES", 42, 54], ["chinensis var", "OBSERVATION", 27, 40]]], ["\u2018Jintao\u2019 or cv.", [["cv", "SPECIES", 12, 14]]], ["\u2018Hort16A\u2019 located near Faenza F (44\u00b0 17\u2032 8\u2033 N; 11\u00b0 120 53\u2032 0\u2033 E), Sarna (44\u00b0 15\u2032 13\u201dN; 11\u00b0 52\u2032 50\u2033 E) and Imola (44\u00b0 37\u2032 42\u201d N, 11\u00b0 68\u2032 85\u2033 E).", [["8\u2033", "CHEMICAL", 41, 43], ["Sarna", "TEST", 66, 71], ["Imola", "TEST", 106, 111], ["Sarna", "ANATOMY", 66, 71]]], ["In all the studied orchards, at the beginning of the experiments, the incidence of bacterial canker was approximately 50%, assessed by monitoring of visual symptoms on vines.", [["canker", "ANATOMY", 93, 99], ["bacterial canker", "DISEASE", 83, 99], ["bacterial canker", "PROBLEM", 83, 99], ["visual symptoms", "PROBLEM", 149, 164], ["bacterial canker", "OBSERVATION", 83, 99]]], ["To monitor the microclimate conditions, humidity (EasyLog-UBS-1), temperature and leaf wetness (Spectrum data-loggers 1000 Series Micro Stations) sensors were placed in each orchard.", [["leaf", "ANATOMY", 82, 86], ["leaf", "ORGAN", 82, 86], ["the microclimate conditions", "PROBLEM", 11, 38], ["Spectrum data", "TEST", 96, 109]]], ["Rainfalls data was obtained by Dexter Service of Regione Emilia Romagna (Italy).Field Monitoring of Symptoms ::: Materials and MethodsDuring three seasons (2013\u20132015), the presence of bacterial canker symptoms was recorded on a population of canes in five commercial orchards.", [["canker", "ANATOMY", 194, 200], ["canker symptoms", "DISEASE", 194, 209], ["Symptoms", "PROBLEM", 100, 108], ["bacterial canker symptoms", "PROBLEM", 184, 209], ["bacterial", "OBSERVATION_MODIFIER", 184, 193], ["canker", "OBSERVATION", 194, 200]]], ["In the same locations, meteorological data were also collected.Field Monitoring of Symptoms ::: Materials and MethodsThe canes were selected and tagged in March.", [["canes", "CANCER", 121, 126], ["meteorological data", "TEST", 23, 42], ["Symptoms", "PROBLEM", 83, 91], ["Methods", "TREATMENT", 110, 117], ["The canes", "TREATMENT", 117, 126]]], ["The symptom assessment was performed weekly from April to November, by recording the number of bacterial canker lesions on the leaves.", [["lesions", "ANATOMY", 112, 119], ["leaves", "ANATOMY", 127, 133], ["canker lesions", "DISEASE", 105, 119], ["canker lesions", "PATHOLOGICAL_FORMATION", 105, 119], ["leaves", "ORGANISM_SUBDIVISION", 127, 133], ["The symptom assessment", "TEST", 0, 22], ["bacterial canker lesions", "PROBLEM", 95, 119], ["bacterial", "OBSERVATION_MODIFIER", 95, 104], ["canker", "OBSERVATION_MODIFIER", 105, 111], ["lesions", "OBSERVATION", 112, 119]]], ["Starting from 2014, to obtain timely information on the bacterial spread in the orchard, potted sentinel plants of A. chinensis var. deliciosa (cvs.", [["A. chinensis", "ORGANISM", 115, 127], ["deliciosa", "ORGANISM", 133, 142], ["A. chinensis", "SPECIES", 115, 127], ["deliciosa", "SPECIES", 133, 142], ["A. chinensis var", "SPECIES", 115, 131], ["deliciosa", "SPECIES", 133, 142], ["the bacterial spread", "PROBLEM", 52, 72]]], ["After a 7-day exposure, Psa populations were determined in six sentinel plants, while six more were maintained in a greenhouse for 3 weeks before leaf spots were recorded.Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsFor experiments in controlled conditions, transgenic Psa strains, derived from CFBP7286 (biovar 3), isolated in Italy from A. chinensis var. chinensis, retaining the wild-type virulence and expressing a green CFBP7286-GFPuv or red CFBP7286-DsED fluorescent proteins were used for experimental inoculation [10].", [["leaf spots", "ANATOMY", 146, 156], ["Psa populations", "CELL", 24, 39], ["Psa", "GENE_OR_GENE_PRODUCT", 298, 301], ["CFBP7286 (biovar 3", "ORGANISM", 324, 342], ["A. chinensis", "ORGANISM", 368, 380], ["chinensis", "ORGANISM", 386, 395], ["CFBP7286-GFPuv", "GENE_OR_GENE_PRODUCT", 454, 468], ["red CFBP7286-DsED fluorescent proteins", "GENE_OR_GENE_PRODUCT", 472, 510], ["green CFBP7286", "PROTEIN", 448, 462], ["GFPuv", "PROTEIN", 463, 468], ["red CFBP7286", "PROTEIN", 472, 484], ["DsED fluorescent proteins", "PROTEIN", 485, 510], ["A. chinensis", "SPECIES", 368, 380], ["chinensis", "SPECIES", 386, 395], ["A. chinensis var", "SPECIES", 368, 384], ["chinensis", "SPECIES", 386, 395], ["Psa populations", "TEST", 24, 39], ["leaf spots", "PROBLEM", 146, 156], ["Bacterial Growth", "PROBLEM", 171, 187], ["Materials", "TREATMENT", 224, 233], ["Methods", "TREATMENT", 238, 245], ["experiments in controlled conditions", "PROBLEM", 249, 285], ["transgenic Psa strains", "PROBLEM", 287, 309], ["type virulence", "PROBLEM", 416, 430], ["red CFBP7286", "TEST", 472, 484], ["DsED fluorescent proteins", "TREATMENT", 485, 510], ["experimental inoculation", "TREATMENT", 525, 549], ["sentinel plants", "OBSERVATION", 63, 78], ["Growth", "OBSERVATION_MODIFIER", 181, 187], ["chinensis var", "OBSERVATION", 371, 384]]], ["Bacteria were grown in liquid Lysogenic Broth medium (27 \u00b0C, under agitation at 120 rpm) for 2 days, then precipitated by centrifugation and resuspended in sterile 10 mM MgSO4.Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsPotted plants were inoculated with a bacterial suspension (approx.", [["MgSO4", "CHEMICAL", 170, 175], ["MgSO4", "CHEMICAL", 170, 175], ["Bacteria", "CELL", 0, 8], ["MgSO4", "SIMPLE_CHEMICAL", 170, 175], ["Bacteria", "PROBLEM", 0, 8], ["agitation", "PROBLEM", 67, 76], ["sterile 10 mM MgSO4", "TREATMENT", 156, 175], ["Bacterial Growth", "PROBLEM", 176, 192], ["MethodsPotted plants", "TREATMENT", 243, 263], ["a bacterial suspension", "TREATMENT", 285, 307], ["grown", "OBSERVATION_MODIFIER", 14, 19], ["liquid Lysogenic", "OBSERVATION_MODIFIER", 23, 39], ["Broth medium", "OBSERVATION_MODIFIER", 40, 52], ["Growth", "OBSERVATION_MODIFIER", 186, 192]]], ["In all cases, the plants were kept at 100% RH for 48 h post inoculation.", [["inoculation", "PROBLEM", 60, 71]]], ["For each experimental condition, 5\u20138 biological replicates were used in a randomized block design.Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsLeaf scars on A. chinensis var. deliciosa and A. chinensis var. chinensis canes were inoculated with 20-\u03bcL drops of bacterial suspension (approx.", [["A. chinensis", "ORGANISM", 186, 198], ["deliciosa", "ORGANISM", 204, 213], ["A. chinensis", "ORGANISM", 218, 230], ["chinensis", "ORGANISM", 236, 245], ["A. chinensis", "SPECIES", 186, 198], ["deliciosa", "SPECIES", 204, 213], ["A. chinensis", "SPECIES", 218, 230], ["chinensis", "SPECIES", 236, 245], ["A. chinensis var", "SPECIES", 186, 202], ["deliciosa", "SPECIES", 204, 213], ["A. chinensis var", "SPECIES", 218, 234], ["a randomized block design", "TREATMENT", 72, 97], ["Bacterial Growth", "PROBLEM", 98, 114], ["MethodsLeaf scars", "PROBLEM", 165, 182], ["chinensis canes", "TREATMENT", 236, 251], ["bacterial suspension", "TREATMENT", 288, 308], ["Growth", "OBSERVATION_MODIFIER", 108, 114], ["scars", "OBSERVATION", 177, 182], ["chinensis var", "OBSERVATION", 189, 202], ["chinensis var", "OBSERVATION", 221, 234], ["bacterial suspension", "OBSERVATION", 288, 308]]], ["107 CFU mL\u22121) after natural leaf fall or mechanical removal of the leaf.", [["leaf", "ANATOMY", 28, 32], ["leaf", "ANATOMY", 67, 71], ["leaf", "ORGAN", 28, 32], ["leaf", "ORGAN", 67, 71], ["natural leaf fall", "TREATMENT", 20, 37], ["mechanical removal of the leaf", "TREATMENT", 41, 71], ["leaf fall", "OBSERVATION", 28, 37], ["mechanical removal", "OBSERVATION", 41, 59], ["leaf", "ANATOMY", 67, 71]]], ["The inoculation was performed 1, 2, 3, 4 or 15 days after detachment.", [["The inoculation", "TEST", 0, 15], ["detachment", "PROBLEM", 58, 68], ["detachment", "OBSERVATION", 58, 68]]], ["Ten days after inoculation, the samples were surface-sterilized and Psa endophytic population was determined.Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsPruning cuts were inoculated as described for leaf scars.", [["samples", "ANATOMY", 32, 39], ["surface", "ANATOMY", 45, 52], ["leaf scars", "ANATOMY", 229, 239], ["leaf scars", "PATHOLOGICAL_FORMATION", 229, 239], ["inoculation", "PROBLEM", 15, 26], ["the samples", "TEST", 28, 39], ["surface", "TEST", 45, 52], ["Psa endophytic population", "TEST", 68, 93], ["Bacterial Growth", "PROBLEM", 109, 125], ["Materials", "TREATMENT", 162, 171], ["MethodsPruning cuts", "TREATMENT", 176, 195], ["leaf scars", "PROBLEM", 229, 239], ["Growth", "OBSERVATION_MODIFIER", 119, 125], ["scars", "OBSERVATION", 234, 239]]], ["Host colonization was assed 10 days after inoculation as previously described.Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsClosed (BBCH 00) or swollen (BBCH 03) [30] buds were inoculated by applying for 24 h a cotton plug soaked in bacterial suspension.", [["buds", "ANATOMY", 195, 199], ["BBCH 03", "CHEMICAL", 181, 188], ["buds", "ORGANISM", 195, 199], ["cotton", "SPECIES", 239, 245], ["Host colonization", "TREATMENT", 0, 17], ["inoculation", "PROBLEM", 42, 53], ["Bacterial Growth", "PROBLEM", 78, 94], ["MethodsClosed (BBCH", "TREATMENT", 145, 164], ["swollen", "PROBLEM", 172, 179], ["a cotton plug", "TREATMENT", 237, 250], ["bacterial suspension", "TREATMENT", 261, 281], ["colonization", "OBSERVATION", 5, 17], ["Growth", "OBSERVATION_MODIFIER", 88, 94], ["bacterial suspension", "OBSERVATION", 261, 281]]], ["Ten days later, the phenological stage of the bud (bud swelling, BBCH 01-03; bud burst, BBCH 07; sprouting buds, BBCH 09) was recorded, and Psa population was determined.", [["bud", "ANATOMY", 46, 49], ["bud", "ANATOMY", 51, 54], ["bud", "ANATOMY", 77, 80], ["buds", "ANATOMY", 107, 111], ["BBCH 01-03", "CHEMICAL", 65, 75], ["bud", "DEVELOPING_ANATOMICAL_STRUCTURE", 46, 49], ["bud", "ORGANISM_SUBDIVISION", 51, 54], ["buds", "ORGANISM_SUBDIVISION", 107, 111], ["the bud (bud swelling", "PROBLEM", 42, 63], ["BBCH", "TEST", 65, 69], ["bud burst", "TEST", 77, 86], ["BBCH", "TEST", 88, 92], ["BBCH", "TEST", 113, 117], ["Psa population", "TEST", 140, 154], ["bud", "ANATOMY_MODIFIER", 46, 49], ["bud", "OBSERVATION_MODIFIER", 51, 54], ["swelling", "OBSERVATION", 55, 63]]], ["Lenticels were inoculated using the same protocol.", [["the same protocol", "TREATMENT", 32, 49]]], ["The penetration of Psa through the lenticel was determined 7\u201340 days post inoculation by excising the surrounding tissue and using its internal face to inoculate Lysogenic Broth Agar medium amended with cycloheximide (100 mg L\u22121) and kanamycin (50 mg L\u22121).Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsHost invasion through natural openings on leaves (stomata, trichomes) was tested by directly spraying the bacterial suspension on the target organs.", [["lenticel", "ANATOMY", 35, 43], ["tissue", "ANATOMY", 114, 120], ["leaves", "ANATOMY", 372, 378], ["stomata", "ANATOMY", 380, 387], ["trichomes", "ANATOMY", 389, 398], ["organs", "ANATOMY", 471, 477], ["cycloheximide", "CHEMICAL", 203, 216], ["kanamycin", "CHEMICAL", 234, 243], ["cycloheximide", "CHEMICAL", 203, 216], ["kanamycin", "CHEMICAL", 234, 243], ["Psa", "GENE_OR_GENE_PRODUCT", 19, 22], ["tissue", "TISSUE", 114, 120], ["cycloheximide", "SIMPLE_CHEMICAL", 203, 216], ["kanamycin", "SIMPLE_CHEMICAL", 234, 243], ["stomata", "MULTI-TISSUE_STRUCTURE", 380, 387], ["trichomes", "TISSUE", 389, 398], ["organs", "ORGAN", 471, 477], ["The penetration of Psa", "PROBLEM", 0, 22], ["inoculation", "TREATMENT", 74, 85], ["cycloheximide", "TREATMENT", 203, 216], ["kanamycin", "TREATMENT", 234, 243], ["Bacterial Growth", "PROBLEM", 256, 272], ["surrounding tissue", "OBSERVATION", 102, 120], ["Growth", "OBSERVATION_MODIFIER", 266, 272], ["bacterial suspension", "OBSERVATION", 436, 456]]], ["Female flowers were inoculated by brushing stigmas with contaminated pollen, whilst male flowers were sprayed with a bacterial suspension.", [["flowers", "ANATOMY", 7, 14], ["pollen", "ANATOMY", 69, 75], ["flowers", "ANATOMY", 89, 96], ["pollen", "ORGANISM_SUBDIVISION", 69, 75], ["flowers", "ORGANISM_SUBDIVISION", 89, 96], ["brushing stigmas", "PROBLEM", 34, 50], ["contaminated pollen", "PROBLEM", 56, 75], ["a bacterial suspension", "TREATMENT", 115, 137], ["bacterial suspension", "OBSERVATION", 117, 137]]], ["Roots were inoculated by dipping in the bacterial suspension for 1 min.", [["the bacterial suspension", "TREATMENT", 36, 60]]], ["Subsequently, the plants were placed in sterile sand until analysis.", [["the plants", "TREATMENT", 14, 24]]], ["Host colonization was assed 1, 3, 7, 14, 21 and 30 days after inoculation according to the different inoculated organ.Bacterial Growth, Inoculation and Quantification ::: Materials and MethodsEpiphytic bacterial populations were obtained by washing the samples in 10 mM MgSO4 for 30 min under energic agitation (150 rpm).", [["organ", "ANATOMY", 112, 117], ["samples", "ANATOMY", 253, 260], ["MgSO4", "CHEMICAL", 270, 275], ["MgSO4", "CHEMICAL", 270, 275], ["organ", "ORGAN", 112, 117], ["MgSO4", "SIMPLE_CHEMICAL", 270, 275], ["Host colonization", "PROBLEM", 0, 17], ["inoculation", "TREATMENT", 62, 73], ["Bacterial Growth", "PROBLEM", 118, 134], ["MethodsEpiphytic bacterial populations", "PROBLEM", 185, 223], ["10 mM MgSO4", "TREATMENT", 264, 275], ["energic agitation", "TREATMENT", 293, 310], ["colonization", "OBSERVATION", 5, 17], ["inoculated organ", "OBSERVATION", 101, 117], ["Growth", "OBSERVATION_MODIFIER", 128, 134], ["bacterial populations", "OBSERVATION", 202, 223]]], ["To assess the growth of the pathogen within the tissues, the plant samples were surface-sterilized by 1-min washes in 70% ethanol, 1.5% NaOCl, and twice in sterile water, then homogenized in 10 mM MgSO4.", [["tissues", "ANATOMY", 48, 55], ["samples", "ANATOMY", 67, 74], ["surface", "ANATOMY", 80, 87], ["ethanol", "CHEMICAL", 122, 129], ["NaOCl", "CHEMICAL", 136, 141], ["MgSO4", "CHEMICAL", 197, 202], ["ethanol", "CHEMICAL", 122, 129], ["NaOCl", "CHEMICAL", 136, 141], ["MgSO4", "CHEMICAL", 197, 202], ["tissues", "TISSUE", 48, 55], ["ethanol", "SIMPLE_CHEMICAL", 122, 129], ["NaOCl", "SIMPLE_CHEMICAL", 136, 141], ["MgSO4", "SIMPLE_CHEMICAL", 197, 202], ["1.5% NaOCl", "TREATMENT", 131, 141], ["10 mM MgSO4", "TREATMENT", 191, 202], ["growth", "OBSERVATION_MODIFIER", 14, 20], ["pathogen", "OBSERVATION", 28, 36]]], ["The bacterial concentrations (colony-forming units per mL, CFU mL\u22121) were determined by plating sequential tenfold dilutions of the bacterial suspensions on agarised Lysogenic Broth medium amended with cycloheximide (100 mg L\u22121).", [["colony", "ANATOMY", 30, 36], ["cycloheximide", "CHEMICAL", 202, 215], ["cycloheximide", "CHEMICAL", 202, 215], ["cycloheximide", "SIMPLE_CHEMICAL", 202, 215], ["The bacterial concentrations", "TEST", 0, 28], ["the bacterial suspensions", "TREATMENT", 128, 153], ["cycloheximide", "TREATMENT", 202, 215], ["bacterial", "OBSERVATION_MODIFIER", 4, 13], ["concentrations", "OBSERVATION_MODIFIER", 14, 28], ["bacterial suspensions", "OBSERVATION", 132, 153]]], ["The molecular identity of dubious colonies, and the overall reliability of the method were confirmed with a PCR recognition and quantification protocol [31].Visualization of Colonization and Migration inside the Host Tissues ::: Materials and MethodsPsa colonization of the host plant was monitored by fluorescent microscopy and confocal laser scanning microscopy.", [["colonies", "ANATOMY", 34, 42], ["dubious colonies", "CELL_LINE", 26, 42], ["dubious colonies", "PROBLEM", 26, 42], ["a PCR recognition", "TEST", 106, 123], ["quantification protocol", "TEST", 128, 151], ["Colonization", "PROBLEM", 174, 186], ["fluorescent microscopy", "TEST", 302, 324], ["confocal laser scanning microscopy", "TEST", 329, 363], ["dubious colonies", "OBSERVATION", 26, 42], ["Colonization", "OBSERVATION", 174, 186], ["Migration", "OBSERVATION_MODIFIER", 191, 200], ["Host Tissues", "OBSERVATION", 212, 224]]], ["Microscopical observation of samples inoculated with fluorescent bacteria was performed using a motorized microscope (SMZ25, Nikon, Tokyo, Japan) fitted with a BHS (GHS) filter set (excitation light 450\u2013490 nm, emission 510 nm) used to visualize the fluorescent bacteria.", [["samples", "ANATOMY", 29, 36], ["Microscopical observation of samples", "TEST", 0, 36], ["fluorescent bacteria", "PROBLEM", 53, 73], ["a motorized microscope", "TEST", 94, 116], ["the fluorescent bacteria", "PROBLEM", 246, 270], ["fluorescent bacteria", "OBSERVATION", 250, 270]]], ["Optical sections were obtained with a C1-S confocal laser scanning microscope (CLSM) equipped with an Argon laser.", [["sections", "ANATOMY", 8, 16], ["Optical sections", "TEST", 0, 16], ["an Argon laser", "TREATMENT", 99, 113]]], ["PlanApo objectives 40, 60 and 100\u00d7 (Nikon, Tokyo, Japan) and BHS (GHS) filter set were used for image acquisition.", [["PlanApo objectives", "TEST", 0, 18], ["BHS (GHS) filter set", "TREATMENT", 61, 81], ["image acquisition", "TEST", 96, 113]]], ["Images were acquired and analysed by the NIS-Elements C Microscope Imaging Software (Nikon, Tokyo, Japan).Visualization of Colonization and Migration inside the Host Tissues ::: Materials and MethodsThe rates of Psa migration through plant tissues were calculated by determining the endophytic bacterial population in several plant organs, accounting for distance from the inoculation point and acropetal/basipetal direction.", [["tissues", "ANATOMY", 240, 247], ["organs", "ANATOMY", 332, 338], ["Psa", "GENE_OR_GENE_PRODUCT", 212, 215], ["tissues", "TISSUE", 240, 247], ["organs", "ORGAN", 332, 338], ["Images", "TEST", 0, 6], ["Imaging", "TEST", 67, 74], ["Colonization", "PROBLEM", 123, 135], ["Methods", "TREATMENT", 192, 199], ["Psa migration", "TREATMENT", 212, 225], ["the endophytic bacterial population", "PROBLEM", 279, 314], ["Colonization", "OBSERVATION", 123, 135], ["Migration", "OBSERVATION_MODIFIER", 140, 149], ["Host Tissues", "OBSERVATION", 161, 173], ["Psa migration", "OBSERVATION", 212, 225], ["plant tissues", "OBSERVATION", 234, 247], ["endophytic", "OBSERVATION_MODIFIER", 283, 293], ["bacterial", "OBSERVATION_MODIFIER", 294, 303], ["population", "OBSERVATION", 304, 314], ["several", "OBSERVATION_MODIFIER", 318, 325], ["plant organs", "OBSERVATION", 326, 338], ["inoculation point", "OBSERVATION", 373, 390], ["basipetal direction", "OBSERVATION", 405, 424]]], ["Actinidia chinensis var. deliciosa (cv.", [["Actinidia chinensis", "ORGANISM", 0, 19], ["deliciosa", "ORGANISM", 25, 34], ["Actinidia chinensis", "SPECIES", 0, 19], ["deliciosa", "SPECIES", 25, 34], ["Actinidia chinensis var", "SPECIES", 0, 23], ["cv", "SPECIES", 36, 38], ["chinensis var", "OBSERVATION", 10, 23]]], ["\u2018Hayward\u2019) and A. chinensis var. chinensis (cv.", [["A. chinensis", "ORGANISM", 15, 27], ["chinensis", "ORGANISM", 33, 42], ["cv", "TISSUE", 44, 46], ["A. chinensis", "SPECIES", 15, 27], ["chinensis", "SPECIES", 33, 42], ["A. chinensis var", "SPECIES", 15, 31], ["chinensis", "SPECIES", 33, 42], ["cv", "SPECIES", 44, 46], ["chinensis var", "OBSERVATION", 18, 31]]], ["\u2018Hort16A\u2019) plants were stab-inoculated on the stem.", [["stem", "ANATOMY", 46, 50], ["stem", "TISSUE", 46, 50], ["stab", "PROBLEM", 23, 27], ["stab", "OBSERVATION", 23, 27], ["stem", "ANATOMY", 46, 50]]], ["Three weeks or 4 months later, Psa populations were determined in 1-cm samples taken above and below the inoculation point.", [["samples", "ANATOMY", 71, 78], ["Psa populations", "CELL", 31, 46], ["Psa populations", "TEST", 31, 46], ["inoculation point", "OBSERVATION", 105, 122]]], ["Maximum linear migration rates were also calculated from freshly excised canes, immersed in bacterial suspension (7.3 \u00d7 105 CFU mL\u22121) diluted in 10 mM MgSO4 and maintained at approx.", [["MgSO4", "CHEMICAL", 151, 156], ["MgSO4", "CHEMICAL", 151, 156], ["MgSO4", "SIMPLE_CHEMICAL", 151, 156], ["Maximum linear migration rates", "PROBLEM", 0, 30], ["bacterial suspension", "TREATMENT", 92, 112], ["10 mM MgSO4", "TREATMENT", 145, 156], ["linear", "OBSERVATION_MODIFIER", 8, 14], ["migration", "OBSERVATION_MODIFIER", 15, 24], ["bacterial", "OBSERVATION_MODIFIER", 92, 101], ["suspension", "OBSERVATION_MODIFIER", 102, 112]]], ["After 20 days, samples of wood tissue were taken every 10 cm to determine the furthest distance where Psa could be found.Influence of Temperature and Relative Humidity on Psa Growth in Plants ::: Materials and MethodsThe infection threshold was evaluated on the four main cultivars of A. chinensis var. chinensis and A. chinensis var. deliciosa, i.e.", [["samples", "ANATOMY", 15, 22], ["wood tissue", "ANATOMY", 26, 37], ["infection", "DISEASE", 221, 230], ["wood tissue", "TISSUE", 26, 37], ["Psa", "GENE_OR_GENE_PRODUCT", 102, 105], ["A. chinensis", "ORGANISM", 285, 297], ["chinensis", "ORGANISM", 303, 312], ["A. chinensis", "ORGANISM", 317, 329], ["deliciosa", "ORGANISM", 335, 344], ["A. chinensis", "SPECIES", 285, 297], ["chinensis", "SPECIES", 303, 312], ["A. chinensis", "SPECIES", 317, 329], ["deliciosa", "SPECIES", 335, 344], ["A. chinensis var", "SPECIES", 285, 301], ["chinensis", "SPECIES", 303, 312], ["A. chinensis var", "SPECIES", 317, 333], ["deliciosa", "SPECIES", 335, 344], ["samples of wood tissue", "TEST", 15, 37], ["Psa", "TEST", 102, 105], ["Methods", "TREATMENT", 210, 217], ["The infection threshold", "PROBLEM", 217, 240], ["wood tissue", "OBSERVATION", 26, 37], ["infection", "OBSERVATION", 221, 230], ["chinensis var", "OBSERVATION", 288, 301], ["chinensis var", "OBSERVATION", 320, 333]]], ["\u2018Zesy002\u2019, \u2018Hort16A\u2019, \u2018Jintao\u2019 and \u2018Hayward\u2019.", [["Zesy002", "CHEMICAL", 1, 8], ["Zesy002", "TREATMENT", 1, 8]]], ["Experimental inoculations were performed in controlled conditions on 3-year-old potted plants.", [["Experimental inoculations", "PROBLEM", 0, 25]]], ["The experiment was repeated three times, and each repetition consisted in 30 plants per cultivar divided in three biological replicates of ten plants.", [["cultivar", "TREATMENT", 88, 96]]], ["Half of the plants were spray-inoculated with a wild type strain of Psa (CFBP7286, biovar 3) and the other half with a GFPuv-Psa in order to visualize the colonization of the plant tissues.", [["tissues", "ANATOMY", 181, 188], ["plants", "ORGANISM", 12, 18], ["Psa", "ORGANISM", 68, 71], ["biovar 3", "ORGANISM", 83, 91], ["GFPuv-Psa", "GENE_OR_GENE_PRODUCT", 119, 128], ["tissues", "TISSUE", 181, 188], ["GFPuv", "PROTEIN", 119, 124], ["Psa", "PROTEIN", 125, 128], ["the plants", "TREATMENT", 8, 18], ["Psa", "TEST", 68, 71], ["biovar", "TEST", 83, 89], ["a GFPuv-Psa", "TREATMENT", 117, 128], ["colonization", "OBSERVATION", 155, 167], ["plant tissues", "OBSERVATION", 175, 188]]], ["Plants were inoculated with increasing concentrations of the pathogen (approx.", [["the pathogen", "PROBLEM", 57, 69], ["increasing", "OBSERVATION_MODIFIER", 28, 38], ["concentrations", "OBSERVATION_MODIFIER", 39, 53], ["pathogen", "OBSERVATION_MODIFIER", 61, 69]]], ["102, 103, 104, 105 CFU mL\u22121) and incubated in different temperature and humidity combinations (Table 1).Influence of Temperature and Relative Humidity on Psa Growth in Plants ::: Materials and MethodsPsa endophytic population was quantified at 3, 6, 24, 48, 72, 96 and 120 h post-inoculation.", [["MethodsPsa endophytic population", "TEST", 193, 225], ["endophytic", "OBSERVATION_MODIFIER", 204, 214], ["population", "OBSERVATION_MODIFIER", 215, 225]]], ["Symptoms were assessed at 7, 14 and 21 days post-inoculation.", [["Symptoms", "PROBLEM", 0, 8]]], ["The infection threshold was calculated according to the following equation:", [["infection", "DISEASE", 4, 13], ["The infection threshold", "PROBLEM", 0, 23], ["infection", "OBSERVATION", 4, 13]]]], "PMC7187849": [["IntroductionThe orthopaedic practice of AAHKS members, like virtually every other industry in the United States, has been significantly burdened by the negative economic effects of the worldwide COVID-19 pandemic.", [["pandemic", "PROBLEM", 204, 212]]], ["Elective cases have been essentially eliminated.", [["Elective cases", "TREATMENT", 0, 14]]], ["Fracture cases have slowed, and clinic visits have dropped by as much as 40-90 percent due to social distancing \u2013 all of which have contributed to significant strain on orthopaedic practices.IntroductionThe cessation of elective total hip and knee arthroplasty has also had a dramatic effect on AAHKS Industry Partners.", [["hip", "ANATOMY", 235, 238], ["knee", "ANATOMY", 243, 247], ["Fracture", "DISEASE", 0, 8], ["hip", "ORGANISM_SUBDIVISION", 235, 238], ["Fracture cases", "PROBLEM", 0, 14], ["significant strain on orthopaedic practices", "PROBLEM", 147, 190], ["elective total hip and knee arthroplasty", "TREATMENT", 220, 260], ["slowed", "OBSERVATION_MODIFIER", 20, 26], ["hip", "ANATOMY", 235, 238], ["knee", "ANATOMY", 243, 247], ["arthroplasty", "OBSERVATION", 248, 260]]], ["Severe dips in 1st and 2nd quarter implant sales revenue have forced companies to take pro-active steps to conserve capital and maintain liquidity during these uncertain times.", [["Severe dips", "PROBLEM", 0, 11], ["1st and 2nd quarter implant", "TREATMENT", 15, 42], ["dips", "OBSERVATION_MODIFIER", 7, 11]]], ["The significant financial resources AAHKS Industry Partners have historically committed to support national and regional orthopaedic meetings, surgeon education, clinical research, surgical/vendor OR support, and technological innovation have required re-distribution to varying degrees to maintain fiscal solvency.IntroductionForecasts for when US elective procedures may resume suggest that inpatient procedures could potentially restart in some states by mid-May, and most if not all states by the end of June 20201.", [["surgical/vendor", "TREATMENT", 181, 196], ["support", "TREATMENT", 200, 207], ["IntroductionForecasts", "TREATMENT", 315, 336], ["US elective procedures", "TREATMENT", 346, 368], ["inpatient procedures", "TREATMENT", 393, 413], ["significant", "OBSERVATION_MODIFIER", 4, 15]]], ["Orthopaedic practice models of AAHKS members differ significantly and will be affected to varying extents moving forward; the ability to increase production during the 2nd half of the fiscal year for the private practice, academic, and hospital employed surgeon must be considered both separately and as a collective; needs in terms of optimal industry support will be heterogeneous.", [["optimal industry support", "TREATMENT", 336, 360], ["heterogeneous", "OBSERVATION_MODIFIER", 369, 382]]], ["Due to the rapidly changing environment and risk of a resurgent COVID-19 virus, long-term strategies must also be articulated to safely prevent another catastrophic full-scale shutdown of elective cases.MethodsExecutive leadership of AAHKS Industry Partners with a significant footprint in elective hip and knee arthroplasty were contacted to participate in a brief blinded survey (Table 1) and optional phone or Zoom interview with a member of the AAHKS Industry Relations Committee (IRC).", [["hip", "ANATOMY", 299, 302], ["knee", "ANATOMY", 307, 311], ["COVID-19 virus", "ORGANISM", 64, 78], ["hip", "ORGANISM_SUBDIVISION", 299, 302], ["COVID-19 virus", "SPECIES", 64, 78], ["a resurgent COVID-19 virus", "TREATMENT", 52, 78], ["long-term strategies", "TREATMENT", 80, 100], ["a significant footprint in elective hip and knee arthroplasty", "TREATMENT", 263, 324], ["significant", "OBSERVATION_MODIFIER", 265, 276], ["footprint", "OBSERVATION_MODIFIER", 277, 286], ["hip", "ANATOMY", 299, 302], ["knee", "ANATOMY", 307, 311], ["arthroplasty", "OBSERVATION", 312, 324]]], ["The survey consisted of questions covering 5 topics to gauge changes in industry support resource allocation and work force including: Resources designated for orthopaedic meetings, Resources designated for surgeon education, Resources designated for strategic points of emphasis, Effect on industry work-force, and Measures taken to meet increased 3rd and 4th quarter demand.MethodsResults were tabulated and distributed a cohort of AAHKS Member Surgeons with disparate practice models including, Private practice, \u2018Academic\u2019 practice, and Hospital employed practice.", [["increased 3rd and 4th quarter demand", "TREATMENT", 339, 375]]], ["Support for Web-Based Live and Recorded content was also expected to again increase in 2021 (70%).Resources Designated for Strategic Points of Emphasis: ::: ResultsThe most significant trends identified for resources designated for strategic points of emphasis included a decrease in Marketing allocation (60% in 2020), and increased allocation for Site of Service/Outpatient Joint Replacement and COVID-19 Related Operative Safety Measures (70% and 90% of responders in 2020, 70% and 50% in 2021)Measures Taken to Meet Increased 3rd and 4th Quarter Demand: ::: ResultsIn anticipation of a Q3/Q4 2020 surge in elective joint arthroplasty, 90% of responding Industry Partners anticipated no significant decrease in their sales workforce.", [["joint", "ANATOMY", 619, 624], ["joint", "MULTI-TISSUE_STRUCTURE", 619, 624], ["Outpatient Joint Replacement", "TREATMENT", 365, 393], ["COVID", "TREATMENT", 398, 403], ["Operative Safety Measures", "TREATMENT", 415, 440], ["a Q3/Q4 2020 surge in elective joint arthroplasty", "TREATMENT", 588, 637], ["decrease", "OBSERVATION_MODIFIER", 272, 280], ["Joint", "ANATOMY", 376, 381], ["joint", "ANATOMY", 619, 624], ["arthroplasty", "OBSERVATION", 625, 637], ["significant", "OBSERVATION_MODIFIER", 690, 701], ["decrease", "OBSERVATION_MODIFIER", 702, 710]]], ["Resources designated to increase available instrumentation and support implant production was expected to increase (40%, 50% respectively) or remain unchanged (60%, 40% respectively).", [["available instrumentation", "TREATMENT", 33, 58], ["support implant production", "TREATMENT", 63, 89], ["unchanged", "OBSERVATION_MODIFIER", 149, 158]]], ["No Industry Partner anticipated decreases in instrumentation, implant production, or sales workforce during fiscal year 2020.Indirect Education Support: National and Regional Meetings ::: DiscussionIndustry Partners expressed trepidation in their support of Regional Meetings in 2020 (67% decrease) and a level of uncertainty with regard to the 2020 AAHKS Annual Meeting (30% uncertain, 30% decreased resource allocation).", [["instrumentation", "TREATMENT", 45, 60], ["decreases", "OBSERVATION_MODIFIER", 32, 41], ["instrumentation", "OBSERVATION", 45, 60]]], ["This critical continued resource allocation moving forward indirectly supports the educational mission of our largest arthroplasty society.", [["our largest arthroplasty society", "TREATMENT", 106, 138], ["largest", "OBSERVATION_MODIFIER", 110, 117], ["arthroplasty", "OBSERVATION", 118, 130]]], ["The extent to which COVID-19 and associated societal scars lingers may very well affect the scope, scale, attendance, and importance of all in person regional and national orthopaedic meetings for the foreseeable future.Direct Education Support: ::: DiscussionIn terms of direct support to surgeon education, a small downtrend of support at each level of training was identified for 2020, however a unanimous increase in resources directed towards web-based educational platforms was seen which can potentially benefit all learners.", [["COVID", "TEST", 20, 25], ["associated societal scars lingers", "PROBLEM", 33, 66], ["scars", "OBSERVATION", 53, 58]]], ["As physicians are forced to embrace and become comfortable with telemedicine secondary to COVID-19 induced social distancing, remote engagement and education supported by our Industry Partners may become a mainstay to reach a large number of individuals without geographic or temporal limitations in a cost and time efficient manner.Surgical Support During 3rd and 4th Quarter 2020 ::: DiscussionA common theme across survey responses and phone interviews was a significant commitment to enhanced surgeon support during the anticipated uptick of elective arthroplasty procedure in the second half of the fiscal year.", [["telemedicine", "TREATMENT", 64, 76], ["COVID", "TREATMENT", 90, 95], ["elective arthroplasty procedure", "TREATMENT", 546, 577], ["arthroplasty", "OBSERVATION", 555, 567]]], ["Defining the needs of AAHKS members with different practice models and articulating an appropriate response will allow our Industry Partners to help smooth the transition back to the Operative Room for all arthroplasty surgeons.", [["AAHKS members", "TREATMENT", 22, 35], ["different practice models", "TREATMENT", 41, 66], ["all arthroplasty surgeons", "TREATMENT", 202, 227], ["arthroplasty", "OBSERVATION", 206, 218]]], ["This is a potential action item for AAHKS and national leadership as we look to the future in 2020 and beyond.Surgical Support During 3rd and 4th Quarter 2020 ::: DiscussionOf Industry responders 70% expected to allocate more resources to \u2018Site of Service\u2019 support such as outpatient joint arthroplasty in both 2020 and 2021.", [["joint", "ANATOMY", 284, 289], ["joint", "MULTI-TISSUE_STRUCTURE", 284, 289], ["Service\u2019 support", "TREATMENT", 248, 264], ["outpatient joint arthroplasty", "TREATMENT", 273, 302], ["joint", "ANATOMY", 284, 289], ["arthroplasty", "OBSERVATION", 290, 302]]], ["COVID-19 related operative safety measures were also a highly emphasized (90% and 50% in 2020 and 2021 respectively).", [["COVID", "TEST", 0, 5]]], ["As this first wave of COVID-19 tamponades, the expected surge of elective cases currently backlogged will likely entail maximally stressing the elective capabilities in certain centers; the needs will be varied and inherently dependent on surgeon practice model.", [["COVID-19 tamponades", "PROBLEM", 22, 41], ["elective cases", "TREATMENT", 65, 79]]], ["Both sides of the aisle of our profession are currently bracing for the possibility of extended weekday schedules and/or weekend elective schedules where none existed prior.", [["bracing", "TREATMENT", 56, 63], ["elective schedules", "TREATMENT", 129, 147]]], ["There will be increased emphasis on efficiency of the non-surgical aspects of cases: pre-op preparation, anesthesia time, turn-over times in the OR, etc. Surgical efficiency will also be stressed, yet hopefully maintaining its rightful place behind quality and safety.", [["pre-op preparation", "TREATMENT", 85, 103], ["anesthesia time", "TREATMENT", 105, 120], ["Surgical efficiency", "PROBLEM", 154, 173], ["increased", "OBSERVATION_MODIFIER", 14, 23], ["efficiency", "OBSERVATION", 163, 173]]], ["Our relationship with Industry and our implant vendors can play a critical role during this time.Surgical Support During 3rd and 4th Quarter 2020 ::: DiscussionOn the vendor side, there could be a significantly greater tug-of-war for implant reps to be present in multiple hospitals or surgery centers at once, even late into the evenings or on weekends.", [["implant reps", "TREATMENT", 234, 246], ["surgery", "TREATMENT", 286, 293]]], ["As such, central sterilization efforts will heavily be put to the test as well.", [["central sterilization efforts", "TREATMENT", 9, 38], ["the test", "TEST", 62, 70]]], ["Refill of implants will be demanded more quickly, and more individual units of the same size will be expected to be available at once, to work through the backlog.", [["Refill of implants", "TREATMENT", 0, 18], ["implants", "OBSERVATION", 10, 18]]], ["We expect that the hip and knee implant manufacturers will do their best to provide the supply required, as their sales will have been reduced for 3 months or more.Private Practice Perspective ::: DiscussionAmid the current shutdown of elective arthroplasty, private orthopedic groups, like any independent service provider, have been put at significant at risk.", [["hip", "ANATOMY", 19, 22], ["knee", "ANATOMY", 27, 31], ["hip", "ORGANISM_SUBDIVISION", 19, 22], ["knee", "ORGANISM_SUBDIVISION", 27, 31], ["the hip and knee implant", "TREATMENT", 15, 39], ["elective arthroplasty", "TREATMENT", 236, 257], ["hip", "ANATOMY", 19, 22], ["knee", "ANATOMY", 27, 31], ["implant", "OBSERVATION", 32, 39], ["arthroplasty", "OBSERVATION", 245, 257]]], ["That said, with the assistance of Industry, private practice groups supporting Orthopaedic Hospitals and physician owned ambulatory surgery centers (ASCs) may have enhanced logistical mobility to ramp up elective case load at a greater rate than hospital employed or academic orthopaedic Surgeons.", [["ambulatory surgery", "TREATMENT", 121, 139]]], ["The ultimate sustainability of private orthopedic practices must come through a resumption of normal business practices.", [["private orthopedic practices", "TREATMENT", 31, 59]]], ["In the meantime, favorable financing structures for capital expenditures and volume based economic incentives are potential opportunities for Industry Partners to help \u2018weather the storm\u2019.Private Practice Perspective ::: DiscussionThere is also risk moving forward that further interruptions in business could be anticipated in the fourth quarter.", [["favorable", "OBSERVATION_MODIFIER", 17, 26]]], ["Some epidemiologists and infectious disease experts have predicted that COVID-19 infections will drop precipitously over the summer, only to come roaring back in the late fall and winter2.", [["infectious disease", "DISEASE", 25, 43], ["infections", "DISEASE", 81, 91], ["COVID-19", "ORGANISM", 72, 80], ["COVID", "TEST", 72, 77], ["infectious", "OBSERVATION_MODIFIER", 25, 35]]], ["Hospitals will inevitably shoulder the burden of treating infected patients, as they have currently.", [["patients", "ORGANISM", 67, 75], ["patients", "SPECIES", 67, 75]]], ["Site of care, including outpatient surgery centers and physicians owned hospitals will likely be the \u2018clean\u2019 hospitals moving forward.", [["outpatient surgery", "TREATMENT", 24, 42]]], ["These sites which will see less viral burden can serve a public role without placing additional stress on hospital systems.", [["These sites", "PROBLEM", 0, 11]]], ["In anticipation, industry could play a large role in helping orthopaedic surgeons maintain care pathways that ultimately reduce patient exposure to the Covid-19 virus.Academic Practice Perspective ::: DiscussionThe academic arthroplasty surgeon faces a different set of potential pifalls.", [["pifalls", "DISEASE", 280, 287], ["patient", "ORGANISM", 128, 135], ["Covid-19 virus", "ORGANISM", 152, 166], ["pifalls", "CANCER", 280, 287], ["patient", "SPECIES", 128, 135], ["Covid-19 virus", "SPECIES", 152, 166], ["care pathways", "TREATMENT", 91, 104], ["the Covid", "TEST", 148, 157], ["The academic arthroplasty surgeon", "TREATMENT", 211, 244], ["potential pifalls", "PROBLEM", 270, 287]]], ["A push for efficiency may also have an extended impact on teaching at academic institutions, wanting to catch up on wait-lists and make up for lost revenue, as a priority over technical instruction.Academic Practice Perspective ::: DiscussionVendor support may be limited due to more stringent access restrictions in tertiary hospitals where COVID-19 patients are still popping up even after the initial surge has abated.", [["patients", "ORGANISM", 351, 359], ["patients", "SPECIES", 351, 359], ["Vendor support", "TREATMENT", 242, 256]]], ["Furthermore, at many institutions there is no contract with one or two manufacturers, but rather a capitation model with a multitude of vendors used for primary and revision joint surgery.", [["joint", "ANATOMY", 174, 179], ["joint", "MULTI-TISSUE_STRUCTURE", 174, 179], ["primary and revision joint surgery", "TREATMENT", 153, 187], ["no", "UNCERTAINTY", 43, 45], ["revision joint", "OBSERVATION", 165, 179]]], ["It is possible that due to the financial blow of COVID-19, the model currently in place is urged to change in order to produce more savings on implant costs.", [["COVID", "TEST", 49, 54], ["implant costs", "TREATMENT", 143, 156]]], ["Finally, the confidence that there is no risk of coronavirus transmission will need to be instilled in the patients proceeding to elective surgery, which may be more difficult at a tertiary care center.", [["coronavirus", "DISEASE", 49, 60], ["coronavirus", "ORGANISM", 49, 60], ["patients", "ORGANISM", 107, 115], ["patients", "SPECIES", 107, 115], ["coronavirus", "SPECIES", 49, 60], ["coronavirus transmission", "PROBLEM", 49, 73], ["elective surgery", "TREATMENT", 130, 146], ["no risk of", "UNCERTAINTY", 38, 48], ["coronavirus", "OBSERVATION", 49, 60]]], ["Whether this involves increased testing, antibody testing or advanced PPE usage is uncertain.Hospital Employed Practice Perspective ::: DiscussionMuch like the position of an academic surgeon, the hospital employed orthopaedic surgeon may have to a degree had a buffer against the immediate economic ramifications of COVID-19 fallout.", [["increased testing", "TEST", 22, 39], ["antibody testing", "TEST", 41, 57], ["advanced PPE usage", "TREATMENT", 61, 79], ["a buffer", "TREATMENT", 260, 268], ["increased", "OBSERVATION_MODIFIER", 22, 31]]], ["While the hospital employed practice is unlikely to be inundated with a surge of semi-urgent revision or infection cases compared to a tertiary referral center, control over when and how to increase production is variable and administration dependent.Hospital Employed Practice Perspective ::: DiscussionAs surgical moratoriums are lifted, is likely that hospital systems will place an emphasis on the rapid resumption of highly profitable elective cases such as total joint arthroplasty to offset fiscal losses imposed by the COVID-19 shutdown3.", [["joint", "ANATOMY", 469, 474], ["infection", "DISEASE", 105, 114], ["joint", "MULTI-TISSUE_STRUCTURE", 469, 474], ["COVID-19 shutdown3", "DNA", 527, 545], ["semi-urgent revision", "TREATMENT", 81, 101], ["infection cases", "PROBLEM", 105, 120], ["profitable elective cases", "TREATMENT", 429, 454], ["total joint arthroplasty", "TREATMENT", 463, 487], ["fiscal losses", "PROBLEM", 498, 511], ["the COVID", "TEST", 523, 532], ["revision", "OBSERVATION", 93, 101], ["joint", "ANATOMY", 469, 474], ["arthroplasty", "OBSERVATION", 475, 487]]], ["In the short term, and emphasis on educational offerings has not been lost, but has been transitioned to a less hands on and more technologically driven \u2018social-distancing\u2019 friendly medium.", [["short term", "OBSERVATION_MODIFIER", 7, 17]]], ["This may very well become a significant aspect of our profession\u2019s \u2018new normal\u2019.", [["significant", "OBSERVATION_MODIFIER", 28, 39]]], ["Support for \u2018hands on\u2019 training that is a stalwart of total joint arthroplasty education will likely rebound but may take time and patience.ConclusionsIt is apparent that arthroplasty surgeons and Industry will have to maximize their efforts to work together safely, cohesively, respectfully and efficiently more than ever before, to weather the tidal wave of surgeries that is sure to come and forge a stronger working relationship and fortify our profession.", [["joint", "ANATOMY", 60, 65], ["joint", "MULTI-TISSUE_STRUCTURE", 60, 65], ["\u2019 training", "TREATMENT", 21, 31], ["a stalwart of total joint arthroplasty education", "TREATMENT", 40, 88], ["arthroplasty surgeons", "TREATMENT", 171, 192], ["surgeries", "TREATMENT", 360, 369], ["joint", "ANATOMY", 60, 65], ["arthroplasty", "OBSERVATION", 66, 78], ["arthroplasty", "OBSERVATION", 171, 183]]], ["Early and open communication will be paramount to smoothly adapting to changes in volume and disparate needs of surgeons and practices moving forward.ConclusionsOrthopaedic surgeons, hospitals, and most importantly patients across the United States have benefited greatly from symbiotic partnerships with manufacturers of orthopaedic products and implants.", [["patients", "ORGANISM", 215, 223], ["patients", "SPECIES", 215, 223], ["orthopaedic products", "TREATMENT", 322, 342], ["implants", "TREATMENT", 347, 355], ["orthopaedic products", "OBSERVATION", 322, 342]]], ["Although the current pandemic threatens massive upheaval across the industry, it also provides an opportunity to strengthen the Surgeon-Industry partnership in 2020 and beyond, enhancing our ability to achieve our ultimate goal \u2013 the assurance of access to quality orthopedic care for the American public.", [["quality orthopedic care", "TREATMENT", 257, 280], ["massive", "OBSERVATION_MODIFIER", 40, 47]]]], "PMC7447203": [["But that\u2019s ancient!\u201dKatherine \u2013 \u201cIt is ancient, but it works\u2026\u201d(Scene from Theodore Melfi\u2019s film \u201cHidden Figures,\u201d 2016).This excerpt describes the breakthrough of the NASA team working on the calculation of the re-entry coordinates for John Glenn\u2019s first orbital flight outside the atmosphere.", [["Katherine", "CHEMICAL", 20, 29], ["breakthrough", "OBSERVATION_MODIFIER", 147, 159]]], ["When faced a problem that cannot be solved analytically, Katherine Johnson, the woman who worked as the team \u201ccalculator,\u201d suggested to use the Euler method\u2014a step-by-step calculation for solving the differential equations of motion (Develaki 2019).", [["woman", "ORGANISM", 80, 85], ["woman", "SPECIES", 80, 85]]], ["Today, the Euler method is implemented in computer models that are investigated in introductory physics courses (e.g., Chabay and Sherwood 2008) and allows educators to expand the scope of problems that students can tackle.IntroductionDeveloping and using computational models reflects an important goal for K-12 science education, within a range of scientific practices such as designing and employing experimental investigations, analyzing measurement data and communicating them (NRC 2012).", [["K", "CHEMICAL", 308, 309], ["K-12 science education", "TREATMENT", 308, 330], ["experimental investigations", "TEST", 403, 430], ["analyzing measurement data", "TEST", 432, 458]]], ["Indeed, there is growing evidence for doing classroom inquiry that entails a dual focus on experimental measurement and computational modeling in primary and secondary schools (e.g., Farris et al. 2019; Fuhrmann et al. 2018).", [["experimental measurement", "TEST", 91, 115]]], ["However, research on teachers\u2019 attitudes towards integration of computational models in the context of experimental investigations is scarce (Gerard et al. 2011), and thus, teachers\u2019 implementation of instruction that involves both experimental classroom inquiry and construction of computational models, remains an open field of research.IntroductionIn this paper, we describe science teachers\u2019 engagement with inquiry-based curricular modules for 9th grade physics that introduce computational models.", [["9th grade physics", "PROBLEM", 449, 466]]], ["The modules include a structured, inquiry-based experimental component, and a theoretical component in which computational models are used to verify the experimental observations.", [["a structured, inquiry-based experimental component", "PROBLEM", 20, 70], ["a theoretical component", "PROBLEM", 76, 99], ["modules", "OBSERVATION", 4, 11], ["structured", "OBSERVATION_MODIFIER", 22, 32], ["experimental", "OBSERVATION_MODIFIER", 48, 60], ["component", "OBSERVATION_MODIFIER", 61, 70], ["theoretical", "OBSERVATION_MODIFIER", 78, 89], ["component", "OBSERVATION_MODIFIER", 90, 99]]], ["Drawing on studies that address teachers\u2019 attitudes and self-efficacy as indicators for implementation of inquiry teaching, we ask how do teachers\u2019 prior experiences in teaching physics influence their self-efficacy and attitudes towards inquiry-based learning practices?", [["Drawing on studies", "TEST", 0, 18], ["inquiry teaching", "TREATMENT", 106, 122]]], ["Specifically, in relation to computational modeling, we ask how does teachers\u2019 prior involvement with programming influence their self-efficacy in, and experience of computational modeling?Coordinating Theory and Experimental Evidence: a Model-Based Perspective ::: Literature ReviewA scientific investigation integrates two endeavors: the formation or revision of predictive theoretical constructs and the design of experiments that produce reliable observations or measurements (Klahr and Dunbar 1988).", [["revision", "TREATMENT", 353, 361], ["predictive theoretical constructs", "PROBLEM", 365, 398], ["revision", "OBSERVATION", 353, 361]]], ["In studying the development of scientific practices among students, researchers can focus on practices of experimental design such as the selection and control of variables (Chen and Klahr 1999) or the evaluation of measured data (Allie et al. 1998; Kanari and Millar 2004), or they can study how students use and conceptualize theoretical ideas.", [["the evaluation", "TEST", 198, 212]]], ["Judging experimental results as implausible in light of learners\u2019 \u201cna\u00efve\u201d theories is a crucial aspect of the theory-experiment interaction (Kuhn 2011).Coordinating Theory and Experimental Evidence: a Model-Based Perspective ::: Literature ReviewIn many introductory college and high school courses, the interaction between theory and experiment plays out in structured labs designed to \u201cprove\u201d or concretize theoretical statements.", [["structured labs", "TEST", 359, 374]]], ["Although the purpose of these labs is to substantiate the theory students learn in lecture courses, studies show that they do no contribute to students\u2019 content knowledge, as measured by test performance (Holmes and Wieman 2018).", [["these labs", "TEST", 24, 34]]], ["For example, in the Investigative Science Learning Environment (ISLE) curriculum (Etkina et al. 2006a), students design experiments to develop and then test model-based explanations of observed phenomena.", [["test model", "TEST", 152, 162], ["observed phenomena", "PROBLEM", 185, 203], ["phenomena", "OBSERVATION", 194, 203]]], ["This approach brings the design of experiments and the analysis of measurement data to the fore, and often challenges students\u2019 prior knowledge.", [["the analysis", "TEST", 51, 63], ["measurement data", "TEST", 67, 83]]], ["To do so, an extended amount of time is allocated to judging the reliability of measurement data.", [["measurement data", "TEST", 80, 96]]], ["Educational research shows that in these transformed labs, there is no decline in students\u2019 perceptions of their expertise in conducting experiments as in the structured lab (Wilcox and Lewandowski 2018).Coordinating Theory and Experimental Evidence: a Model-Based Perspective ::: Literature ReviewA specific case of coordinating theory and experiments is the construction and evaluation of models.", [["these transformed labs", "TEST", 35, 57], ["evaluation of models", "TEST", 377, 397], ["no", "UNCERTAINTY", 68, 70], ["decline", "OBSERVATION_MODIFIER", 71, 78]]], ["In introductory physics courses, models are usually instantiations of general, theoretical principles such as Newton\u2019s laws, in generic systems such as orbital motion under the influence of a centripetal force (Halloun and Hestenes 1987).", [["orbital motion", "OBSERVATION", 152, 166]]], ["Recently, researchers who design upper-level laboratories, suggested a new modeling framework, in which model construction, evaluation and revision is utilized for two inter-connected modeling cycles: the measurement model cycle and the theoretical model cycle (Zwickl et al. 2015; Dounas-Frazer and Lewandowski 2018).", [["evaluation", "TEST", 124, 134], ["revision", "TREATMENT", 139, 147], ["the measurement model cycle", "TEST", 201, 228]]], ["This framework provides two possible reactions to a misalignment of theory-based model and measurements: revising the measurement model\u2014the instruments used or the interpretation of the measurement data, or, revising the theoretical model.", [["the measurement model\u2014the instruments", "TREATMENT", 114, 151], ["the measurement data", "TEST", 182, 202]]], ["While this framework has been suggested for upper-level undergraduate labs that often involve sophisticated measurement equipment, it is a useful construct for guiding scientific investigations at various levels.", [["guiding scientific investigations", "TEST", 160, 193]]], ["It suggests designing investigations with explicit awareness to both the judgment of measurement data, and to the limitations of the theory-based, physical system models.", [["measurement data", "TEST", 85, 101]]], ["The measurement and/or the theoretical models can be revised to achieve better alignment of theory and the behavior of the actual physical system.", [["The measurement", "TEST", 0, 15]]], ["In this approach, students manipulate parameters of the simulated system to learn about its mechanism.", [["the simulated system", "TREATMENT", 52, 72]]], ["For example, students investigate a simulation of collisions and compare the velocities before and after the collision to deduce the law of conservation of momentum (De Jong et al. 1999).", [["the velocities", "TEST", 73, 87]]], ["A different educational approach is to engage students in constructing the computational model (VanLehn 2013; Wagh and Wilensky 2018).", [["A different educational approach", "TREATMENT", 0, 32]]], ["Engaging in model construction requires learning environments that allow students to add or change model features.", [["learning environments", "TREATMENT", 40, 61], ["change model features", "PROBLEM", 92, 113]]], ["For example, in a computational model of a falling paratrooper, students decide whether the magnitude of the drag force depends on the velocity or not.", [["the velocity", "TEST", 131, 143]]], ["They then examine whether their definition of the drag force yields a velocity pattern that reaches a relatively low terminal velocity as expected (Develaki 2017).Constructing Computational Models vs. Using Readymade Ones ::: Literature ReviewConstructing computational models and especially accessing their code has been explored in secondary school physics (Aiken et al. 2013; Sherin et al. 1993; Langbeheim et al. 2019; Hutchins et al. 2020), and in a few introductory college texts (Redish and Wilson 1993; Chabay and Sherwood 2008; Orban et al. 2018).", [["the drag force", "TEST", 46, 60], ["a velocity pattern", "TEST", 68, 86], ["a relatively low terminal velocity", "PROBLEM", 100, 134], ["relatively", "OBSERVATION_MODIFIER", 102, 112], ["low", "OBSERVATION_MODIFIER", 113, 116], ["terminal", "OBSERVATION_MODIFIER", 117, 125], ["velocity", "OBSERVATION_MODIFIER", 126, 134]]], ["However, there are only few examples of using simulations side by side with experiments.", [["few", "OBSERVATION_MODIFIER", 24, 27]]], ["Despite its basic level of content, this study shows that even young students are able to think about variations in measurement, and relate real-world observations to computational models.", [["this study", "TEST", 36, 46]]], ["Similarly, in Fuhrmann et al. (2018) students studied the osmosis of sugar water through an egg membrane experimentally and then explored a computer, particle-based model that mimics the experimental results.", [["egg membrane", "ANATOMY", 92, 104], ["sugar", "CHEMICAL", 69, 74], ["egg membrane", "MULTI-TISSUE_STRUCTURE", 92, 104], ["an egg membrane", "TREATMENT", 89, 104], ["egg membrane", "ANATOMY", 92, 104]]], ["However, only actively designing the model results in developing nuanced understanding of the role of models in scientific investigations.", [["scientific investigations", "TEST", 112, 137]]], ["This requires teachers and students to transition from being users of computer programs to being builders of programs, which can be viewed as a substantial change in computing culture (Ben-David Kolikant and Ben-Ari 2008) or an educational paradigm shift (DiSessa 2001).Teachers\u2019 Self-Efficacy in Inquiry-Based Teaching ::: Literature ReviewImplementing inquiry-based teaching that involves designing experiments, interpreting measurement data, and constructing models is challenging.", [["a substantial change", "PROBLEM", 142, 162], ["computing culture", "TEST", 166, 183], ["interpreting measurement data", "TEST", 414, 443]]], ["In this study, we consider two main factors that determine the extent to which teachers implement such teaching in their classrooms: (1) teachers\u2019 self-efficacy in teaching the subject matter (e.g., Lakshmanan et al. 2011); (2) teachers\u2019 attitudes regarding inquiry-based learning and their beliefs in its effectiveness (Blanchard et al. 2009).Teachers\u2019 Self-Efficacy in Inquiry-Based Teaching ::: Literature ReviewSelf-efficacy is a set of beliefs regarding one\u2019s capabilities to perform well in a certain field (Bandura 1997).", [["this study", "TEST", 3, 13]]], ["These beliefs are one of the main driving forces that motivate people to put effort and pursue challenging tasks.", [["people", "ORGANISM", 63, 69], ["people", "SPECIES", 63, 69]]], ["In preliminary acquisition of an expertise, there are several factors influencing self-efficacy, such as observing others demonstrating successful performances, and most importantly, one\u2019s own mastery experiences.", [["several", "OBSERVATION_MODIFIER", 54, 61]]], ["Similarly, teachers who had meaningful views of the pedagogical approaches to inquiry, grounded in learning theories, were more likely to adopt inquiry-based learning practices in their classrooms (Blanchard et al. 2009).Teachers\u2019 Self-Efficacy in Inquiry-Based Teaching ::: Literature ReviewReformed teaching pedagogies and curricula are usually introduced in professional development (PD) workshops, so that successful implementations can be related to the teachers\u2019 backgrounds and/or to the PD process.", [["PD", "DISEASE", 495, 497]]], ["The structure, duration, and content of PDs is an important factor influencing the implementation of reformed instruction and curricular innovations.", [["curricular innovations", "TREATMENT", 126, 148], ["structure", "OBSERVATION_MODIFIER", 4, 13]]], ["A survey study showed that PDs that focus on content knowledge and provide opportunities for active learning have the strongest positive effect on teachers\u2019 self-reported increase in knowledge and skills (Garet el at.", [["A survey study", "TEST", 0, 14], ["PDs", "PROBLEM", 27, 30]]], ["There are only few examples of teacher training programs that include computer programming (e.g., Repenning et al. 2020).", [["teacher training programs", "TREATMENT", 31, 56], ["few", "OBSERVATION_MODIFIER", 15, 18]]], ["Such courses are necessary for boosting their self-efficacy in computational modeling and knowledge of computational thinking (Papadakis and Kalogiannakis 2019).Experimental Section of the Learning Module ::: Scope of the Current StudyThe experimental section of both modules comprised six 90-min lessons that are summarized in Table 1.", [["the Current Study", "TEST", 218, 235]]], ["In the first module, the theoretical exploration focuses on the \u201cpeculiar\u201d lack of covariance of the period of the oscillating spring system and its amplitude.", [["the theoretical exploration", "TEST", 21, 48], ["theoretical", "OBSERVATION_MODIFIER", 25, 36], ["exploration", "OBSERVATION", 37, 48], ["oscillating spring", "OBSERVATION", 115, 133], ["amplitude", "OBSERVATION_MODIFIER", 149, 158]]], ["In the second, it focuses on the apparent discrepancy between the Aristotelian view (that mass influences the falling rate of objects) and the Galilean view (that it does not).Scaffolding measurement and data analysis practices\u2014the measurement and data analysis methods are introduced in a guided manner in the initial lessons.", [["the Aristotelian view", "TEST", 62, 83], ["mass", "PROBLEM", 90, 94], ["the Galilean view", "TEST", 139, 156], ["Scaffolding measurement", "TEST", 176, 199], ["data analysis", "TEST", 204, 217], ["the measurement", "TEST", 228, 243], ["data analysis methods", "TEST", 248, 269], ["mass", "OBSERVATION", 90, 94]]], ["In subsequent lessons, the teacher removes some of the direct instructions: first in asking students to plan and justify an experimental design to answer a common research question (e.g., how does the falling rate of paper cups change when increasing its mass?) and then in planning and justifying an experimental design to study a question that students generate by themselves (see Table 1 for examples)Raising student accountability\u2014students build an evaluation rubric for experimental investigations based on fabricated student reports, in order to develop awareness for reporting standards.", [["an evaluation rubric", "TEST", 450, 470], ["experimental investigations", "TEST", 475, 502]]], ["Then, they share their evaluation criteria to produce a unified rubric.", [["their evaluation criteria", "TEST", 17, 42]]], ["Finally, they use the consensus evaluation rubric to provide feedback on the presentations of their peers.Experimental Section of the Learning Module ::: Scope of the Current StudyAfter completing the experimental section, and sharing their inquiry projects using posters or presentations, the students proceed to study a theoretical model of the phenomenon.", [["the consensus evaluation", "TEST", 18, 42], ["the experimental section", "TREATMENT", 197, 221]]], ["The theoretical section includes a qualitative, conceptual section and the quantitative computational section.Qualitative Theoretical Modeling ::: Scope of the Current StudyThe qualitative, conceptual section comprises two lessons in which students construct a paper and pencil theoretical model that explains the phenomenon that they investigated experimentally.", [["the Current Study", "TEST", 156, 173], ["the phenomenon", "PROBLEM", 310, 324]]], ["For example, in the oscillating spring-mass unit, students analyze the trace of the oscillating mass, using motion patterns produced by the Tracker video analysis software (Brown and Cox 2009).", [["the oscillating mass", "PROBLEM", 80, 100], ["the Tracker video analysis", "TEST", 136, 162], ["mass", "OBSERVATION", 39, 43], ["trace", "OBSERVATION_MODIFIER", 71, 76], ["oscillating", "OBSERVATION_MODIFIER", 84, 95], ["mass", "OBSERVATION", 96, 100]]], ["Their analysis leads to the discovery that the maximal speed of the mass corresponds to the amplitude, or the distance covered by the mass during one period of oscillation.", [["Their analysis", "TEST", 0, 14], ["the mass", "PROBLEM", 64, 72], ["the mass", "PROBLEM", 130, 138], ["mass", "OBSERVATION", 68, 72], ["amplitude", "OBSERVATION_MODIFIER", 92, 101], ["mass", "OBSERVATION", 134, 138]]], ["This finding is used to hypothesize qualitatively that the length of the motion path and the average speed of the mass cancel each other out, and therefore, their ratio\u2014the period of one oscillation\u2014is constant.Quantitative Computational Modeling ::: Scope of the Current StudyThe purpose of the final unit in the module is to introduce a quantitative approach for comparing the measurements and the theory-based model.", [["the measurements", "TEST", 375, 391], ["mass", "OBSERVATION", 114, 118]]], ["The analytical equations of motion of both processes we discussed\u2014harmonic oscillations and falling with a drag force\u2014are nonlinear and involve mathematics beyond that of 9th grade.", [["\u2014harmonic oscillations", "PROBLEM", 65, 87], ["a drag force\u2014are nonlinear", "TREATMENT", 105, 131]]], ["The computational models of motion with air drag and of the oscillating spring-mass systems were realized using trinket.io\u2014a free, online tool for building coding activities and courses.", [["air drag", "PROBLEM", 40, 48], ["the oscillating spring", "TREATMENT", 56, 78], ["mass systems", "PROBLEM", 79, 91], ["air drag", "OBSERVATION", 40, 48]]], ["Python was chosen since it replaced introductory level programming languages that were used in the past such as Pascal, BASIC, and Fortran.", [["Python", "TREATMENT", 0, 6], ["introductory level programming languages", "TREATMENT", 36, 76]]], ["Figure 1 illustrates the trinket interface that has the code on the left side and the graphic output on the right.", [["the graphic output", "TEST", 82, 100], ["left", "ANATOMY_MODIFIER", 68, 72], ["graphic", "OBSERVATION_MODIFIER", 86, 93], ["output", "OBSERVATION_MODIFIER", 94, 100], ["right", "ANATOMY_MODIFIER", 108, 113]]], ["The unit introduced all the necessary programming ideas so that students (and teachers in the PD workshop) were not expected to have prior experience with VPython.", [["VPython", "TREATMENT", 155, 162]]], ["The supplementary material provides detailed information on the introduction of the computational model.Quantitative Computational Modeling ::: Scope of the Current StudyThe Euler method presents the theoretically predicted motion pattern using three linear equations, calculated repeatedly every time step.", [["the Current Study", "TEST", 153, 170]]], ["The first equation calculates the net force according to the current location or velocity of the object; the second calculates the new velocity of the object, based on Newton\u2019s 2nd law; and the third updates the location of the object based on the new velocity.", [["net force", "OBSERVATION", 34, 43], ["velocity", "OBSERVATION_MODIFIER", 81, 89], ["new", "OBSERVATION_MODIFIER", 131, 134], ["velocity", "OBSERVATION_MODIFIER", 135, 143], ["object", "OBSERVATION_MODIFIER", 151, 157], ["object", "OBSERVATION", 228, 234], ["new", "OBSERVATION_MODIFIER", 248, 251], ["velocity", "OBSERVATION_MODIFIER", 252, 260]]], ["For example, the implementation of these three equations for the falling with air drag problem is shown in lines 14\u201316 of the code shown in Fig. 1.", [["air drag problem", "PROBLEM", 78, 94], ["air drag", "OBSERVATION", 78, 86]]], ["In addition to using relatively simple linear equations, this approach promotes the analysis of the dynamics of specific moments during objects\u2019 motion patterns, thereby facilitating the comprehension of the process as a whole (Sherin et al. 1993; Sherin 2001).Context and Research Questions ::: MethodologyThe two modules were introduced in two summer PD workshops that span four full days and a total of 30 hours of contact.", [["relatively simple linear equations", "TREATMENT", 21, 55], ["two", "OBSERVATION_MODIFIER", 311, 314], ["modules", "OBSERVATION", 315, 322]]], ["The first 2 days of the PD focused on experimental investigations, and the last 2 days focused on the related theory and computational modeling.", [["PD", "DISEASE", 24, 26], ["experimental investigations", "TEST", 38, 65]]], ["Teachers worked in small groups and shared their experiences in discussions with the rest of the participants and the workshop instructors.", [["participants", "SPECIES", 97, 109]]], ["This group consisted of new teachers, and a few experienced teachers in other fields such as math, who were new to teaching physics topics.Data Collection and Analysis ::: MethodologyThe first research question asked how do teachers\u2019 prior experiences in teaching physics influence their self-efficacy and attitudes towards inquiry-based learning practices in a PD workshop.", [["PD", "DISEASE", 362, 364]]], ["The internal consistency of the self-efficacy scale was high\u2014Cronbach \u03b1 = 0.85.1b.", [["Cronbach", "TEST", 61, 69], ["internal", "OBSERVATION_MODIFIER", 4, 12], ["consistency", "OBSERVATION_MODIFIER", 13, 24]]], ["The E-CLASS includes items such as \u201cThe primary purpose of doing physics experiments is to confirm previously known results (strongly agree, agree etc.)\u201d.", [["E-CLASS", "DNA", 4, 11]]], ["The survey utilized a 4-level Likert scale.", [["a 4-level Likert scale", "TREATMENT", 20, 42]]], ["We used exploratory factor analysis to aggregate fifteen statements into two categories: (a) goals of inquiry-based laboratory practices, (b) goals of structured laboratory practices.", [["exploratory factor analysis", "TEST", 8, 35]]], ["The full list of items, the corresponding categories and internal consistency scores are shown in Table 2.Data Collection and Analysis ::: Methodology2.", [["internal consistency scores", "TEST", 57, 84], ["Methodology2", "TREATMENT", 139, 151]]], ["The internal consistency of the self-efficacy scale was substantial\u2014Cronbach \u03b1 = 0.76, but the distribution of the ratings in the posttest was not normally distributed (Shapiro-Wilk W = 0.94, p = 0.03)Programming activity appreciation\u2014Three statements addressed specifically the coding activity \u201cThe coding activity was interesting,\u201d \u201cThe coding activity improved my understanding of the physics of the spring-mass system / free-fall with drag,\u201d \u201cI understood everything I did in the coding activity\u201d (strongly agree, agree, etc.).", [["the self-efficacy scale", "TREATMENT", 28, 51], ["Cronbach", "TEST", 68, 76], ["Shapiro", "TEST", 169, 176], ["mass system", "PROBLEM", 410, 421], ["internal", "OBSERVATION_MODIFIER", 4, 12], ["consistency", "OBSERVATION_MODIFIER", 13, 24]]], ["The internal consistency of the activity appreciation scale was substantial\u2014Cronbach \u03b1 = 0.74.Data Collection and Analysis ::: MethodologyThe full survey can be found in the online supplement.", [["Cronbach", "TEST", 76, 84], ["Data Collection", "TEST", 94, 109], ["Analysis", "TEST", 114, 122], ["internal", "OBSERVATION_MODIFIER", 4, 12], ["consistency", "OBSERVATION_MODIFIER", 13, 24]]], ["In addition, we used transcripts from the activity itself to corroborate our survey findings.Physics Teaching Self-Efficacy ::: FindingsThe self-efficacy related to teaching physics in 9th grade was relatively high before the workshop with an average rating of 3.91 out of 5.", [["our survey findings", "TEST", 73, 92], ["teaching physics", "TEST", 165, 181], ["an average rating", "TEST", 240, 257], ["high", "OBSERVATION_MODIFIER", 210, 214]]], ["This difference is significant (t = \u2212 2.56, p = 0.017).Teachers\u2019 Overall Appreciation of the PD ::: FindingsThe characterization of teachers\u2019 perceptions of the contribution of the workshop was based on two forms of data: Likert-scale ratings and open-ended questions.", [["t", "TEST", 32, 33], ["p", "TEST", 44, 45], ["Likert-scale ratings", "TEST", 222, 242], ["significant", "OBSERVATION_MODIFIER", 19, 30]]], ["The average ratings were calculated and analyzed according on the teachers\u2019 experience as shown in Table 3.", [["The average ratings", "TEST", 0, 19]]], ["In the other categories, the differences between the experienced and novice teachers were very small.", [["very", "OBSERVATION_MODIFIER", 90, 94], ["small", "OBSERVATION_MODIFIER", 95, 100]]], ["Also, an index measure, combining all of the items, reveals no significant difference among groups (t = \u2212 0.146, p = 0.88) and between workshops (t = \u2212 1.21, p = 0.23).Teachers\u2019 Overall Appreciation of the PD ::: FindingsThe responses to the open question, corroborate these findings.", [["an index measure", "TEST", 6, 22], ["t", "TEST", 100, 101], ["p", "TEST", 113, 114], ["workshops", "TEST", 135, 144], ["t", "TEST", 146, 147], ["p", "TEST", 158, 159], ["index", "OBSERVATION", 9, 14], ["no", "UNCERTAINTY", 60, 62], ["significant", "OBSERVATION_MODIFIER", 63, 74], ["difference", "OBSERVATION_MODIFIER", 75, 85]]], ["I learned to use Excel for analyzing an experimental graph and fitting it to an equation.Whereas Ana, a novice teacher in her first year wrote:The main contributing aspects were the parallel investigations, the discussions about classroom inquiry, its meaning and its implementation.", [["an experimental graph", "TREATMENT", 37, 58], ["the parallel investigations", "TEST", 178, 205], ["main", "OBSERVATION_MODIFIER", 147, 151]]], ["In relation to the computational tools, Vera mentioned Excel which was used to analyze the experimental data, and Ana mentioned step-by-step computational modeling.Teachers\u2019 Overall Appreciation of the PD ::: FindingsOverall, teachers mentioned five main components of the PD: the two most common topics, both mentioned by 54% of the teachers, were the structured inquiry sequence and/or the computational modeling activity.", [["PD", "DISEASE", 273, 275]]], ["In addition, 41% mentioned the measurement error analysis and/or the active learning format of the workshop.", [["the measurement error analysis", "TEST", 27, 57]]], ["Finally, 24% of the teachers mentioned the contribution of the workshop to their understanding of fundamental physics concepts.Attitudes towards Laboratory Practices ::: FindingsThe differences in attitudes towards laboratory experiments before and after the PD were relatively minor as shown in Table 4.", [["PD", "DISEASE", 259, 261], ["laboratory experiments", "TEST", 215, 237], ["the PD", "TREATMENT", 255, 261]]], ["The teachers\u2019 rating of the importance of lab purposes associated with traditional structured lab (category b.) decreased during the workshop, and goals related to inquiry practices have slightly increased.", [["inquiry practices", "TREATMENT", 164, 181], ["decreased", "OBSERVATION_MODIFIER", 112, 121], ["slightly", "OBSERVATION_MODIFIER", 187, 195], ["increased", "OBSERVATION_MODIFIER", 196, 205]]], ["However, a closer examination shows that these differences were not the same across groups.", [["a closer examination", "TEST", 9, 29]]], ["The ratings of inquiry lab goals among novice teachers increased, whereas the experienced teachers\u2019 ratings slightly decreased.", [["slightly", "OBSERVATION_MODIFIER", 108, 116], ["decreased", "OBSERVATION_MODIFIER", 117, 126]]], ["This difference is marginally significant (p < 0.1).Teachers\u2019 Programming Self-Efficacy ::: FindingsThe average rating of programming self-efficacy before the activity was 3.11 (SD = 1.01), and at the end of the workshop, it increased to 3.65 (SD = 0.93).", [["the activity", "TEST", 155, 167], ["SD", "TEST", 178, 180], ["SD", "TEST", 244, 246], ["marginally", "OBSERVATION_MODIFIER", 19, 29], ["significant", "OBSERVATION_MODIFIER", 30, 41]]], ["A Wilcoxon signed rank test shows that the difference between pretest and posttest is significant (W = 930, p = 0.030).", [["A Wilcoxon signed rank test", "TEST", 0, 27]]], ["We found significant differences in self-efficacy both pre and post the activity, between teachers that declared to have prior knowledge in programming and teachers who did not.", [["significant", "OBSERVATION_MODIFIER", 9, 20], ["differences", "OBSERVATION_MODIFIER", 21, 32]]], ["Teachers with prior programming knowledge rated their self-efficacy significantly higher than teachers without such knowledge, both in the pretest (t = \u2212 3.49, p = 0.0013) and in the posttest (W = 80, p = 0.0055).Teachers\u2019 Appreciation of the Programming Activity ::: FindingsA Wilcoxon test shows that appreciation of the coding activity was similar among teachers with (M = 3.93, SD = 0.55) and without (M = 3.46, SD = 1.08) prior experience in programming (p = 0.239).", [["Wilcoxon test", "TEST", 278, 291], ["SD", "TEST", 382, 384], ["SD", "TEST", 416, 418]]], ["This variance is also evident in the boxplot in Fig. 2 (left).", [["Fig", "OBSERVATION_MODIFIER", 48, 51], ["left", "ANATOMY_MODIFIER", 56, 60]]], ["A scatter plot of the activity appreciation ratings vs. the self-efficacy of the teachers is shown in Fig. 2 (right).", [["scatter", "OBSERVATION_MODIFIER", 2, 9], ["plot", "OBSERVATION_MODIFIER", 10, 14], ["right", "ANATOMY_MODIFIER", 110, 115]]], ["I erased everything!A: maybe press here?V: No, here.", [["No", "UNCERTAINTY", 43, 45]]], ["It\u2019s annoying.A: I really like (unclear)V: I like ExcelA: Excel is really awesome,V: It is helpful.", [["annoying", "PROBLEM", 5, 13]]], ["It is the most convenient tool!Vera is frustrated with the computational modeling activity because of the technical problem that erased the changes in her code.", [["frustrated", "PROBLEM", 39, 49], ["the technical problem", "PROBLEM", 102, 123], ["frustrated", "OBSERVATION", 39, 49]]], ["This minor background detail might also explain their different approaches to computational modeling and indicate the importance of early exposure to computer programming.DiscussionThis study addressed two research questions\u2014the first asked how prior experience in teaching physics influenced teaching self-efficacy and attitudes towards inquiry-based laboratory practices.", [["computational modeling", "TEST", 78, 100], ["computer programming", "TREATMENT", 150, 170]]], ["The significantly higher self-efficacy in teaching physics of the experienced teachers is also in line with prior research on the effect of experience on teaching self-efficacy (Tschannen-Moran and Hoy 2007).", [["significantly", "OBSERVATION_MODIFIER", 4, 17], ["higher", "OBSERVATION_MODIFIER", 18, 24]]], ["While experience was related to self-efficacy, the overall appreciation of the learning modules was positive among both experienced and novice teachers.", [["self-efficacy", "PROBLEM", 32, 45]]], ["This is true for the appreciation of the experimental and computational aspects of the modules, and specifically in relation to the computational modeling activity.", [["experimental", "OBSERVATION", 41, 53], ["modules", "OBSERVATION", 87, 94]]], ["Table 3 shows that for the two main aspects of the workshop\u2014computational modeling and conducting structured inquiry (items 3 and 6)\u2014both groups responded similarly, and positively.DiscussionThe workshops\u2019 purpose was to introduce a novel approach for coordinating experimental measurements and theoretical, computational modeling.", [["a novel approach", "TREATMENT", 231, 247]]], ["This approach differs from traditional structured labs that aim at illustrating or reinforcing theoretical concepts.", [["traditional structured labs", "TEST", 27, 54]]], ["Teachers\u2019 decrease in ratings of traditional goals, and the increase in ratings of inquiry practices related to the coordination of experimental results and theory, indicate that the workshop had some influence on the attitudes towards the main goals of the lab.", [["inquiry practices", "TREATMENT", 83, 100], ["decrease", "OBSERVATION_MODIFIER", 10, 18], ["increase", "OBSERVATION_MODIFIER", 60, 68]]], ["The differences may be related to prior acquaintance with inquiry practices: the mastery experience in the workshop might have boosted the novice teachers\u2019 belief in the importance of these practices, but not those of the experienced teachers who were already confident.", [["may be related to", "UNCERTAINTY", 16, 33]]], ["This difference probably reflects a process of self-selection\u2014students or teachers who persist in their degree or teaching\u2014are more likely to have positive attitudes towards the importance of the practices that they acquired (Wilcox and Lewandowski 2018).DiscussionThe second research question addressed the relation between prior involvement with programming, self-efficacy, and attitudes towards the computational modeling activity.", [["probably reflects", "UNCERTAINTY", 16, 33]]], ["We found that the self-efficacy related to programming of most teachers has increased during the workshop, although teachers with no programming experience were still less efficacious than the teachers with programming experience at the end of the workshop.", [["increased", "OBSERVATION_MODIFIER", 76, 85]]], ["The conversation between the two teachers hints that the difference in appreciation may be rooted in different dispositions towards the adaptation of new technologies: Vera expressed resentment towards the computational modeling activity and contrasted it with her satisfaction with Excel\u2014a user-friendly interface for data visualization that was also used in the workshop.", [["data visualization", "TEST", 319, 337]]], ["Vera\u2019s reaction reflects the difficulty in switching from the \u201cculture\u201d of computer users of programs such as Excel to the \u201cculture\u201d of computer programmers that requires planning and debugging (Kolikant and Ben-Ari 2008).", [["Vera\u2019s reaction", "PROBLEM", 0, 15]]], ["One way to overcome such barriers is by introducing programming to children at a young age to prevent the perpetuation of the culture focusing on merely using readymade computer artifacts, to a culture views the computer as tool for developing new artifacts (DiSessa 2001).", [["children", "ORGANISM", 67, 75], ["children", "SPECIES", 67, 75], ["the culture", "TEST", 122, 133], ["a culture views", "TEST", 192, 207], ["new artifacts", "PROBLEM", 244, 257], ["new", "OBSERVATION_MODIFIER", 244, 247], ["artifacts", "OBSERVATION", 248, 257]]], ["For example, the computational model uses symbols for the variables of force \u201cF\u201d and velocity \u201cv\u201d and allows to perform calculations with them (see lines 14\u201315 in Fig. 1) this type of representation is not possible in Excel, nor is it possible to simulate motion in a dynamic manner.Conclusion and ImplicationsAt the beginning of this paper, we referenced the \u201cHidden Figures\u201d movie scene to introduce the computational Euler method as a legitimate, and sometimes even necessary, substitute for analytical/mathematical modeling.", [["the computational Euler method", "TREATMENT", 402, 432], ["analytical/mathematical modeling", "TREATMENT", 495, 527], ["not possible", "UNCERTAINTY", 202, 214]]], ["We believe that since computational modeling plays a central and indispensable role in scientific inquiry, this practice needs to be represented in school science, and the only way to do this is by investing in teacher PD.", [["PD", "DISEASE", 219, 221]]], ["In this study, we examined science teachers\u2019 reactions towards a PD workshop that introduced inquiry-based modules with a computational modeling component.", [["PD", "DISEASE", 65, 67], ["this study", "TEST", 3, 13], ["a PD workshop", "TREATMENT", 63, 76], ["a computational modeling component", "PROBLEM", 120, 154]]], ["Specifically, we found that most teachers\u2019 attitudes towards the computational modeling were positive, and their self-efficacy beliefs regarding computational modeling increased.", [["computational modeling", "PROBLEM", 145, 167], ["increased", "OBSERVATION_MODIFIER", 168, 177]]], ["The main limitation of our study is that it does not describe the actual implementation of the modules by the teachers in their classrooms.", [["our study", "TEST", 23, 32], ["main", "OBSERVATION_MODIFIER", 4, 8], ["limitation", "OBSERVATION_MODIFIER", 9, 19]]], ["This would be a subject for an additional study.", [["an additional study", "TEST", 28, 47]]], ["Nevertheless, we note that despite the positive reactions at the end of the workshop, only 25% of the teachers implemented the modules in their classrooms in the subsequent year.", [["the positive reactions", "PROBLEM", 35, 57]]], ["Similarly, Farris et al. (2019) wrote that \u201cevident in the teacher\u2019s instructional approach was the tension between supporting students\u2019 exploration (of the computational model) and the curricular need for the production of canonically correct representations\u2026 that are mandated by the curriculum and that they would need in standardized tests.\u201d", [["exploration", "TEST", 137, 148], ["standardized tests", "TEST", 325, 343]]], ["In our case, we found that the \u201cfree-fall\u201d module, which is more aligned with the middle-school curriculum, has a better chance to be implemented than the oscillations module.", [["the \u201cfree-fall\u201d module", "PROBLEM", 27, 49], ["the oscillations module", "PROBLEM", 151, 174], ["free", "OBSERVATION_MODIFIER", 32, 36], ["fall\u201d module", "OBSERVATION", 37, 49], ["more", "OBSERVATION_MODIFIER", 60, 64], ["aligned", "OBSERVATION_MODIFIER", 65, 72], ["middle", "ANATOMY_MODIFIER", 82, 88]]], ["Another way that may be useful for streamlining the learning module is by embedding the programming activities in a learning management system such as Moodle.", [["a learning management system", "TREATMENT", 114, 142]]], ["In the workshop, teachers had to split their attention between a paper worksheet, and the VPython code on the computer.", [["VPython code", "DNA", 90, 102]]], ["In a revised version of the module that was created to support teachers in distance teaching during the COVID-19 shutdown, we embedded the VPython code within an online worksheet in a learning management system.", [["COVID", "DNA", 104, 109], ["VPython code", "DNA", 139, 151], ["a learning management system", "TREATMENT", 182, 210]]], ["This places the programming section as an integral component of the learning unit, and can encourage students and teachers to use it.Conclusion and ImplicationsYet, another way to encourage teachers to implement is by maintaining a professional learning community of the implementing teachers.", [["the programming section", "TREATMENT", 12, 35]]], ["At first, we used a model of individual teacher support that included planning sessions and classroom observations with the PD team.", [["individual teacher support", "TREATMENT", 29, 55]]]], "PMC7087286": [["IntroductionPorcine deltacoronavirus (PDCoV), a member of the family Coronaviridae, order Nidovirales, is an enveloped, single-stranded positive-sense RNA virus [1].", [["deltacoronavirus", "GENE_OR_GENE_PRODUCT", 20, 36], ["PDCoV", "GENE_OR_GENE_PRODUCT", 38, 43], ["Coronaviridae", "GENE_OR_GENE_PRODUCT", 69, 82], ["Nidovirales", "GENE_OR_GENE_PRODUCT", 90, 101], ["IntroductionPorcine deltacoronavirus", "TREATMENT", 0, 36], ["Nidovirales", "TREATMENT", 90, 101]]], ["The genome of PDCoV is 25.4 kb in length, making it the smallest genome among the known coronaviruses (CoVs) [2].", [["PDCoV", "GENE_OR_GENE_PRODUCT", 14, 19], ["coronaviruses", "ORGANISM", 88, 101], ["PDCoV", "DNA", 14, 19], ["25.4 kb", "OBSERVATION_MODIFIER", 23, 30], ["smallest genome", "OBSERVATION", 56, 71], ["coronaviruses", "OBSERVATION", 88, 101]]], ["The coding region of PDCoV is flanked by short 5\u2032 and 3\u2032 untranslated regions (UTRs), and the gene order is 5\u2032-UTR-ORF1a-ORF1b-S-E-M-NS6-N-NS7-3\u2032-UTR.", [["PDCoV", "GENE_OR_GENE_PRODUCT", 21, 26], ["PDCoV", "DNA", 21, 26], ["short 5\u2032 and 3\u2032 untranslated regions", "DNA", 41, 77], ["UTRs", "DNA", 79, 83], ["UTR", "DNA", 111, 114], ["ORF1a", "DNA", 115, 120], ["ORF1b", "DNA", 121, 126], ["S", "DNA", 127, 128], ["E", "DNA", 129, 130], ["NS6", "DNA", 133, 136], ["N", "DNA", 137, 138], ["NS7", "DNA", 139, 142], ["3\u2032", "DNA", 143, 145], ["UTR", "DNA", 146, 149], ["short 5\u2032 and 3\u2032 untranslated regions", "PROBLEM", 41, 77], ["UTR", "TEST", 111, 114], ["ORF1a", "TEST", 115, 120], ["ORF1b", "TEST", 121, 126], ["NS6", "TEST", 133, 136], ["NS7", "TEST", 139, 142], ["PDCoV", "OBSERVATION", 21, 26], ["short", "OBSERVATION_MODIFIER", 41, 46]]], ["PDCoV encodes at least four structural proteins, including the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins, as well as two accessory proteins, NS6 and NS7 [3\u20136].", [["membrane", "ANATOMY", 88, 96], ["PDCoV", "GENE_OR_GENE_PRODUCT", 0, 5], ["E", "GENE_OR_GENE_PRODUCT", 84, 85], ["membrane", "CELLULAR_COMPONENT", 88, 96], ["nucleocapsid (N) proteins", "GENE_OR_GENE_PRODUCT", 106, 131], ["NS6", "GENE_OR_GENE_PRODUCT", 168, 171], ["NS7", "GENE_OR_GENE_PRODUCT", 176, 179], ["PDCoV", "PROTEIN", 0, 5], ["structural proteins", "PROTEIN", 28, 47], ["spike (S), envelope (E), membrane (M)", "PROTEIN", 63, 100], ["nucleocapsid (N) proteins", "PROTEIN", 106, 131], ["accessory proteins", "PROTEIN", 148, 166], ["NS6", "PROTEIN", 168, 171], ["NS7", "PROTEIN", 176, 179], ["3\u20136", "PROTEIN", 181, 184], ["the spike (S", "TEST", 59, 71], ["envelope (E), membrane (M), and nucleocapsid (N) proteins", "TEST", 74, 131], ["two accessory proteins", "TEST", 144, 166], ["NS7", "TEST", 176, 179]]], ["The S protein is responsible for receptor binding and membrane fusion and acts as the major antigen inducing neutralizing antibodies [7].", [["membrane", "ANATOMY", 54, 62], ["membrane", "CELLULAR_COMPONENT", 54, 62], ["S protein", "PROTEIN", 4, 13], ["neutralizing antibodies", "PROTEIN", 109, 132], ["The S protein", "TEST", 0, 13], ["receptor binding", "PROBLEM", 33, 49], ["membrane fusion", "TREATMENT", 54, 69], ["neutralizing antibodies", "PROBLEM", 109, 132], ["membrane fusion", "OBSERVATION", 54, 69]]], ["The N protein is highly conserved and plays a critical role in viral RNA encapsidation [8].", [["N protein", "PROTEIN", 4, 13], ["The N protein", "TEST", 0, 13], ["viral RNA encapsidation", "TREATMENT", 63, 86]]], ["The M and E proteins are important for virion assembly and budding [9].IntroductionDuring a molecular surveillance study performed by Yuen and coworkers in 2012, PDCoV was first identified in swine specimens in Hong Kong [10].", [["virion", "ANATOMY", 39, 45], ["specimens", "ANATOMY", 198, 207], ["virion", "CELLULAR_COMPONENT", 39, 45], ["PDCoV", "CANCER", 162, 167], ["swine", "ORGANISM", 192, 197], ["M and E proteins", "PROTEIN", 4, 20], ["swine", "SPECIES", 192, 197], ["swine", "SPECIES", 192, 197], ["The M and E proteins", "TREATMENT", 0, 20], ["a molecular surveillance study", "TEST", 90, 120]]], ["Following the first detection of PDCoV in pigs with diarrhea in Ohio, USA, in February 2014, dozens of PDCoV strains were identified in the United States, Canada, South Korea, China, and Thailand [4, 5, 11\u201316].", [["PDCoV", "CHEMICAL", 33, 38], ["diarrhea", "DISEASE", 52, 60], ["PDCoV", "CANCER", 33, 38], ["pigs", "ORGANISM", 42, 46], ["pigs", "SPECIES", 42, 46], ["PDCoV", "SPECIES", 33, 38], ["pigs", "SPECIES", 42, 46], ["PDCoV", "SPECIES", 103, 108], ["PDCoV", "TREATMENT", 33, 38], ["diarrhea", "PROBLEM", 52, 60], ["PDCoV strains", "TREATMENT", 103, 116], ["diarrhea", "OBSERVATION", 52, 60]]], ["Piglets infected with PDCoV are characterized by watery diarrhea, variable vomiting, and dehydration [3].", [["PDCoV", "CHEMICAL", 22, 27], ["watery diarrhea", "DISEASE", 49, 64], ["vomiting", "DISEASE", 75, 83], ["dehydration", "DISEASE", 89, 100], ["Piglets", "ORGANISM", 0, 7], ["Piglets", "SPECIES", 0, 7], ["PDCoV", "SPECIES", 22, 27], ["PDCoV", "TREATMENT", 22, 27], ["watery diarrhea", "PROBLEM", 49, 64], ["variable vomiting", "PROBLEM", 66, 83], ["dehydration", "PROBLEM", 89, 100], ["infected", "OBSERVATION", 8, 16], ["watery", "OBSERVATION_MODIFIER", 49, 55], ["diarrhea", "OBSERVATION", 56, 64], ["variable", "OBSERVATION_MODIFIER", 66, 74], ["vomiting", "OBSERVATION", 75, 83]]], ["Notably, PDCoV-positive piglets are frequently co-infected with other enteric viruses, such as porcine epidemic diarrhea virus (PEDV), rotavirus, transmissible gastroenteritis coronavirus (TGEV), and porcine respiratory coronavirus (PRCV), which considerably increases the morbidity and mortality of piglets [17].", [["piglets", "ANATOMY", 24, 31], ["enteric viruses", "DISEASE", 70, 85], ["porcine epidemic diarrhea virus", "DISEASE", 95, 126], ["rotavirus", "DISEASE", 135, 144], ["transmissible gastroenteritis coronavirus", "DISEASE", 146, 187], ["TGEV", "DISEASE", 189, 193], ["porcine respiratory coronavirus", "DISEASE", 200, 231], ["PRCV", "DISEASE", 233, 237], ["PDCoV", "GENE_OR_GENE_PRODUCT", 9, 14], ["piglets", "ORGANISM", 24, 31], ["porcine epidemic diarrhea virus", "ORGANISM", 95, 126], ["rotavirus", "ORGANISM", 135, 144], ["transmissible gastroenteritis coronavirus", "ORGANISM", 146, 187], ["TGEV", "ORGANISM", 189, 193], ["porcine respiratory coronavirus", "ORGANISM", 200, 231], ["piglets", "ORGANISM", 300, 307], ["PDCoV", "PROTEIN", 9, 14], ["piglets", "SPECIES", 24, 31], ["porcine epidemic diarrhea virus", "SPECIES", 95, 126], ["transmissible gastroenteritis coronavirus", "SPECIES", 146, 187], ["TGEV", "SPECIES", 189, 193], ["porcine respiratory coronavirus", "SPECIES", 200, 231], ["piglets", "SPECIES", 300, 307], ["porcine epidemic diarrhea virus", "SPECIES", 95, 126], ["PEDV", "SPECIES", 128, 132], ["rotavirus", "SPECIES", 135, 144], ["transmissible gastroenteritis coronavirus", "SPECIES", 146, 187], ["TGEV", "SPECIES", 189, 193], ["porcine respiratory coronavirus", "SPECIES", 200, 231], ["PRCV", "SPECIES", 233, 237], ["PDCoV", "TEST", 9, 14], ["positive piglets", "PROBLEM", 15, 31], ["other enteric viruses", "PROBLEM", 64, 85], ["porcine epidemic diarrhea virus", "PROBLEM", 95, 126], ["PEDV", "PROBLEM", 128, 132], ["rotavirus", "PROBLEM", 135, 144], ["transmissible gastroenteritis coronavirus (TGEV)", "PROBLEM", 146, 194], ["porcine respiratory coronavirus", "PROBLEM", 200, 231], ["positive piglets", "OBSERVATION", 15, 31], ["enteric", "ANATOMY", 70, 77], ["viruses", "OBSERVATION", 78, 85], ["gastroenteritis coronavirus", "OBSERVATION", 160, 187], ["respiratory coronavirus", "OBSERVATION", 208, 231]]], ["PDCoV outbreaks have been reported in many countries worldwide and have caused significant economic losses in the pork industry.", [["pork", "ORGANISM_SUBDIVISION", 114, 118], ["PDCoV", "SPECIES", 0, 5], ["pork", "SPECIES", 114, 118], ["significant", "OBSERVATION_MODIFIER", 79, 90], ["economic", "OBSERVATION_MODIFIER", 91, 99], ["losses", "OBSERVATION", 100, 106]]], ["Moreover, due to the unique genome replication strategy of coronavirus, PDCoV undergoes RNA mutation and recombination events at high frequency, giving rise to new variants, which makes it extremely difficult to control and eliminate [18].IntroductionIn 2015, Saif and coworkers reported that a PDCoV strain named OH-FD22 caused severe atrophic enteritis accompanied by severe diarrhea and vomiting in gnotobiotic piglets [19].", [["OH-FD22", "CHEMICAL", 314, 321], ["enteritis", "DISEASE", 345, 354], ["diarrhea", "DISEASE", 377, 385], ["vomiting", "DISEASE", 390, 398], ["OH-FD22", "CHEMICAL", 314, 321], ["coronavirus", "ORGANISM", 59, 70], ["PDCoV", "GENE_OR_GENE_PRODUCT", 72, 77], ["OH-FD22", "SIMPLE_CHEMICAL", 314, 321], ["PDCoV", "DNA", 72, 77], ["piglets", "SPECIES", 414, 421], ["coronavirus", "PROBLEM", 59, 70], ["PDCoV", "TREATMENT", 72, 77], ["RNA mutation", "PROBLEM", 88, 100], ["recombination events", "PROBLEM", 105, 125], ["new variants", "PROBLEM", 160, 172], ["a PDCoV strain", "TREATMENT", 293, 307], ["severe atrophic enteritis", "PROBLEM", 329, 354], ["severe diarrhea", "PROBLEM", 370, 385], ["vomiting", "PROBLEM", 390, 398], ["gnotobiotic piglets", "TREATMENT", 402, 421], ["severe", "OBSERVATION_MODIFIER", 329, 335], ["atrophic", "OBSERVATION_MODIFIER", 336, 344], ["enteritis", "OBSERVATION", 345, 354], ["severe", "OBSERVATION_MODIFIER", 370, 376], ["diarrhea", "OBSERVATION", 377, 385]]], ["Macroscopic examination revealed that the jejunum and ileum are the major targets for PDCoV infection, and the pathological lesions were similar to, but milder than, those caused by PEDV [19].", [["jejunum", "ANATOMY", 42, 49], ["ileum", "ANATOMY", 54, 59], ["lesions", "ANATOMY", 124, 131], ["infection", "DISEASE", 92, 101], ["jejunum", "MULTI-TISSUE_STRUCTURE", 42, 49], ["ileum", "ORGAN", 54, 59], ["PDCoV", "CANCER", 86, 91], ["lesions", "PATHOLOGICAL_FORMATION", 124, 131], ["PDCoV", "SPECIES", 86, 91], ["PEDV", "SPECIES", 182, 186], ["Macroscopic examination", "TEST", 0, 23], ["PDCoV infection", "PROBLEM", 86, 101], ["the pathological lesions", "PROBLEM", 107, 131], ["PEDV", "PROBLEM", 182, 186], ["jejunum", "ANATOMY", 42, 49], ["ileum", "ANATOMY", 54, 59], ["infection", "OBSERVATION", 92, 101], ["pathological", "OBSERVATION_MODIFIER", 111, 123], ["lesions", "OBSERVATION", 124, 131]]], ["Subsequently, the pathogenicity of several American strains, including USA/IL/2014, Michigan/8977, and Ohio CVM I, was investigated in piglets [20].", [["IL", "GENE_OR_GENE_PRODUCT", 75, 77], ["piglets", "ORGANISM", 135, 142], ["piglets", "SPECIES", 135, 142], ["USA/IL/2014, Michigan/8977", "SPECIES", 71, 97], ["Ohio CVM I", "SPECIES", 103, 113]]], ["These American strains exhibited pathogenic characteristics similar to those of OH-FD22.", [["OH-FD22", "CHEMICAL", 80, 87], ["OH-FD22", "SIMPLE_CHEMICAL", 80, 87], ["pathogenic characteristics", "PROBLEM", 33, 59]]], ["In addition, it has been reported that newborn piglets inoculated with two recent Chinese PDCoV isolates, named CHN-HN-2014 and CHN-GD-2016, developed clear clinical signs, including severe diarrhea, vomiting, and dehydration [21, 22].IntroductionIn this study, we successfully isolated a high-growth PDCoV strain, hereafter referred to as CHN-HG-2017, from feces of a pig on a farm located in Huanggang, Hubei province.", [["feces", "ANATOMY", 358, 363], ["CHN", "CHEMICAL", 112, 115], ["diarrhea", "DISEASE", 190, 198], ["vomiting", "DISEASE", 200, 208], ["dehydration", "DISEASE", 214, 225], ["CHN-HG-2017", "CHEMICAL", 340, 351], ["piglets", "ORGANISM", 47, 54], ["PDCoV", "ORGANISM", 90, 95], ["CHN-HN-2014", "CELL", 112, 123], ["CHN-GD-2016", "CELL", 128, 139], ["CHN-HG-2017", "CELL", 340, 351], ["feces", "ORGANISM_SUBDIVISION", 358, 363], ["pig", "ORGANISM", 369, 372], ["piglets", "SPECIES", 47, 54], ["pig", "SPECIES", 369, 372], ["Chinese PDCoV", "SPECIES", 82, 95], ["pig", "SPECIES", 369, 372], ["clear clinical signs", "PROBLEM", 151, 171], ["severe diarrhea", "PROBLEM", 183, 198], ["vomiting", "PROBLEM", 200, 208], ["dehydration", "PROBLEM", 214, 225], ["this study", "TEST", 250, 260], ["a high-growth PDCoV strain", "PROBLEM", 287, 313], ["severe", "OBSERVATION_MODIFIER", 183, 189], ["diarrhea", "OBSERVATION", 190, 198]]], ["Analysis of the genomic sequence suggested that CHN-HG-2017 is a potential recombinant virus derived from Chinese and Vietnam PDCoV strains.", [["CHN-HG-2017", "CHEMICAL", 48, 59], ["the genomic sequence", "TEST", 12, 32], ["HG", "TEST", 52, 54], ["a potential recombinant virus", "PROBLEM", 63, 92], ["Vietnam PDCoV strains", "TREATMENT", 118, 139]]], ["Furthermore, the pathogenicity of CHN-HG-2017 in 5-day-old piglets was investigated by clinical assessment, the quantification of viral shedding and distribution, histology, and immunohistochemistry.Collection of clinical samples and treatment ::: Materials and methodsFeces (n = 17) from pigs experiencing diarrhea were obtained from farms in Huanggang, Hubei province.", [["samples", "ANATOMY", 222, 229], ["CHN-HG-2017", "CHEMICAL", 34, 45], ["diarrhea", "DISEASE", 307, 315], ["CHN-HG-2017", "CELL", 34, 45], ["piglets", "ORGANISM", 59, 66], ["pigs", "ORGANISM", 289, 293], ["piglets", "SPECIES", 59, 66], ["pigs", "SPECIES", 289, 293], ["pigs", "SPECIES", 289, 293], ["HG", "TEST", 38, 40], ["clinical assessment", "TEST", 87, 106], ["viral shedding", "PROBLEM", 130, 144], ["histology", "TEST", 163, 172], ["immunohistochemistry", "TEST", 178, 198], ["methodsFeces", "TEST", 262, 274], ["diarrhea", "PROBLEM", 307, 315], ["viral shedding", "OBSERVATION", 130, 144]]], ["They tested PDCoV-positive by N-gene-based RT-PCR as reported previously [12].", [["PDCoV", "GENE_OR_GENE_PRODUCT", 12, 17], ["PDCoV", "DNA", 12, 17], ["N-gene", "DNA", 30, 36], ["PDCoV", "TEST", 12, 17], ["PCR", "TEST", 46, 49]]], ["These clinical samples were subsequently subjected to virus isolation.", [["samples", "ANATOMY", 15, 22], ["samples", "CANCER", 15, 22], ["These clinical samples", "TEST", 0, 22], ["virus isolation", "TREATMENT", 54, 69]]], ["Briefly, 1 g of PDCoV-positive feces was suspended in 5 ml of Dulbecco\u2032s modified Eagle\u2032s medium (Gibco, Grand Island, NY, USA), vortexed for 5 minutes, and centrifuged at 4000\u00d7g for 15 minutes at 4 \u00b0C. The supernatants were filtered through a 0.22-\u03bcm filter (Millipore, Billerica, MA) and stored at -80 \u00b0C for PDCoV isolation.Virus isolation, propagation, and titration ::: Materials and methodsLLC-PK1 cells (ATCC CL-101) were obtained from the American Type Culture Collection (Rockville, MD, USA) and were used for PDCoV isolation.", [["feces", "ANATOMY", 31, 36], ["supernatants", "ANATOMY", 207, 219], ["methodsLLC-PK1 cells", "ANATOMY", 389, 409], ["ATCC CL-101", "ANATOMY", 411, 422], ["PDCoV", "CHEMICAL", 16, 21], ["PDCoV", "GENE_OR_GENE_PRODUCT", 16, 21], ["feces", "ORGANISM", 31, 36], ["Virus", "ORGANISM", 327, 332], ["methodsLLC-PK1 cells", "CELL", 389, 409], ["ATCC CL-101", "CELL", 411, 422], ["PDCoV", "PROTEIN", 16, 21], ["methodsLLC-PK1 cells", "CELL_LINE", 389, 409], ["ATCC CL-101", "CELL_LINE", 411, 422], ["ATCC CL-101", "SPECIES", 411, 422], ["PDCoV", "SPECIES", 519, 524], ["PDCoV", "TEST", 16, 21], ["positive feces", "PROBLEM", 22, 36], ["a 0.22-\u03bcm filter (Millipore, Billerica, MA", "TREATMENT", 242, 284], ["PDCoV isolation", "TREATMENT", 311, 326], ["Virus isolation", "TREATMENT", 327, 342], ["Materials", "TEST", 375, 384], ["methodsLLC", "TEST", 389, 399], ["PK1 cells", "TEST", 400, 409], ["ATCC CL", "TEST", 411, 418], ["PDCoV isolation", "TREATMENT", 519, 534], ["feces", "OBSERVATION", 31, 36]]], ["LLC-PK1 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS, Gibco).", [["LLC-PK1 cells", "ANATOMY", 0, 13], ["fetal bovine serum", "ANATOMY", 58, 76], ["FBS", "ANATOMY", 78, 81], ["LLC-PK1 cells", "CELL", 0, 13], ["bovine", "ORGANISM", 64, 70], ["serum", "ORGANISM_SUBSTANCE", 71, 76], ["FBS", "ORGANISM_SUBSTANCE", 78, 81], ["Gibco", "ORGANISM_SUBSTANCE", 83, 88], ["LLC-PK1 cells", "CELL_LINE", 0, 13], ["bovine", "SPECIES", 64, 70], ["bovine", "SPECIES", 64, 70], ["LLC", "TEST", 0, 3], ["PK1 cells", "PROBLEM", 4, 13], ["DMEM", "TEST", 31, 35], ["fetal bovine serum", "TEST", 58, 76], ["FBS", "TEST", 78, 81], ["PK1 cells", "OBSERVATION", 4, 13]]], ["The maintenance medium for PDCoV propagation was DMEM with 10% tryptose phosphate broth (TPB) and 10 \u03bcg of trypsin (Sigma) per ml.", [["tryptose phosphate", "CHEMICAL", 63, 81], ["tryptose phosphate", "CHEMICAL", 63, 81], ["PDCoV", "SIMPLE_CHEMICAL", 27, 32], ["tryptose phosphate broth", "SIMPLE_CHEMICAL", 63, 87], ["trypsin", "GENE_OR_GENE_PRODUCT", 107, 114], ["trypsin", "PROTEIN", 107, 114], ["PDCoV propagation", "TREATMENT", 27, 44], ["10% tryptose phosphate broth (TPB", "TREATMENT", 59, 92], ["trypsin", "TREATMENT", 107, 114]]], ["Cells were cultured in a 6-well plate until they reached 70-80% confluence and were then washed three times with PBS.", [["Cells", "ANATOMY", 0, 5], ["Cells", "CELL", 0, 5], ["Cells", "TEST", 0, 5], ["PBS", "TREATMENT", 113, 116]]], ["Filtered inoculum (500 \u03bcl) in 1.5 ml of maintenance medium was added to the cell monolayers, and the cells were kept at 37 \u00b0C in 5% CO2 for 2 h.", [["cell monolayers", "ANATOMY", 76, 91], ["cells", "ANATOMY", 101, 106], ["CO2", "CHEMICAL", 132, 135], ["CO2", "CHEMICAL", 132, 135], ["cell monolayers", "CELL", 76, 91], ["cells", "CELL", 101, 106], ["CO2", "SIMPLE_CHEMICAL", 132, 135], ["Filtered inoculum", "TREATMENT", 0, 17], ["maintenance medium", "TREATMENT", 40, 58], ["the cell monolayers", "TREATMENT", 72, 91], ["the cells", "TREATMENT", 97, 106], ["inoculum", "OBSERVATION_MODIFIER", 9, 17], ["cell monolayers", "OBSERVATION", 76, 91]]], ["The cells were then washed three times with PBS, and 2 ml of maintenance medium was added to each well.", [["cells", "ANATOMY", 4, 9], ["cells", "CELL", 4, 9], ["PBS", "TREATMENT", 44, 47], ["maintenance medium", "TREATMENT", 61, 79]]], ["The inoculated cells were cultured continuously at 37 \u00b0C in 5% CO2.", [["cells", "ANATOMY", 15, 20], ["CO2", "CHEMICAL", 63, 66], ["CO2", "CHEMICAL", 63, 66], ["cells", "CELL", 15, 20], ["CO2", "SIMPLE_CHEMICAL", 63, 66], ["inoculated cells", "CELL_LINE", 4, 20], ["The inoculated cells", "TEST", 0, 20], ["inoculated cells", "OBSERVATION", 4, 20]]], ["When a cytopathic effect (CPE) was obvious in the infected cells, the plates were frozen and thawed twice.", [["cells", "ANATOMY", 59, 64], ["cells", "CELL", 59, 64], ["infected cells", "CELL_TYPE", 50, 64], ["a cytopathic effect (CPE", "PROBLEM", 5, 29], ["the infected cells", "PROBLEM", 46, 64], ["cytopathic", "OBSERVATION_MODIFIER", 7, 17], ["infected cells", "OBSERVATION", 50, 64]]], ["Subsequently, the supernatants were stored at -80 \u00b0C as seed stocks for plaque purification and for the next passage.", [["supernatants", "ANATOMY", 18, 30], ["plaque", "ANATOMY", 72, 78], ["the supernatants", "TEST", 14, 30], ["plaque purification", "TREATMENT", 72, 91]]], ["The isolates were plaque-purified as described previously [20].", [["plaque", "ANATOMY", 18, 24], ["plaque", "PROBLEM", 18, 24], ["plaque", "OBSERVATION", 18, 24]]], ["The virus titer was determined based on the 50% tissue culture infectious dose (TCID50) on LLC-PK1 cells in 96-well plates as described previously [20].Immunofluorescence assay (IFA) ::: Materials and methodsThe N gene of CHN-HG-2017 was amplified by RT-PCR, and the PCR product was cloned into the pET28a vector.", [["tissue", "ANATOMY", 48, 54], ["LLC-PK1 cells", "ANATOMY", 91, 104], ["tissue", "TISSUE", 48, 54], ["LLC-PK1 cells", "CELL", 91, 104], ["CHN-HG-2017", "CELL", 222, 233], ["pET28a", "GENE_OR_GENE_PRODUCT", 299, 305], ["LLC-PK1 cells", "CELL_LINE", 91, 104], ["N gene", "DNA", 212, 218], ["CHN-HG-2017", "DNA", 222, 233], ["PCR product", "DNA", 267, 278], ["pET28a vector", "DNA", 299, 312], ["The virus titer", "TEST", 0, 15], ["LLC", "TEST", 91, 94], ["PK1 cells", "TEST", 95, 104], ["Immunofluorescence assay", "TEST", 152, 176], ["HG", "TEST", 226, 228], ["PCR", "TEST", 254, 257], ["the PCR product", "TREATMENT", 263, 278], ["virus", "OBSERVATION", 4, 9]]], ["The recombinant plasmid was expressed in Escherichia coli Rosetta (DE3) under IPTG induction.", [["plasmid", "ANATOMY", 16, 23], ["IPTG", "CHEMICAL", 78, 82], ["IPTG", "CHEMICAL", 78, 82], ["Escherichia coli", "ORGANISM", 41, 57], ["Rosetta", "ORGANISM", 58, 65], ["DE3", "GENE_OR_GENE_PRODUCT", 67, 70], ["recombinant plasmid", "DNA", 4, 23], ["Escherichia coli Rosetta", "SPECIES", 41, 65], ["Escherichia coli", "SPECIES", 41, 57], ["The recombinant plasmid", "TREATMENT", 0, 23], ["Escherichia coli Rosetta (DE3", "TREATMENT", 41, 70], ["IPTG induction", "TREATMENT", 78, 92], ["Escherichia coli Rosetta", "OBSERVATION", 41, 65]]], ["Subsequently, female BALB/c mice were immunized with the purified recombinant N protein.", [["female", "ORGANISM", 14, 20], ["BALB/c mice", "ORGANISM", 21, 32], ["purified recombinant N protein", "PROTEIN", 57, 87], ["mice", "SPECIES", 28, 32], ["mice", "SPECIES", 28, 32], ["female BALB/c mice", "TREATMENT", 14, 32]]], ["After hybridoma cell fusion and selection, one strain of hybridoma cells that secreted an anti-N protein monoclonal antibody (mAb), named A3, was selected.Immunofluorescence assay (IFA) ::: Materials and methodsLLC-PK1 cells were seeded on sterilized coverslips placed in 24-well plates and then mock-infected or infected with plaque-purified PDCoV at a multiplicity of infection (MOI) of 0.01.", [["hybridoma cell", "ANATOMY", 6, 20], ["hybridoma cells", "ANATOMY", 57, 72], ["methodsLLC-PK1 cells", "ANATOMY", 204, 224], ["plaque", "ANATOMY", 327, 333], ["PDCoV", "CHEMICAL", 343, 348], ["infection", "DISEASE", 370, 379], ["hybridoma cell", "CELL", 6, 20], ["hybridoma cells", "CELL", 57, 72], ["methodsLLC-PK1 cells", "CELL", 204, 224], ["hybridoma cells", "CELL_LINE", 57, 72], ["anti-N protein monoclonal antibody", "PROTEIN", 90, 124], ["mAb", "PROTEIN", 126, 129], ["A3", "PROTEIN", 138, 140], ["methodsLLC-PK1 cells", "CELL_LINE", 204, 224], ["hybridoma cell fusion", "TREATMENT", 6, 27], ["selection", "TREATMENT", 32, 41], ["hybridoma cells", "PROBLEM", 57, 72], ["an anti-N protein monoclonal antibody", "TEST", 87, 124], ["Immunofluorescence assay", "TEST", 155, 179], ["Materials", "TEST", 190, 199], ["methodsLLC", "TEST", 204, 214], ["PK1 cells", "PROBLEM", 215, 224], ["sterilized coverslips", "TREATMENT", 240, 261], ["plaque", "PROBLEM", 327, 333], ["infection", "PROBLEM", 370, 379], ["hybridoma cell fusion", "OBSERVATION", 6, 27], ["hybridoma cells", "OBSERVATION", 57, 72], ["plaque", "OBSERVATION", 327, 333], ["infection", "OBSERVATION", 370, 379]]], ["At 24 h postinfection (HPI), cells were fixed with 4% paraformaldehyde for 15 min at room temperature (RT) and then permeabilized with 0.1% Triton X-100 for 10 min.", [["cells", "ANATOMY", 29, 34], ["paraformaldehyde", "CHEMICAL", 54, 70], ["Triton X-100", "CHEMICAL", 140, 152], ["paraformaldehyde", "CHEMICAL", 54, 70], ["cells", "CELL", 29, 34], ["paraformaldehyde", "SIMPLE_CHEMICAL", 54, 70], ["Triton X-100", "SIMPLE_CHEMICAL", 140, 152], ["4% paraformaldehyde", "TREATMENT", 51, 70], ["0.1% Triton", "TREATMENT", 135, 146]]], ["Subsequently, cells were blocked with 5% skimmed milk in PBS for 1 h at room temperature and incubated with mAb A3 for 1 h.", [["cells", "ANATOMY", 14, 19], ["milk", "ANATOMY", 49, 53], ["cells", "CELL", 14, 19], ["milk", "ORGANISM_SUBSTANCE", 49, 53], ["mAb A3", "PROTEIN", 108, 114], ["5% skimmed milk in PBS", "TREATMENT", 38, 60]]], ["The cells were treated with fluorescein isothiocyanate (FITC)-labeled goat anti-mouse IgG secondary antibodies (Invitrogen) and then stained with 4\u2032,6-diamidino-2-phenylindole (Invitrogen) for 15 min at room temperature.", [["cells", "ANATOMY", 4, 9], ["fluorescein isothiocyanate", "CHEMICAL", 28, 54], ["4\u2032,6-diamidino-2-phenylindole", "CHEMICAL", 146, 175], ["fluorescein isothiocyanate", "CHEMICAL", 28, 54], ["FITC", "CHEMICAL", 56, 60], ["4\u2032,6-diamidino-2-phenylindole", "CHEMICAL", 146, 175], ["cells", "CELL", 4, 9], ["fluorescein isothiocyanate", "SIMPLE_CHEMICAL", 28, 54], ["FITC", "SIMPLE_CHEMICAL", 56, 60], ["goat", "ORGANISM", 70, 74], ["4\u2032,6-diamidino-2-phenylindole", "SIMPLE_CHEMICAL", 146, 175], ["Invitrogen", "SIMPLE_CHEMICAL", 177, 187], ["fluorescein isothiocyanate (FITC)-labeled goat anti-mouse IgG secondary antibodies", "PROTEIN", 28, 110], ["goat", "SPECIES", 70, 74], ["anti-mouse", "SPECIES", 75, 85], ["goat", "SPECIES", 70, 74], ["fluorescein isothiocyanate (FITC)", "TREATMENT", 28, 61], ["labeled goat anti-mouse IgG secondary antibodies", "TREATMENT", 62, 110], ["diamidino", "TREATMENT", 151, 160], ["phenylindole (Invitrogen", "TREATMENT", 163, 187]]], ["Fluorescence was examined using a fluorescence microscope (Olympus IX73, Japan).Western blot analysis ::: Materials and methodsLLC-PK1 cells were infected with PDCoV and harvested with lysis buffer (65 mM Tris-HCl [pH 6.8], 4% sodium dodecyl sulfate, 3% DL-dithiothreitol and 40% glycerol) supplemented with PMSF.", [["methodsLLC-PK1 cells", "ANATOMY", 120, 140], ["Tris-HCl", "CHEMICAL", 205, 213], ["sodium dodecyl sulfate", "CHEMICAL", 227, 249], ["DL-dithiothreitol", "CHEMICAL", 254, 271], ["glycerol", "CHEMICAL", 280, 288], ["Tris-HCl", "CHEMICAL", 205, 213], ["sodium dodecyl sulfate", "CHEMICAL", 227, 249], ["dithiothreitol", "CHEMICAL", 257, 271], ["glycerol", "CHEMICAL", 280, 288], ["PMSF", "CHEMICAL", 308, 312], ["methodsLLC-PK1 cells", "CELL", 120, 140], ["Tris-HCl", "SIMPLE_CHEMICAL", 205, 213], ["sodium dodecyl sulfate", "SIMPLE_CHEMICAL", 227, 249], ["DL-dithiothreitol", "SIMPLE_CHEMICAL", 254, 271], ["glycerol", "SIMPLE_CHEMICAL", 280, 288], ["PMSF", "SIMPLE_CHEMICAL", 308, 312], ["methodsLLC-PK1 cells", "CELL_LINE", 120, 140], ["PDCoV", "SPECIES", 160, 165], ["a fluorescence microscope", "TEST", 32, 57], ["Materials", "TEST", 106, 115], ["methodsLLC", "TEST", 120, 130], ["PK1 cells", "PROBLEM", 131, 140], ["PDCoV", "TREATMENT", 160, 165], ["lysis buffer", "TREATMENT", 185, 197], ["Tris", "TEST", 205, 209], ["pH", "TEST", 215, 217], ["4% sodium dodecyl sulfate", "TREATMENT", 224, 249], ["dithiothreitol", "TREATMENT", 257, 271], ["40% glycerol)", "TREATMENT", 276, 289], ["PMSF", "TREATMENT", 308, 312]]], ["Proteins isolated from the lysate were separated by 12% SDS-PAGE and then transferred to a polyvinylidene difluoride membrane.", [["lysate", "ANATOMY", 27, 33], ["polyvinylidene", "CHEMICAL", 91, 105], ["difluoride", "CHEMICAL", 106, 116], ["lysate", "ORGANISM_SUBSTANCE", 27, 33], ["membrane", "CELLULAR_COMPONENT", 117, 125], ["Proteins", "TEST", 0, 8], ["the lysate", "TREATMENT", 23, 33], ["a polyvinylidene difluoride membrane", "TREATMENT", 89, 125]]], ["The membrane was blocked with 10% dry milk and then incubated with the PDCoV-N-specific mAb A3.", [["membrane", "ANATOMY", 4, 12], ["milk", "ANATOMY", 38, 42], ["membrane", "CELLULAR_COMPONENT", 4, 12], ["milk", "ORGANISM_SUBSTANCE", 38, 42], ["mAb A3", "GENE_OR_GENE_PRODUCT", 88, 94], ["PDCoV", "PROTEIN", 71, 76], ["N-specific mAb A3", "PROTEIN", 77, 94], ["10% dry milk", "TREATMENT", 30, 42], ["the PDCoV", "TREATMENT", 67, 76]]], ["After washing three times with PBST, the membrane was incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (ABclonal) for 45 min at room temperature.", [["membrane", "ANATOMY", 41, 49], ["membrane", "CELLULAR_COMPONENT", 41, 49], ["horseradish peroxidase", "SIMPLE_CHEMICAL", 69, 91], ["HRP", "SIMPLE_CHEMICAL", 93, 96], ["goat", "ORGANISM", 109, 113], ["ABclonal", "SIMPLE_CHEMICAL", 130, 138], ["horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG", "PROTEIN", 69, 128], ["ABclonal", "PROTEIN", 130, 138], ["horseradish", "SPECIES", 69, 80], ["goat", "SPECIES", 109, 113], ["anti-mouse", "SPECIES", 114, 124], ["goat", "SPECIES", 109, 113], ["PBST", "TREATMENT", 31, 35], ["horseradish peroxidase", "TREATMENT", 69, 91], ["conjugated goat anti-mouse IgG", "TREATMENT", 98, 128]]], ["Signals were detected using a SuperSignal West Pico Luminal Kit (Pierce).Electron microscopy ::: Materials and methodsAfter inoculation with CHN-HG-2017, LLC-PK1 cells were harvested when more than 80% CPE was observed.", [["LLC-PK1 cells", "ANATOMY", 154, 167], ["CHN", "CHEMICAL", 141, 144], ["CHN-HG-2017", "CELL", 141, 152], ["LLC-PK1 cells", "CELL", 154, 167], ["LLC-PK1 cells", "CELL_LINE", 154, 167], ["a SuperSignal West Pico Luminal Kit (Pierce)", "TREATMENT", 28, 72], ["Electron microscopy", "TEST", 73, 92], ["CHN", "TEST", 141, 144], ["HG", "TEST", 145, 147], ["LLC", "TEST", 154, 157], ["PK1 cells", "PROBLEM", 158, 167], ["LLC", "ANATOMY", 154, 157]]], ["Cells were frozen and thawed three times and then centrifuged at 10,000\u00d7g at 4 \u00b0C for 20 min.", [["Cells", "ANATOMY", 0, 5], ["Cells", "CELL", 0, 5], ["Cells", "TEST", 0, 5]]], ["The supernatants were filtered and ultracentrifuged at 30,000\u00d7g for 2 h at 4 \u00b0C. The pellets were resuspended in PBS and centrifuged in a non-linear 30%\u201360% sucrose gradient at 30,000\u00d7g for 3 h at 4 \u00b0C. The virions that sedimented in the interphase between the 30% and 45% sucrose layers were diluted with sterile PBS.", [["supernatants", "ANATOMY", 4, 16], ["virions", "ANATOMY", 207, 214], ["interphase", "ANATOMY", 238, 248], ["sucrose", "CHEMICAL", 157, 164], ["sucrose", "CHEMICAL", 273, 280], ["sucrose", "CHEMICAL", 157, 164], ["sucrose", "CHEMICAL", 273, 280], ["sucrose", "SIMPLE_CHEMICAL", 157, 164], ["interphase", "CELLULAR_COMPONENT", 238, 248], ["ultracentrifuged", "TREATMENT", 35, 51], ["The pellets", "TREATMENT", 81, 92], ["sucrose gradient", "TREATMENT", 157, 173], ["The virions", "PROBLEM", 203, 214], ["45% sucrose layers", "TREATMENT", 269, 287], ["sterile PBS", "TREATMENT", 306, 317], ["virions", "OBSERVATION", 207, 214], ["sedimented", "OBSERVATION_MODIFIER", 220, 230]]], ["The sucrose was then removed by centrifugation for 1 h at 30,000\u00d7g.", [["sucrose", "CHEMICAL", 4, 11], ["sucrose", "CHEMICAL", 4, 11], ["sucrose", "SIMPLE_CHEMICAL", 4, 11], ["The sucrose", "TREATMENT", 0, 11]]], ["The virions were resuspended in PBS, stained with 2% phosphotungstic acid, and examined using a transmission electron microscope (Hitachi H-7000FA, Japan).Phylogenetic and recombination analysis ::: Materials and methodsViral RNA was extracted from CHN-HG-2017-infected LLC-PK1 cells using TRIzol Reagent (Invitrogen, USA) according to manufacturer\u2032s instructions. cDNA was synthesized from the extracted RNA using random primers and a Takara RNA PCR Kit (Takara, Japan).", [["virions", "ANATOMY", 4, 11], ["LLC-PK1 cells", "ANATOMY", 270, 283], ["phosphotungstic acid", "CHEMICAL", 53, 73], ["phosphotungstic acid", "CHEMICAL", 53, 73], ["phosphotungstic acid", "SIMPLE_CHEMICAL", 53, 73], ["Viral", "ORGANISM", 220, 225], ["CHN-HG-2017", "CELL", 249, 260], ["LLC-PK1 cells", "CELL", 270, 283], ["Viral RNA", "RNA", 220, 229], ["CHN-HG-2017-infected LLC-PK1 cells", "CELL_LINE", 249, 283], ["cDNA", "DNA", 365, 369], ["The virions", "TREATMENT", 0, 11], ["2% phosphotungstic acid", "TREATMENT", 50, 73], ["a transmission electron microscope", "TEST", 94, 128], ["Hitachi H", "TEST", 130, 139], ["methodsViral RNA", "TEST", 213, 229], ["HG", "TEST", 253, 255], ["infected LLC", "PROBLEM", 261, 273], ["PK1 cells", "TREATMENT", 274, 283], ["TRIzol Reagent", "TREATMENT", 290, 304], ["random primers", "TREATMENT", 415, 429], ["a Takara RNA PCR Kit", "TREATMENT", 434, 454], ["LLC", "ANATOMY", 270, 273]]], ["The whole genome of CHN-HG-2017 was sequenced using 26 pairs of primers reported by Lorsirigool et al. [23].", [["CHN-HG-2017", "CELL", 20, 31], ["CHN", "DNA", 20, 23], ["2017", "DNA", 27, 31], ["CHN-HG-2017", "SPECIES", 20, 31], ["HG", "TEST", 24, 26], ["primers", "TREATMENT", 64, 71]]], ["Based on the sequence that was obtained, a pair of primers (PDCoV-5\u2032GSP, 5\u2032- GATTACGCCAAGCTTTAGATCGCAAGGTGGGTTGGGCTCC-3\u2032; PDCoV-3\u2032GSP, 5\u2032-GATTACGCCAAGCTTCGTCGTAAGACCCAACATCAAGCT-3\u2032) was designed to verify the 5\u2032- and 3\u2032- terminal sequences of CHN-HG-2017 using a SMARTer RACE 5\u2032/3\u2032 Kit (Takara) according to manufacturer\u2032s instructions.", [["PDCoV", "DNA", 60, 65], ["PDCoV", "DNA", 122, 127], ["5\u2032- and 3\u2032- terminal sequences", "DNA", 209, 239], ["SMARTer RACE 5", "DNA", 263, 277], ["a pair of primers", "TEST", 41, 58], ["PDCoV", "TEST", 60, 65], ["GSP", "TEST", 68, 71], ["\u2032", "TEST", 74, 75], ["GATTACGCCAAGCTTTAGATCGCAAGGTGGGTTGGGCTCC", "TEST", 77, 117], ["PDCoV", "TEST", 122, 127], ["GATTACGCCAAGCTTCGTCGTAAGACCCAACATCAAGCT", "TEST", 138, 177], ["a SMARTer RACE", "TREATMENT", 261, 275], ["Kit (Takara)", "TREATMENT", 282, 294]]], ["The sequences were combined using DNASTAR Lasergene 7.0, and the assembled genome sequence was submitted to the GenBank database under the accession number MF095123.", [["MF095123", "CHEMICAL", 156, 164], ["assembled genome sequence", "DNA", 65, 90], ["The sequences", "TEST", 0, 13], ["DNASTAR Lasergene", "TEST", 34, 51]]], ["Multiple sequence alignments and phylogenetic analysis were performed using the neighbor-joining method with MEGA 7 software (http://www.mehasoftware.net/).", [["MEGA 7 software", "DNA", 109, 124], ["Multiple sequence alignments", "TEST", 0, 28], ["phylogenetic analysis", "TEST", 33, 54]]], ["The aligned sequences were scanned for recombination events, using the Recombination Detection Program (RDP).Inoculation of pigs with PDCoV strain CHN-HG-2017 ::: Materials and methodsAnimal experiments were carried out strictly according to the Guide for the Care and Use of Animals in Research of the People\u2032s Republic of China.", [["pigs", "ORGANISM", 124, 128], ["pigs", "SPECIES", 124, 128], ["pigs", "SPECIES", 124, 128]]], ["All experimental procedures were approved by the Scientific Ethics Committee of Huazhong Agricultural University (HZAUSW-2018-005).", [["HZAUSW-2018-005", "CHEMICAL", 114, 129], ["All experimental procedures", "TREATMENT", 0, 27]]], ["Twelve 5-day-old piglets were purchased from a commercial pig farm and were randomly divided into two groups, which were housed in separated containments.", [["piglets", "ORGANISM", 17, 24], ["pig", "ORGANISM", 58, 61], ["piglets", "SPECIES", 17, 24], ["pig", "SPECIES", 58, 61], ["pig", "SPECIES", 58, 61], ["a commercial pig farm", "TREATMENT", 45, 66]]], ["Prior to PDCoV inoculation, piglets were confirmed to be negative for PDCoV, PEDV, TGEV, and rotavirus by testing rectal swabs by RT-PCR.", [["rectal swabs", "ANATOMY", 114, 126], ["PDCoV", "CHEMICAL", 9, 14], ["piglets", "ORGANISM", 28, 35], ["PDCoV", "GENE_OR_GENE_PRODUCT", 70, 75], ["PEDV", "GENE_OR_GENE_PRODUCT", 77, 81], ["TGEV", "ORGANISM", 83, 87], ["rotavirus", "ORGANISM", 93, 102], ["rectal swabs", "MULTI-TISSUE_STRUCTURE", 114, 126], ["piglets", "SPECIES", 28, 35], ["PDCoV", "SPECIES", 9, 14], ["piglets", "SPECIES", 28, 35], ["PDCoV", "SPECIES", 70, 75], ["PEDV", "SPECIES", 77, 81], ["TGEV", "SPECIES", 83, 87], ["rotavirus", "SPECIES", 93, 102], ["PDCoV inoculation", "TREATMENT", 9, 26], ["piglets", "TREATMENT", 28, 35], ["PDCoV", "PROBLEM", 70, 75], ["PEDV", "PROBLEM", 77, 81], ["TGEV", "PROBLEM", 83, 87], ["rotavirus", "PROBLEM", 93, 102], ["rectal swabs", "TEST", 114, 126], ["RT", "TEST", 130, 132], ["PCR", "TEST", 133, 136]]], ["Neutralizing antibodies against PDCoV were not detected in sera of the piglets or sows.", [["sera", "ANATOMY", 59, 63], ["PDCoV", "GENE_OR_GENE_PRODUCT", 32, 37], ["sera", "ORGANISM_SUBSTANCE", 59, 63], ["piglets", "ORGANISM", 71, 78], ["sows", "ORGANISM", 82, 86], ["Neutralizing antibodies", "PROTEIN", 0, 23], ["PDCoV", "PROTEIN", 32, 37], ["piglets", "SPECIES", 71, 78], ["PDCoV", "SPECIES", 32, 37], ["piglets", "SPECIES", 71, 78], ["Neutralizing antibodies", "TEST", 0, 23], ["PDCoV", "PROBLEM", 32, 37]]], ["After acclimation for 24 h, the challenged group was inoculated orally with a CHN-HG-2017 preparation with a titer of 1 \u00d7 106 TCID50/ml (10 ml per pig), while the mock-infected group was inoculated with 10 ml of maintenance medium.", [["CHN-HG-2017", "CHEMICAL", 78, 89], ["CHN", "SIMPLE_CHEMICAL", 78, 81], ["pig", "ORGANISM", 147, 150], ["pig", "SPECIES", 147, 150], ["pig", "SPECIES", 147, 150], ["a titer", "TREATMENT", 107, 114], ["maintenance medium", "TREATMENT", 212, 230]]], ["Clinical symptoms, including vomiting, diarrhea, lethargy, and appetite loss, were observed and recorded daily.", [["vomiting", "DISEASE", 29, 37], ["diarrhea", "DISEASE", 39, 47], ["lethargy", "DISEASE", 49, 57], ["appetite loss", "DISEASE", 63, 76], ["Clinical symptoms", "PROBLEM", 0, 17], ["vomiting", "PROBLEM", 29, 37], ["diarrhea", "PROBLEM", 39, 47], ["lethargy", "PROBLEM", 49, 57], ["appetite loss", "PROBLEM", 63, 76]]], ["Rectal swabs were collected daily from each piglet from the first day post-inoculation (DPI) to the end of the experiment.", [["Rectal swabs", "ANATOMY", 0, 12], ["Rectal swabs", "ORGANISM_SUBSTANCE", 0, 12], ["piglet", "ORGANISM_SUBDIVISION", 44, 50], ["Rectal swabs", "TEST", 0, 12]]], ["Swabs were submerged into 1 ml of PBS immediately after collection.", [["Swabs", "ANATOMY", 0, 5], ["Swabs", "TREATMENT", 0, 5], ["PBS", "TREATMENT", 34, 37], ["collection", "PROBLEM", 56, 66]]], ["Randomly selected piglets from each group (n = 3) were subjected to necropsy at 4 DPI, and prolonged PDCoV shedding was monitored in the remaining pigs until 21 DPI.", [["DPI", "CHEMICAL", 161, 164], ["piglets", "ORGANISM", 18, 25], ["pigs", "ORGANISM", 147, 151], ["piglets", "SPECIES", 18, 25], ["pigs", "SPECIES", 147, 151], ["PDCoV", "SPECIES", 101, 106], ["prolonged PDCoV shedding", "TREATMENT", 91, 115]]], ["At necropsy, tissues of duodenum, jejunum, ileum, cecum, colon, rectum, liver, spleen, lung, kidney, and blood were collected for analysis by real-time RT-PCR.", [["tissues", "ANATOMY", 13, 20], ["duodenum", "ANATOMY", 24, 32], ["jejunum", "ANATOMY", 34, 41], ["ileum", "ANATOMY", 43, 48], ["cecum", "ANATOMY", 50, 55], ["colon", "ANATOMY", 57, 62], ["rectum", "ANATOMY", 64, 70], ["liver", "ANATOMY", 72, 77], ["spleen", "ANATOMY", 79, 85], ["lung", "ANATOMY", 87, 91], ["kidney", "ANATOMY", 93, 99], ["blood", "ANATOMY", 105, 110], ["tissues", "TISSUE", 13, 20], ["duodenum", "MULTI-TISSUE_STRUCTURE", 24, 32], ["jejunum", "MULTI-TISSUE_STRUCTURE", 34, 41], ["ileum", "MULTI-TISSUE_STRUCTURE", 43, 48], ["cecum", "MULTI-TISSUE_STRUCTURE", 50, 55], ["colon", "MULTI-TISSUE_STRUCTURE", 57, 62], ["rectum", "MULTI-TISSUE_STRUCTURE", 64, 70], ["liver", "ORGAN", 72, 77], ["spleen", "ORGAN", 79, 85], ["lung", "ORGAN", 87, 91], ["kidney", "ORGAN", 93, 99], ["blood", "ORGANISM_SUBSTANCE", 105, 110], ["tissues of duodenum, jejunum, ileum, cecum, colon, rectum, liver, spleen, lung, kidney, and blood", "PROBLEM", 13, 110], ["analysis", "TEST", 130, 138], ["duodenum", "ANATOMY", 24, 32], ["jejunum", "ANATOMY", 34, 41], ["ileum", "ANATOMY", 43, 48], ["cecum", "ANATOMY", 50, 55], ["colon", "ANATOMY", 57, 62], ["rectum", "ANATOMY", 64, 70], ["liver", "ANATOMY", 72, 77], ["spleen", "ANATOMY", 79, 85], ["lung", "ANATOMY", 87, 91], ["kidney", "ANATOMY", 93, 99]]], ["Tissues of duodenum, jejunum, ileum, cecum, and colon were also fixed with 10% formalin for histopathology and immunohistochemistry analysis.", [["Tissues", "ANATOMY", 0, 7], ["duodenum", "ANATOMY", 11, 19], ["jejunum", "ANATOMY", 21, 28], ["ileum", "ANATOMY", 30, 35], ["cecum", "ANATOMY", 37, 42], ["colon", "ANATOMY", 48, 53], ["formalin", "CHEMICAL", 79, 87], ["formalin", "CHEMICAL", 79, 87], ["Tissues", "TISSUE", 0, 7], ["duodenum", "MULTI-TISSUE_STRUCTURE", 11, 19], ["jejunum", "MULTI-TISSUE_STRUCTURE", 21, 28], ["ileum", "MULTI-TISSUE_STRUCTURE", 30, 35], ["cecum", "MULTI-TISSUE_STRUCTURE", 37, 42], ["colon", "ORGAN", 48, 53], ["formalin", "SIMPLE_CHEMICAL", 79, 87], ["10% formalin", "TREATMENT", 75, 87], ["histopathology", "TEST", 92, 106], ["immunohistochemistry analysis", "TEST", 111, 140], ["duodenum", "ANATOMY", 11, 19], ["jejunum", "ANATOMY", 21, 28], ["ileum", "ANATOMY", 30, 35], ["cecum", "ANATOMY", 37, 42], ["colon", "ANATOMY", 48, 53]]], ["Sera collected at 0, 4, 7, 21 DPI from piglets were tested for neutralizing antibodies against PDCoV.Real-time RT-PCR analysis ::: Materials and methodsThe number of viral RNA copies in fecal swabs, sera, and tissue samples was determined by real-time RT-PCR.", [["Sera", "ANATOMY", 0, 4], ["fecal swabs", "ANATOMY", 186, 197], ["sera", "ANATOMY", 199, 203], ["tissue samples", "ANATOMY", 209, 223], ["Sera", "ORGANISM_SUBSTANCE", 0, 4], ["piglets", "ORGANISM", 39, 46], ["fecal swabs", "ORGANISM_SUBSTANCE", 186, 197], ["sera", "ORGANISM_SUBSTANCE", 199, 203], ["tissue samples", "TISSUE", 209, 223], ["neutralizing antibodies", "PROTEIN", 63, 86], ["PDCoV", "PROTEIN", 95, 100], ["viral RNA copies", "RNA", 166, 182], ["piglets", "SPECIES", 39, 46], ["PDCoV", "SPECIES", 95, 100], ["Sera", "TEST", 0, 4], ["neutralizing antibodies", "TREATMENT", 63, 86], ["PDCoV", "TREATMENT", 95, 100], ["viral RNA copies", "TEST", 166, 182], ["fecal swabs", "TEST", 186, 197], ["sera", "TEST", 199, 203], ["tissue samples", "TEST", 209, 223], ["viral RNA", "OBSERVATION", 166, 175], ["fecal swabs", "ANATOMY", 186, 197]]], ["Briefly, fecal swab samples diluted in DMEM were homogenized and centrifuged at 6000\u00d7g for 5 min.", [["fecal swab samples", "ANATOMY", 9, 27], ["fecal swab samples", "ORGANISM_SUBSTANCE", 9, 27], ["fecal swab samples", "TEST", 9, 27], ["fecal", "ANATOMY", 9, 14]]], ["An aliquot (200 \u03bcl) of supernatant was extracted for viral RNA isolation.", [["supernatant", "ANATOMY", 23, 34], ["viral RNA", "RNA", 53, 62], ["An aliquot", "TREATMENT", 0, 10], ["supernatant", "TREATMENT", 23, 34], ["viral RNA isolation", "TREATMENT", 53, 72], ["viral RNA isolation", "OBSERVATION", 53, 72]]], ["One gram of various tissue samples was mechanically homogenized in 1 ml of DMEM, and 200 \u03bcl of the supernatant was used for RNA extraction.", [["tissue samples", "ANATOMY", 20, 34], ["supernatant", "ANATOMY", 99, 110], ["tissue samples", "TISSUE", 20, 34], ["various tissue samples", "TEST", 12, 34], ["DMEM", "TREATMENT", 75, 79], ["the supernatant", "TREATMENT", 95, 110], ["RNA extraction", "TREATMENT", 124, 138], ["various tissue", "OBSERVATION_MODIFIER", 12, 26]]], ["Two hundred \u03bcl of serum was also used for RNA extraction.", [["serum", "ANATOMY", 18, 23], ["serum", "ORGANISM_SUBSTANCE", 18, 23], ["RNA extraction", "TREATMENT", 42, 56]]], ["Viral RNA was extracted using TRIzol Reagent (Invitrogen, USA) according to the manufacturer\u2032s protocols and was treated with DNase I. One \u03bcg of total RNA was used for cDNA synthesis by reverse transcription using an iScript cDNA Synthesis Kit (Bio-Rad). cDNA amplification was performed using the iTaq Universal Probes Supermix (Bio-Rad) with primers and probes targeting the N gene of PDCoV, as described by Ma et al. [3].", [["Viral", "ORGANISM", 0, 5], ["Bio-Rad", "GENE_OR_GENE_PRODUCT", 245, 252], ["PDCoV", "GENE_OR_GENE_PRODUCT", 387, 392], ["Viral RNA", "RNA", 0, 9], ["cDNA", "DNA", 255, 259], ["iTaq Universal Probes Supermix (Bio-Rad", "DNA", 298, 337], ["N gene", "DNA", 377, 383], ["PDCoV", "DNA", 387, 392], ["Viral RNA", "PROBLEM", 0, 9], ["TRIzol Reagent", "TREATMENT", 30, 44], ["the manufacturer\u2032s protocols", "TREATMENT", 76, 104], ["DNase I.", "TREATMENT", 126, 134], ["total RNA", "TREATMENT", 145, 154], ["cDNA synthesis", "TREATMENT", 168, 182], ["an iScript cDNA Synthesis Kit", "TREATMENT", 214, 243], ["cDNA amplification", "TEST", 255, 273], ["the iTaq Universal Probes Supermix (Bio-Rad) with primers", "TREATMENT", 294, 351], ["the N gene of PDCoV", "TREATMENT", 373, 392]]], ["The recombinant plasmid pET28a-N containing the N gene of PDCoV was serially diluted tenfold to generate a standard curve for each plate.", [["plasmid", "ANATOMY", 16, 23], ["pET28a-N", "GENE_OR_GENE_PRODUCT", 24, 32], ["PDCoV", "CANCER", 58, 63], ["pET28a", "DNA", 24, 30], ["N", "DNA", 31, 32], ["N gene", "DNA", 48, 54], ["PDCoV", "DNA", 58, 63], ["The recombinant plasmid pET28a", "TREATMENT", 0, 30], ["the N gene of PDCoV", "TREATMENT", 44, 63], ["a standard curve for each plate", "TREATMENT", 105, 136]]], ["Real-time RT-PCR was carried out using an Applied Biosystems 7500 Fast Real-Time PCR System (Life Technologies, USA).", [["RT-PCR", "TEST", 10, 16], ["an Applied Biosystems", "TEST", 39, 60]]], ["The thermal cycling parameters were as follows: 2 min at 50 \u00b0C, 10 min at 95 \u00b0C, and 40 cycles of 15 s at 95 \u00b0C and 1 min at 60 \u00b0C. The number of copies of PDCoV viral RNA in the tested samples was calculated based on the standard curve.Neutralization assay (NA) ::: Materials and methodsThe presence of PDCoV-specific neutralizing antibodies in serum samples was determined using a virus neutralizing (VN) test.", [["samples", "ANATOMY", 186, 193], ["serum samples", "ANATOMY", 346, 359], ["PDCoV", "GENE_OR_GENE_PRODUCT", 156, 161], ["PDCoV", "GENE_OR_GENE_PRODUCT", 304, 309], ["serum samples", "ORGANISM_SUBSTANCE", 346, 359], ["PDCoV viral RNA", "RNA", 156, 171], ["PDCoV", "PROTEIN", 304, 309], ["neutralizing antibodies", "PROTEIN", 319, 342], ["PDCoV", "SPECIES", 156, 161], ["The thermal cycling parameters", "TEST", 0, 30], ["PDCoV viral RNA", "TREATMENT", 156, 171], ["the tested samples", "TEST", 175, 193], ["the standard curve", "TEST", 218, 236], ["Neutralization assay", "TEST", 237, 257], ["PDCoV", "TEST", 304, 309], ["specific neutralizing antibodies", "PROBLEM", 310, 342], ["serum samples", "TEST", 346, 359], ["a virus neutralizing (VN) test", "TEST", 381, 411], ["viral RNA", "OBSERVATION", 162, 171], ["neutralizing", "OBSERVATION_MODIFIER", 319, 331]]], ["Briefly, LLC-PK1 cells were grown in 96-well plates until they reached 90% confluence.", [["LLC-PK1 cells", "ANATOMY", 9, 22], ["LLC-PK1 cells", "CELL", 9, 22], ["LLC-PK1 cells", "CELL_LINE", 9, 22], ["LLC-PK1 cells", "TEST", 9, 22], ["LLC", "ANATOMY", 9, 12], ["PK1 cells", "OBSERVATION", 13, 22], ["confluence", "OBSERVATION_MODIFIER", 75, 85]]], ["The CHN-HG-2017 stock was diluted in DMEM to make 200 TCID50 viral stocks.", [["CHN-HG-2017", "CHEMICAL", 4, 15], ["CHN", "SIMPLE_CHEMICAL", 4, 7]]], ["Fifty \u03bcl of the diluted virus was then mixed with an equal volume of twofold serial dilutions of individual inactivated sera in 96-well plates and incubated at 37 \u00b0C for 1 h.", [["sera", "ANATOMY", 120, 124], ["sera", "ORGANISM_SUBSTANCE", 120, 124], ["the diluted virus", "TREATMENT", 12, 29], ["twofold serial dilutions", "TREATMENT", 69, 93], ["individual inactivated sera", "TEST", 97, 124]]], ["After washing twice with maintenance medium, LLC-PK1 cells were incubated with the mixture at 37 \u00b0C for 1 h.", [["LLC-PK1 cells", "ANATOMY", 45, 58], ["LLC-PK1 cells", "CELL", 45, 58], ["LLC-PK1 cells", "CELL_LINE", 45, 58], ["maintenance medium", "TREATMENT", 25, 43], ["PK1 cells", "PROBLEM", 49, 58], ["LLC", "ANATOMY", 45, 48]]], ["The mixture was then removed, and the cell monolayers were washed three times with PBS and cultured in maintenance medium at 37 \u00b0C in a 5% CO2 incubator for 2 days.", [["cell monolayers", "ANATOMY", 38, 53], ["CO2", "CHEMICAL", 139, 142], ["CO2", "CHEMICAL", 139, 142], ["cell monolayers", "CELL", 38, 53], ["the cell monolayers", "TREATMENT", 34, 53], ["PBS", "TREATMENT", 83, 86], ["a 5% CO2 incubator", "TREATMENT", 134, 152], ["cell monolayers", "OBSERVATION", 38, 53]]], ["The neutralization antibody titers were calculated as the reciprocal of the highest dilution of serum at which PDCoV infection was blocked.Histology and immunohistochemistry ::: Materials and methodsAt necropsy, tissues of duodenum, jejunum, ileum, cecum, colon, and rectum collected from the inoculated and control groups were separated and fixed in 10% formalin for 24 h at room temperature and then dehydrated, embedded, sectioned, and mounted on glass slides.", [["serum", "ANATOMY", 96, 101], ["tissues", "ANATOMY", 212, 219], ["duodenum", "ANATOMY", 223, 231], ["jejunum", "ANATOMY", 233, 240], ["ileum", "ANATOMY", 242, 247], ["cecum", "ANATOMY", 249, 254], ["colon", "ANATOMY", 256, 261], ["rectum", "ANATOMY", 267, 273], ["infection", "DISEASE", 117, 126], ["formalin", "CHEMICAL", 355, 363], ["formalin", "CHEMICAL", 355, 363], ["serum", "ORGANISM_SUBSTANCE", 96, 101], ["PDCoV", "GENE_OR_GENE_PRODUCT", 111, 116], ["tissues", "TISSUE", 212, 219], ["duodenum", "MULTI-TISSUE_STRUCTURE", 223, 231], ["jejunum", "MULTI-TISSUE_STRUCTURE", 233, 240], ["ileum", "MULTI-TISSUE_STRUCTURE", 242, 247], ["cecum", "MULTI-TISSUE_STRUCTURE", 249, 254], ["colon", "ORGAN", 256, 261], ["rectum", "ORGAN", 267, 273], ["formalin", "SIMPLE_CHEMICAL", 355, 363], ["PDCoV", "SPECIES", 111, 116], ["The neutralization antibody titers", "TEST", 0, 34], ["PDCoV infection", "PROBLEM", 111, 126], ["dehydrated", "PROBLEM", 402, 412], ["neutralization", "OBSERVATION", 4, 18], ["antibody titers", "OBSERVATION", 19, 34], ["infection", "OBSERVATION", 117, 126], ["duodenum", "ANATOMY", 223, 231], ["jejunum", "ANATOMY", 233, 240], ["ileum", "ANATOMY", 242, 247], ["cecum", "ANATOMY", 249, 254], ["colon", "ANATOMY", 256, 261], ["rectum", "ANATOMY", 267, 273], ["inoculated", "OBSERVATION_MODIFIER", 293, 303]]], ["The samples were stained with hematoxylin and eosin (H&E), and the slides were examined and analyzed by conventional microscopy.", [["samples", "ANATOMY", 4, 11], ["hematoxylin", "CHEMICAL", 30, 41], ["eosin", "CHEMICAL", 46, 51], ["hematoxylin", "SIMPLE_CHEMICAL", 30, 41], ["eosin", "SIMPLE_CHEMICAL", 46, 51], ["The samples", "TEST", 0, 11], ["hematoxylin", "TREATMENT", 30, 41], ["eosin", "TEST", 46, 51], ["the slides", "TEST", 63, 73], ["conventional microscopy", "TEST", 104, 127]]], ["Three representative villi and crypts with integrated longitudinal sections were randomly selected from each H&E-stained jejunum and ileum.", [["villi", "ANATOMY", 21, 26], ["crypts", "ANATOMY", 31, 37], ["sections", "ANATOMY", 67, 75], ["jejunum", "ANATOMY", 121, 128], ["ileum", "ANATOMY", 133, 138], ["villi", "MULTI-TISSUE_STRUCTURE", 21, 26], ["crypts", "MULTI-TISSUE_STRUCTURE", 31, 37], ["longitudinal sections", "MULTI-TISSUE_STRUCTURE", 54, 75], ["jejunum", "MULTI-TISSUE_STRUCTURE", 121, 128], ["ileum", "MULTI-TISSUE_STRUCTURE", 133, 138], ["integrated longitudinal sections", "TREATMENT", 43, 75], ["villi", "ANATOMY", 21, 26], ["jejunum", "ANATOMY", 121, 128], ["ileum", "ANATOMY", 133, 138]]], ["Villus-height-to-crypt-depth (VH/CD) ratios were calculated using a computerized image system (NIS-Elements 3.2).", [["Villus", "ANATOMY", 0, 6], ["crypt", "ANATOMY", 17, 22], ["crypt", "MULTI-TISSUE_STRUCTURE", 17, 22], ["Villus", "TEST", 0, 6], ["height", "TEST", 7, 13], ["VH/CD) ratios", "TEST", 30, 43], ["a computerized image system", "TEST", 66, 93], ["NIS", "TEST", 95, 98], ["height", "OBSERVATION_MODIFIER", 7, 13], ["crypt", "ANATOMY_MODIFIER", 17, 22]]], ["Five-micron-thick sections obtained from formalin-fixed paraffin-embedded tissues were placed onto positively charged glass slides, and the slides were air dried for 30 min.", [["sections", "ANATOMY", 18, 26], ["tissues", "ANATOMY", 74, 81], ["formalin", "CHEMICAL", 41, 49], ["formalin", "CHEMICAL", 41, 49], ["paraffin", "CHEMICAL", 56, 64], ["sections", "MULTI-TISSUE_STRUCTURE", 18, 26], ["tissues", "TISSUE", 74, 81], ["micron-thick sections", "TEST", 5, 26], ["formalin-fixed paraffin-embedded tissues", "TREATMENT", 41, 81], ["air dried", "OBSERVATION", 152, 161]]], ["The tissue sections were deparaffinized, and the slides were rinsed and then incubated with target retrieval solution (Sigma-Aldrich, USA).", [["tissue sections", "ANATOMY", 4, 19], ["tissue sections", "CANCER", 4, 19], ["The tissue sections", "TEST", 0, 19], ["the slides", "TEST", 45, 55], ["target retrieval solution", "TREATMENT", 92, 117]]], ["The sections were blocked with 1% BSA, incubated with PDCoV-N-specific monoclonal antibodies for 30 min, and then with HRP-conjugated goat anti-mouse IgG secondary antibodies (Zhongshan Biotechnology Co., Beijing, China).", [["sections", "ANATOMY", 4, 12], ["sections", "MULTI-TISSUE_STRUCTURE", 4, 12], ["BSA", "SIMPLE_CHEMICAL", 34, 37], ["PDCoV-N-", "SIMPLE_CHEMICAL", 54, 62], ["HRP", "SIMPLE_CHEMICAL", 119, 122], ["PDCoV", "PROTEIN", 54, 59], ["N-specific monoclonal antibodies", "PROTEIN", 60, 92], ["HRP", "PROTEIN", 119, 122], ["conjugated goat anti-mouse IgG secondary antibodies", "PROTEIN", 123, 174], ["goat", "SPECIES", 134, 138], ["anti-mouse", "SPECIES", 139, 149], ["goat", "SPECIES", 134, 138], ["The sections", "TEST", 0, 12], ["1% BSA", "TEST", 31, 37], ["PDCoV", "TEST", 54, 59], ["N-specific monoclonal antibodies", "TEST", 60, 92], ["HRP", "TEST", 119, 122]]], ["The samples were visualized using a substrate-chromogen reagent (3-amino-9-ethylcarbazole/H2O2, Solarbio, China).", [["samples", "ANATOMY", 4, 11], ["3-amino-9-ethylcarbazole", "CHEMICAL", 65, 89], ["H2O2", "CHEMICAL", 90, 94], ["chromogen", "CHEMICAL", 46, 55], ["3-amino-9-ethylcarbazole", "CHEMICAL", 65, 89], ["H2O2", "CHEMICAL", 90, 94], ["3-amino-9-ethylcarbazole", "SIMPLE_CHEMICAL", 65, 89], ["H2O2", "SIMPLE_CHEMICAL", 90, 94], ["The samples", "TEST", 0, 11], ["a substrate-chromogen reagent", "TREATMENT", 34, 63], ["amino", "TEST", 67, 72], ["ethylcarbazole", "TREATMENT", 75, 89], ["H2O2", "TREATMENT", 90, 94]]], ["Tissues from piglets in the negative control group were used as controls.Virus isolation ::: ResultsOf the 17 PDCoV-positive feces inoculated onto LLC-PK1 monolayers, only one caused obvious CPE in the form of enlarged, rounded and clustered cells at 24 HPI and rapidly detached from the monolayers at 36 HPI (Fig. 1A).", [["Tissues", "ANATOMY", 0, 7], ["feces", "ANATOMY", 125, 130], ["LLC-PK1 monolayers", "ANATOMY", 147, 165], ["cells", "ANATOMY", 242, 247], ["monolayers", "ANATOMY", 288, 298], ["Tissues", "CANCER", 0, 7], ["piglets", "ORGANISM", 13, 20], ["Virus", "ORGANISM", 73, 78], ["PDCoV", "GENE_OR_GENE_PRODUCT", 110, 115], ["feces", "ORGANISM", 125, 130], ["LLC-PK1 monolayers", "CELL", 147, 165], ["cells", "CELL", 242, 247], ["monolayers", "CELL", 288, 298], ["LLC-PK1 monolayers", "CELL_LINE", 147, 165], ["enlarged, rounded and clustered cells", "CELL_TYPE", 210, 247], ["piglets", "SPECIES", 13, 20], ["PDCoV", "TEST", 110, 115], ["LLC", "TEST", 147, 150], ["PK1 monolayers", "TEST", 151, 165], ["obvious CPE", "PROBLEM", 183, 194], ["enlarged, rounded and clustered cells", "PROBLEM", 210, 247], ["piglets", "OBSERVATION_MODIFIER", 13, 20], ["negative", "OBSERVATION_MODIFIER", 28, 36], ["obvious", "OBSERVATION_MODIFIER", 183, 190], ["CPE", "OBSERVATION", 191, 194], ["enlarged", "OBSERVATION", 210, 218], ["rounded", "OBSERVATION_MODIFIER", 220, 227], ["clustered cells", "OBSERVATION", 232, 247]]], ["This PDCoV isolate, designated as CHN-HG-2017, tested positive for PDCoV and negative for other enteric viruses by RT-PCR (data not shown).", [["PDCoV", "CANCER", 5, 10], ["CHN-HG-2017", "CELL", 34, 45], ["PDCoV", "GENE_OR_GENE_PRODUCT", 67, 72], ["PDCoV", "SPECIES", 67, 72], ["HG", "TEST", 38, 40], ["PDCoV", "PROBLEM", 67, 72], ["other enteric viruses", "PROBLEM", 90, 111], ["RT-PCR", "TEST", 115, 121], ["viruses", "OBSERVATION", 104, 111]]], ["CHN-HG-2017 was further passaged in LLC-PK1 cells for a total of 10 passages, indicating that the PDCoV CHN-HG-2017 strain could be stably propagated in LLC-PK1 cells.Virus isolation ::: ResultsTo confirm that virus propagation had occurred, the infectivity of the plaque-purified CHN-HG-2017 strain in LLC-PK1 cells was tested by IFA and western blot with an mAb against the PDCoV N protein.", [["LLC-PK1 cells", "ANATOMY", 36, 49], ["LLC-PK1 cells", "ANATOMY", 153, 166], ["plaque", "ANATOMY", 265, 271], ["LLC-PK1 cells", "ANATOMY", 303, 316], ["CHN-HG-2017", "CHEMICAL", 0, 11], ["CHN-HG-2017", "CHEMICAL", 104, 115], ["CHN-HG-2017", "CHEMICAL", 281, 292], ["CHN", "SIMPLE_CHEMICAL", 0, 3], ["LLC-PK1 cells", "CELL", 36, 49], ["PDCoV", "GENE_OR_GENE_PRODUCT", 98, 103], ["HG-2017 strain", "CELL", 108, 122], ["LLC-PK1 cells", "CELL", 153, 166], ["Virus", "ORGANISM", 167, 172], ["plaque", "PATHOLOGICAL_FORMATION", 265, 271], ["CHN-HG-2017 strain", "CELL", 281, 299], ["LLC-PK1 cells", "CELL", 303, 316], ["PDCoV N", "GENE_OR_GENE_PRODUCT", 376, 383], ["LLC-PK1 cells", "CELL_LINE", 36, 49], ["LLC-PK1 cells", "CELL_LINE", 153, 166], ["LLC-PK1 cells", "CELL_LINE", 303, 316], ["mAb", "PROTEIN", 360, 363], ["PDCoV N protein", "PROTEIN", 376, 391], ["HG", "TEST", 4, 6], ["PK1 cells", "TEST", 40, 49], ["the PDCoV CHN", "TEST", 94, 107], ["HG", "TEST", 108, 110], ["strain", "PROBLEM", 116, 122], ["virus propagation", "PROBLEM", 210, 227], ["the plaque", "PROBLEM", 261, 271], ["purified CHN", "TEST", 272, 284], ["HG", "TEST", 285, 287], ["PK1 cells", "PROBLEM", 307, 316], ["IFA", "TEST", 331, 334], ["western blot", "TEST", 339, 351], ["an mAb", "TEST", 357, 363], ["LLC", "ANATOMY", 36, 39], ["LLC", "ANATOMY", 153, 156], ["PK1 cells", "OBSERVATION", 157, 166], ["virus", "OBSERVATION", 210, 215], ["plaque", "OBSERVATION", 265, 271], ["LLC", "ANATOMY", 303, 306]]], ["As shown in Fig. 1A, PDCoV-specific immunofluorescence was detected in most cells at 24 HPI, and the N protein was mainly localized in the cytoplasm.", [["cells", "ANATOMY", 76, 81], ["cytoplasm", "ANATOMY", 139, 148], ["1A", "GENE_OR_GENE_PRODUCT", 17, 19], ["PDCoV", "GENE_OR_GENE_PRODUCT", 21, 26], ["cells", "CELL", 76, 81], ["cytoplasm", "ORGANISM_SUBSTANCE", 139, 148], ["PDCoV", "PROTEIN", 21, 26], ["N protein", "PROTEIN", 101, 110], ["PDCoV", "TEST", 21, 26], ["specific immunofluorescence", "TEST", 27, 54], ["the N protein", "TEST", 97, 110], ["Fig", "OBSERVATION", 12, 15], ["most cells", "OBSERVATION_MODIFIER", 71, 81]]], ["N protein was also detected in PDCoV-infected LLC-PK1 cells by western blot (Fig. 1B).", [["LLC-PK1 cells", "ANATOMY", 46, 59], ["PDCoV", "SIMPLE_CHEMICAL", 31, 36], ["LLC-PK1 cells", "CELL", 46, 59], ["N protein", "PROTEIN", 0, 9], ["PDCoV-infected LLC-PK1 cells", "CELL_LINE", 31, 59], ["N protein", "TEST", 0, 9], ["PDCoV", "TEST", 31, 36], ["PK1 cells", "PROBLEM", 50, 59], ["western blot", "TEST", 63, 75], ["infected", "OBSERVATION_MODIFIER", 37, 45], ["LLC", "ANATOMY", 46, 49]]], ["The morphology of the PDCoV particles purified from the supernatants of CHN-HG-2017-infected LLC-PK1 cells was examined by electron microscopy (EM) using negatively stained preparations.", [["supernatants", "ANATOMY", 56, 68], ["LLC-PK1 cells", "ANATOMY", 93, 106], ["CHN-HG-2017", "CHEMICAL", 72, 83], ["PDCoV", "GENE_OR_GENE_PRODUCT", 22, 27], ["CHN-HG-2017", "CELL", 72, 83], ["LLC-PK1 cells", "CELL", 93, 106], ["CHN-HG-2017-infected LLC-PK1 cells", "CELL_LINE", 72, 106], ["the PDCoV particles", "PROBLEM", 18, 37], ["HG", "TEST", 76, 78], ["PK1 cells", "PROBLEM", 97, 106], ["electron microscopy", "TEST", 123, 142], ["LLC", "ANATOMY", 93, 96]]], ["As shown in Fig. 2, typical crown-shaped coronavirus particles with spiky surface projections and an average diameter of 80-160 nm were observed.", [["surface", "ANATOMY", 74, 81], ["coronavirus", "ORGANISM", 41, 52], ["typical crown-shaped coronavirus particles", "PROBLEM", 20, 62], ["Fig", "OBSERVATION", 12, 15], ["typical", "OBSERVATION_MODIFIER", 20, 27], ["crown", "OBSERVATION_MODIFIER", 28, 33], ["shaped", "OBSERVATION_MODIFIER", 34, 40], ["coronavirus particles", "OBSERVATION", 41, 62], ["spiky", "OBSERVATION_MODIFIER", 68, 73], ["surface", "OBSERVATION_MODIFIER", 74, 81], ["average", "OBSERVATION_MODIFIER", 101, 108], ["diameter", "OBSERVATION_MODIFIER", 109, 117], ["160 nm", "OBSERVATION_MODIFIER", 124, 130]]], ["These results clearly showed that a strain of PDCoV had been successfully isolated and identified.Phylogenetic and recombination analysis of the genome sequence of CHN-HG-2017 ::: ResultsThe complete nucleotide sequence of the genome of CHN-HG-2017 was determined and deposited in the GenBank database under the accession number MF095123.", [["PDCoV", "CHEMICAL", 46, 51], ["CHN-HG-2017", "CHEMICAL", 237, 248], ["MF095123", "CHEMICAL", 329, 337], ["PDCoV", "GENE_OR_GENE_PRODUCT", 46, 51], ["CHN-HG-2017", "CELL", 237, 248], ["CHN", "DNA", 237, 240], ["PDCoV", "SPECIES", 46, 51], ["CHN-HG-2017", "SPECIES", 237, 248], ["a strain of PDCoV", "PROBLEM", 34, 51], ["HG", "TEST", 241, 243]]], ["Similar to other PDCoV strains, the complete genome sequence of CHN-HG-2017 is 25,399 nt in length, consisting of 5\u2032 UTR-1ab-S-E-M-NS6-N-NS7-3\u2032 UTR, and predicted transcription regulatory sequences (TRSs) were located at the 5\u2032 end of each gene with a highly conserved core sequence of 5\u2032 -ACCAC-3\u2032 (Table 1).", [["PDCoV", "GENE_OR_GENE_PRODUCT", 17, 22], ["CHN-HG-2017", "CELL", 64, 75], ["UTR", "DNA", 117, 120], ["1ab", "DNA", 121, 124], ["S", "DNA", 125, 126], ["E", "DNA", 127, 128], ["M", "DNA", 129, 130], ["NS6", "DNA", 131, 134], ["N", "DNA", 135, 136], ["NS7-3\u2032 UTR", "DNA", 137, 147], ["transcription regulatory sequences", "DNA", 163, 197], ["TRSs", "DNA", 199, 203], ["5\u2032 end", "DNA", 225, 231], ["other PDCoV strains", "PROBLEM", 11, 30], ["HG", "TEST", 68, 70], ["UTR", "TEST", 117, 120], ["NS6", "TEST", 131, 134], ["NS7", "TEST", 137, 140], ["UTR", "TEST", 144, 147], ["TRSs", "TEST", 199, 203], ["ACCAC", "TEST", 290, 295]]], ["Moreover, CHN-HG-2017 shared 97.6%-99.1% nucleotide sequence identity with the other 74 PDCoV strains in the database.", [["CHN-HG-2017", "CHEMICAL", 10, 21], ["nucleotide", "CHEMICAL", 41, 51], ["nucleotide", "CHEMICAL", 41, 51], ["HG", "TEST", 14, 16], ["nucleotide sequence identity", "TEST", 41, 69]]], ["Phylogenetic analysis indicated that the PDCoV strains from the United States and South Korea clustered into a large clade, whereas CHN-HG-2017 clustered with other PDCoV strains detected in China since 2014.", [["CHN-HG-2017", "CELL", 132, 143], ["Phylogenetic analysis", "TEST", 0, 21], ["the PDCoV strains", "PROBLEM", 37, 54], ["HG", "TEST", 136, 138], ["other PDCoV strains", "PROBLEM", 159, 178], ["large", "OBSERVATION_MODIFIER", 111, 116], ["clade", "OBSERVATION", 117, 122]]], ["These data imply that the Chinese strains might share a more recent common ancestor with the US and South Korean strains than the ancestor of the strains from Thailand, Laos, and Vietnam (Fig. 3A).", [["the Chinese strains", "PROBLEM", 22, 41]]], ["Notably, phylogenetic trees based on the S gene displayed a similar clustering pattern (Fig. 3B).Phylogenetic and recombination analysis of the genome sequence of CHN-HG-2017 ::: ResultsThe RNA genome of coronaviruses can undergo high-frequency recombination due to its large size [24].", [["coronaviruses", "ORGANISM", 204, 217], ["S gene", "DNA", 41, 47], ["RNA genome", "DNA", 190, 200], ["phylogenetic trees", "PROBLEM", 9, 27], ["coronaviruses", "PROBLEM", 204, 217], ["high-frequency recombination", "TREATMENT", 230, 258], ["phylogenetic trees", "OBSERVATION", 9, 27], ["large", "OBSERVATION_MODIFIER", 270, 275], ["size", "OBSERVATION_MODIFIER", 276, 280]]], ["We therefore analyzed the genome sequence of CHN-HG-2017 using RDP.", [["CHN-HG-2017", "CELL", 45, 56], ["HG", "TEST", 49, 51]]], ["As depicted in Fig. 4A, two PDCoV strains, Vietnam/HaNoi6/2015 (GenBank accession number: KX834351) and CH/SXD1/2015 (GenBank accession number: KT021234), might represent the parent lineages of CHN-HG-2017.", [["CHN", "CHEMICAL", 194, 197], ["4A", "GENE_OR_GENE_PRODUCT", 20, 22], ["CHN-HG-2017", "CELL", 194, 205], ["Vietnam/HaNoi6/2015 (GenBank accession number: KX834351) and CH/SXD1/2015 (GenBank accession number: KT021234", "SPECIES", 43, 152], ["Fig", "OBSERVATION", 15, 18]]], ["Similarity plot and bootscanning analyses predicted the potential breakpoints in CHN-HG-2017 to be at nt 3153 and 4249.", [["CHN", "CHEMICAL", 81, 84], ["Similarity plot", "TEST", 0, 15], ["bootscanning analyses", "TEST", 20, 41], ["HG", "TEST", 85, 87]]], ["We therefore divided the aligned sequences into three separate segments: one from nt 1 up to the breakpoint at position 3153, another from the breakpoint at position 3153 to the breakpoint at position 4249, and the last one from the breakpoint at position 4249 to the end.", [["nt 1", "DNA", 82, 86], ["position 3153", "DNA", 111, 124], ["position 3153", "DNA", 157, 170], ["position 4249", "DNA", 192, 205], ["position 4249", "DNA", 247, 260]]], ["A phylogenetic analysis of these segments using the maximum-likelihood algorithm suggested the CH/SXD1/2015 strain from China to be its major parent and the Vietnam/HaNoi6/2015 strain from Vietnam to be its minor parent (Fig. 4B), providing strong evidence that recombination events had occurred.Clinical observations in pigs challenged with CHN-HG-2017 ::: ResultsTo investigate the pathogenicity of CHN-HG-2017, 5-day-old piglets were challenged with CHN-HG-2017 via oral feeding (Table 2).", [["oral", "ANATOMY", 469, 473], ["CHN", "CHEMICAL", 342, 345], ["CHN", "CHEMICAL", 401, 404], ["CHN-HG-2017", "CHEMICAL", 453, 464], ["pigs", "ORGANISM", 321, 325], ["CHN-HG-2017", "CELL", 401, 412], ["piglets", "ORGANISM", 424, 431], ["oral", "ORGANISM_SUBDIVISION", 469, 473], ["pigs", "SPECIES", 321, 325], ["piglets", "SPECIES", 424, 431], ["Vietnam/HaNoi6/2015 strain", "SPECIES", 157, 183], ["pigs", "SPECIES", 321, 325], ["A phylogenetic analysis", "TEST", 0, 23], ["likelihood algorithm", "TEST", 60, 80], ["recombination events", "PROBLEM", 262, 282], ["HG", "TEST", 405, 407]]], ["All piglets from the negative control groups were in good health throughout the course of study with no observed clinical signs (Fig. 5A and B).", [["piglets", "ORGANISM", 4, 11], ["piglets", "SPECIES", 4, 11]]], ["As expected, three of the six piglets in the challenged group showed diarrhea at 1 DPI, and more piglets developed varying degrees of diarrhea, vomiting, lethargy and anorexia at 2-6 DPI (Fig. 5C and D).", [["diarrhea", "DISEASE", 69, 77], ["DPI", "CHEMICAL", 83, 86], ["diarrhea", "DISEASE", 134, 142], ["vomiting", "DISEASE", 144, 152], ["lethargy", "DISEASE", 154, 162], ["anorexia", "DISEASE", 167, 175], ["piglets", "ORGANISM", 30, 37], ["piglets", "ORGANISM", 97, 104], ["piglets", "SPECIES", 30, 37], ["piglets", "SPECIES", 97, 104], ["diarrhea", "PROBLEM", 69, 77], ["diarrhea", "PROBLEM", 134, 142], ["vomiting", "PROBLEM", 144, 152], ["lethargy", "PROBLEM", 154, 162], ["anorexia", "PROBLEM", 167, 175], ["diarrhea", "OBSERVATION", 69, 77], ["varying degrees", "OBSERVATION_MODIFIER", 115, 130], ["diarrhea", "OBSERVATION", 134, 142]]], ["Lethargy, anorexia and the progression to watery diarrhea were most severe at 3-6 DPI, and the piglets gradually recovered thereafter (Table 3).", [["Lethargy", "DISEASE", 0, 8], ["anorexia", "DISEASE", 10, 18], ["diarrhea", "DISEASE", 49, 57], ["piglets", "ORGANISM", 95, 102], ["piglets", "SPECIES", 95, 102], ["Lethargy", "PROBLEM", 0, 8], ["anorexia", "PROBLEM", 10, 18], ["watery diarrhea", "PROBLEM", 42, 57], ["anorexia", "OBSERVATION", 10, 18], ["progression", "OBSERVATION_MODIFIER", 27, 38], ["most severe", "OBSERVATION_MODIFIER", 63, 74]]], ["Notably, no PDCoV-associated deaths were observed in this study.", [["PDCoV", "CHEMICAL", 12, 17], ["deaths", "DISEASE", 29, 35], ["PDCoV-associated deaths", "PROBLEM", 12, 35], ["this study", "TEST", 53, 63], ["no", "UNCERTAINTY", 9, 11], ["deaths", "OBSERVATION", 29, 35]]], ["These results demonstrated that CHN-HG-2017 is pathogenic to newborn piglets.Fecal shedding, virus distribution, and neutralizing antibody against CHN-HG-2017 ::: ResultsTo determine the duration of fecal shedding and to monitor the changing load of CHN-HG-2017, we attempted to detect viral RNA in rectal swab samples from 1 to 21 DPI by quantitative real-time RT-PCR.", [["Fecal", "ANATOMY", 77, 82], ["fecal", "ANATOMY", 199, 204], ["rectal swab samples", "ANATOMY", 299, 318], ["CHN-HG-2017", "CHEMICAL", 32, 43], ["CHN", "CHEMICAL", 250, 253], ["CHN", "SIMPLE_CHEMICAL", 32, 35], ["piglets", "ORGANISM", 69, 76], ["Fecal", "ORGANISM_SUBSTANCE", 77, 82], ["fecal", "ORGANISM_SUBSTANCE", 199, 204], ["CHN-HG-2017", "CELL", 250, 261], ["rectal swab samples", "ORGANISM_SUBSTANCE", 299, 318], ["neutralizing antibody", "PROTEIN", 117, 138], ["viral RNA", "RNA", 286, 295], ["piglets", "SPECIES", 69, 76], ["Fecal shedding, virus distribution", "PROBLEM", 77, 111], ["neutralizing antibody", "TEST", 117, 138], ["fecal shedding", "PROBLEM", 199, 213], ["HG", "TEST", 254, 256], ["viral RNA", "PROBLEM", 286, 295], ["rectal swab samples", "TEST", 299, 318], ["PCR", "TEST", 365, 368], ["shedding", "OBSERVATION", 83, 91], ["virus distribution", "OBSERVATION", 93, 111], ["viral RNA", "OBSERVATION", 286, 295], ["rectal", "ANATOMY", 299, 305]]], ["The viral RNA was detected in six out of six rectal swab samples collected from the challenged group from 1 DPI to 14 DPI.", [["rectal swab samples", "ANATOMY", 45, 64], ["DPI", "CHEMICAL", 118, 121], ["viral RNA", "RNA", 4, 13], ["The viral RNA", "PROBLEM", 0, 13], ["six rectal swab samples", "TEST", 41, 64], ["viral RNA", "OBSERVATION", 4, 13]]], ["The PDCoV RNA copy number in homogenized rectal swab supernatants reached a peak of over 108 copies/ml at 2-4 DPI (Fig. 6A).", [["rectal swab supernatants", "ANATOMY", 41, 65], ["PDCoV", "GENE_OR_GENE_PRODUCT", 4, 9], ["rectal swab", "ORGANISM_SUBSTANCE", 41, 52], ["PDCoV RNA", "RNA", 4, 13], ["rectal swab supernatants", "TEST", 41, 65]]], ["Notably, no PDCoV RNA was detected in samples from piglets in the negative control throughout the study.Fecal shedding, virus distribution, and neutralizing antibody against CHN-HG-2017 ::: ResultsThe distribution of CHN-HG-2017 in various tissues was also examined by quantitative real-time RT-PCR in three pigs from each group sacrificed at 4 DPI.", [["samples", "ANATOMY", 38, 45], ["Fecal", "ANATOMY", 104, 109], ["tissues", "ANATOMY", 240, 247], ["CHN-HG-2017", "CHEMICAL", 217, 228], ["PDCoV", "GENE_OR_GENE_PRODUCT", 12, 17], ["piglets", "ORGANISM", 51, 58], ["Fecal", "ORGANISM_SUBSTANCE", 104, 109], ["CHN-HG-2017", "CELL", 217, 228], ["tissues", "TISSUE", 240, 247], ["pigs", "ORGANISM", 308, 312], ["PDCoV RNA", "RNA", 12, 21], ["neutralizing antibody", "PROTEIN", 144, 165], ["piglets", "SPECIES", 51, 58], ["pigs", "SPECIES", 308, 312], ["PDCoV", "SPECIES", 12, 17], ["pigs", "SPECIES", 308, 312], ["PDCoV RNA", "PROBLEM", 12, 21], ["the study", "TEST", 94, 103], ["Fecal shedding, virus distribution", "PROBLEM", 104, 138], ["neutralizing antibody", "TEST", 144, 165], ["HG", "TEST", 221, 223], ["no", "UNCERTAINTY", 9, 11], ["PDCoV RNA", "OBSERVATION", 12, 21], ["negative", "OBSERVATION", 66, 74], ["shedding", "OBSERVATION", 110, 118], ["virus distribution", "OBSERVATION", 120, 138], ["distribution", "OBSERVATION_MODIFIER", 201, 213]]], ["Viral RNA was detected in two of three duodenums (average 106.86 copies/g), three of three jejunums (average 108.26 copies/g), three of three ileums (average 108.4 copies/g), three of three ceca (average 108.42 copies/g), three of three colons (average 107.96 copies/g), and three of three rectums (average 106.95 copies/g).", [["duodenums", "ANATOMY", 39, 48], ["jejunums", "ANATOMY", 91, 99], ["ileums", "ANATOMY", 142, 148], ["ceca", "ANATOMY", 190, 194], ["colons", "ANATOMY", 237, 243], ["rectums", "ANATOMY", 290, 297], ["Viral", "ORGANISM", 0, 5], ["duodenums", "CANCER", 39, 48], ["jejunums", "CANCER", 91, 99], ["ileums", "CANCER", 142, 148], ["ceca", "ORGAN", 190, 194], ["colons", "MULTI-TISSUE_STRUCTURE", 237, 243], ["Viral RNA", "RNA", 0, 9], ["Viral RNA", "PROBLEM", 0, 9], ["RNA", "OBSERVATION", 6, 9], ["ceca", "ANATOMY", 190, 194], ["colons", "ANATOMY", 237, 243]]], ["It was also detected in one of three livers (105.96 copies/g), one of three spleens (106.91 copies/g), one of three kidneys (106.9 copies/g) and one of three lungs (106.02 copies/g), but no viral RNA was detected in the blood (Fig. 6B).Fecal shedding, virus distribution, and neutralizing antibody against CHN-HG-2017 ::: ResultsTo investigate when PDCoV neutralizing antibodies were detectable in the infected piglets, serum samples collected at 0, 4, 7, 21 DPI were tested for PDCoV-neutralizing antibodies.", [["livers", "ANATOMY", 37, 43], ["spleens", "ANATOMY", 76, 83], ["kidneys", "ANATOMY", 116, 123], ["lungs", "ANATOMY", 158, 163], ["blood", "ANATOMY", 220, 225], ["Fecal", "ANATOMY", 236, 241], ["piglets", "ANATOMY", 411, 418], ["serum samples", "ANATOMY", 420, 433], ["livers", "ORGAN", 37, 43], ["spleens", "ORGAN", 76, 83], ["kidneys", "ORGAN", 116, 123], ["lungs", "ORGAN", 158, 163], ["blood", "ORGANISM_SUBSTANCE", 220, 225], ["Fecal", "ORGANISM_SUBSTANCE", 236, 241], ["PDCoV", "GENE_OR_GENE_PRODUCT", 349, 354], ["piglets", "ORGANISM", 411, 418], ["serum samples", "ORGANISM_SUBSTANCE", 420, 433], ["PDCoV", "GENE_OR_GENE_PRODUCT", 479, 484], ["viral RNA", "RNA", 190, 199], ["neutralizing antibody", "PROTEIN", 276, 297], ["PDCoV neutralizing antibodies", "PROTEIN", 349, 378], ["PDCoV", "PROTEIN", 479, 484], ["neutralizing antibodies", "PROTEIN", 485, 508], ["piglets", "SPECIES", 411, 418], ["PDCoV", "SPECIES", 349, 354], ["PDCoV", "SPECIES", 479, 484], ["copies/g", "TEST", 92, 100], ["copies/g", "TEST", 131, 139], ["copies/g", "TEST", 172, 180], ["viral RNA", "PROBLEM", 190, 199], ["the blood", "TEST", 216, 225], ["Fecal shedding, virus distribution", "PROBLEM", 236, 270], ["neutralizing antibody", "TEST", 276, 297], ["PDCoV neutralizing antibodies", "TEST", 349, 378], ["serum samples", "TEST", 420, 433], ["DPI", "TEST", 459, 462], ["PDCoV", "TEST", 479, 484], ["neutralizing antibodies", "PROBLEM", 485, 508], ["livers", "ANATOMY", 37, 43], ["spleens", "ANATOMY", 76, 83], ["kidneys", "ANATOMY", 116, 123], ["lungs", "ANATOMY", 158, 163], ["no", "UNCERTAINTY", 187, 189], ["viral RNA", "OBSERVATION", 190, 199], ["shedding", "OBSERVATION", 242, 250], ["virus distribution", "OBSERVATION", 252, 270]]], ["Virus-neutralizing (VN) antibodies in sera were detected as early as 4 DPI in sera of PDCoV-inoculated piglets, and the titers increased gradually and peaked at 21 DPI (Table 4).", [["sera", "ANATOMY", 38, 42], ["sera", "ANATOMY", 78, 82], ["piglets", "ANATOMY", 103, 110], ["DPI", "CHEMICAL", 71, 74], ["PDCoV", "CHEMICAL", 86, 91], ["Virus-neutralizing (VN) antibodies", "GENE_OR_GENE_PRODUCT", 0, 34], ["sera", "ORGANISM_SUBSTANCE", 38, 42], ["DPI", "SIMPLE_CHEMICAL", 71, 74], ["sera", "ORGANISM_SUBSTANCE", 78, 82], ["PDCoV", "SIMPLE_CHEMICAL", 86, 91], ["piglets", "ORGANISM", 103, 110], ["Virus-neutralizing (VN) antibodies", "PROTEIN", 0, 34], ["piglets", "SPECIES", 103, 110], ["PDCoV", "SPECIES", 86, 91], ["Virus", "TEST", 0, 5], ["neutralizing (VN) antibodies in sera", "TEST", 6, 42], ["sera", "TEST", 78, 82], ["PDCoV", "TEST", 86, 91], ["the titers", "TEST", 116, 126], ["neutralizing", "OBSERVATION", 6, 18]]], ["PDCoV-specific neutralizing antibodies were not observed in sera from the control piglets.Gross pathology, histopathology, and immunohistochemistry ::: ResultsTo determine the gross pathological and histological changes in piglets infected with CHN-HG-2017, three of the six pigs in each group were selected randomly for necropsy at 4 DPI.", [["sera", "ANATOMY", 60, 64], ["PDCoV", "CHEMICAL", 0, 5], ["CHN", "CHEMICAL", 245, 248], ["PDCoV", "SIMPLE_CHEMICAL", 0, 5], ["sera", "ORGANISM_SUBSTANCE", 60, 64], ["piglets", "ORGANISM", 82, 89], ["piglets", "ORGANISM", 223, 230], ["pigs", "ORGANISM", 275, 279], ["PDCoV", "PROTEIN", 0, 5], ["neutralizing antibodies", "PROTEIN", 15, 38], ["piglets", "SPECIES", 82, 89], ["piglets", "SPECIES", 223, 230], ["pigs", "SPECIES", 275, 279], ["PDCoV", "TREATMENT", 0, 5], ["specific neutralizing antibodies", "TEST", 6, 38], ["Gross pathology", "TEST", 90, 105], ["the gross pathological and histological changes", "PROBLEM", 172, 219], ["HG", "TEST", 249, 251], ["necropsy", "TREATMENT", 321, 329], ["neutralizing antibodies", "OBSERVATION", 15, 38], ["pathology", "OBSERVATION", 96, 105], ["gross", "OBSERVATION_MODIFIER", 176, 181], ["pathological", "OBSERVATION", 182, 194], ["histological", "OBSERVATION", 199, 211], ["piglets", "OBSERVATION_MODIFIER", 223, 230], ["infected", "OBSERVATION_MODIFIER", 231, 239]]], ["The small intestines, where yellow watery contents had accumulated, were clearly transparent, thin-walled, and gas-distended in the PDCoV-challenged pigs (Fig. 7A).", [["intestines", "ANATOMY", 10, 20], ["PDCoV", "CHEMICAL", 132, 137], ["intestines", "ORGAN", 10, 20], ["watery", "ORGANISM_SUBDIVISION", 35, 41], ["PDCoV", "SIMPLE_CHEMICAL", 132, 137], ["pigs", "ORGANISM", 149, 153], ["pigs", "SPECIES", 149, 153], ["yellow watery contents", "PROBLEM", 28, 50], ["distended", "PROBLEM", 115, 124], ["small", "OBSERVATION_MODIFIER", 4, 9], ["intestines", "ANATOMY", 10, 20], ["transparent", "OBSERVATION_MODIFIER", 81, 92], ["walled", "OBSERVATION_MODIFIER", 99, 105], ["gas", "OBSERVATION_MODIFIER", 111, 114], ["distended", "OBSERVATION", 115, 124]]], ["No other lesions were observed in any other organs of the challenged groups or in any of the organs of the negative control pigs (Fig. 7B).", [["lesions", "ANATOMY", 9, 16], ["organs", "ANATOMY", 44, 50], ["organs", "ANATOMY", 93, 99], ["lesions", "PATHOLOGICAL_FORMATION", 9, 16], ["organs", "ORGAN", 44, 50], ["organs", "ORGAN", 93, 99], ["pigs", "ORGANISM", 124, 128], ["pigs", "SPECIES", 124, 128], ["other lesions", "PROBLEM", 3, 16], ["lesions", "OBSERVATION", 9, 16], ["negative", "OBSERVATION", 107, 115]]], ["These results showed that the small intestine is the major target of CHN-HG-2017 infection.", [["small intestine", "ANATOMY", 30, 45], ["CHN-HG-2017", "CHEMICAL", 69, 80], ["infection", "DISEASE", 81, 90], ["small intestine", "ORGAN", 30, 45], ["CHN-HG-2017", "CELL", 69, 80], ["the small intestine", "PROBLEM", 26, 45], ["infection", "PROBLEM", 81, 90], ["small", "OBSERVATION_MODIFIER", 30, 35], ["intestine", "ANATOMY", 36, 45], ["HG", "OBSERVATION_MODIFIER", 73, 75], ["infection", "OBSERVATION", 81, 90]]], ["Microscopic lesions in the small intestine were also observed by microscopy.", [["lesions", "ANATOMY", 12, 19], ["small intestine", "ANATOMY", 27, 42], ["Microscopic lesions", "PATHOLOGICAL_FORMATION", 0, 19], ["small intestine", "ORGAN", 27, 42], ["Microscopic lesions in the small intestine", "PROBLEM", 0, 42], ["microscopy", "TEST", 65, 75], ["lesions", "OBSERVATION", 12, 19], ["small intestine", "ANATOMY", 27, 42]]], ["Compared to those of the negative control piglets, the intestinal villi of the PDCoV-infected piglets were blunted and fragmented and exhibited atrophy and vacuolation, especially in the jejunum and ileum (Fig. 7C and D and Table 5).", [["intestinal villi", "ANATOMY", 55, 71], ["piglets", "ANATOMY", 94, 101], ["jejunum", "ANATOMY", 187, 194], ["ileum", "ANATOMY", 199, 204], ["atrophy", "DISEASE", 144, 151], ["piglets", "ORGANISM", 42, 49], ["intestinal villi", "MULTI-TISSUE_STRUCTURE", 55, 71], ["PDCoV", "GENE_OR_GENE_PRODUCT", 79, 84], ["piglets", "ORGANISM", 94, 101], ["jejunum", "MULTI-TISSUE_STRUCTURE", 187, 194], ["ileum", "MULTI-TISSUE_STRUCTURE", 199, 204], ["piglets", "SPECIES", 42, 49], ["piglets", "SPECIES", 94, 101], ["blunted", "PROBLEM", 107, 114], ["atrophy", "PROBLEM", 144, 151], ["vacuolation", "PROBLEM", 156, 167], ["intestinal villi", "ANATOMY", 55, 71], ["infected piglets", "OBSERVATION", 85, 101], ["blunted", "OBSERVATION_MODIFIER", 107, 114], ["fragmented", "OBSERVATION_MODIFIER", 119, 129], ["atrophy", "OBSERVATION", 144, 151], ["vacuolation", "OBSERVATION_MODIFIER", 156, 167], ["jejunum", "ANATOMY", 187, 194], ["ileum", "ANATOMY", 199, 204]]], ["Moreover, aggregation of lymphocytes and hyperemia in the intestinal lamina propria were also observed (Fig. 7C and D), but the intestines of the negative control were normal (Fig. 7E and F).", [["lymphocytes", "ANATOMY", 25, 36], ["intestinal lamina propria", "ANATOMY", 58, 83], ["intestines", "ANATOMY", 128, 138], ["hyperemia", "DISEASE", 41, 50], ["lymphocytes", "CELL", 25, 36], ["intestinal lamina propria", "TISSUE", 58, 83], ["intestines", "ORGAN", 128, 138], ["lymphocytes", "CELL_TYPE", 25, 36], ["aggregation of lymphocytes", "PROBLEM", 10, 36], ["hyperemia in the intestinal lamina propria", "PROBLEM", 41, 83], ["aggregation", "OBSERVATION_MODIFIER", 10, 21], ["lymphocytes", "OBSERVATION", 25, 36], ["hyperemia", "OBSERVATION_MODIFIER", 41, 50], ["intestinal lamina", "ANATOMY", 58, 75], ["propria", "ANATOMY_MODIFIER", 76, 83], ["intestines", "ANATOMY", 128, 138], ["negative", "OBSERVATION", 146, 154]]], ["Consistent with the histopathological results, PDCoV antigen was detected by immunohistochemical staining in the cytoplasm of the infected villous enterocytes (Fig. 7G and H).", [["cytoplasm", "ANATOMY", 113, 122], ["villous enterocytes", "ANATOMY", 139, 158], ["PDCoV antigen", "GENE_OR_GENE_PRODUCT", 47, 60], ["cytoplasm", "ORGANISM_SUBSTANCE", 113, 122], ["villous enterocytes", "CELL", 139, 158], ["PDCoV antigen", "PROTEIN", 47, 60], ["infected villous enterocytes", "CELL_TYPE", 130, 158], ["PDCoV antigen", "TEST", 47, 60], ["immunohistochemical staining", "TEST", 77, 105], ["infected villous enterocytes", "OBSERVATION", 130, 158]]], ["No PDCoV antigen was detected in the negative controls (Fig. 7I and J).", [["PDCoV antigen", "GENE_OR_GENE_PRODUCT", 3, 16], ["PDCoV antigen", "PROTEIN", 3, 16], ["PDCoV antigen", "PROBLEM", 3, 16]]], ["These results show that CHN-HG-2017 infection can cause intestinal lesions in newborn piglets, especially in the jejunum and ileum.DiscussionPDCoV is a newly emerged enteropathogenic coronavirus that causes diarrhea, dehydration and death in neonatal piglets.", [["intestinal lesions", "ANATOMY", 56, 74], ["jejunum", "ANATOMY", 113, 120], ["ileum", "ANATOMY", 125, 130], ["CHN-HG-2017", "CHEMICAL", 24, 35], ["infection", "DISEASE", 36, 45], ["intestinal lesions", "DISEASE", 56, 74], ["DiscussionPDCoV", "CHEMICAL", 131, 146], ["enteropathogenic coronavirus", "DISEASE", 166, 194], ["diarrhea", "DISEASE", 207, 215], ["dehydration", "DISEASE", 217, 228], ["death", "DISEASE", 233, 238], ["CHN", "SIMPLE_CHEMICAL", 24, 27], ["intestinal lesions", "PATHOLOGICAL_FORMATION", 56, 74], ["piglets", "ORGANISM", 86, 93], ["jejunum", "MULTI-TISSUE_STRUCTURE", 113, 120], ["ileum", "ORGAN", 125, 130], ["coronavirus", "ORGANISM", 183, 194], ["piglets", "ORGANISM", 251, 258], ["piglets", "SPECIES", 86, 93], ["piglets", "SPECIES", 251, 258], ["HG", "TEST", 28, 30], ["infection", "PROBLEM", 36, 45], ["intestinal lesions in newborn piglets", "PROBLEM", 56, 93], ["a newly emerged enteropathogenic coronavirus", "PROBLEM", 150, 194], ["diarrhea", "PROBLEM", 207, 215], ["dehydration", "PROBLEM", 217, 228], ["death in neonatal piglets", "PROBLEM", 233, 258], ["intestinal", "ANATOMY", 56, 66], ["lesions", "OBSERVATION", 67, 74], ["newborn piglets", "OBSERVATION", 78, 93], ["jejunum", "ANATOMY", 113, 120], ["ileum", "ANATOMY", 125, 130], ["enteropathogenic coronavirus", "OBSERVATION", 166, 194], ["diarrhea", "OBSERVATION", 207, 215]]], ["Since PDCoV was first reported in Hong Kong, it has spread to many countries around the world, leading to significant economic losses in the pork industry.", [["PDCoV", "CHEMICAL", 6, 11], ["PDCoV", "GENE_OR_GENE_PRODUCT", 6, 11], ["pork", "ORGANISM_SUBDIVISION", 141, 145], ["pork", "SPECIES", 141, 145], ["significant", "OBSERVATION_MODIFIER", 106, 117], ["economic", "OBSERVATION_MODIFIER", 118, 126], ["losses", "OBSERVATION", 127, 133]]], ["In mainland China, the prevalence of PDCoV in pigs was reported to be 33.71% in Jiangxi province [17], 23.4% in Guangdong province [15], and 10.2% in Hebei province [25].", [["PDCoV", "DISEASE", 37, 42], ["PDCoV", "CANCER", 37, 42], ["pigs", "ORGANISM", 46, 50], ["pigs", "SPECIES", 46, 50], ["PDCoV", "SPECIES", 37, 42], ["pigs", "SPECIES", 46, 50]]], ["Although the prevalence of PDCoV in China has been widely reported, only a few PDCoV strains could be successfully isolated in cultured cells until now.DiscussionIn the present study, feces from PDCoV-infected pigs on farms located in central China were used to isolate PDCoV in LLC-PK1 cells.", [["cells", "ANATOMY", 136, 141], ["feces", "ANATOMY", 184, 189], ["LLC-PK1 cells", "ANATOMY", 279, 292], ["PDCoV", "DISEASE", 27, 32], ["PDCoV", "CHEMICAL", 195, 200], ["PDCoV", "CANCER", 27, 32], ["cells", "CELL", 136, 141], ["feces", "ORGANISM_SUBDIVISION", 184, 189], ["pigs", "ORGANISM", 210, 214], ["PDCoV", "CELL", 270, 275], ["LLC-PK1 cells", "CELL", 279, 292], ["cultured cells", "CELL_LINE", 127, 141], ["LLC-PK1 cells", "CELL_LINE", 279, 292], ["pigs", "SPECIES", 210, 214], ["PDCoV", "SPECIES", 27, 32], ["pigs", "SPECIES", 210, 214], ["PDCoV", "SPECIES", 270, 275], ["a few PDCoV strains", "PROBLEM", 73, 92], ["the present study", "TEST", 165, 182], ["PDCoV", "TREATMENT", 195, 200], ["infected pigs on farms", "TREATMENT", 201, 223], ["infected", "OBSERVATION", 201, 209], ["central China", "ANATOMY", 235, 248], ["LLC", "ANATOMY", 279, 282], ["PK1 cells", "OBSERVATION", 283, 292]]], ["Typical CPE was observed in infected LLC-PK1 cells at 24 h after inoculation.", [["LLC-PK1 cells", "ANATOMY", 37, 50], ["LLC-PK1 cells", "CELL", 37, 50], ["LLC-PK1 cells", "CELL_LINE", 37, 50], ["Typical CPE", "PROBLEM", 0, 11], ["PK1 cells", "PROBLEM", 41, 50], ["inoculation", "PROBLEM", 65, 76], ["CPE", "OBSERVATION", 8, 11], ["infected", "OBSERVATION_MODIFIER", 28, 36], ["LLC", "ANATOMY", 37, 40]]], ["Following plaque purification, the PDCoV strain was confirmed by IFA and electron microscopy.", [["plaque", "ANATOMY", 10, 16], ["plaque purification", "TREATMENT", 10, 29], ["the PDCoV strain", "PROBLEM", 31, 47], ["electron microscopy", "TEST", 73, 92], ["plaque", "OBSERVATION", 10, 16]]], ["Notably, only one PDCoV strain was isolated from a total of 17 PDCoV-positive feces samples, indicating that the success rate for virus isolation was still relatively low.", [["samples", "ANATOMY", 84, 91], ["PDCoV", "GENE_OR_GENE_PRODUCT", 18, 23], ["PDCoV", "GENE_OR_GENE_PRODUCT", 63, 68], ["feces", "ORGANISM", 78, 83], ["one PDCoV strain", "PROBLEM", 14, 30], ["positive feces samples", "PROBLEM", 69, 91], ["the success rate", "TEST", 109, 125], ["virus isolation", "PROBLEM", 130, 145]]], ["This low rate of PDCoV isolation might be attributed to a small amount of infectious virus in the fecal samples collected for virus isolation.", [["fecal samples", "ANATOMY", 98, 111], ["PDCoV", "CANCER", 17, 22], ["fecal samples", "ORGANISM_SUBSTANCE", 98, 111], ["PDCoV isolation", "TREATMENT", 17, 32], ["a small amount of infectious virus", "PROBLEM", 56, 90], ["the fecal samples", "TEST", 94, 111], ["virus isolation", "TREATMENT", 126, 141], ["small", "OBSERVATION_MODIFIER", 58, 63], ["amount", "OBSERVATION_MODIFIER", 64, 70], ["infectious virus", "OBSERVATION", 74, 90], ["fecal", "ANATOMY", 98, 103]]], ["In addition, the time at which the sample is collected might also contribute to the success of PDCoV isolation.DiscussionTo characterize the virus isolate, the complete genome of CHN-HG-2017 was sequenced and analyzed.", [["PDCoV", "CANCER", 95, 100], ["CHN-HG-2017", "CELL", 179, 190], ["CHN", "DNA", 179, 182], ["2017", "DNA", 186, 190], ["PDCoV", "SPECIES", 95, 100], ["CHN-HG-2017", "SPECIES", 179, 190], ["PDCoV isolation", "TREATMENT", 95, 110], ["the virus isolate", "PROBLEM", 137, 154], ["HG", "TEST", 183, 185]]], ["While the genome organization is similar to those of other reported PDCoVs, the genome size of 25,399 nt is somewhat different from the others.", [["PDCoVs", "GENE_OR_GENE_PRODUCT", 68, 74], ["PDCoVs", "DNA", 68, 74], ["25,399 nt", "DNA", 95, 104], ["the genome size", "TEST", 76, 91], ["genome", "OBSERVATION_MODIFIER", 80, 86], ["size", "OBSERVATION_MODIFIER", 87, 91], ["somewhat", "OBSERVATION_MODIFIER", 108, 116], ["different", "OBSERVATION_MODIFIER", 117, 126]]], ["Moreover, we identified predicted TRSs at the 5\u2032 end of each gene of CHN-HG-2017, each with a highly conserved core sequence of 5\u2032-ACCAC-3\u2032, which appears to be unique to members of the genus Deltacoronavirus.", [["TRSs", "GENE_OR_GENE_PRODUCT", 34, 38], ["5\u2032-ACCAC-3", "GENE_OR_GENE_PRODUCT", 128, 138], ["Deltacoronavirus", "GENE_OR_GENE_PRODUCT", 192, 208], ["TRSs", "DNA", 34, 38], ["5\u2032 end", "DNA", 46, 52], ["CHN", "DNA", 69, 72], ["5\u2032-ACCAC-3\u2032", "DNA", 128, 139], ["TRSs", "TEST", 34, 38], ["HG", "TEST", 73, 75], ["genus Deltacoronavirus", "OBSERVATION", 186, 208]]], ["Multiple sequence alignment and phylogenetic analysis showed that all of the known PDCoV strains share a high level of nucleotide sequence identities.", [["nucleotide", "CHEMICAL", 119, 129], ["nucleotide", "CHEMICAL", 119, 129], ["PDCoV", "GENE_OR_GENE_PRODUCT", 83, 88], ["Multiple sequence alignment", "TEST", 0, 27], ["phylogenetic analysis", "TEST", 32, 53], ["the known PDCoV strains", "PROBLEM", 73, 96]]], ["However, CHN-HG-2017 was most closely related to other Chinese PDCoV strains.", [["CHN-HG-2017", "CHEMICAL", 9, 20], ["PDCoV", "GENE_OR_GENE_PRODUCT", 63, 68], ["Chinese PDCoV", "SPECIES", 55, 68], ["HG", "TEST", 13, 15], ["Chinese PDCoV strains", "TREATMENT", 55, 76]]], ["Our phylogenetic analysis suggests that PDCoV strains from China, the United States and South Korea are clustered in the same clade, whereas the PDCoV strains from Thailand, Laos, and Vietnam are clustered in another clade.DiscussionLike other coronaviruses, PDCoV has the potential to undergo recombination at a very high frequency.", [["PDCoV", "CHEMICAL", 259, 264], ["PDCoV strains", "ORGANISM", 40, 53], ["PDCoV strains", "ORGANISM", 145, 158], ["coronaviruses", "ORGANISM", 244, 257], ["PDCoV", "GENE_OR_GENE_PRODUCT", 259, 264], ["Our phylogenetic analysis", "TEST", 0, 25], ["PDCoV strains", "PROBLEM", 40, 53], ["the PDCoV strains", "PROBLEM", 141, 158], ["PDCoV", "TREATMENT", 259, 264]]], ["In this study, we employed the Recombination Detection Program (RDP) to analyze the genome of CHN-HG-2017 in search of any recombined fragments.", [["fragments", "ANATOMY", 134, 143], ["CHN-HG-2017", "CELL", 94, 105], ["CHN", "DNA", 94, 97], ["recombined fragments", "DNA", 123, 143], ["this study", "TEST", 3, 13], ["HG", "TEST", 98, 100], ["any recombined fragments", "PROBLEM", 119, 143], ["fragments", "OBSERVATION", 134, 143]]], ["Intriguingly, CHN-HG-2017 was found to be a possible recombinant virus derived from parental strains from China and Vietnam.", [["CHN-HG-2017", "CHEMICAL", 14, 25], ["CHN-HG", "TEST", 14, 20], ["recombinant virus", "PROBLEM", 53, 70], ["parental strains", "PROBLEM", 84, 100], ["virus", "OBSERVATION", 65, 70]]], ["The potential breakpoints in CHN-HG-2017 were located at nt 3153 and 4249 in the nsp3 region.", [["nt 3153 and 4249", "DNA", 57, 73], ["nsp3 region", "DNA", 81, 92], ["HG", "TEST", 33, 35]]], ["Deletion mutations in the nsp3 region in PDCoV have been reported recently [6, 26], suggesting that nsp3 which encodes a papain-like protease, may be a hotspot for genetic modification.", [["nsp3", "GENE_OR_GENE_PRODUCT", 26, 30], ["PDCoV", "GENE_OR_GENE_PRODUCT", 41, 46], ["nsp3", "GENE_OR_GENE_PRODUCT", 100, 104], ["papain", "GENE_OR_GENE_PRODUCT", 121, 127], ["nsp3 region", "DNA", 26, 37], ["PDCoV", "DNA", 41, 46], ["nsp3", "PROTEIN", 100, 104], ["papain-like protease", "PROTEIN", 121, 141], ["Deletion mutations in the nsp3 region", "PROBLEM", 0, 37], ["nsp3", "PROBLEM", 100, 104], ["a papain-like protease", "PROBLEM", 119, 141], ["genetic modification", "TREATMENT", 164, 184]]], ["To our knowledge, this is the first time that a recombination event has been identified in the Nsp3 region of PDCoV.", [["Nsp3", "GENE_OR_GENE_PRODUCT", 95, 99], ["PDCoV", "GENE_OR_GENE_PRODUCT", 110, 115], ["Nsp3 region", "DNA", 95, 106], ["PDCoV", "DNA", 110, 115], ["a recombination event", "PROBLEM", 46, 67]]], ["The emergence of recombinant strains from China and Vietnam will probably bring new challenges to the prevention and control of PDCoV.DiscussionTo investigate the pathogenicity of this putative recombinant strain, 5-day-old piglets were inoculated orally with CHN-HG-2017.", [["PDCoV", "DISEASE", 128, 133], ["CHN-HG", "CHEMICAL", 260, 266], ["PDCoV", "CANCER", 128, 133], ["piglets", "ORGANISM", 224, 231], ["piglets", "SPECIES", 224, 231], ["PDCoV", "SPECIES", 128, 133], ["Vietnam", "TREATMENT", 52, 59], ["PDCoV", "TREATMENT", 128, 133], ["this putative recombinant strain", "PROBLEM", 180, 212]]], ["As expected, severe diarrhea with vomiting and lethargy in piglets was observed from 1 to 6 DPI, suggesting that CHN-HG-2017 is pathogenic to newborn piglets.", [["diarrhea", "DISEASE", 20, 28], ["vomiting", "DISEASE", 34, 42], ["lethargy", "DISEASE", 47, 55], ["DPI", "CHEMICAL", 92, 95], ["CHN-HG-2017", "CHEMICAL", 113, 124], ["piglets", "ORGANISM", 59, 66], ["CHN", "SIMPLE_CHEMICAL", 113, 116], ["piglets", "ORGANISM", 150, 157], ["piglets", "SPECIES", 59, 66], ["piglets", "SPECIES", 150, 157], ["severe diarrhea", "PROBLEM", 13, 28], ["vomiting", "PROBLEM", 34, 42], ["lethargy", "PROBLEM", 47, 55], ["severe", "OBSERVATION_MODIFIER", 13, 19], ["diarrhea", "OBSERVATION", 20, 28]]], ["The viral RNA distribution in various tissues was also examined.", [["tissues", "ANATOMY", 38, 45], ["tissues", "TISSUE", 38, 45], ["The viral RNA distribution in various tissues", "PROBLEM", 0, 45], ["viral RNA", "OBSERVATION", 4, 13], ["distribution", "OBSERVATION_MODIFIER", 14, 26], ["various tissues", "ANATOMY", 30, 45]]], ["Viral RNA levels were higher in intestines than in other tissues.", [["intestines", "ANATOMY", 32, 42], ["tissues", "ANATOMY", 57, 64], ["Viral", "ORGANISM", 0, 5], ["intestines", "ORGAN", 32, 42], ["tissues", "TISSUE", 57, 64], ["Viral RNA levels", "TEST", 0, 16], ["RNA levels", "OBSERVATION", 6, 16], ["higher", "OBSERVATION_MODIFIER", 22, 28], ["intestines", "ANATOMY", 32, 42]]], ["Previously, it was reported that coronavirus HKU15 may be able to spread through the respiratory route, in addition to fecal-oral transmission [27].", [["respiratory", "ANATOMY", 85, 96], ["oral", "ANATOMY", 125, 129], ["HKU15", "CHEMICAL", 45, 50], ["fecal-oral transmission", "DISEASE", 119, 142], ["coronavirus HKU15", "ORGANISM", 33, 50], ["oral", "ORGANISM_SUBDIVISION", 125, 129], ["coronavirus", "SPECIES", 33, 44], ["coronavirus HKU15", "PROBLEM", 33, 50], ["fecal", "ANATOMY", 119, 124]]], ["In line with other reports, viral RNA of CHN-HG-2017 was also detected in the lungs of some animals, albeit with no gross lesions observed, suggesting that PDCoV may also cause respiratory infection.DiscussionIt is noteworthy that we only observed microscopic lesions in the jejunum and ileum in piglets challenged with CHN-HG-2017.", [["lungs", "ANATOMY", 78, 83], ["gross lesions", "ANATOMY", 116, 129], ["respiratory", "ANATOMY", 177, 188], ["lesions", "ANATOMY", 260, 267], ["jejunum", "ANATOMY", 275, 282], ["ileum", "ANATOMY", 287, 292], ["CHN-HG-2017", "CHEMICAL", 41, 52], ["PDCoV", "CHEMICAL", 156, 161], ["respiratory infection", "DISEASE", 177, 198], ["CHN-HG", "CHEMICAL", 320, 326], ["CHN-HG-2017", "CELL", 41, 52], ["lungs", "ORGAN", 78, 83], ["gross lesions", "PATHOLOGICAL_FORMATION", 116, 129], ["PDCoV", "GENE_OR_GENE_PRODUCT", 156, 161], ["lesions", "PATHOLOGICAL_FORMATION", 260, 267], ["jejunum", "MULTI-TISSUE_STRUCTURE", 275, 282], ["ileum", "ORGAN", 287, 292], ["piglets", "ORGANISM", 296, 303], ["viral RNA", "RNA", 28, 37], ["piglets", "SPECIES", 296, 303], ["HG", "TEST", 45, 47], ["gross lesions", "PROBLEM", 116, 129], ["PDCoV", "TREATMENT", 156, 161], ["respiratory infection", "PROBLEM", 177, 198], ["microscopic lesions in the jejunum", "PROBLEM", 248, 282], ["viral RNA", "OBSERVATION", 28, 37], ["lungs", "ANATOMY", 78, 83], ["no", "UNCERTAINTY", 113, 115], ["gross", "OBSERVATION_MODIFIER", 116, 121], ["lesions", "OBSERVATION", 122, 129], ["may also cause", "UNCERTAINTY", 162, 176], ["respiratory", "ANATOMY", 177, 188], ["infection", "OBSERVATION", 189, 198], ["microscopic", "OBSERVATION_MODIFIER", 248, 259], ["lesions", "OBSERVATION", 260, 267], ["jejunum", "ANATOMY", 275, 282], ["ileum", "ANATOMY", 287, 292]]], ["In striking contrast, microscopic lesions were observed in all sections of small intestine infected with PEDV [28].", [["lesions", "ANATOMY", 34, 41], ["sections", "ANATOMY", 63, 71], ["small intestine", "ANATOMY", 75, 90], ["PEDV", "CHEMICAL", 105, 109], ["lesions", "PATHOLOGICAL_FORMATION", 34, 41], ["small intestine", "ORGAN", 75, 90], ["PEDV", "SPECIES", 105, 109], ["microscopic lesions", "PROBLEM", 22, 41], ["small intestine", "PROBLEM", 75, 90], ["PEDV", "PROBLEM", 105, 109], ["microscopic", "OBSERVATION_MODIFIER", 22, 33], ["lesions", "OBSERVATION", 34, 41], ["small", "OBSERVATION_MODIFIER", 75, 80], ["intestine", "ANATOMY", 81, 90], ["infected", "OBSERVATION", 91, 99]]], ["Moreover, unlike PEDV, PDCoV infection usually does not result in the death of newborn piglets despite the fact that these animals exhibit lethargy and anorexia and have watery diarrhea.", [["PEDV", "CHEMICAL", 17, 21], ["infection", "DISEASE", 29, 38], ["death", "DISEASE", 70, 75], ["lethargy", "DISEASE", 139, 147], ["anorexia", "DISEASE", 152, 160], ["watery diarrhea", "DISEASE", 170, 185], ["PDCoV", "GENE_OR_GENE_PRODUCT", 23, 28], ["piglets", "ORGANISM", 87, 94], ["piglets", "SPECIES", 87, 94], ["PEDV", "SPECIES", 17, 21], ["PDCoV", "SPECIES", 23, 28], ["PEDV", "PROBLEM", 17, 21], ["PDCoV infection", "PROBLEM", 23, 38], ["the death of newborn piglets", "PROBLEM", 66, 94], ["lethargy", "PROBLEM", 139, 147], ["anorexia", "PROBLEM", 152, 160], ["watery diarrhea", "PROBLEM", 170, 185], ["PEDV", "OBSERVATION", 17, 21], ["infection", "OBSERVATION", 29, 38], ["lethargy", "OBSERVATION", 139, 147]]], ["These results indicated that the virulence of PDCoV is milder than that of PEDV.DiscussionRecently, it was shown that VN antibodies could be detected in 14-day-old piglets inoculated with PDCoV OH-FD22 at about 7 DPI and that VN antibody titers increased gradually and remained high at the end of the experiment [29].", [["PDCoV", "CHEMICAL", 46, 51], ["PEDV", "CHEMICAL", 75, 79], ["PDCoV OH-FD22", "CHEMICAL", 188, 201], ["DPI", "CHEMICAL", 213, 216], ["OH-FD22", "CHEMICAL", 194, 201], ["PDCoV", "SIMPLE_CHEMICAL", 46, 51], ["VN antibodies", "GENE_OR_GENE_PRODUCT", 118, 131], ["piglets", "ORGANISM", 164, 171], ["PDCoV OH-FD22", "SIMPLE_CHEMICAL", 188, 201], ["VN antibody", "GENE_OR_GENE_PRODUCT", 226, 237], ["VN antibodies", "PROTEIN", 118, 131], ["VN antibody", "PROTEIN", 226, 237], ["piglets", "SPECIES", 164, 171], ["PEDV", "SPECIES", 75, 79], ["PDCoV", "SPECIES", 188, 193], ["the virulence of PDCoV", "PROBLEM", 29, 51], ["PEDV", "PROBLEM", 75, 79], ["VN antibodies", "TEST", 118, 131], ["PDCoV OH", "TREATMENT", 188, 196], ["FD22", "TREATMENT", 197, 201], ["VN antibody titers", "TEST", 226, 244], ["high", "OBSERVATION_MODIFIER", 278, 282]]], ["However, to our knowledge, there are currently no reports on the development of PDCoV-specific antibodies in sera of pigs infected with Chinese PDCoV.", [["sera", "ANATOMY", 109, 113], ["PDCoV", "CHEMICAL", 80, 85], ["PDCoV", "SIMPLE_CHEMICAL", 80, 85], ["sera", "ORGANISM_SUBSTANCE", 109, 113], ["pigs", "ORGANISM", 117, 121], ["PDCoV", "PROTEIN", 80, 85], ["specific antibodies", "PROTEIN", 86, 105], ["pigs", "SPECIES", 117, 121], ["pigs", "SPECIES", 117, 121], ["Chinese PDCoV", "SPECIES", 136, 149], ["PDCoV", "TEST", 80, 85], ["Chinese PDCoV", "TREATMENT", 136, 149]]], ["Our study showed that serum PDCoV VN antibodies could be detected as early as 4 DPI in PDCoV-infected piglets.", [["serum", "ANATOMY", 22, 27], ["DPI", "CHEMICAL", 80, 83], ["PDCoV", "CHEMICAL", 87, 92], ["serum", "ORGANISM_SUBSTANCE", 22, 27], ["PDCoV VN antibodies", "GENE_OR_GENE_PRODUCT", 28, 47], ["PDCoV", "SIMPLE_CHEMICAL", 87, 92], ["piglets", "ORGANISM", 102, 109], ["serum PDCoV VN antibodies", "PROTEIN", 22, 47], ["piglets", "SPECIES", 102, 109], ["PDCoV", "SPECIES", 28, 33], ["PDCoV", "SPECIES", 87, 92], ["Our study", "TEST", 0, 9], ["serum PDCoV VN antibodies", "TEST", 22, 47], ["infected piglets", "OBSERVATION", 93, 109]]], ["VN antibody titers increased and remained high until 21 DPI, when all pigs in the challenged groups had completely recuperated.DiscussionIn conclusion, we successfully isolated, characterized and obtained a high titer of CHN-HG-2017 in cultured cells.", [["cells", "ANATOMY", 245, 250], ["CHN-HG-2017", "CHEMICAL", 221, 232], ["VN antibody", "GENE_OR_GENE_PRODUCT", 0, 11], ["pigs", "ORGANISM", 70, 74], ["CHN-HG-2017", "CELL", 221, 232], ["cells", "CELL", 245, 250], ["VN antibody", "PROTEIN", 0, 11], ["cultured cells", "CELL_LINE", 236, 250], ["pigs", "SPECIES", 70, 74], ["pigs", "SPECIES", 70, 74], ["VN antibody titers", "TEST", 0, 18], ["HG", "TEST", 225, 227]]], ["We showed that CHN-HG-2017 is probably a recombinant virus derived from CH/SXD1/2015 and Vietnam/HaNoi6/2015.", [["CHN-HG-2017", "CHEMICAL", 15, 26], ["CHN", "SIMPLE_CHEMICAL", 15, 18], ["HG", "TEST", 19, 21], ["a recombinant virus", "PROBLEM", 39, 58]]], ["Pathogenicity testing of CHN-HG-2017 revealed that this virus is still pathogenic in piglets despite multiple passages in cultured cells.", [["cells", "ANATOMY", 131, 136], ["CHN-HG-2017", "CHEMICAL", 25, 36], ["CHN-HG-2017", "CELL", 25, 36], ["piglets", "ORGANISM", 85, 92], ["cells", "CELL", 131, 136], ["cultured cells", "CELL_LINE", 122, 136], ["piglets", "SPECIES", 85, 92], ["Pathogenicity testing of CHN", "TEST", 0, 28], ["HG", "TEST", 29, 31], ["this virus", "PROBLEM", 51, 61], ["pathogenic in piglets", "PROBLEM", 71, 92], ["multiple passages in cultured cells", "PROBLEM", 101, 136], ["pathogenic", "OBSERVATION", 71, 81], ["multiple", "OBSERVATION_MODIFIER", 101, 109], ["passages", "OBSERVATION", 110, 118]]], ["High levels of serum VN antibodies were also detected in sera of infected animals.", [["serum", "ANATOMY", 15, 20], ["sera", "ANATOMY", 57, 61], ["serum", "ORGANISM_SUBSTANCE", 15, 20], ["VN antibodies", "GENE_OR_GENE_PRODUCT", 21, 34], ["sera", "ORGANISM_SUBSTANCE", 57, 61], ["serum VN antibodies", "PROTEIN", 15, 34], ["serum VN antibodies", "TEST", 15, 34]]], ["Not only will our findings be useful for understanding the molecular epidemiology and pathogenesis of PDCoV, but they also provide insights for the development of effective vaccines against this important pathogen.", [["PDCoV", "DISEASE", 102, 107], ["PDCoV", "CANCER", 102, 107], ["PDCoV", "TREATMENT", 102, 107], ["effective vaccines", "TREATMENT", 163, 181], ["this important pathogen", "PROBLEM", 190, 213]]]]}